Acute appendicitis, with complications

APPENDACUT_COMPLIC

appendicitis: Acute inflammation of the vermiform appendix.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K35.0, K35.1 Hospital discharge: ICD-9 — 540[0-1] Hospital discharge: ICD-8 — 540 Hospital discharge: excluded ICD-8 — 54090\|54099 Cause of death: ICD-10 — K35.0, K35.1 Cause of death: ICD-9 — 540[0-1] Cause of death: ICD-8 — 540 Cause of death: excluded ICD-8 — 54090\|54099 2 out of 7 registries used, show all original rules.	9164
4. Check minimum number of events None	9164
5. Include endpoints None	9164
6. Filter based on genotype QC (FinnGen only)	9164

Control definitions (FinnGen only)

Control exclude: K11_APPENDIX

Extra metadata

First used in FinnGen datafreeze: DF3

NAME	APPENDACUT_COMPLIC
CONTROL_EXCLUDE	K11_APPENDIX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K35[0-1]
HD_ICD_9	540[0-1]
HD_ICD_8	540
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL	54090\|54099
COD_MAINONLY
COD_ICD_10	K35[0-1]
COD_ICD_9	540[0-1]
COD_ICD_8	540
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL	54090\|54099
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Acute appendicitis, with complications based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	84045	36878	46560
Only index persons	72602	32822	39780
Unadjusted period prevalence (%)
Whole population	1.19	1.06	1.30
Only index persons	1.38	1.21	1.52
Median age at first event (years)
Whole population	33.29	33.34	32.99
Only index persons	30.31	30.74	29.95

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9164	4436	4728
Unadjusted period prevalence (%)	1.81	1.51	2.08
Median age at first event (years)	33.67	30.89	36.29

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8367: Matched controls
83666

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

54001

ICD-8 Finland

Acute appendicitis, Cum peritonitide diffusa

+∞

323.0

421

54003

ICD-8 Finland

Acute appendicitis, Cum abscessu

+∞

323.0

412

K35.0

ICD-10 Finland

Acute appendicitis with generalized peritonitis

13334.6

323.0

2050

K35.9

ICD-10 Finland

Acute appendicitis, unspecified

526.0

323.0

1521

54000

ICD-8 Finland

Acute appendicitis, Perforans

+∞

323.0

611

5400B

ICD-9 Finland

Acute appendicitis, With generalised peritonitis[APPENDICITIS ACUTA CUM PERITONITIDE CIRCUMSCRIPTA]

+∞

323.0

477

JEA01

NOMESCO Finland

Laparoscopic appendectomy

75.4

323.0

1275

199

54091

ICD-8 Finland

Acute appendicitis, Gangraenosa, peritonitide non indicata

+∞

323.0

1841

54002

ICD-8 Finland

Acute appendicitis, Cum peritonitide circumscripta

+∞

323.0

329

5401A

ICD-9 Finland

Acute appendicitis, With peritoneal abscess

+∞

323.0

426

JEA00

NOMESCO Finland

Appendectomy

28.5

323.0

1723

754

6421

FHL

Appendicectomy

19.7

323.0

1227

724

K35.1

ICD-10 Finland

Acute appendicitis with peritoneal abscess

16384.0

323.0

1597

5400A

ICD-9 Finland

Acute appendicitis, With generalised peritonitis[APPENDICITIS ACUTA CUM PERITONITIDE DIFFUSA]

+∞

319.8

305

P01AB01

ATC

metronidazole; oral, rectal

2.0

182.5

3415

21383

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.9

160.0

1113

4237

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

113.1

2745

17984

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

78.0

2080

13692

K36

ICD-10 Finland

Other appendicitis

694.1

70.2

K37

ICD-10 Finland

Unspecified appendicitis

39.1

70.1

54099

ICD-8 Finland

Acute appendicitis, Without mention of peritonitis

+∞

67.8

D88

ICPC

Appendicitis

304.6

59.4

5409X

ICD-9 Finland

Acute appendicitis, Without mention of peritonitis

+∞

54.2

R10.0

ICD-10 Finland

Acute abdomen

3.1

45.4

266

885

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

45.3

1397

9363

K35

ICD-10 Finland

Acute appendicitis

22.9

39.6

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

38.3

541

2838

JFB20

NOMESCO Finland

Ileocaecal resection

8.2

37.2

103

JAH01

NOMESCO Finland

Laparoscopy

2.3

34.8

335

1489

99850

ICD-8 Finland

Other complications of surgical procedures, Postoperative wound infection

7.2

33.6

117

JAH00

NOMESCO Finland

Laparotomy

2.8

33.0

217

780

J01DB01

ATC

cefalexin; oral

1.4

32.7

6201

56707

54009

ICD-8 Finland

+∞

30.2

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

27.2

866

5794

J01MA12

ATC

levofloxacin; systemic

1.4

26.2

1234

8976

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.0

23.5

305

1547

54200

ICD-8 Finland

Other appendicitis, Appendicitis chronica

+∞

21.9

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

8.7

21.0

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

20.2

671

4523

54208

ICD-8 Finland

Other appendicitis

+∞

18.8

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

10.0

17.8

JFB30

NOMESCO Finland

Right hemicolectomy

2.9

17.6

108

377

JEA10

NOMESCO Finland

Appendectomy with drainage

42.1

17.3

54199

ICD-8 Finland

Appendicitis, unqualified

+∞

16.7

J01MA02

ATC

ciprofloxacin; systemic

1.2

15.0

2522

21780

K65.0

ICD-10 Finland

Acute peritonitis

2.9

14.6

294

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.7

14.2

271

1580

N02BE01

ATC

paracetamol; systemic, rectal

1.2

13.7

6306

59783

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

3.4

13.2

187

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

13.0

1276

10327

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

3.0

13.0

244

J01DA01

ATC

[U] cefalexin; systemic

1.2

12.8

4409

40541

UJF32

NOMESCO Finland

Coloscopy

1.2

12.1

1544

12888

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.2

11.7

2728

24179

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

10.9

419

2918

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.2

10.6

108

501

JEW96

NOMESCO Finland

Other operation on appendix

+∞

10.4

5420A

ICD-9 Finland

Other appendicitis[APPENDICITIS CHRONICA]

+∞

10.4

8140/3-C18.1

ICD-O-3

Adenocarcinoma, NOS, of appendix

30.0

9.4

5410X

ICD-9 Finland

Appendicitis, unqualified[APPENDICITIS NUD]

+∞

9.4

54308

ICD-8 Finland

Other diseases of appendix, Alii definiti

+∞

9.4

5428X

ICD-9 Finland

Other appendicitis[APPENDICITIS ALIA DEFINITA]

+∞

9.4

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

4.3

9.1

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

9.0

1186

9915

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

2.3

8.8

328

WX110

NOMESCO Finland

Local anesthesy

1.1

8.6

4732

44468

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

6.2

8.3

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.7

8.2

167

1000

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

2.4

8.1

266

6429

FHL

Other measure in this category

33.4

8.1

B01AB05

ATC

enoxaparin; parenteral

1.2

7.9

1781

15632

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

2.1

7.8

411

6565

FHL

Sewerage the other way

80.2

7.4

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.0

7.4

450

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.2

7.3

898

7442

54090

ICD-8 Finland

Acute appendicitis, Phlegmonosa, peritonitide non indicata

+∞

7.3

K56.7

ICD-10 Finland

Ileus, unspecified

2.0

7.0

422

D06

ICPC

Abdominal pain localized other

1.4

7.0

391

2917

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.7

7.0

146

887

F20.9

ICD-10 Finland

Schizophrenia, unspecified

1.8

6.9

119

682

JAK00

NOMESCO Finland

Laparotomy and drainage of peritoneal cavity

5.3

6.7

D37.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Appendix

4.5

6.7

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

3.7

6.6

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

2.2

6.6

270

8240/3-C18.2

ICD-O-3

Neuroendocrine tumor, NOS, of ascending colon

8.7

6.5

WX402

NOMESCO Finland

General anaesthesia

1.2

6.5

925

7784

JAD10

NOMESCO Finland

Repair of incisional hernia

2.5

6.5

200

S18

ICPC

Laceration/cut

1.1

6.3

2528

23098

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.2

6.3

891

7494

K50.0

ICD-10 Finland

Crohn disease of small intestine

2.0

6.3

395

R4110

NOMESCO Finland

Physiotherapy

1.2

6.3

1550

13684

54093

ICD-8 Finland

+∞

6.2

K38.8

ICD-10 Finland

Other specified diseases of appendix

+∞

6.2

J01FF01

ATC

clindamycin; systemic

1.2

6.2

1646

14604

SPAT1153

SPAT

Removal of sutures

1.1

6.2

1866

16715

N05AH02

ATC

clozapine; systemic

1.8

6.1

105

603

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

2.0

6.1

385

8240/3-C18.1

ICD-O-3

Neuroendocrine tumor, NOS, of appendix

10.0

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3002256) Pathology report gross observation

1487

9119

1.75

76.89

1.3

—

(3023368) Bacteria identified in Blood by Culture

2533

19513

1.41

43.81

4.5

4.4

—

(3042936) Bacteria identified in Isolate by Culture

1489

10387

1.52

43.16

1.9

2.1

—

(3044640) Blood type and Crossmatch panel - Blood

2848

22847

1.36

37.12

2.5

2.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2775

22765

1.31

29.38

2.7

2.6

57.79

58.28

u/l

0.11

2569

21077

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4328

37801

1.27

27.66

6.2

6.4

11.62

11.53

umol/l

0.18

4120

35903

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2107

17448

1.27

19.08

2.5

2.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3856

34179

1.22

18.60

4.1

4.0

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1164

9020

1.33

17.25

8.3

7.4

104.53

104.52

mmol/l

0.02

1129

8825

(3013826) Glucose [Moles/volume] in Serum or Plasma

4659

42788

1.18

13.44

5.2

4.8

6.79

6.72

mmol/l

1.28

4387

40060

(3032080) INR in Blood by Coagulation assay

3276

29287

1.18

12.81

8.5

9.0

1.20

1.25

inr

3.19

947

8399

(3013650) Neutrophils [#/volume] in Blood by Automated count

4589

42299

1.17

12.08

10.1

9.3

4.39

4.08

e9/l

12.72

4011

36972

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

877

6860

1.31

11.98

2.6

33.68

47.85

u/l

1.16

764

5886

(3031040) Bacteria [#/volume] in Urine by Automated count

5021

46710

1.17

11.47

4.3

4.2

285.56

1470.72

e6/l

3.51

646

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5975

56364

1.17

11.37

7.9

7.7

77.86

78.09

u/l

0.13

5672

53252

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3048

27319

1.17

11.13

3.5

42.48

76.91

ng/l

1.11

2056

18332

(3000850) Epithelial cells [#/volume] in Urine

1759

15136

1.20

10.18

2.7

2.6

7.06

5.11

e6/l

3.23

1528

13272

(3002582) Erythrocytes [#/volume] in Urine

2456

21822

1.17

9.70

3.4

3.2

80.27

87.74

e6/l

0.07

1927

16788

(3033658) Prothrombin time (PT) actual/Normal

2139

18798

1.18

9.66

4.3

4.0

89.46

90.04

0.50

2090

18323

(3021447) Carbon dioxide [Partial pressure] in Venous blood

818

6524

1.28

9.60

3.7

4.1

5.82

5.83

kpa

0.07

788

6329

(3024354) Oxygen [Partial pressure] in Venous blood

678

5286

1.31

9.48

3.0

3.4

4.72

4.64

kpa

0.31

652

5109

(3024561) Albumin [Mass/volume] in Serum or Plasma

3413

31240

1.15

8.83

5.2

5.0

35.02

35.59

g/l

6.68

3161

29101

(3002032) Base excess in Venous blood by calculation

808

6507

1.27

8.75

3.7

4.1

1.73

1.91

mmol/l

0.65

665

5263

(3012544) pH of Venous blood

835

6784

1.25

8.38

3.7

4.1

7.40

7.38

—

(3000991) Gas panel - Venous blood

742

5993

1.26

7.84

10.1

8.9

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

776

6310

1.25

7.74

8.6

7.4

1.33

1.35

mmol/l

0.17

753

6062

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1331

11433

1.19

7.68

1.8

—

(3026782) Osmolality of Urine

1600

14005

1.17

7.36

2.9

2.8

542.70

553.16

mosm/kgh2o

1.04

1359

11962

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3463

32000

1.13

7.35

7.0

6.2

1.21

mmol/l

0.05

3160

29105

(3037467) Urinalysis macro (dipstick) panel - Urine

5237

49699

1.13

7.00

4.3

4.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1107

9443

1.20

6.88

6.4

6.2

1.02

1.04

mmol/l

0.71

1030

8833

(3030467) Casts [#/volume] in Urine by Automated count

2212

19925

1.15

6.86

3.3

3.2

0.53

0.42

e6/l

0.59

1699

14983

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

634

5118

1.26

6.75

1.6

1.7

—

(36304419) Bacteria [Presence] in Urine

2154

19395

1.14

6.69

3.2

3.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1006

8562

1.20

6.40

2.6

2.8

9.12

8.65

umol/l

0.22

873

7483

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5333

50815

1.12

6.31

3.2

3.1

49.75

49.27

u/l

0.15

5032

47655

(3018095) Leukocytes [#/volume] in Urine

2764

25378

1.13

6.26

3.9

3.7

75.75

87.35

e6/l

0.45

2047

18110

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

562

4563

1.25

5.73

11.4

9.5

0.68

0.67

0.24

557

4529

(40758558) Short blood count panel - Blood

2040

18477

1.13

5.67

7.4

7.0

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

562

4577

1.24

5.58

11.3

9.4

1.37

1.38

0.07

557

4547

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

865

7367

1.19

5.47

4.3

4.1

18.24

26.48

ug/l

0.59

694

5983

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7590

74066

1.14

5.45

15.9

14.1

32.30

23.57

mg/l

52.92

6284

58729

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

325

2488

1.32

5.32

3.2

0.34

u/ml

0.07

180

1431

(40768804) Tissue Pathology biopsy report

3195

29792

1.11

5.31

2.1

—

(3016502) Oxygen saturation in Arterial blood

875

7485

1.19

5.27

9.0

8.0

95.61

95.65

0.06

848

7215

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3763

35408

1.11

5.22

7.8

6.9

1.21

mmol/l

0.19

3188

29962

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

558

4576

1.23

5.21

4.1

3.5

5.14

kpa

0.01

519

4219

(3019069) Monocytes/100 leukocytes in Blood

3683

34668

1.10

5.01

6.8

6.4

8.58

8.64

0.58

3477

32515

(3019550) Sodium [Moles/volume] in Serum or Plasma

7751

75856

1.14

4.88

17.8

15.9

139.59

139.70

mmol/l

3.28

7598

74031

(3009343) pH of Capillary blood

547

4510

1.23

4.87

4.1

3.5

7.41

7.42

0.26

572

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

288

2200

1.32

4.83

1.6

1.7

—

(3006504) Eosinophils/100 leukocytes in Blood

3661

34501

1.10

4.80

6.4

6.2

2.82

2.87

0.65

3446

32188

(3022096) Basophils/100 leukocytes in Blood

3553

33443

1.10

4.77

6.5

6.2

0.67

0.68

0.65

3346

31220

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

421

3387

1.25

4.71

4.0

4.4

24.08

24.11

mmol/l

0.08

385

3033

(3002173) Hemoglobin [Mass/volume] in Arterial blood

805

6913

1.18

4.65

9.6

8.4

122.10

122.02

g/l

0.03

774

6671

(3023511) Choriogonadotropin [Units/volume] in Urine

146

1009

1.45

4.51

1.4

1.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

7770

76136

1.13

4.48

17.9

16.0

3.97

mmol/l

1.47

7600

74164

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

494

4071

1.23

4.45

1.7

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

398

3207

1.25

4.41

2.5

3.0

0.65

0.66

0.16

386

3068

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

407

3289

1.25

4.40

2.5

3.0

1.32

1.29

0.20

407

3269

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

185

1344

1.38

4.34

1.6

1.8

—

(3009261) Glucose [Presence] in Urine by Test strip

3773

35730

1.10

4.32

3.6

3.5

0.00

estimate

2.58

688

6309

(3004119) Hemoglobin [Mass/volume] in Venous blood

515

4276

1.22

4.32

3.0

3.6

129.83

129.71

g/l

0.04

503

4179

(42870588) Differential panel, method unspecified - Blood

2671

24919

1.10

4.17

6.3

6.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

3731

35370

1.09

4.11

4.8

4.7

0.00

estimate

1.34

712

6552

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

521

4354

1.21

4.10

4.1

3.5

1.79

1.72

mmol/l

0.15

395

3203

(3035350) Ketones [Presence] in Urine by Test strip

3723

35298

1.09

4.08

3.6

3.5

0.00

estimate

1.08

681

6401

(3009445) Proteinase 3 Ab [Units/volume] in Serum

392

3189

1.24

4.02

1.6

14.66

12.84

u/ml

0.08

(3020779) Urea [Moles/volume] in Serum or Plasma

768

6657

1.17

3.98

8.0

7.8

10.10

9.86

mmol/l

0.40

733

6364

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

265

2060

1.29

3.98

2.0

2.2

7407.31

4994.17

u/l

0.36

820

(3018010) Neutrophils/100 leukocytes in Blood

3701

35113

1.09

3.96

6.3

6.0

57.77

57.26

1.78

3480

32883

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1768

16190

1.11

3.95

1.8

1.44

1.17

mg/l

1.69

1356

12476

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

383

3118

1.24

3.91

4.0

4.1

48.16

49.10

0.29

375

3084

(3006315) Basophils [#/volume] in Blood

3884

36940

1.09

3.91

6.2

6.0

0.04

e9/l

0.44

3352

31995

(3002030) Lymphocytes/100 leukocytes in Blood

3754

35652

1.09

3.91

6.5

6.2

27.45

27.87

1.55

3521

33243

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

295

2334

1.27

3.87

2.4

2.2

90.66

91.31

0.18

273

2179

(3007853) Bacteria identified in Skin by Aerobe culture

989

8762

1.14

3.81

1.8

—

(3013115) Eosinophils [#/volume] in Blood

4004

38162

1.09

3.80

6.6

6.2

0.19

0.20

e9/l

0.93

3518

33611

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

890

7840

1.15

3.72

1.7

1.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2927

27563

1.09

3.65

3.7

3.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

884

7796

1.15

3.64

1.7

—

(3027801) Oxygen [Partial pressure] in Arterial blood

945

8377

1.14

3.61

8.7

7.5

12.15

12.47

kpa

1.08

908

8004

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

945

8381

1.14

3.59

8.7

7.5

5.12

5.08

kpa

0.61

910

8001

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2132

19800

1.10

3.59

3.1

3.0

1317.69

1413.37

ng/l

0.62

1830

16962

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

267

2108

1.27

3.59

2.7

2.5

193.75

190.70

0.23

254

2005

(3001604) Monocytes [#/volume] in Blood

3858

36780

1.08

3.57

6.2

5.9

0.59

e9/l

0.76

3341

31865

(3022313) Gas panel - Capillary blood

394

3254

1.22

3.55

4.3

3.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2095

19459

1.10

3.51

3.3

3.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1348

12242

1.12

3.49

2.9

2.8

1.03

1.11

e6/l

0.35

743

7000

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1261

11411

1.12

3.47

3.1

2.9

3.01

2.25

e6/l

1.67

660

6218

(3003396) Base excess in Arterial blood by calculation

940

8354

1.14

3.47

8.7

7.5

1.05

1.01

mmol/l

0.11

739

6496

(3052592) Norovirus Ag [Presence] in Stool

125

2.16

3.47

1.2

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

928

8241

1.14

3.46

4.2

4.4

241.13

241.38

u/l

0.02

885

7803

(3022217) INR in Platelet poor plasma by Coagulation assay

1054

9445

1.13

3.42

23.7

23.8

1.42

1.34

inr

1.00

159

1389

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

498

4224

1.19

3.39

1.5

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.57

3.37

7.1

9.9

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1316

11967

1.12

3.33

3.4

0.82

mmol/l

0.42

1233

11214

(3013707) Erythrocyte sedimentation rate by Westergren method

5600

54290

1.08

3.26

4.1

4.0

12.28

11.79

mm/h

1.64

5188

50488

(3027273) Bicarbonate [Moles/volume] in Venous blood

403

3370

1.20

3.23

3.5

3.6

25.13

25.18

mmol/l

0.11

389

3258

(3019198) Lymphocytes [#/volume] in Blood

3957

37876

1.08

3.19

6.3

6.0

1.89

1.92

e9/l

0.59

3490

33450

(3012501) Base excess in Blood by calculation

211

1647

1.29

3.15

3.8

4.2

2.80

2.50

mmol/l

0.95

142

1105

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

336

2768

1.22

3.14

1.1

1.00

10.17

u/ml

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

341

2817

1.22

3.11

4.4

3.7

24.90

24.80

mmol/l

0.24

313

2573

(3036489) Thrombin time

336

2778

1.22

3.04

2.1

21.68

21.44

0.19

302

2420

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

318

2618

1.22

3.01

3.7

3.5

2703.07

2246.05

u/ml

0.07

275

2256

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

118

852

1.39

3.00

2.9

3.2

3.07

13.04

nmol/l

0.90

112

828

(3017315) Amylase [Enzymatic activity/volume] in Urine

370

1.60

2.99

1.2

1.3

246.29

437.92

u/l

1.49

338

(1616796) Gas panel - Central venous blood

209

1643

1.28

2.97

4.2

3.7

—

(3021589) Normoblasts [#/volume] in Blood

3378

32216

1.08

2.93

10.7

9.6

0.00

e9/l

0.64

2745

26342

(3013512) EKG study

2190

20546

1.09

2.88

3.9

3.8

—

(3042517) Benzodiazepines panel - Urine

2.50

2.86

2.2

2.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1245

11386

1.11

2.84

2.2

2.1

29.91

29.88

0.07

1209

11045

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

249

2013

1.24

2.82

1.5

5.64

14.04

iu/ml

—

(3024928) Oxygen saturation in Venous blood

195

1535

1.28

2.77

2.5

3.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

7124

69899

1.09

2.75

14.5

13.0

82.46

82.21

ml/min/173m2

0.44

5924

58034

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

264

2154

1.23

2.75

2.7

3.77

3.60

g/l

0.92

249

2046

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2621

24819

1.08

2.71

3.2

3.3

31.93

34.93

u/l

1.32

2490

23549

(3019309) Folate [Moles/volume] in Red Blood Cells

1411

13022

1.10

2.68

1.8

1.7

1181.54

1161.77

nmol/l

0.32

1085

9915

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

360

3039

1.19

2.66

2.0

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

769

6876

1.13

2.63

2.3

0.21

g/l

0.44

707

6401

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

221

1.72

2.60

2.6

2.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

221

1.72

2.60

2.6

2.9

—

(3029937) Albumin [Presence] in Urine by Test strip

2008

18847

1.08

2.59

4.0

3.9

0.00

estimate

2.77

649

6278

(3022806) Fractional oxyhemoglobin in Capillary blood

123

920

1.34

2.56

1.8

1.9

90.30

89.59

0.74

123

905

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

221

1785

1.24

2.56

2.5

2.4

107.63

112.53

ug/min

0.06

135

1097

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

189

1501

1.26

2.53

3.7

3.5

456.59

582.84

u/ml

0.19

176

1374

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

152

1175

1.30

2.52

2.8

2.7

8468.86

1718.81

u/ml

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2335

22074

1.08

2.50

2.1

2.2

227.29

222.46

u/l

0.08

2212

20743

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

344

2912

1.19

2.49

2.4

1.9

2.32

2.26

ug/l

0.04

312

2572

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

449

3886

1.16

2.48

12.6

9.8

24.42

24.24

mmol/l

0.52

413

3632

(3028626) Oxygen [Partial pressure] in Capillary blood

197

1579

1.25

2.45

3.6

3.0

8.08

8.12

kpa

0.11

187

1453

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1082

9906

1.10

2.43

2.7

2.6

22.14

23.20

1.82

939

8508

(3010421) pH of Blood

235

1923

1.23

2.43

3.8

4.2

7.42

0.41

209

1615

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

588

5199

1.14

2.42

4.4

4.0

96.75

92.92

ng/l

0.36

515

4522

(3000494) Fungus identified in Specimen by Culture

954

8682

1.11

2.41

1.4

1.5

—

(3037121) Protein [Mass/volume] in Urine

293

2453

1.20

2.41

3.5

3.2

0.29

0.31

g/l

0.20

140

1096

(3018405) Lactate [Moles/volume] in Arterial blood

304

2555

1.20

2.40

3.9

1.32

1.39

mmol/l

0.63

296

2513

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

6.25

2.37

1.2

1.0

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1241

11461

1.10

2.33

2.7

2.6

12.76

13.27

umol/l

1.71

1161

10673

(3010144) Erythrocytes [#/volume] in Synovial fluid

669

1.38

2.32

1.5

1.4

155705.90

106335.32

e6/l

0.27

455

(3019150) Specific gravity of Urine by Refractometry

1647

15406

1.08

2.31

4.1

3.9

1.02

kg/l

0.63

258

2308

(3015377) Calcium [Moles/volume] in Serum or Plasma

2504

23796

1.07

2.30

3.4

3.5

2.35

mmol/l

0.01

2182

20904

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

213

1738

1.23

2.28

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

460

4020

1.15

2.26

11.9

10.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

298

2520

1.19

2.22

1.6

126.67

297.55

titre

1.65

102

(3022145) Colonoscopy Study observation

909

8293

1.11

2.21

1.4

—

(4034850)

281

2367

1.19

2.19

7.7

9.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.24

2.17

1.2

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

628

1.37

2.15

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

628

1.37

2.15

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

628

1.37

2.15

1.6

1.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2112

20000

1.07

2.13

2.7

2.6

3125.76

4272.88

umol/l

0.79

1840

17509

(3043409) Potassium [Moles/volume] in Arterial blood

259

2172

1.20

2.13

4.4

4.2

3.84

3.90

mmol/l

1.18

231

2040

(3043410) Blood group antigens tested for on Red Blood Cells

189

1.70

2.12

1.5

1.8

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3057

29328

1.06

2.08

2.3

2.2

76.55

76.50

nmol/l

0.03

2770

26588

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

204

1678

1.22

2.06

1.6

1.7

—

(36660697) Celiac disease serology panel - Serum

613

5497

1.12

2.05

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.18

2.04

2.6

2.4

0.27

0.46

u/field

0.70

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8010

79199

1.09

2.04

10.8

10.3

27.10

27.26

u/l

0.30

7777

76583

(3009466) Valproate [Moles/volume] in Serum or Plasma

141

1115

1.27

2.03

6.1

5.0

357.28

366.97

umol/l

0.33

121

957

(3030981) Hyaline casts [#/volume] in Urine by Automated count

440

3867

1.14

2.03

3.0

2.7

0.31

0.28

e6/l

0.20

426

3764

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

116

895

1.30

2.02

1.1

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

2393

22797

1.07

2.02

3.4

3.2

7.78

7.83

mmol/l

0.24

2070

19209

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1635

15374

1.08

2.00

1.3

2.20

1.78

u/ml

0.45

445

4245

(3020682) Albumin/Creatinine [Ratio] in Urine

2358

22462

1.07

1.99

4.2

4.0

9.43

9.09

mg/mmol

0.15

1568

14506

(3019225) pH of Specimen

765

6962

1.11

1.97

4.6

4.3

—

(3018418) pH of Serum or Plasma

2202

20939

1.07

1.96

4.6

4.2

7.40

0.93

426

4008

(3038177) Helicobacter pylori Ab [Presence] in Serum

1281

0.76

1.95

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

370

1.46

1.94

1.7

2.0

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

224

1872

1.20

1.94

3.8

3.1

24.84

24.70

mmol/l

0.19

196

1626

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1147

10648

1.09

1.94

2.7

2.6

2.36

2.32

g/l

1.53

1076

9910

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

183

1506

1.22

1.87

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

183

1506

1.22

1.87

1.3

—

(3046861) Legionella sp Ag [Presence] in Urine

2.65

1.86

1.1

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.09

1.86

1.6

2.1

—

(3048689) Calprotectin [Mass/mass] in Stool

947

8737

1.09

1.85

2.4

117.83

132.45

ug/g

0.85

760

6962

(3042631) Mycobacterium sp identified in Specimen

124

979

1.27

1.84

2.5

2.8

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

126

997

1.27

1.84

1.1

1.3

0.61

1.96

nmol/l

0.61

115

963

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

115

1.83

1.82

5.8

5.6

—

(3013727) Leukocytes other/100 leukocytes in Blood

238

1.56

1.80

5.3

3.5

57.15

53.40

0.50

227

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

188

1559

1.21

1.79

5.8

5.7

459.30

2583.90

iu/ml

1.09

220

(44786800) Granulocytes/100 leukocytes in Body fluid

1.96

1.79

1.6

1.3

18.84

26.67

0.38

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1890

17935

1.07

1.79

2.3

2.2

2.95

2.93

mg/l

0.16

1635

15375

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3002

28899

1.06

1.77

2.0

95.41

95.26

pmol/l

0.06

1646

15438

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

681

6201

1.11

1.76

2.1

2.3

7.04

7.63

ug/l

0.42

601

5444

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

153

1247

1.23

1.74

1.7

1.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

796

7311

1.10

1.73

3.8

3.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

148

1204

1.23

1.72

3.7

3.0

0.86

0.82

nmol/l

0.43

120

893

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

339

1.45

1.71

1.1

168.65

182.55

iu/ml

0.21

339

(3020876) Protein [Mass/time] in 24 hour Urine

620

1.33

1.70

2.0

1.9

0.51

1.18

g/24h

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

210

1.57

1.70

1.0

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

760

1.29

1.70

1.6

1.7

—

(3021901) Oxygen saturation in Capillary blood

162

1334

1.22

1.68

3.5

2.9

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

259

2225

1.17

1.68

1.8

—

(3020891) Body temperature

326

2851

1.15

1.67

4.9

4.8

—

(3004588) Protein electrophoresis panel - Serum or Plasma

538

4857

1.11

1.66

2.4

2.3

—

(3012516) Albumin [Mass/volume] in Urine

2234

21366

1.06

1.64

3.4

3.3

460.60

423.64

mg/l

0.13

1472

13734

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

513

1.35

1.62

1.2

1.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

865

8004

1.09

1.61

3.1

2.5

1.78

0.01

769

7095

(3052851) Hemolysis interference index of Serum or Plasma

252

2169

1.17

1.61

3.3

3.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

147

1205

1.22

1.61

3.2

3.4

1.49

1.55

0.09

112

926

(40767503) Oxygen content in Capillary blood by calculation

184

1542

1.20

1.61

3.3

2.6

16.32

16.35

0.03

100

810

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

125

1007

1.24

1.61

1.1

1.3

0.26

nmol/l

—

(3040151) Glucose [Moles/volume] in Capillary blood

101

794

1.28

1.59

9.8

14.3

7.19

7.41

mmol/l

0.33

669

(3008037) Lactate [Moles/volume] in Venous blood

180

1509

1.20

1.57

3.1

3.2

1.60

1.62

mmol/l

0.11

175

1474

(40768441) Liver Pathology biopsy report

559

1.33

1.57

1.2

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1698

16127

1.06

1.57

1.6

1.5

19.81

20.09

nmol/l

0.34

1469

13926

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

317

2783

1.14

1.56

1.9

1.8

—

(3024731) MCV [Entitic volume]

8335

82692

1.09

1.54

22.8

20.4

91.03

91.00

0.19

8241

81596

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

288

2514

1.15

1.54

2.6

2.3

455.24

602.92

ug/l

0.62

270

2361

(3026008) Bacteria identified in Urine by Culture

2087

19961

1.06

1.53

2.9

3.0

—

(3019977) pH of Arterial blood

407

1.38

1.53

2.2

2.9

7.41

7.42

0.34

144

(3026361) Erythrocytes [#/volume] in Blood

8335

82705

1.09

1.50

22.8

20.5

4.50

4.52

e12/l

5.00

8109

80493

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

341

1.41

1.49

4.6

3.4

—

(3007461) Platelets [#/volume] in Blood

8328

82636

1.09

1.48

22.9

20.5

250.39

250.28

e9/l

0.05

8137

80644

(3017704) Immunofixation for Urine

385

1.38

1.46

1.5

1.6

—

(3000963) Hemoglobin [Mass/volume] in Blood

8336

82726

1.08

1.46

23.0

20.6

135.55

136.51

g/l

7.35

8236

81627

(3035941) MCH [Entitic mass]

8332

82687

1.08

1.45

22.7

20.4

30.35

0.02

8238

81594

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

939

8764

1.08

1.44

4.4

4.3

31.65

31.95

0.38

671

6095

(3010813) Leukocytes [#/volume] in Blood

8335

82721

1.08

1.44

22.9

20.5

6.83

6.70

e9/l

4.91

8106

80494

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.04

1.43

1.1

1.3

143.83

125.56

ug/l

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

113

917

1.24

1.40

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

205

1.51

1.39

1.0

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

646

5946

1.09

1.39

2.9

2.5

69.76

69.88

e9/l

0.03

479

4493

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

263

0.57

1.39

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

390

1.36

1.37

1.6

2.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

281

2473

1.14

1.37

2.6

2.7

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.94

1.36

1.0

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

503

4582

1.10

1.36

7.0

24.56

24.49

mmol/l

0.15

471

4272

(3036603) Volume of Urine

477

1.32

1.35

1.5

1.7

1662.25

1997.84

0.65

112

(3024869) Neuronal Ab [Presence] in Serum

143

1.61

1.34

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1731

16531

1.06

1.34

4.5

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

435

1.34

1.33

11.0

12.6

0.64

0.62

mmol/l

0.18

400

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

109

887

1.23

1.33

1.1

1.3

—

nmol/l

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

376

1.36

1.31

2.0

1.6

2.00

3.09

u/field

0.71

267

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

665

1.27

1.31

1.5

31.77

29.35

0.26

397

(40761511) CBC panel - Blood by Automated count

7799

77266

1.06

1.31

14.4

13.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

119

981

1.22

1.29

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

187

1606

1.17

1.29

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

676

1.26

1.28

1.5

1.4

6.75

6.31

mmol/l

0.55

630

(3000764) Benzodiazepines [Presence] in Urine

292

2594

1.13

1.25

2.5

2.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

252

1.43

1.25

1.7

1.9

—

(3027944) Amphetamines [Presence] in Urine

289

2566

1.13

1.25

2.4

2.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

361

3248

1.12

1.25

2.0

1.7

1.59

1.55

g/l

0.37

311

2774

(3020650) Glucose [Presence] in Urine

191

0.52

1.25

1.2

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

1068

10075

1.07

1.24

1.4

1.3

620.18

512.54

titre

0.87

224

2028

(3016244) Insulin [Units/volume] in Serum or Plasma

406

1.33

1.24

3.8

3.6

30.73

27.10

mu/l

0.30

385

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

389

1.34

1.23

1.6

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

389

1.34

1.23

1.6

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

389

1.34

1.23

1.6

2.0

—

(3025130) Human papilloma virus identified in Specimen

103

842

1.23

1.6

1.8

—

(3016879) Cocaine [Presence] in Urine

272

2411

1.13

1.22

2.6

2.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

104

852

1.22

2.1

2.4

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.63

1.21

7.2

11.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

140

1184

1.19

1.18

1.7

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

401

1.32

1.18

1.7

1.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

249

2204

1.13

1.16

3.6

3.3

45.27

82.56

mg/l

0.79

199

1782

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

704

1.24

1.15

1.6

1.8

—

(3028300) Cannabinoids [Presence] in Urine

293

2620

1.12

1.15

2.6

2.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

146

1243

1.18

1.15

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.50

1.15

1.6

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

403

1.32

1.15

1.7

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

109

904

1.21

1.15

1.5

1.6

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

427

0.70

1.14

1.3

1.5

1.07

1.20

nmol/l

0.39

325

(3044927) Protein electrophoresis panel - Urine

705

1.24

1.14

1.1

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

571

1.26

1.14

1.7

1.6

—

(3027008) Opiates [Presence] in Urine

292

2613

1.12

1.14

2.5

2.0

—

(3020630) Protein [Mass/volume] in Serum or Plasma

636

5913

1.08

1.13

2.6

2.5

66.31

66.54

g/l

0.31

580

5422

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

166

1919

0.86

1.12

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

243

2736

0.89

1.11

1.6

1.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

248

2203

1.13

1.10

3.6

3.3

30.67

51.17

mg/l

2.38

199

1785

(3041354) Potassium [Moles/volume] in Venous blood

105

872

1.21

1.10

2.1

2.3

4.05

4.08

mmol/l

0.33

105

860

(3035285) Chloride [Moles/volume] in Venous blood

105

872

1.21

1.10

2.1

2.3

105.06

105.40

mmol/l

0.29

105

860

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

213

1874

1.14

1.10

1.3

2.81

7.11

u/ml

2.65

302

(3025941) Bacteria identified in Stool by Culture

450

4130

1.09

1.2

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

549

1.26

1.08

1.6

1.7

—

(3002385) Erythrocyte distribution width [Ratio]

6232

61506

1.04

1.06

19.0

17.0

13.68

13.69

0.05

6098

60223

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

179

1561

1.15

1.06

1.7

1.5

—

(40768446) Kidney Pathology biopsy report

305

1.35

1.04

1.9

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

814

1.21

1.04

1.7

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

336

0.68

1.03

1.1

1388.20

1536.42

miu/ml

0.33

336

(46235355) HIV 1 and 2 tests - Meaningful Use set

1299

12410

1.05

1.02

1.8

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.92

1.02

1.8

1.5

439.56

333.91

umol/24h

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

449

0.73

0.99

3.0

2.8

29.25

38.73

—

153

(3019060) Gas panel - Arterial blood

516

4788

1.08

0.99

4.6

4.9

—

(3009677) Dengue virus Ab [Presence] in Serum

2.17

0.98

1.0

1.2

—

(3013862) HLA-DP [Type]

0.00

0.97

0.0

1.0

—

(4268621)

784

1.20

0.97

2.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

208

1846

1.13

0.97

1.3

4.90

4.98

u/ml

0.01

181

(3014599) Egg white IgE Ab [Units/volume] in Serum

412

0.73

0.97

1.0

0.72

0.95

u/ml

0.29

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

240

2150

1.12

0.96

3.6

3.2

2.45

3.60

ratio

0.49

174

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

310

1.32

0.96

1.0

1.1

16.47

5.27

u/ml

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3194

31175

1.04

0.95

2.9

2.8

140.01

136.14

ug/l

0.33

2973

29015

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

328

2989

1.10

0.95

4.5

5.3

1.70

1.68

0.09

306

2805

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

182

2061

0.88

0.95

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

216

1.39

0.95

1.2

1.3

—

(3045716) Anion gap in Serum or Plasma

337

1.31

0.94

1.5

2.2

8.84

9.20

mmol/l

0.27

259

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

227

2030

1.12

0.94

1.3

32.64

38.67

u/ml

0.11

128

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1581

15215

1.05

0.94

1.7

25729680.64

32401394.05

pmol/l

0.22

1337

12799

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

509

4734

1.08

0.94

1.2

130.53

145.74

iu/ml

0.41

205

1827

(3011397) Hemoglobin [Presence] in Urine by Test strip

1712

16507

1.05

0.93

3.4

3.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

106

899

1.18

0.92

1.7

1.6

56.85

58.47

0.16

562

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

243

2698

0.90

0.92

1.9

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

643

1.21

0.92

1.3

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

243

1.36

0.92

2.2

3.2

—

(21494434) Karyotype in Bone marrow

607

1.22

0.92

1.1

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.82

0.92

1.0

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

132

1141

1.16

0.91

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7148

70830

1.04

0.90

3.9

1.35

1.31

mmol/l

4.19

6599

65494

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

152

1331

1.14

0.89

1.8

1.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

224

2011

1.12

0.88

3.4

3.0

1.75

1.53

mg/l

3.18

208

1855

(40761536) Microorganisms panel - Urine sediment

637

5990

1.07

0.88

4.0

3.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1429

13748

1.05

0.87

1.5

2.39

2.48

g/l

1.15

869

8639

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

228

2052

1.11

0.87

1.2

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

174

1541

1.13

0.87

1.5

—

(3011985) Renin [Units/volume] in Plasma

115

989

1.16

0.86

1.5

34.56

62.73

mu/l

3.02

104

882

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

171

1513

1.13

0.86

2.9

1.9

0.77

0.84

nmol/l

0.89

137

1277

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

237

2138

1.11

0.86

1.9

1.6

0.23

0.24

g/l

0.16

221

2029

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

504

0.77

0.85

1.1

1.0

45.33

42.75

ng/l

0.15

349

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

704

1.19

0.85

3.1

—

(3023419) Bacteria identified in Sputum by Culture

107

916

1.17

0.85

2.4

2.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

167

0.60

0.84

1.5

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1307

12559

1.05

0.84

1.5

—

(3012898) Urea [Moles/volume] in Urine

1.63

0.84

1.5

1.4

130.69

168.33

mmol/l

0.95

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1461

14077

1.05

0.84

3.8

3.7

374.62

552.67

ng/l

1.06

1116

10790

(3042733) HLA Ab [Presence] in Serum

265

1.32

0.84

5.4

5.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

309

1.30

0.83

2.5

2.3

—

(4024509)

642

1.20

0.83

1.7

1.5

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

274

1.32

0.83

1.8

1.5

63.69

64.71

0.07

229

(3006184) Hemoglobin [Mass/volume] in Capillary blood

186

1660

1.12

0.83

2.9

2.2

129.33

129.99

g/l

0.13

138

1183

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4835

47619

1.03

0.83

2.9

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

238

0.67

0.82

1.2

—

27.10

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

501

0.78

0.82

1.1

1.0

704.71

732.22

ng/l

0.16

340

(3020491) Glucose [Moles/volume] in Blood

561

1.21

0.82

2.2

1.8

7.44

6.70

mmol/l

0.96

388

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.69

0.82

1.5

1.0

20.33

14.67

iu/ml

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

146

1.44

0.82

3.8

2.0

7.18

7.74

mmol/l

0.44

(3011288) Drugs identified in Urine by Screen method

190

1701

1.12

0.81

3.6

2.9

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

499

0.78

0.80

1.1

1.0

327.17

318.25

ng/l

0.09

350

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

829

1.17

0.80

1.2

1.1

95.07

96.96

0.32

774

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

157

1390

1.13

0.80

1.6

1.5

109.08

115.49

u/ml

0.45

312

(3004616) Nuclear Ab [Presence] in Serum

103

885

1.17

0.80

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

215

1.35

0.80

1.3

1.2

42.13

39.17

g/l

0.47

117

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

162

1438

1.13

0.80

1.8

1.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

338

1.27

0.79

1.2

1.6

7.80

12.54

nmol/l

0.22

274

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

710

1.18

0.79

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

170

1514

1.13

0.79

1.2

1.3

51.40

41.28

u/ml

0.25

150

(3008757) Leukocyte morphology finding [Identifier] in Blood

775

1.18

0.79

4.3

3.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

173

1543

1.12

0.79

3.9

3.4

30.14

26.63

mg/l

0.58

109

970

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

282

0.71

0.79

1.3

1.8

2643.00

13265.77

u/ml

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.67

0.78

6.0

4.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

508

0.79

0.78

1.0

—

(1002224) Polysomnography panel

368

3410

1.08

0.78

1.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

128

1121

1.14

0.78

3.6

2.9

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

235

2135

1.10

0.77

1.5

1.4

290.93

273.32

ug/g

0.64

141

1257

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.77

0.0

4.3

—

3.67

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

259

2366

1.10

0.76

1.7

1.6

290.83

296.93

mu/l

0.15

239

2158

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.77

0.76

1.2

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

296

1.28

0.76

2.4

—

(40760410) HLA-B [Type] by High resolution

0.00

0.76

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.76

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.76

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.76

0.0

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

1.70

0.75

1.1

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.52

0.75

1.3

1.9

—

(3005719) IgG [Mass/volume] in Serum or Plasma

594

5610

1.06

0.75

2.8

2.6

10.29

10.58

g/l

1.02

530

5143

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.64

0.75

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.57

0.74

1.0

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

144

1276

1.13

0.74

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

284

2610

1.09

0.74

2.4

2.3

3.09

3.07

g/l

0.13

226

2049

(3037756) Immunofixation for Serum or Plasma

164

1466

1.12

0.74

1.7

1.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

670

1.18

0.73

1.2

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

115

1005

1.15

0.73

1.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5624

55583

1.03

0.73

4.0

3.9

14.74

14.71

pmol/l

0.38

5131

50878

(3000475) Leukocytes [#/volume] in Synovial fluid

195

1761

1.11

0.73

1.8

1.6

13525.21

13184.12

e6/l

0.04

150

1257

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.84

0.73

9.3

5.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

210

1.33

0.73

1.1

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

238

2172

1.10

0.73

1.3

1.2

—

(3048879) Bone marrow aspiration report

193

1.35

0.73

1.3

1.9

—

(3026250) Tacrolimus [Mass/volume] in Blood

352

1.25

0.72

32.0

34.3

7.14

7.37

ug/l

0.32

325

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

230

2097

1.10

0.72

2.6

2.2

0.02

0.03

g/l

0.61

211

1928

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

235

2145

1.10

0.72

2.6

2.1

37.32

37.77

g/l

0.52

205

1867

(3036071) Salmonella sp Ab [Titer] in Serum

237

1.31

0.72

1.3

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

242

2213

1.10

0.71

1.9

1.6

1.17

1.19

g/l

0.37

228

2102

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.55

0.71

1.6

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

185

1669

1.11

0.71

3.4

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

1.62

0.71

1.0

0.10

0.14

u/ml

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.58

0.71

2.0

1.9

—

(3026480) Teichoate Ab [Titer] in Serum

1.58

0.71

1.0

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

462

1.21

0.70

1.7

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

213

1938

1.10

0.70

2.7

2.2

0.00

g/l

0.79

194

1774

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

300

1.27

0.70

1.7

2.2

—

(3051611) Lipemic interference index of Serum or Plasma

720

1.17

0.70

3.8

3.5

—

(3008898) HLA-B27 [Presence]

231

2525

0.91

0.70

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

101

1.49

0.70

1.1

1.0

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

143

1.40

0.70

1.2

1.3

0.83

112.80

mg/l

1.26

108

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

683

6497

1.06

0.69

1.8

1.9

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

257

2362

1.09

0.69

2.8

2.3

0.71

0.91

g/l

0.61

221

2047

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

520

0.81

0.69

1.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

340

3162

1.08

0.69

1.8

2.0

38.57

39.20

u/l

0.22

300

2815

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

105

918

1.15

0.68

1.3

293.20

289.66

pmol/l

0.04

691

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

136

1210

1.13

0.68

1.1

114.05

8576.03

iu/ml

0.54

278

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

231

1.30

0.67

1.3

109.68

110.23

0.03

206

(4146454)

757

0.84

0.66

2.8

2.7

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.63

0.66

1.0

1.1

—

36.00

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

119

1.43

0.66

2.0

1.5

9.50

9.51

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1089

0.87

0.66

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

407

0.79

0.66

4.3

6.0

41.00

8403.51

u/ml

—

(44790047)

799

1.15

0.66

1.4

1.5

—

(44790048)

799

1.15

0.66

1.4

1.5

—

(44806118)

799

1.15

0.66

1.4

1.5

—

(44790049)

799

1.15

0.66

1.4

1.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.79

0.66

7.4

7.8

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.79

0.66

1.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

125

1109

1.13

0.66

1.1

122.13

117.16

1.07

118

1001

(3014271) Vancomycin [Susceptibility]

339

1.24

0.66

2.9

3.0

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

558

1.18

0.66

1.2

38.00

46.04

u/ml

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

115

1015

1.13

0.66

1.6

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

219

2004

1.10

0.66

2.6

2.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

229

2100

1.09

0.65

1.3

8.84

10.06

u/l

0.70

183

1720

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

134

1195

1.12

0.65

1.1

1.3

61.98

36.31

u/l

0.48

118

1036

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

559

1.18

0.65

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

209

1910

1.10

0.65

2.7

2.2

0.00

g/l

0.00

194

1769

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

277

1.26

0.65

1.2

—

(3044007) Cell count panel - Peritoneal fluid

213

0.70

0.64

2.3

2.0

—

(4094501)

197

2158

0.91

0.64

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

137

1.39

0.64

1.5

2.0

19.14

17.41

umol/l

0.18

137

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

149

1339

1.11

0.64

3.3

3.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

251

1.28

0.63

1.3

1.2

0.30

0.31

g/l

0.03

203

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

129

1151

1.12

0.63

1.2

3.88

3.58

u/ml

0.06

380

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

552

1.18

0.62

1.9

3.03

1.73

u/field

0.92

225

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6851

67985

1.03

0.62

5.8

5.6

39.98

39.72

mmol/mol

1.39

6367

63327

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.52

0.62

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

216

1982

1.09

0.62

1.5

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

697

0.85

0.62

1.4

1.26

1.37

promille

0.22

535

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

297

1.25

0.62

1.7

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

297

1.25

0.62

1.7

2.2

—

(3006462) Nitrate [Presence] in Urine

334

1.23

0.60

3.0

3.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

280

1.25

0.60

1.1

1.2

—

(3028433) Virus identified in Specimen by Culture

267

0.75

0.60

1.1

1.2

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

1.8

—

2258.40

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.60

0.0

1.5

—

4.54

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

122

1.39

0.60

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

760

1.15

0.59

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

174

1.32

0.59

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

120

1342

0.89

0.59

1.6

1.5

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

0.00

0.59

0.0

1.1

—

1.14

—

(3017509) Phencyclidine [Presence] in Urine

1.53

0.59

4.1

1.6

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

168

1529

1.10

0.58

1.2

20.17

25.13

u/ml

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

208

1914

1.09

0.58

1.1

7.21

6.95

u/ml

0.03

259

(3033799) Differential panel - Peritoneal fluid

242

0.74

0.57

1.8

2.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

149

1.34

0.57

6.8

5.8

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

315

2949

1.07

0.57

4.7

5.4

0.86

0.89

0.98

296

2770

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6753

67037

1.03

0.56

4.7

4.5

2.90

2.12

mu/l

0.74

6220

61661

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

291

2718

1.07

0.56

1.7

3.34

3.75

mg/l

0.36

215

1896

(3017181) Myelocytes/100 leukocytes in Blood

652

6238

1.05

0.56

4.0

4.2

1.00

0.92

0.23

208

1792

(3009871) Measles virus Ab [Titer] in Serum

263

0.76

0.55

1.6

1.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1541

15825

0.97

0.55

2.9

0.77

0.76

ug/l

0.10

1001

10193

(40761995) Spermatozoa Progressive [#/volume] in Semen

150

1.33

0.55

3.4

2.9

—

(3000285) Sodium [Moles/volume] in Blood

0.56

0.55

2.0

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

109

973

1.12

0.55

1.5

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

229

2122

1.08

0.55

1.2

1186.67

798.36

titre

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

275

1.24

0.55

1.1

—

(3012565) Volume of 24 hour Urine

366

1.20

0.55

2.3

2.2

2276.84

2029.36

0.66

324

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

440

1.18

0.54

1.3

1.5

5.18

6.25

u/l

1.10

382

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

177

1.30

0.54

1.1

—

(3000012) Reticulocyte production index

385

1.20

0.54

1.6

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

475

4514

1.06

0.54

1.4

1.3

237.93

230.66

u/ml

0.05

445

4178

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

285

1.23

0.53

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

231

1.26

0.53

1.9

1.5

2.21

2.73

0.17

199

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

187

1721

1.09

0.53

1.9

1.8

3.81

9.41

iu/l

0.60

635

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

740

1.14

0.53

1.4

1.5

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.54

0.53

1.0

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

872

8412

1.04

0.53

1.7

1.6

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

553

1.16

0.53

2.0

2.7

616.44

705.81

e6/l

0.51

229

(4035726)

674

6467

1.05

0.52

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

107

958

1.12

0.52

1.4

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

516

1.16

0.52

2.8

2.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

196

1.28

0.52

1.2

937.30

409.34

ug/l

0.27

106

(3011648) Oxygen content in Venous blood

582

1.15

0.52

2.0

2.2

10.98

11.05

0.04

582

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.62

0.52

1.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

113

1016

1.11

0.52

5.6

6.7

11.25

11.51

mg/l

0.26

106

937

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

392

0.82

0.51

1.5

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

111

1233

0.90

0.51

1.1

—

(4306422)

127

1150

1.11

0.51

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

305

1.21

0.51

1.1

—

(21494755) Public health laboratory ask at order entry panel

768

7972

0.96

0.51

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

810

0.88

0.51

1.0

1.1

3.17

0.35

u/ml

0.50

179

(3039443) Prostate specific Ag panel - Serum or Plasma

179

1649

1.09

0.51

1.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

206

1.26

0.50

1.1

84.27

87.00

0.18

107

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

748

7202

1.04

0.50

1.9

2.0

—

(3004775) Volume in Urine collected for unspecified duration

593

1.15

0.50

2.4

2.3

654.55

651.32

0.02

405

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

361

1.19

0.50

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

713

0.87

0.50

3.0

3.7

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

352

1.19

0.50

1.3

1.5

3.71

3.69

—

(3019174) dRVVT (LA screen)

1.49

0.49

1.1

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

108

972

1.11

0.49

1.7

1.5

32.79

32.94

g/l

0.04

100

881

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1293

12586

1.03

0.48

1.3

23.11

33.28

iu/ml

3.16

382

3964

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1070

10384

1.03

0.48

1.7

1.6

—

(3003338) MCHC [Mass/volume]

6353

63982

0.98

0.48

19.8

17.7

332.72

332.79

g/l

0.24

6311

63497

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.52

0.48

1.7

3.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

666

6922

0.96

0.48

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

227

2118

1.07

0.48

1.2

1.3

222.45

215.68

miu/ml

0.10

955

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

122

1108

1.10

0.48

1.5

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

484

1.16

0.47

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

604

5799

1.04

0.47

4.3

4.0

1.23

mmol/l

0.08

551

5093

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.46

0.46

1.1

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

462

0.84

0.46

1.3

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

461

4826

0.95

0.46

1.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

187

0.75

0.45

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

970

0.90

0.45

1.1

5.89

3.40

u/ml

0.53

362

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

147

1.29

0.45

1.2

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

301

2844

1.06

0.45

1.3

1.51

0.94

u/ml

0.25

265

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

211

2258

0.93

0.45

1.5

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

770

1.12

0.44

1.2

1.4

—

31.25

—

(3002523) Influenza virus A Ag [Presence] in Specimen

112

1231

0.91

0.44

1.1

—

(4281824)

737

0.88

0.44

1.2

—

(3034426) Prothrombin time (PT)

274

1.21

0.44

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

1.45

0.44

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

905

0.89

0.44

1.1

3.09

3.54

u/ml

0.10

348

(3035611) Eosinophils/100 leukocytes in Synovial fluid

1.37

0.44

2.0

1.5

0.21

0.81

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

601

1.13

0.43

1.1

1.0

276.25

283.37

mg/l

0.38

548

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

126

1375

0.92

0.43

1.1

1.24

1.39

u/ml

0.13

523

(3042111) Morphology [Interpretation] in Bone marrow Narrative

112

1229

0.91

0.43

1.9

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

479

1.15

0.43

1.2

—

(3023383) Lactate [Moles/volume] in Pleural fluid

220

1.23

0.43

1.3

3.04

3.29

mmol/l

0.19

201

(3022621) pH of Urine by Test strip

490

4697

1.05

0.43

3.1

2.8

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

104

944

1.10

0.43

1.4

1.5

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

1.61

0.43

5.2

5.5

1.48

0.83

mg/l

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.61

0.43

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

295

2791

1.06

0.43

2.4

2.2

7.43

7.37

g/l

0.23

232

2087

(3003327) Ova and parasites identified in Stool by Light microscopy

251

2366

1.06

0.41

1.7

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.43

0.41

2.2

2.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

218

2046

1.07

0.41

1.1

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

352

3352

1.05

0.41

3.7

3.4

45.91

50.04

u/ml

0.13

344

3228

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.41

0.0

1.2

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.41

0.0

2.4

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(3021440) Promyelocytes/100 leukocytes in Blood

613

5914

1.04

0.40

4.1

4.3

0.12

0.13

0.14

192

1653

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

380

0.84

0.40

1.5

8.01

7.84

mmol/l

0.11

230

(3020874) Milk IgE Ab [Units/volume] in Serum

423

0.85

0.40

1.0

1.1

0.63

2.01

u/ml

0.76

118

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

172

0.76

0.40

1.1

1.4

—

(3006270) Folate [Moles/volume] in Blood

643

1.12

0.40

1.2

400.35

360.67

nmol/l

0.81

545

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

165

1535

1.08

0.40

1.2

1.44

3.64

u/ml

0.90

111

(40768795) Lymph node Pathology biopsy report

710

1.11

0.40

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

294

2789

1.06

0.40

2.4

2.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

663

1.12

0.39

1.3

1.6

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.34

0.39

1.5

1.4

10.32

336716.54

nmol/l

0.72

(40765096) Chromosome analysis panel by Banding

214

1.22

0.39

1.3

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

432

0.86

0.39

1.1

3.37

10.76

nmol/l

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

778

1.11

0.39

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

227

2139

1.06

0.39

1.3

1.2

203.53

115.08

titre

0.56

191

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

100

1095

0.91

0.39

1.1

2.44

13.69

au/ml

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

148

0.74

0.38

1.2

1.1

0.54

0.70

umol/24h

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

124

1.29

0.38

1.8

1.7

151.67

149.40

ng/l

0.01

124

(4212803)

1.36

0.38

1.0

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

401

1.15

0.37

2.1

2.3

17.78

29.91

umol/l

—

(3012441) Differential panel - Pleural fluid

742

1.11

0.37

1.9

1.5

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

1.33

0.37

2.6

3.6

47.00

39.92

umol/l

0.58

(42529406) Shigella sp [Presence] in Stool by Culture

218

2056

1.06

0.37

1.1

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

161

1.24

0.37

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

161

1.24

0.37

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

152

1.25

0.36

1.1

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

169

0.77

0.36

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

169

0.77

0.36

1.4

1.6

—

(3005011) Chlamydia sp Ab [Titer] in Serum

116

0.69

0.36

1.3

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

568

5487

1.04

0.36

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

588

5684

1.04

0.36

3.7

4.0

0.67

0.62

0.21

149

1299

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

180

0.78

0.36

1.2

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1296

12685

1.03

0.36

3.2

3.1

2.45

mmol/l

0.73

1109

11080

(3026726) Creatinine [Moles/volume] in Specimen

1.27

0.36

2.4

2.5

191.78

196.20

umol/l

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

147

1576

0.93

0.36

1.2

1.3

3.82

3.81

mmol/l

0.04

142

1471

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

215

2031

1.06

0.35

1.1

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

156

1458

1.07

0.35

1.5

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

273

2597

1.05

0.35

2.5

2.2

9.90

10.29

g/l

0.99

230

2204

(3037556) Urate [Mass/volume] in Serum or Plasma

217

1.20

0.35

1.2

1.4

—

(3022689) Creatine [Moles/volume] in Urine

217

1.20

0.35

2.1

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

536

1.12

0.35

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

536

1.12

0.35

1.2

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7529

74993

1.02

0.34

4.8

2.76

2.79

mmol/l

1.67

6992

69666

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

537

1.12

0.34

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

362

0.86

0.34

1.9

2.2

77.43

163.43

ug/min

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

103

1117

0.92

0.34

1.1

2.40

1.72

u/ml

0.23

256

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

452

1.13

0.34

6.2

6.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

122

1132

1.08

0.34

1.2

3.75

4.37

u/ml

0.18

501

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

358

1.15

0.34

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

767

1.10

0.33

2.1

1.5

34.33

28.43

iu/ml

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.33

0.33

5.0

3.1

—

(40761535) Cells panel - Urine sediment

605

5864

1.03

0.33

3.7

3.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

292

2788

1.05

0.33

2.4

2.2

3.70

3.84

g/l

1.19

221

1998

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

657

0.90

0.33

1.4

1.3

73.74

111.43

pmol/l

0.35

208

(3051593) INR in Capillary blood by Coagulation assay

321

1.15

0.33

14.3

10.7

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

118

1.27

0.33

1.0

1.1

94.19

79.92

ug/l

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

102

941

1.08

0.33

1.4

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

816

1.09

0.33

2.3

2.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1042

0.92

0.33

1.1

1.3

7.56

7.32

mmol/l

0.35

779

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

539

1.11

0.33

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

539

1.11

0.33

1.2

1.1

—

(3018572) Chloride [Moles/volume] in Blood

157

1670

0.94

0.32

6.7

7.3

105.63

105.19

mmol/l

0.57

145

1504

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

540

1.11

0.32

1.2

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

132

0.76

0.32

1.2

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

137

1.24

0.32

1.1

1.3

—

(3011412) CD3 cells [#/volume] in Blood

722

1.09

0.32

1.9

2.4

1.02

1.15

e9/l

0.32

422

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

176

0.80

0.32

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

154

0.78

0.32

1.0

2.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

128

1.25

0.31

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

128

1.25

0.31

1.3

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

128

1.25

0.31

1.3

1.1

—

(3039000) Anion gap in Blood

157

1669

0.94

0.31

6.7

7.3

11.09

11.28

mmol/l

0.36

145

1503

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.30

0.31

1.5

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

512

1.11

0.31

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

122

1137

1.07

0.31

1.6

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

427

4422

0.96

0.31

3.9

3.4

4.45

4.48

pmol/l

0.25

386

3938

(3032057) Clostridioides difficile [Presence] in Stool

156

1.22

0.31

1.6

1.9

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

186

0.81

0.30

1.2

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

193

1.19

0.30

1.4

1.3

42.54

37.65

0.19

126

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

153

0.78

0.30

6.5

7.2

—

(44806420)

184

1.20

0.30

2.6

2.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

387

4013

0.96

0.30

1.6

1.7

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

315

1.14

0.30

1.3

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

306

1.14

0.29

1.5

2.5

—

(40768793) Breast Pathology biopsy report

153

1443

1.06

0.29

1.2

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

214

2246

0.95

0.29

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

107

0.75

0.29

1.1

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

650

1.09

0.28

1.0

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

525

5096

1.03

0.28

2.3

2.4

20.65

25.24

au/ml

0.33

301

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

478

1.11

0.28

1.3

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

167

1.20

0.28

1.1

1.2

207.64

314.60

pmol/l

1.91

121

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

151

0.79

0.28

1.2

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.29

0.28

3.1

1.9

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

615

6314

0.97

0.27

2.4

2.2

11.92

12.84

nmol/l

2.01

555

5611

(3022493) Free Hemoglobin [Mass/volume] in Plasma

327

1.13

0.27

5.8

5.3

5478.04

766.39

mg/l

0.40

238

(3013637) Mi-2 Ab [Presence] in Serum

177

1.19

0.27

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

177

1.19

0.27

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

177

1.19

0.27

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

177

1.19

0.27

1.0

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

233

1.16

0.27

1.8

2.0

—

(3003694) ABO and Rh group [Type] in Blood

2065

20386

1.02

0.27

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

111

1185

0.94

0.27

1.1

2.07

1.09

u/ml

0.27

475

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

131

1.22

0.27

1.8

1.2

93.75

106.89

0.90

123

(3000492) Spirometry study

752

7347

1.03

0.27

1.5

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

356

1.12

0.27

1.2

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

215

0.84

0.27

1.6

1.5

9.11

8.91

ug/l

0.14

215

(3035880) pH of Pleural fluid

404

1.11

0.26

1.5

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

347

1.12

0.26

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

366

1.12

0.26

1.3

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

366

1.12

0.26

1.3

1.5

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

187

1.18

0.26

1.1

1.5

555.68

415.57

mu/l

0.56

178

(3045142) Bone marrow Pathology biopsy report

808

1.08

0.26

1.2

1.3

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

104

1.25

0.26

1.0

1.1

0.07

1.61

u/ml

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

675

6589

1.03

0.26

2.2

2.3

386.27

368.48

nmol/l

0.72

633

6058

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

159

1508

1.06

0.26

1.2

—

(3024263) Appearance of Synovial fluid

405

0.89

0.26

1.4

1.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

206

1.17

0.26

1.2

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

116

1234

0.94

0.26

1.1

3.42

5.06

u/ml

0.67

599

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2168

21937

0.98

0.25

4.0

4.1

21.79

21.86

0.07

1021

10269

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.67

0.25

1.2

1.40

1.73

umol/24h

—

(40762365) Oxygen content in Arterial blood by calculation

132

1.21

0.25

1.8

3.0

14.57

14.87

ml/dl

0.19

124

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

239

2293

1.04

0.25

1.4

1.3

—

(40768797) Stomach Pathology biopsy report

1026

10072

1.02

0.25

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

207

1.16

0.25

1.3

1.2

100.00

102.93

0.16

188

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

483

1.10

0.24

1.3

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

203

1943

1.05

0.24

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

802

1.07

0.24

2.0

1.7

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

596

6104

0.97

0.24

2.9

2.6

63.95

67.50

ml/min/173m2

1.14

253

2375

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

115

1.22

0.23

3.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

477

4645

1.03

0.23

1.2

1.3

50.84

53.21

au/ml

0.06

211

(4027681)

437

1.10

0.23

1.2

1.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.32

0.23

1.0

1.1

—

(3016750) Collection duration of Urine

418

1.10

0.23

2.2

486.73

493.63

min

0.16

318

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

179

0.84

0.23

1.6

1.2

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

190

1.16

0.23

1.1

1.5

72.18

72.59

0.04

181

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1213

11944

1.02

0.23

1.3

10.31

11.99

u/ml

0.39

469

4761

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.28

0.23

1.0

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

327

0.89

0.22

2.1

1.6

—

1487465.63

iu/ml

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7178

71553

1.01

0.22

4.5

4.4

5.98

5.94

mmol/l

1.87

6593

65794

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.76

0.22

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.74

0.22

2.7

2.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

452

0.91

0.22

1.1

5.91

10.26

iu/ml

1.06

111

(3003181) Sodium [Moles/volume] in Urine

111

1174

0.94

0.22

1.4

73.09

63.52

mmol/l

1.38

934

(3008295) Osmolality of Serum or Plasma

721

0.93

0.22

1.6

1.4

280.34

280.20

mosm/kgh2o

0.01

568

(3010937) Rubella virus Ab [Presence] in Serum

1.22

0.22

1.4

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.22

0.22

1.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

147

1401

1.05

0.22

1.2

1.3

272.61

276.22

u/ml

0.05

894

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

116

1.21

0.22

2.3

1.9

—

(4211845)

372

1.10

0.21

3.0

—

(3004451) EKG impression Narrative

357

0.90

0.21

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

229

1.14

0.21

1.3

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

1.19

0.21

1.6

2.0

2.06

2.90

mg/l

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.21

0.0

1.2

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1049

0.94

0.21

1.6

1.5

—

(3023410) Appearance of Cerebral spinal fluid

709

0.93

0.21

1.3

1.5

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.21

0.0

1.2

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.21

0.0

1.2

—

75.98

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

152

1589

0.96

0.20

1.3

1.4

265.03

3533.39

e6/l

0.80

120

1284

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.25

0.20

1.2

1.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.25

0.20

1.5

1.2

7.38

10.39

mg/l

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

470

0.91

0.20

1.3

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

518

1.08

0.20

1.9

2.6

496.26

490.47

e6/l

0.02

434

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

324

0.89

0.20

2.0

1.9

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

499

1.08

0.20

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

499

1.08

0.20

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

422

1.09

0.20

1.2

1.4

52.00

394.71

titre

—

(3045414) Leukocytes [Presence] in Urine

312

3213

0.97

0.20

1.9

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

202

1.14

0.20

1.3

1.1

81.50

86.93

0.26

108

(3013293) Extractable nuclear Ab [Presence] in Serum

111

0.81

0.20

1.2

1.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

587

5749

1.02

0.20

1.7

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

114

0.79

0.20

1.1

—

(4198724)

307

1.11

0.20

3.2

2.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

490

1.08

0.19

1.6

17.36

24.00

u/ml

1.14

109

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.20

0.19

1.3

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.20

0.19

1.0

—

(3017569) Oxygen content in Arterial blood

365

1.10

0.19

1.5

2.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

450

4395

1.03

0.19

2.0

1.9

1.12

1.35

g/l

3.53

410

4036

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.18

0.19

1.0

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.18

0.19

1.2

1.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

241

2332

1.03

0.19

1.6

0.12

10.89

iu/ml

0.91

512

(3024471) HLA-A [Type]

260

1.12

0.19

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

118

1.19

0.19

1.6

1.4

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

364

0.91

0.19

1.1

1.20

18.56

u/ml

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

478

0.92

0.19

1.3

1.7

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

337

1.10

0.19

1.7

1.8

76.14

146.33

umol/l

2.37

171

(3006922) Hepatitis E virus Ab [Presence] in Serum

531

1.07

0.18

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

487

4767

1.02

0.18

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

381

3718

1.03

0.18

2.3

2.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

185

0.86

0.18

1.1

—

(3047189) Immunofixation for 24 hour Urine

342

0.91

0.18

2.0

1.6

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

147

1.16

0.18

3.4

2.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

396

1.09

0.18

1.1

1.24

1.09

u/l

0.48

188

(3025159) Blasts/100 leukocytes in Blood

570

5591

1.02

0.18

4.2

4.3

0.04

0.20

1.18

161

1399

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

348

1.09

0.17

1.4

1.1

—

(3001729) Color of Synovial fluid

1.15

0.17

2.0

1.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

558

0.93

0.17

1.8

2.1

12.95

14.75

0.32

253

(3037692) Legionella sp identified in Specimen by Organism specific culture

268

0.90

0.17

1.2

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.11

0.17

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.76

0.17

1.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

0.75

0.17

1.8

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

153

1589

0.96

0.17

1.3

1.4

18.51

28.89

e6/l

0.46

114

1215

(3050794) Legionella sp Ab [Presence] in Serum

0.72

0.16

1.0

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

101

1.19

0.16

12.2

11.9

6.35

5.44

mmol/l

0.25

101

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

813

0.95

0.16

1.2

52.58

63.51

u/l

1.58

539

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

690

0.94

0.16

1.0

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

856

1.05

0.16

1.6

1.5

5025.61

2257.31

e6/l

0.39

626

(3047007) Chlamydophila sp Ab [Presence] in Serum

102

1068

0.95

0.16

1.1

1.2

—

(40768443) Skin Pathology biopsy report

327

3192

1.03

0.16

1.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

597

0.94

0.16

1.3

1.1

—

34.87

—

(4010399)

512

5216

0.98

0.16

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

206

1.12

0.16

4.0

1.8

—

(40758292) HTLV I+II Ab panel - Serum

130

0.85

0.16

1.6

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

148

1535

0.96

0.15

1.5

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

293

3004

0.97

0.15

1.8

—

(40757373) Influenza virus identified in Isolate

151

0.86

0.15

1.2

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

160

1545

1.04

0.15

1.2

—

(3015183) Erythrocyte sedimentation rate

380

0.92

0.15

1.2

—

(3005033) Fetal Nuchal fold Thickness US

1005

0.95

0.15

1.5

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

160

1656

0.97

0.15

2.3

2.9

34.29

35.45

umol/l

0.20

139

1410

(3028679) Herpes simplex virus Ab [Presence] in Serum

380

1.08

0.15

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.15

0.15

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

937

1.05

0.15

1.4

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

230

2364

0.97

0.15

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

286

0.91

0.15

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

349

3566

0.98

0.15

1.3

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7337

73216

1.01

0.14

4.3

1.43

1.44

mmol/l

2.92

6814

68095

(40768800) Prostate Pathology biopsy report

161

1663

0.97

0.14

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

131

1.15

0.14

1.5

1.2

91.50

72.60

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

160

0.87

0.14

1.3

1.6

0.26

0.39

ug/l

—

104

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

382

1.07

0.14

1.1

12.58

27.37

u/l

3.64

295

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

719

7289

0.99

0.14

1.7

1.8

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

499

1.06

0.14

2.0

2.6

0.18

0.22

e9/l

0.81

429

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1011

0.96

0.13

1.5

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

797

0.95

0.13

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

646

1.05

0.13

1.8

2.3

39.88

43.63

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

383

1.07

0.13

1.1

79.30

90.61

u/l

0.82

307

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

510

1.06

0.13

1.3

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

479

0.94

0.13

1.3

1.4

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.17

0.13

6.1

9.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

138

0.87

0.13

1.0

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

117

0.85

0.13

1.2

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

530

0.94

0.13

1.9

2.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

167

1623

1.03

0.12

2.0

1.5

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

560

1.05

0.12

1.1

437.92

274.79

mg/l

0.92

482

(3023323) Follitropin [Units/volume] in Serum or Plasma

349

3425

1.02

0.12

1.4

1.3

28.97

31.33

iu/l

0.66

298

2951

(3020961) Endomysium IgA Ab [Titer] in Serum

320

3261

0.98

0.12

1.2

1.1

267.67

229.43

titre

0.15

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

522

1.05

0.12

1.5

1.3

1.52

1.66

u/ml

0.06

237

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

846

1.04

0.12

1.4

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

172

1766

0.97

0.11

1.2

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

935

0.96

0.11

1.2

1.3

75.27

64.58

u/ml

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

366

1.07

0.11

3.4

3.9

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

874

8831

0.99

0.11

7.4

6.9

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

601

1.05

0.11

1.2

185.00

189.36

titre

0.01

110

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

670

1.05

0.11

1.3

1.4

9.84

3.44

ug/l

0.52

574

(3021788) Differential panel - Synovial fluid

138

1340

1.03

0.11

1.7

1.5

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

153

1.11

0.11

1.0

1.1

77.69

59.99

u/ml

0.33

146

(1761868) Lipid panel - Serum or Plasma

2773

27863

0.99

0.11

2.8

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

984

0.97

0.11

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

142

1460

0.97

0.11

1.3

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

113

1166

0.97

0.10

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

526

0.95

0.10

1.3

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

760

0.96

0.10

1.4

1.3

2.74

2.99

g/l

0.64

535

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

177

0.90

0.10

1.0

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7384

73728

1.01

0.10

4.4

4.3

4.65

4.68

mmol/l

1.45

6899

68920

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

627

0.96

0.10

3.8

29.63

41.79

u/ml

0.95

621

(3027135) IgG subclass 1 [Mass/volume] in Serum

759

0.96

0.10

1.4

1.3

6.10

6.69

g/l

0.76

532

(3024139) IgG subclass 3 [Mass/volume] in Serum

759

0.96

0.10

1.4

1.3

0.57

0.41

g/l

0.38

535

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

840

1.04

0.10

2.4

2.0

36.86

23.27

mg/l

0.98

216

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

187

1829

1.02

0.10

2.0

1.9

198.32

200.98

pmol/l

0.12

178

1734

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1025

10332

0.99

0.09

1.4

1.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.06

0.09

1.0

1.3

—

(3044941) Cell count panel - Synovial fluid

118

1148

1.03

0.09

1.5

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

176

1798

0.98

0.09

1.3

588.22

528.89

mg/l

0.60

169

1707

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

374

3792

0.99

0.09

1.9

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

370

0.95

0.09

1.4

1.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.13

0.09

1.2

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

272

1.07

0.09

1.2

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

321

1.06

0.09

2.1

1.7

—

(3045462) Protein/Creatinine [Ratio] in Urine

1.11

0.09

6.7

3.6

26.50

30.30

g/mol

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.11

0.09

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.07

0.08

1.5

2.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

942

1.03

0.08

1.4

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

805

8118

0.99

0.08

1.6

—

(3049717) Cytology report of Urine Cyto stain

270

2743

0.98

0.08

2.5

2.7

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

263

1.06

0.08

1.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.81

0.08

2.0

2.5

—

(3025315) Body weight

0.79

0.08

3.0

4.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.78

0.08

1.2

1.5

37.00

41.89

umol/l

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

117

1.11

0.08

1.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.08

0.08

1.0

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

350

3545

0.99

0.08

1.0

1.1

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

1.06

0.08

1.1

1.2

—

18.71

—

(3047181) Lactate [Moles/volume] in Blood

237

2333

1.02

0.07

5.5

6.3

1.26

1.30

mmol/l

0.39

215

2054

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.86

0.07

1.2

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

174

0.92

0.07

1.6

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.80

0.07

1.0

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

579

1.04

0.07

1.1

65.09

42.39

mg/l

1.04

477

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

102

1046

0.97

0.07

1.1

1.45

1.52

g/l

1.15

957

(3005988) Vibrio sp identified in Specimen by Organism specific culture

945

1.03

0.07

1.4

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

113

1104

1.02

0.07

1.3

1.4

31.61

29.00

u/l

0.35

906

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

0.85

0.07

1.3

1.4

68.29

76.87

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.84

0.07

1.0

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

0.84

0.07

1.7

1.2

—

(3000330) Specific gravity of Urine by Test strip

352

3561

0.99

0.07

3.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.06

0.07

1.2

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

167

1.08

0.06

4.8

6.5

70.00

70.90

0.04

135

(3024932) HLA-DR beta [Type]

256

1.05

0.06

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

203

0.94

0.06

1.3

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

770

0.97

0.06

1.1

—

12.63

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

345

0.96

0.06

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

296

1.05

0.05

1.8

2.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

192

0.94

0.05

1.2

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

415

1.04

0.05

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

869

0.98

0.05

1.0

1.1

—

(3045424) Erythrocytes [Presence] in Urine

117

1191

0.98

0.05

1.7

1.5

—

(44806071)

100

1.10

0.05

1.0

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2754

27475

1.00

0.05

4.5

4.7

2.78

3.11

ug/l

0.44

2460

24773

(3044889) 12 lead EKG panel

5187

51937

1.00

0.05

3.7

3.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

535

1.03

0.05

1.0

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

598

5945

1.01

0.04

2.7

2.9

213.32

195.70

ng/l

0.18

533

5397

(1761482) Bacteria [#/volume] in Urine by Culture

181

1788

1.01

0.04

3.8

4.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.10

0.04

1.1

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

122

1238

0.99

0.04

1.5

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

755

0.98

0.04

2.6

3.4

59.35

58.25

0.14

481

(3016018) Differential panel - Cerebral spinal fluid

765

0.98

0.04

1.3

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

170

1.06

0.04

1.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

109

0.92

0.04

1.9

1.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

122

1237

0.99

0.04

1.5

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

190

1.05

0.04

1.6

2.2

18123.64

242.43

e6/l

0.73

103

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

978

9744

1.00

0.04

1.8

1.42

1.46

1.13

861

8583

(3017732) Neutrophils [#/volume] in Blood

524

5212

1.01

0.03

3.3

2.9

4.43

4.07

e9/l

1.36

407

4082

(3009542) Hematocrit [Volume Fraction] of Blood

6842

68465

1.00

0.03

16.5

14.9

39.83

40.15

2.13

5011

50549

(3051651) Icteric interference index of Serum or Plasma

438

1.03

0.03

4.0

3.8

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

131

1.07

0.03

2.1

1.1

105.60

78.64

—

(3045788) Cell count panel - Pleural fluid

673

0.98

0.03

1.6

1.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

379

1.03

0.03

1.2

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

441

0.97

0.03

1.1

1.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

310

1.03

0.03

3.9

2.7

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

122

1234

0.99

0.03

1.8

1.6

0.61

0.79

g/l

1.49

948

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

122

1234

0.99

0.03

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

122

1234

0.99

0.03

1.5

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

350

0.97

0.03

1.9

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

350

0.97

0.03

1.9

1.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

108

0.93

0.03

1.3

1.0

—

(3002619) Bacteria identified in Specimen by Culture

138

0.94

0.02

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

928

1.01

0.02

1.1

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

101

998

1.01

0.02

1.1

3.24

3.33

u/ml

0.02

491

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1928

19307

1.00

0.02

1.7

1.6

1.43

1.40

mmol/l

0.72

1609

16307

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

208

0.96

0.02

6.7

7.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

489

0.98

0.02

1.7

1.6

3.71

5.18

u/l

0.46

231

(21494890) Protein electrophoresis panel - 24 hour Urine

729

0.99

0.01

1.9

2.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

382

1.02

0.01

2.1

1.5

12.66

8.39

ug/l

0.29

336

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

173

1.04

0.01

1.5

1.4

23.92

21.77

0.13

143

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

103

1039

0.99

0.01

1.5

1.4

0.36

0.37

nmol/l

0.03

783

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

618

0.99

0.01

1.4

1.3

11.63

11.85

mmol/l

0.08

173

(4062490)

758

0.99

0.01

1.4

1.3

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

307

0.98

0.01

2.3

1.9

140.70

154.30

0.56

286

(3026389) Candida sp identified in Specimen by Organism specific culture

101

1002

1.01

0.01

1.3

—

(3026470) Cobalt [Mass/volume] in Blood

453

1.02

0.01

2.1

2.0

3.60

3.49

ug/l

0.05

395

(3014051) Protein [Presence] in Urine by Test strip

163

1622

1.00

0.01

2.0

2.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

667

0.99

0.01

1.3

—

(3014891) Appearance of Pleural fluid

1.06

0.01

2.0

1.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

166

0.96

0.00

1.3

2.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

246

0.98

0.00

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

416

0.99

0.00

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

694

1.01

0.00

1.5

2.1

14.03

7.26

umol/l

0.47

491

(3028308) Erythrocytes [#/volume] in Pleural fluid

774

1.01

0.00

1.7

1.4

53257.28

66554.10

e6/l

0.17

464

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

104

0.96

0.00

1.3

1.0

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

150

1.00

0.00

5.0

4.5

29.14

90.98

u/l

—

(46235168) Fasting glucose [Moles/volume] in Blood

100

1.00

0.00

1.1

1.3

7.54

7.34

mmol/l

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

221

1.00

0.00

1.4

1.1

—

(4133840)

230

1.00

0.00

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

134

0.97

0.00

2.1

2.9

—

(3000034) Microalbumin [Mass/volume] in Urine

704

0.99

0.00

3.6

3.0

70.20

52.15

mg/l

0.28

515

(3012494) Peanut IgE Ab [Units/volume] in Serum

180

1.00

0.00

1.1

0.41

1.22

u/ml

0.87

(3038071) Oxygen [Partial pressure] in Mixed venous blood

188

1.01

0.00

6.6

7.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

660

1.00

0.00

5.0

155.83

59.28

u/ml

0.68

198

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

126

1258

1.00

0.00

1.1

—

(40768806) Pleura Pathology biopsy report

762

1.00

0.00

1.7

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

434

0.99

0.00

1.1

1.07

1.05

ratio

1.02

140

(3051101) Glucose [Moles/volume] in Cord blood

115

1.04

0.00

4.5

6.7

—

(40762814) Titanium [Mass/volume] in Blood

120

1.00

0.00

2.2

2.3

6.35

4.23

ug/l

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

284

0.99

0.00

2.4

2.8

26.97

28.35

umol/l

0.38

204

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

688

1.00

0.00

1.4

1.3

1.67

1.46

nmol/l

0.58

619

(3016650) Hepatitis A virus Ab [Presence] in Serum

125

1248

1.00

0.00

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

128

1.02

0.00

2.2

1.5

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

251

2506

1.00

0.00

1.9

1.8

38.23

40.41

nmol/l

0.71

245

2432

(4015189)

191

0.99

0.00

1.6

2.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

203

2027

1.00

0.00

2.1

2.0

10.75

11.37

mg/l

0.51

187

1898

(44813793)

495

1.01

0.00

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.86

0.00

6.6

4.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.00

0.00

1.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.90

0.00

1.1

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.87

0.00

1.3

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.00

0.00

2.6

2.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.85

0.00

1.0

1.1

9.40

15.14

u/l

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.43

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.96

0.00

1.0

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.00

0.00

1.0

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

20.78

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.93

0.00

1.0

1.1

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.0

1.2

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.96

0.00

2.4

25.93

20.48

mg/l

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.2

—

76.58

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.0

1.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

18.80

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1470.00

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

0.0

1.0

—

1.82

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.93

0.00

1.2

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

0.96

0.00

1.0

1.2

—

2.23

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.0

8.2

—

15.00

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.0

1.0

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.0

1.8

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.93

0.00

1.0

1.1

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.2

—

38.18

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

0.0

1.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

129.37

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

2.0

—

5.14

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.93

0.00

1.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.98

0.00

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint APPENDACUT_COMPLIC and mortality.

Females

Parameter	HR [95% CI]	p-value
APPENDACUT_COMPLIC	1.249 [1.12, 1.4]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.049

During the follow-up period (1.1.1998 — 31.12.2019), 1325 out of 13079 females with APPENDACUT_COMPLIC died.

Males

Parameter	HR [95% CI]	p-value
APPENDACUT_COMPLIC	1.119 [1.01, 1.25]	0.04
Birth year	0.986 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 1714 out of 14440 males with APPENDACUT_COMPLIC died.

Mortality risk

Mortality risk for people of age

years, who have APPENDACUT_COMPLIC.

N-year risk	Females	Males
1	0.088%	0.216%
5	0.567%	1.277%
10	1.541%	3.117%
15	2.994%	5.806%
20	5.332%	10.039%

Relationships between endpoints

↥

Index endpoint: APPENDACUT_COMPLIC – Acute appendicitis, with complications

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Toxic effect of soaps and detergents

Drug-induced pemphigus

Palatinal maxillary operation

Autoimmune diseases related-to ILD

915 (1.57)

Sclerosis of liver

0 (0.00)

Carcinoma in situ of middle ear and respiratory system

Assault by sharp object

10 (0.10)

Infantile muscular atrophy

Biliary cirrhosis, secondary

Abnormal findings on diagnostic imaging of breast

6 (0.06)

Carcinoma in situ of skin of lip

Other and unspecified erythematous conditions

11 (0.11)

Traumatic amputation of forearm

0 (0.00)

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

292 (1.23)

-0.07 [-0.27, 0.14]

Hyperimmunoglobulin E [IgE] syndrome

ILD medications: prednisolone, methylprednisolone, prednisone

1742 (1.77)

Failure of sterile precautions during surgical operation

0 (0.00)

Microcephaly

0 (0.00)

Carcinoma in situ of penis

Right hemicolectomy

116 (1.03)

Alcohol-induced pseudo-Cushing syndrome

Cardiomyopathies, Primary/intrinsic

116 (0.81)

Carcinoma in situ of skin, other sites/unspecified

Abnormality of red blood cells

Mucopolysaccharidosis, type II

Drug-induced folate deficiency anaemia

0 (0.00)

Hypothermia

20 (0.20)

Use of donepezil

125 (0.74)

Other transepidermal elimination disorders

Unspecified misadventure during surgical and medical care

49 (0.44)

Tuberous sclerosis 1

Benzodiazepine use

1223 (1.75)

Solar urticaria

Porphyria cutanea tarda

Routine general health check-up of defined subpopulation

16 (0.16)

Benign neoplasm: Endocrine gland, other/unspecified

7 (0.08)

Used for control exclusion in common control thyroid runs

2766 (1.77)

Beta thalassaemia

Carcinoma in situ of uteri, other/unspecified

Benign neoplasm: Appendix

23 (0.24)

Other accidental hanging and strangulation

0 (0.00)

Hereditary factor XI deficiency

Other specified air transport accidents

Encephalocele

Hodgkin lymphoma

17 (0.17)

0.12 [-0.48, 0.72]

Abnormal findings in secretions and smears from cervix uteri vagina vulva

425 (1.25)

Calcific aortic valvular stenosis, diagnosis (helper)

Subacute thyrotoxicosis, drug-induced

L02BG Aromatase inhibitors

220 (1.04)

Nutritional anaemias

458 (1.39)

Congenital and developmental myasthenia

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1092 (1.65)

Hereditary angioödema type 1

Retinoblastoma

0 (0.00)

Melanoma in situ of upper limb, including shoulder

Asthma (only as main-diagnosis), excluding more controls

833 (1.46)

0.11 [-0.07, 0.29]

Other and specified injuries of hip and thigh

12 (0.12)

Open wounds involving multiple body regions

Lung cancer and mesothelioma

235 (1.22)

Other systemic involvement of connective tissue

240 (1.11)

Malignant neoplasm of respiratory system and intrathoracic organs

217 (1.17)

Lumbar disc prolapse

706 (1.57)

0.09 [-0.07, 0.25]

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

-0.15 [-0.89, 0.59]

Carcinoma in situ of cervix uteri, exocervix

UC patients in KELA-register (code 208), prior to 1994

58 (0.54)

Benign neoplasm: Short bones of upper limb

8 (0.08)

Injury, poisoning and certain other consequences of external causes

5836 (1.84)

Use of melevodopa decarboxylase inhibitor

Disorders of conjunctiva in diseases classified elsewhere

Other ill-defined and unspecified causes of mortality

56 (0.49)

Fracture of lower limb, level unspecified

0 (0.00)

Melanoma in situ of other and unspecified parts of face

Toxic effects of substances chiefly nonmedicinal as to source

94 (0.67)

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

227 (1.20)

0.17 [-0.11, 0.45]

Injury of blood vessels at hip and thigh level

Ovarian dysfunction: estrogen excess, drug-induced

Iodine-deficiency-related thyroid disorders and allied conditions

Malignant melanoma, excluding all cancers (controls excluding all cancers)

130 (0.81)

-0.16 [-0.42, 0.10]

Explicit viral Sepsis

Methotrexate

123 (0.78)

Use of levodopa

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

82 (0.62)

-0.14 [-0.57, 0.29]

Benign neoplasm: Other/unspecified site

12 (0.12)

Perioral dermatitis, drug-induced

Parodontitis, under 40 years and operation codes

40 (0.30)

Benign neoplasm: Epididymis

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

9 (0.09)

-0.08 [-0.55, 0.39]

Dental pulpitis 3, only avohilmo

31 (0.20)

Injury of muscle and tendon at shoulder and upper arm level

299 (1.20)

Benign neoplasm: Aortic body and other paraganglia

Problems related to life-management difficulty

97 (0.64)

Use of apomorphine

Benign neoplasm: Ribs, sternum and clavicle

0 (0.00)

Benign neoplasm of bone and articular cartilage

54 (0.43)

Functional disorders of polymorphonuclear neutrophils

Carcinoma in situ of rectum

8 (0.08)

Carcinoma in situ of breast, intraductal

57 (0.47)

-0.14 [-0.46, 0.19]

Other sex chromosome abnormalities, female phenotype, not elsewhere classified

0 (0.00)

Adjustment and management of implanted device

159 (0.94)

Adenocarcinoma of pancreas

15 (0.15)

Other helminthiases

0 (0.00)

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

16 (0.16)

Malignant neoplasm, without specification of site

29 (0.28)

Benign lipomatous neoplasm of intrathoracic organs

Burns and corrosions of external body surface, specified by site

81 (0.59)

Squamous cell neoplasms and carcinoma of cervix, excluding all cancers (controls excluding all cancers)

-0.26 [-0.72, 0.19]

Unspecified hairloss

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

67 (0.53)

Other heart diseases, wide

2589 (1.91)

Yellow fever

Poisoning by narcotics and psychodysleptics [hallucinogens]

10 (0.10)

Combinations of oral blood glucose lowering drugs

251 (1.18)

Viral hepatitis, IBD co-morbidity

54 (0.46)

Selective serotonin reuptake inhibitors

1940 (1.69)

Calculus of urinary tract in diseases classified elsewhere

0 (0.00)

Superficial injuries involving multiple body regions

18 (0.18)

L01XE Protein kinase inhibitors

34 (0.31)

Kernicterus

Malignant neoplasm of liver and intrahepatic bile ducts

29 (0.28)

TMD related operations

128 (0.78)

Acquired absence of limb

8 (0.08)

Persons encountering health services for specific procedures and health care

1601 (1.75)

Other inflammatory disorders of orbit (ICD-8 only)

Indeterminate sex and pseudohermaphroditism

Other nutritional deficiencies

700 (1.63)

Von Hippel-Lindau syndrome

Disorders of lens

1801 (1.78)

Unspecified multiple injuries

Discharge of firework

Other orthopaedic follow-up care

42 (0.37)

Disorders of multiple cranial nerves

Murder, homicide, or other assault by rifle, shotgun and larger firearm discharge

Other disorders of middle ear and mastoid in diseases classified elsewhere

Motor disorders, excluding more controls

0.16 [-0.42, 0.75]

Congenital glaucoma

0 (0.00)

21 (0.21)

Tumor necrosis factor alpha inhibitors

98 (0.64)

Exposure to unspecified factor

1068 (1.62)

Familial chondrocalcinosis

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

6 (0.06)

Carcinoma in situ of skin of lower limb, including hip

14 (0.14)

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

263 (1.15)

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

18 (0.18)

Superficial injury of forearm

68 (0.51)

Mucopolysaccharidosis, other/unspecified

Etanercept

40 (0.34)

Benign neoplasm of mesothelial tissue

0 (0.00)

Carcinoma in situ of skin of other and unspecified parts of face

57 (0.48)

Traumatic secondary and recurrent haemorrhage

Melanocytic naevi

248 (1.09)

Exclusions for E4_PCOS_CONSORTIUM

1028 (1.48)

Amputation of toe

64 (0.55)

Obstetric and gynaecological devices associated with adverse incidents

0 (0.00)

Injury of blood vessels at wrist and hand level

Traumatic amputation of part of head

Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)

6 (0.06)

Other rickettsioses

Other (not insulin) diabetes medications

1677 (1.87)

Crohn disease (strict definition, require KELA)

68 (0.58)

Non-follicular lymphoma, hilmo, excluding all cancers

78 (0.61)

0.10 [-0.32, 0.52]

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

9 (0.09)

Linear scleroderma

Assault by blunt object

10 (0.10)

Pedestrian injured in collision with other nonmotor vehicle

0 (0.00)

Injury of blood vessels at ankle and foot level

Common variable immunodeficiency with autoantibodies to B- or T-cells

Substance abuse, excluding more controls

686 (1.70)

0.12 [-0.04, 0.27]

Neonatal jaundice due to drugs or toxins transmitted from mother or given to newborn

Benign neoplasm of colon, rectum, anus and anal canal

741 (1.93)

Carcinoma in situ of endometrium

-0.13 [-0.45, 0.18]

Soft tissue disorders in diseases classified elsewhere

Colitis due to radiation

7 (0.07)

Congenital malformation of vitreous humour

Chromium deficiency

Pedestrian injured in other and unspecified transport accidents

13 (0.14)

Eosinophilia

12 (0.12)

Ependymoma, excluding all cancers (controls excluding all cancers)

0.03 [-0.25, 0.32]

Mastocytosis

-0.44 [-1.00, 0.13]

Wrist or foot drop (acquired)

0 (0.00)

Acetic acid derivatives and related substances

2403 (1.91)

Open wound of shoulder and upper arm

13 (0.13)

Autonomic dysreflexia

0 (0.00)

Benign neoplasm: Central nervous system, other parts/unspecified

Dental pulpitis 2, only avohilmo

4595 (1.68)

Exposure to high-pressure jet

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

127 (0.93)

-0.03 [-0.39, 0.32]

Benign neoplasm of eye and adnexa

70 (0.54)

Benign neoplasm: Vertebral column

Other symptoms and signs involving the digestive system and abdomen

147 (0.88)

Systemic lupus erythematosus

29 (0.28)

Benign neoplasm: Heart

Hyperkinetic disorders, excluding more controls

55 (0.39)

0.16 [-0.13, 0.45]

Conductive and sensorineural hearing loss

944 (1.63)

Use of trihexyphenidyl

0 (0.00)

716 (1.71)

Care involving dialysis

79 (0.65)

Benign neoplasm of other and ill-defined parts of digestive system

148 (0.91)

Use of dimethyl fumarate

5 (0.05)

Other and unspecified injuries of lower leg

52 (0.43)

ILD medications: immunosuppressive drugs

639 (1.48)

Pedal cyclist injured in collision with train or tram

Ophthalmic devices associated with adverse incidents

Other symptoms and signs involving general sensations and perceptions

25 (0.24)

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

18 (0.17)

Poikiloderma of Civatte

0 (0.00)

0.03 [-0.25, 0.32]

Sequelae of injuries of neck and trunk

17 (0.17)

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

2559 (1.94)

Melanocytic naevi of lip

Toxic myoneural disorders

0 (0.00)

Short stature, not elsewhere classified

5 (0.05)

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

515 (1.34)

Other and unspecified water transport accidents

Neglect and abandonment

Inguinal of femoral hernia, unilateral

21 (0.21)

Kaposi sarcoma, excluding all cancers (controls excluding all cancers)

-0.04 [-0.30, 0.21]

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

16 (0.16)

Any gastric operation

5981 (2.74)

Duodenal ulcer - Acute with haemorrhage, drug-induced

0.03 [-0.26, 0.32]

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

680 (1.67)

Peripheral arterial reconstruction

152 (0.96)

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

12 (0.12)

-0.16 [-1.03, 0.71]

Injury of muscle and tendon at wrist and hand level

116 (0.78)

Abnormal findings in nipple discharge synovial fluid wound secretions

12 (0.12)

Injury of muscle and tendon at lower leg level

148 (0.96)

Benign neoplasm: Bone and articular cartilage, unspecified

African trypanosomiasis

Disorders of other visual pathways

0 (0.00)

Injury of blood vessels at abdomen, lower back and pelvis level

Secondary malignant neoplasm of other and unspecified sites

13 (0.14)

Dialysis, with operation codes

130 (0.92)

Disorders of peritoneum in infectious diseases classified elsewhere

Fasciculation

9 (0.09)

Failure in dosage during surgical and medical care

Collagenous colitis

80 (0.64)

Benign neoplasm: Pineal gland

Malignant neoplasm of digestive organs

440 (1.68)

Hyperinsulinism NOS, drug-induced

Carcinoma in situ of lip, oral cavity and pharynx

Benign neoplasm: Bladder

9 (0.09)

Procedures for purposes other than remedying health state

20 (0.20)

Benign neoplasm: Connective and other soft tissue of head, face and neck

16 (0.16)

Benign neoplasm: Pluriglandular involvement

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

41 (0.38)

-0.17 [-0.73, 0.38]

Injury of muscle and tendon at neck level

Unspecified privation

93 (0.69)

Retained (old) foreign body following penetrating wound of orbit

Burn and corrosion, body region unspecified

7 (0.07)

Problems related to education and literacy

Disorders of conjunctiva

769 (1.38)

Other degenerative disorders of globe

L01XA Platinum compounds

Diving or jumping into water causing injury other than drowning or submersion

Motor- or nonmotor-vehicle accident in traffic area

Dislocation, sprain and strain of joints and ligaments of elbow

52 (0.44)

Acute alcohol intoxication ICD-9

27 (0.26)

Fungal Sepsis

39 (0.37)

Ulcerative colitis (strict definition, require KELA)

112 (0.67)

Abnormal results of function studies

63 (0.50)

Strabismus

208 (0.96)

Injuries to the hip and thigh

457 (1.39)

Exposure to uncontrolled fire, not in building or structure

Acquired epidermolysis bullosa

In situ neoplasms

317 (1.25)

Certain conditions originating in the perinatal period

34 (0.25)

Pacemaker

280 (1.20)

Disease of thymus, other/unspecified

0.11 [-0.17, 0.38]

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

238 (1.04)

Benign neoplasm: Cranial nerves

18 (0.18)

Inhalation of gastric contents

Neurological diseases

3916 (1.87)

Hypopituitarism after medical therapy

Dental caries 1, only avohilmo

4114 (1.65)

Necrotizing enterocolitis of fetus and newborn

0 (0.00)

Complications of surgical and medical care, not elsewhere classified

1357 (2.07)

Other transitory neonatal endocrine disorders

Use of tropatepine

Traumatic subcutaneous emphysema

Specific personality disorders

237 (1.15)

Benign neoplasm: Colon

611 (1.86)

Carcinoma in situ of uteri, other/unspecified

Demyelinating diseases of the central nervous system

72 (0.57)

Brain astrocytoma, excluding all cancers (controls excluding all cancers)

0.41 [0.01, 0.81]

Other benign neoplasm of uterus: Corpus uteri

6 (0.06)

DVT of lower extremities and pulmonary embolism

417 (1.46)

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

458 (1.54)

-0.15 [-0.33, 0.03]

116

Hip and thigh

Melanoma in situ of ear and external auricular canal

Parodontitis

994 (1.70)

Malignant neoplasm of other and unspecified female genital organs

11 (0.11)

Use of tolcapone

Carcinoma in situ of oesophagus

Exposure to other and unspecified inanimate mechanical forces

54 (0.45)

Ethmoidectomy

109 (0.75)

Benign neoplasm: Connective and other soft tissue of thorax

5 (0.05)

Foreign body or object entering through skin

39 (0.34)

Sequelae of complication of pregnancy, childbirth and the puerperium

Foreign object accidentally left in body during surgical and medical care

Respiratory tuberculosis, confirmed and not-confirmed

51 (0.45)

Unspecified visual impairment (binocular)

7 (0.07)

ILD medications: pirfenidone

7 (0.07)

Fat embolism (traumatic)

Other operation for atrial fibrillation

Other specified disorders of skin and subcutaneous tissue in diseases classified elsewhere

Hirsprung

Convalescence

36 (0.32)

Acute disseminated encephalitis/encephalomyelitis, drug-induced

Certain infectious and parasitic diseases

3315 (1.89)

Extracorporeal dialysis

61 (0.54)

Bilateral visual impairment (ICD-8)

Ectopic hormone secretion, not elsewhere classified

0 (0.00)

Unspecified jaundice

43 (0.39)

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

19 (0.16)

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

11 (0.11)

0.37 [-0.13, 0.87]

Open wound of neck

9 (0.10)

Calcific aortic valvular stenosis

244 (1.12)

Pemphigus foliaceus

Inguinal or femoral hernia, bilateral

95 (0.71)

Malignant neoplasm of palate, excluding all cancers (controls excluding all cancers)

Benign neoplasm: Pluriglandular involvement

Testicular dysfunction

31 (0.30)

Genitourinary diseases

5416 (1.79)

Family history of other specific disorders

Megavitamin-B6 syndrome

Family history of tobacco abuse

Spotted fever [tick-borne rickettsioses]

Neuronal ceroid lipofuscinosis

0 (0.00)

Copper deficiency

0 (0.00)

Use of biperiden

50 (0.45)

Malignant neoplasms of independent (primary) multiple sites

Burkitt lymphoma, excluding all cancers (controls excluding all cancers)

Marfan's syndrome

8 (0.09)

0.38 [0.02, 0.75]

Rifle, shotgun and larger firearm discharge, undetermined intent

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, excluding all cancers (controls excluding all cancers)

5 (0.05)

0.23 [-0.28, 0.74]

Monoamine oxidase A inhibitors

109 (0.76)

N06DA Anticholinesterases

244 (1.04)

Wilms' tumor

0.24 [-0.19, 0.67]

Persons encountering health services in other circumstances, wide

1903 (1.71)

Glaucoma secondary to other eye disorders

29 (0.27)

Mental and behavioural disorders due to tobacco

71 (0.57)

General- and plastic-surgery devices associated with adverse incidents

Other benign neoplasm of uterus: Cervix uteri

5 (0.05)

Intentional self-harm by explosive material

Other and unspecified vascular occlusions

73 (0.58)

Constitutional tall stature

ILD, hospital admissions

134 (0.90)

Benign neoplasm: Extrahepatic bile ducts

Burns and corrosions

119 (0.79)

Nosocomial condition (hospital)

Use of natalizumab

Lethal midline granuloma

Colectomy operation

231 (1.46)

Use of etilevodopa decarboxylase inhibitor

Lack of expected normal physiological development

5 (0.05)

Fibrosis and sclerosis of liver

Protrusioacetabuli

Benign neoplasm: Endocrine pancreas

GI-bleeding

332 (1.39)

Interstitial emphysema and related conditions originating in the perinatal period

-0.02 [-0.28, 0.24]

Drug phototoxic response

Benign neoplasm: Skin of lip

9 (0.09)

Other abnormalities of plasma proteins

11 (0.11)

Melanoma of uvea

7 (0.07)

-0.01 [-0.45, 0.43]

Persons encountering health services for examination and investigation

4854 (1.75)

Frontotemporal dementia, wide, incl. Pick's disease

Dependence on enabling machines and devices, not elsewhere classified

Hypersecretion of calcitonin

0 (0.00)

Unspecified fall

431 (1.28)

Benign neoplasm: Liver/bile ducts

13 (0.13)

Gangrene, not elsewhere classified

Type 2 diabetes

1943 (1.92)

Melanoma in situ, other sites/unspecified

Persons encountering health services in circumstances related to reproduction

1760 (1.43)

Diagnoses used for exclusion with ILD

273 (1.32)

Diastrofic dysplasy

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

-0.06 [-0.42, 0.31]

Acquired keratosis follicularis

0 (0.00)

Use of cabergoline

8 (0.08)

Benign neoplasm: Connective and other soft tissue, unspecified

7 (0.07)

Combined immunodeficiency, unspecified

Other and unspecified firearm discharge, undetermined intent

Folliculitis ulerythematosa abscedens

0 (0.00)

Relapsing panniculitis [Weber-Christian]

Melanoma in situ of scalp and neck

Iliac crest spur

Scleritis and episcleritis

42 (0.37)

Other CVD (FINNGEN)

133 (0.85)

Drug-induced fever

Injury of intra-abdominal organs

20 (0.20)

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

7 (0.07)

-0.13 [-0.85, 0.58]

Glycogen storage disease

Carcinoma in situ of vulva

-0.19 [-0.57, 0.20]

Leiomyoma of uterus

724 (1.39)

Acné excoriée

Carcinoma in situ, eye

0 (0.00)

Poisoning by medicine, drug-induced

14 (0.15)

Contact with and exposure to communicable diseases

234 (0.92)

Malignant neoplasm of endocrine gland

57 (0.48)

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

9 (0.09)

0.05 [-0.45, 0.55]

Pulmonary haemorrhage originating in the perinatal period

Persons with potential health hazards related to communicable diseases

313 (1.08)

Other and unspecified intracranial injuries

17 (0.17)

Asthma (mode)

970 (1.48)

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

430 (1.28)

Convulsions of newborn

Other abnormal findings of blood chemistry

28 (0.26)

L02BA Anti-estrogens

119 (0.75)

Sequelae of injuries of upper limb

73 (0.56)

Presence of other devices

207 (1.06)

Conduct disorder

16 (0.16)

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

0 (0.00)

-0.03 [-0.35, 0.29]

Plasmodium vivax malaria

Malignant neoplasm of gallbladder, excluding all cancers (controls excluding all cancers)

Neurofibromatosis, type 2

0 (0.00)

0.03 [-0.25, 0.31]

Exposure to ignition or melting of other clothing and apparel

0 (0.00)

Toxic liver disease with chronic active hepatitis, drug-induced

Other neonatal haemorrhages

Primary thrombophilia

Amyloidosis

19 (0.19)

Testicular hyperfunction

0 (0.00)

Dental caries 1 and operation codes

3682 (1.65)

Other conditions originating in the perinatal period

Carcinoma in situ of anus and anal canal

Methaemoglobinaemia

Thyrotoxicosis, other and/or unspecified

171 (0.95)

Transitory endocrine and metabolic disorders specific to fetus and newborn

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

430 (1.28)

-0.11 [-0.27, 0.05]

Other acute viral hepatitis

5 (0.05)

Cluster headache, wide,, including avohilmo

36 (0.32)

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

5 (0.05)

0.23 [-0.17, 0.62]

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

30 (0.28)

0.14 [-0.28, 0.57]

Duodenal ulcer - Acute without haemorrhage or perforation, drug-induced

Intentional self-harm by unspecified means

5 (0.05)

Mood disorders, excluding more controls

1222 (1.60)

Open wound of head

541 (1.49)

Other/unspecified reactive arthropathies

56 (0.48)

External causes of morbidity and mortality

5011 (1.82)

Familial dysautonomia

Molybdenum deficiency, drug-induced

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

39 (0.36)

Liposarcoma, excluding all cancers (controls excluding all cancers)

9 (0.09)

0.40 [-0.03, 0.84]

Contact with other specified venomous animals

Injury of muscle and tendon at forearm level

13 (0.13)

Early lumbar disc prolapse operation

86 (0.62)

Other birth injuries

Nail disorders in diseases classified elsewhere

0 (0.00)

Benign neoplasm: Mesothelial tissue of peritoneum

0 (0.00)

Malignant neoplasm of pyriform sinus, excluding all cancers (controls excluding all cancers)

Manganese deficiency

Alopecia mucinosa, drug-induced

0 (0.00)

Polytrichia

Somnolence, stupor and coma

32 (0.29)

Actinic granuloma

0 (0.00)

Psoriatic and enteropathic arthropathies

86 (0.60)

Failure and rejection of transplanted organs and tissues

9 (0.09)

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

19 (0.18)

1.00 [-1.22, 3.22]

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

156 (0.97)

Maple-syrup-urine disease

0 (0.00)

Correction of physiology of bite - demanding therapy visit

43 (0.36)

Congenital syphilis

Colitis, primary sclerosing

17 (0.18)

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

0 (0.00)

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

223 (1.08)

Other specified metabolic disorders, drug-induced

Psychiatric diseases

2608 (1.67)

Obesity and other hyperalimentation

673 (1.63)

Malignant neoplasm of peripheral nerves and autonomic nervous system

Carcinoma in situ of skin of upper limb, including shoulder

16 (0.16)

Acquired hypertrichosis lanuginosa

Malignant neoplasm of other and unspecified parts of mouth, excluding all cancers (controls excluding all cancers)

5 (0.05)

Arenaviral haemorrhagic fever

0 (0.00)

Use of other anti-dementia drugs, combinations

Appendicitis, broad definition

9164 (21.42)

Carcinoma in situ of cervix uteri, endocervix

Use of selegiline

44 (0.41)

Benign neoplasm: Vagina

9 (0.09)

Assault by hanging, strangulation and suffocation

Oral corticosteroids

1390 (1.70)

Chlamydia psittaci infection

0 (0.00)

Disorders of adult personality and behaviour

290 (1.24)

Metabolic disorder, unspecified, drug-induced

Unspecified effects of radiation

Disorders of gallbladder, biliary tract and pancreas

1395 (1.92)

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx

Pedestrian injured in collision with pedal cycle

35 (0.34)

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

35 (0.29)

0.12 [-0.13, 0.37]

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

82 (0.65)

Dental caries 3

3981 (1.68)

Asthma-related pneumonia or sepsis

373 (1.41)

Unilateral visual impairment (ICD-8)

Myoclonus, drug-induced

0 (0.00)

Malignant neoplasm of placenta

0 (0.00)

Agent resistant to penicillin and related antibiotics

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

6 (0.06)

-0.23 [-0.74, 0.28]

Radiodermatitis

-0.14 [-0.45, 0.17]

Benign neoplasm: Lip

14 (0.14)

Other drug-induced osteomalacia in adults

Transitional cell carcinoma of kidney

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

88 (0.61)

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

24 (0.23)

Carcinoma in situ of anus and anal canal

Asthma, including avohilmo

1391 (1.59)

Triptan medication for migraine, min. 3 purchases

528 (1.34)

Melanocytic naevi of eyelid, including canthus

11 (0.12)

Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)

5 (0.05)

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1599 (1.81)

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1208 (1.76)

Accidental poisoning by and exposure to pesticides

Pneumonia, organism unspecified

1434 (1.85)

Defect, injury or illness of neck

Disturbances of skin sensation

235 (1.07)

Use of ocrelizumab

Other chronic figurate erythema

Use of edaravone

Convulsions, not elsewhere classified

200 (0.93)

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0 (0.00)

Monocytic leukaemia

-0.17 [-0.54, 0.19]

Other early complications of trauma

369 (1.39)

Carcinoma in situ, thyroid and other endocrine glands

Alzheimer’s disease (Early onset), excluding more controls

28 (0.25)

-0.13 [-0.77, 0.50]

Melanocytic naevi of scalp and neck

21 (0.21)

Other abnormal findings in urine

11 (0.11)

Carcinoma in situ of other and unspecified digestive organs

25 (0.25)

Acne vulgaris

43 (0.33)

Tic and related disorders

7 (0.07)

-0.07 [-0.51, 0.36]

Injury of nerves at hip and thigh level

Benign neoplasm: Ill-defined sites within the digestive system

6 (0.06)

IPHG Phlebitis and thrombophlebitis of intracranial venous sinuses

Air embolism (traumatic)

Carcinoma in situ of rectum

8 (0.08)

-0.23 [-0.79, 0.33]

Sequelae of external causes of morbidity and mortality

234 (1.17)

Carcinoma in situ, other and unspecified urinary organs

Injury of unspecified body region

55 (0.46)

Anuria and oliguria

5 (0.05)

Total colectomy operation

25 (0.23)

Malignant neoplasm of breast, HER2-negative

402 (1.25)

Handgun discharge

Crohn disease

150 (1.01)

Bilateral

Disorders of thyroid, IBD co-morbidities

258 (1.12)

Lichen ruber moniliformis

Exposure to excessive natural heat

0 (0.00)

Endovascular or surgical operations to intracerebral aneurysms

56 (0.48)

Tetanus

Disorders of plasma-protein metabolism, not elsewhere classified, drug-induced

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

Type 2 diabetes, definitions combined, including avohilmo

1828 (1.88)

Exposure to excessive cold of man-made origin

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

766 (1.92)

Toxic liver disease with hepatitis, not elsewhere classified, drug-induced

Other sudden death, cause unknown

Parodontitis, under 40 years

42 (0.31)

Use of metixene

0 (0.00)

Congenital ectropion

0 (0.00)

Benign neoplasm: Mesothelial tissue of peritoneum

0 (0.00)

Acquired ichthyosis

Coxibs

2308 (1.80)

Ascariasis

Chromophobe cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

-0.12 [-0.49, 0.26]

Dipeptidyl peptidase 4 (DPP-4) inhibitors

103 (0.75)

Hypothyroidism (congenital or acquired)

1227 (1.65)

Other transitory neonatal electrolyte and metabolic disturbances

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

65 (0.53)

SLE, strict definition

27 (0.26)

Dengue

Congenital malformation syndromes predominantly affecting facial appearance

Open wound of hip and thigh

20 (0.19)

Other injuries of upper limb, level unspecified

8 (0.08)

Deficiency of vitamin E

Benign neoplasm: Female genital organ, unspecified

5 (0.05)

Other and unspecified injuries of abdomen, lower back and pelvis

11 (0.11)

Adverse effects, not elsewhere classified

167 (0.93)

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

6 (0.06)

0.08 [-0.46, 0.61]

Open wound of thorax

9 (0.09)

Respiratory tuberculosis, clinically confirmed

17 (0.18)

Stevens-Johnson syndrome, drug-induced

Human immunodeficiency virus [HIV] disease resulting in other specified diseases

0 (0.00)

Diseases of pulp and periapical tissues, including avohilmo

2517 (1.77)

Vasculitis limited to skin, not elsewhere classified

22 (0.22)

Degeneration of nervous system due to alcohol

13 (0.13)

Injuries to the elbow and forearm

669 (1.42)

Use of memantine

179 (0.92)

Benign neoplasm of other and unspecified female genital organs

31 (0.29)

Senility

6 (0.06)

Other perinatal digestive system disorders

Refsum disease

Inhalation and ingestion of other objects causing obstruction of respiratory tract

Carcinoma in situ of other/unspecified female genital organs

Lupus erythematosus, drug-induced

0 (0.00)

Murder, homicide, or other assault by handgun discharge

Injury of blood vessels of thorax

Ischaemic Stroke, excluding all haemorrhages

665 (1.67)

Diseases of the ear and mastoid process

2021 (1.61)

Smallpox

Laparoscopic right hemicolectomy

70 (0.64)

Carcinoma in situ of other/unspecified male genital organs

Tuberculosis of other organs

11 (0.11)

Malignant neoplasm of trachea, excluding all cancers (controls excluding all cancers)

Personal history of allergy to analgesic agent

5 (0.05)

Secondary parkinsonism, excluding more controls

23 (0.23)

-0.34 [-0.84, 0.15]

Unspecified nephritic syndrome, drug-induced

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

5 (0.05)

-0.43 [-1.02, 0.16]

Aortic valve malfunction, age under 60 years

78 (0.61)

Carcinoma in situ of vagina

5 (0.05)

Carcinoma in situ of bronchus and lung

Anencephaly and similar malformations

0 (0.00)

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

105 (0.70)

Malignant neoplasm of other and ill-defined digestive organs

7 (0.07)

Medicines for HER+ breast cancer

278 (1.12)

Disorders of accommodation

0 (0.00)

Toxic effect of other noxious substances eaten as food

Secondary thrombocytopenia, drug-induced

Injury of urinary and pelvic organs

16 (0.16)

Acne tropica

0 (0.00)

Carcinoma in situ of bronchus and lung

Type of accident

239 (1.07)

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

12 (0.12)

0.47 [-0.15, 1.09]

Arthropod-borne viral fevers and viral haemorrhagic fevers

73 (0.56)

Bitten or struck by other mammals

79 (0.57)

Carcinoma in situ of skin of eyelid, including canthus

Benign neoplasm: Skin of upper limb, including shoulder

16 (0.16)

Molybdenum deficiency

Undefined dementia

87 (0.59)

Parasetamol

4221 (1.92)

Benign neoplasm: Mesothelial tissue of pleura

0 (0.00)

Hypervitaminosis D

0 (0.00)

Beau lines

0 (0.00)

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

31 (0.30)

-0.04 [-0.54, 0.45]

Non-selective monoamine reuptake inhibitors

429 (1.49)

Fissure and fistula of anal and rectal regions

232 (1.11)

Strongyloidiasis

Open wound of abdomen, lower back and pelvis

21 (0.20)

Presence of other functional implants

635 (1.53)

Pedestrian injured in collision with two- or three-wheeled motor vehicle

Benign neoplasm: Ascending colon

119 (0.85)

Carcinoma in situ of oral cavity

-0.17 [-0.47, 0.12]

Macular hole, drug-induced

Afelimomab

Myocardial infarction

756 (1.68)

Reactions and intoxications due to drugs administered to fetus and newborn

Tramadol

1024 (1.78)

Abnormal weight loss

58 (0.47)

Benign neoplasm: Skin of other and unspecified parts of face

80 (0.59)

Dental invagination

0 (0.00)

Benign neoplasm: Ciliary body

Respiratory tuberculosis, bacteriologically and histologically confirmed

13 (0.13)

Benign neoplasm: Conjunctiva

15 (0.15)

Genetic anomalies of leukocytes

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

111 (0.74)

-0.18 [-0.45, 0.09]

Injury of blood vessels at shoulder and upper arm level

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

Use of piribedil

Dental operations, only avohilmo

4629 (1.63)

Injury of nerves at lower leg level

11 (0.12)

Pedestrian injured in collision with heavy transport vehicle or bus

Exposure to sunlight

Drug-induced nonautoimmune haemolytic anaemia

Symptoms and signs involving the skin and subcutaneous tissue

679 (1.50)

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

0 (0.00)

Changes in corneal membranes

-0.30 [-0.61, 0.02]

Parodontitis and operation codes

934 (1.70)

Unspecified urinary incontinence

54 (0.43)

Benign neoplasm: Connective and other soft tissue of pelvis

Other symptoms and signs involving the nervous and musculoskeletal systems

393 (1.33)

Human immunodeficiency virus [HIV] disease

7 (0.07)

Miliaria rubra

Chronic suppurative otitis media, including avohilmo

65 (0.52)

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

197 (1.15)

-0.02 [-0.29, 0.25]

Morphin

11 (0.11)

5-aminosalicylic acid

171 (0.87)

Arthropathic psoriasis

75 (0.55)

Neurofibromatosis, type 1

-0.12 [-0.54, 0.30]

Fracture of upper limb, level unspecified

Contaminated medical or biological substances

Endocrine, nutritional and metabolic diseases

4246 (1.90)

Benign neoplasm: Spinal meninges

9 (0.09)

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

51 (0.40)

0.11 [-0.12, 0.34]

Malignant neoplasm of retroperitoneum and peritoneum

Taurodontism

Thiazolidinediones

Digestive system disorders of fetus and newborn

Implicit Sepsis

1010 (1.97)

Haemangioma and lymphangioma, any site

56 (0.44)

Postpartum care and examination

155 (0.70)

Other psoriatic arthropathies

67 (0.51)

Foreign body in ear

12 (0.12)

Drowning to ice

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

Macular pucker, drug-induced

Macular cyst, drug-induced

Nonvenereal syphilis

Carcinoma in situ of oesophagus

Traumatic amputation of ankle and foot

Benign neoplasm: Prostate

7 (0.07)

Benign neoplasm: Hypopharynx

Cardiovascular diseases

5677 (1.97)

Adenocarcinomas of cervix, excluding all cancers (controls excluding all cancers)

0.47 [0.02, 0.91]

Benign neoplasm: Descending colon

52 (0.45)

Fall on and from ladder

57 (0.48)

Benign neoplasm: Brain, unspecified

6 (0.06)

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

51 (0.44)

Benign neoplasm: Rectum/anal canal icd-9

6 (0.06)

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

107 (0.76)

-0.05 [-0.33, 0.24]

Parkinson's disease, excluding more controls

125 (0.83)

Benign neoplasm: Liver

12 (0.12)

Mental retardation, excluding more controls

28 (0.26)

-0.34 [-0.85, 0.16]

Examination and observation for other reasons

798 (1.60)

Vibratory urticaria

Injuries to the thorax

411 (1.33)

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

47 (0.44)

Hypercarotenaemia

Benign neoplasm: Pituitary gland, craniopharyngeal duct

43 (0.39)

Complications of procedures, not elsewhere classified

1101 (2.06)

Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)

7 (0.07)

-0.03 [-1.45, 1.39]

Malignant neoplasm of eye, brain and central nervous system

27 (0.25)

Family history of certain disabilities and chronic diseases leading to disablement

31 (0.28)

Leisure time condition

147 (0.87)

Other thrombophilia

Injury of nerves at ankle and foot level

Hepatomegaly and splenomegaly, not elsewhere classified

8 (0.08)

Unspecified drowning and submersion

Oedema, not elsewhere classified

309 (1.29)

Post-traumatic wound infection, not elsewhere classified

28 (0.28)

672 (1.67)

Osteogenesis imperfecta

Rash and other nonspecific skin eruption

71 (0.54)

Hirsutism, drug-induced

0 (0.00)

0.36 [0.08, 0.64]

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

396 (1.40)

Frostbite with tissue necrosis

Pyoderma gangrenosum

6 (0.06)

Sulfasalazine

260 (1.10)

Rabies

Gout, FINNGEN

280 (1.30)

Exposure to other specified factors

759 (1.52)

Diffuse brain injury

28 (0.26)

Hereditary nephropathy, not elsewhere classified, drug-induced

Injuries to the shoulder and upper arm

847 (1.52)

Other misadventures during surgical and medical care

24 (0.24)

Other antidepressants

1729 (1.68)

Bacterial agents resistant to antibiotics

Benign neoplasm of mouth and pharynx

91 (0.67)

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

23 (0.23)

Fetal blood loss

Chondrosarcoma, excluding all cancers (controls excluding all cancers)

0.04 [-0.35, 0.42]

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

171 (1.02)

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

36 (0.34)

0.12 [-0.32, 0.57]

Glanders and melioidosis

Malignant neoplasm of tongue

18 (0.18)

Benign neoplasm: Peripheral nerves and autonomic nervous system

11 (0.11)

Polyglandular hyperfunction

0 (0.00)

Type 1 diabetes, strict definition, subgroup 1

51 (0.40)

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

Striking against or struck by other objects

304 (1.21)

Melanoma in situ of lip

Noninfectious colitis NAS

115 (0.77)

Occupational exposure to risk-factors

28 (0.27)

Diabetes medication

1862 (1.88)

Other lack of coordination

13 (0.13)

Septicaemia

486 (1.69)

Use of mazaticol

Butylpyrazolidines

Exclusion endpoint for supernumerary teeth

7 (0.07)

Benign neoplasm: Other parts of oropharynx

Dental caries, including avohilmo

4220 (1.66)

Superficial injury of hip and thigh

116 (0.75)

Schistosomiasis [bilharziasis]

Diphyllobothriasis and sparganosis

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

33 (0.34)

0.00 [-0.39, 0.39]

Other viral hepatitis

58 (0.50)

Traumatic subdural haemorrhage

105 (0.71)

Any dementia, excluding more controls

376 (1.23)

-0.01 [-0.28, 0.26]

Benign neoplasm: Larynx

23 (0.22)

Disorders of puberty, all

6 (0.06)

Sweet's syndrome

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

5 (0.05)

Immobility syndrome (paraplegic)

0 (0.00)

Keratosis follicularis et parafollicularis in cutem penetrans [Kyrle]

0 (0.00)

Other disturbances of temperature regulation of newborn

Explosion of other materials

Isolated proteinuria

22 (0.22)

Agent resistant to other and unspecified antibiotics

Use of tacrine

Hereditary choroidal dystrophy

Visual disturbances in diseases classified elsewhere

0 (0.00)

COPD/asthma related infections

3074 (1.77)

ILD medications

1940 (1.78)

Benign neoplasm: Lower jaw bone

6 (0.06)

Petrositis

0 (0.00)

Benign neoplasm: Vertebral column

Non-small cell lung cancer, adenocarcinoma, helper endpoint

56 (0.49)

Superficial injury of ankle and foot

87 (0.61)

Traumatic subarachnoid haemorrhage

30 (0.29)

Hereditary angioödema type 2

0 (0.00)

Disorders of urea cycle metabolism

General hospital and personal-use devices associated with adverse incidents

Magnesium deficiency, drug-induced

Melanocytic naevi, other sites/unspecified

51 (0.42)

Golimumab

16 (0.15)

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

26 (0.26)

0.60 [-0.01, 1.22]

Fall on and from stairs and steps

219 (1.07)

Merkel cell carcinoma of skin, excluding all cancers (controls excluding all cancers)

Psoriatic arthropathies, strict definition

Reduction defects of unspecified limb

0 (0.00)

Abnormality of white blood cells, not elsewhere classified

5 (0.05)

Spirochaetal infections, other/unspecified

52 (0.42)

Injuries to the neck

167 (0.85)

Anxiety disorders, excluding more controls

988 (1.47)

0.02 [-0.15, 0.18]

L04AX Other immunosuppressants

512 (1.38)

Corneal pigmentations and deposits, drug-induced

Exclusions for E4_PCOS_BROAD

131 (0.79)

Malignant neoplasm of vagina, excluding all cancers (controls excluding all cancers)

-0.11 [-0.48, 0.26]

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

36 (0.33)

Exposure to electric transmission lines

0 (0.00)

Follow-up examination after treatment for malignant neoplasms

96 (0.71)

Victim of lightning

0 (0.00)

Cardiac murmurs and other cardiac sounds

57 (0.42)

Foreign body in respiratory tract

37 (0.33)

Pain, not elsewhere classified

248 (1.10)

Cystic fibrosis with pulmonary manifestations

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

69 (0.57)

Erythema marginatum

0 (0.00)

Headache

701 (1.45)

Anti-inflammatory and antirheumatic products, non-steroids

7557 (1.84)

Symptoms and signs involving cognition, perception, emotional state and behaviour

1185 (1.62)

Organic, including symptomatic, mental disorders

558 (1.40)

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

-0.08 [-0.26, 0.11]

Major coronary heart disease event excluding revascularizations

1004 (1.74)

Carcinoma in situ of other/unspecified female genital organs

Toxic effect of corrosive substances

6 (0.06)

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

6 (0.06)

Melanocytic naevi of other and unspecified parts of face

44 (0.38)

Upper arm

Benign neoplasm: Bronchus and lung

8 (0.08)

Polyneuropathies and other disorders of the peripheral nervous system

190 (1.05)

Miliaria, unspecified

0 (0.00)

Postimmunization arthropathy, drug-induced

Disorders of fructose metabolism

Pelvic region

Budesonide

104 (0.69)

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

11 (0.12)

-0.21 [-0.73, 0.32]

Oesophagitis, drug-induced

-0.35 [-0.73, 0.03]

Malignant neoplasm of hypopharynx, excluding all cancers (controls excluding all cancers)

6 (0.06)

-0.26 [-0.69, 0.16]

Voice disturbances

211 (1.02)

KRA_PSY_EATING, excluding more controls

41 (0.31)

-0.05 [-0.50, 0.40]

Codeine

1696 (1.82)

Use of profenamine

Toxic liver disease with fibrosis and cirrhosis of liver, drug-induced

Lichen planus, including avohilmo

142 (0.86)

Histoplasmosis

Malignant neoplasm of other and ill-defined sites

Postpartum hemorraghe, all women as controls

176 (0.83)

-0.03 [-0.38, 0.32]

Brain medulloblastoma, excluding all cancers (controls excluding all cancers)

Malignant neoplasm of meninges, excluding all cancers (controls excluding all cancers)

0.02 [-0.36, 0.41]

Hypothermia of newborn

0 (0.00)

Malignant neoplasm of oropharynx

Foreign body in alimentary tract

34 (0.30)

Purine nucleoside phosphorylase [PNP] deficiency

Injury of muscle and tendon at hip and thigh level

90 (0.70)

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

263 (1.10)

-0.05 [-0.23, 0.13]

Diseases of tongue

39 (0.33)

Thalassaemia trait

Other benign neoplasm of uterus: Other parts/unspecified

25 (0.24)

Carcinoma in situ of lip, oral cavity and pharynx

COPD, hospital admissions

556 (1.75)

Other special examinations and investigations of persons without complaint or reported diagnosis

2821 (1.73)

Open wound of wrist and hand

415 (1.31)

Burns and corrosions of multiple body regions

6 (0.06)

Other abnormal immunological findings in serum

16 (0.16)

Other chorioretinal disorders in diseases classified elsewhere

0 (0.00)

Other specified disorders of eye and adnexa in diseases classified elsewhere

Findings of drugs and other substances, not normally found in blood

Pulmonary heart disease, diseases of pulmonary circulation

320 (1.37)

Carcinoma in situ of other/unspecified digestive organs

Disorders of pyruvate metabolism and gluconeogenesis

Ainhum

Effects of foreign body entering through natural orifice

212 (1.04)

Calcific aortic valvular stenosis, including rheumatic fever

243 (1.12)

Benign neoplasm: Kidney

19 (0.18)

Other and unspecified injuries of ankle and foot

29 (0.27)

Contact with blunt object, undetermined intent

5 (0.05)

Granuloma faciale [eosinophilic granuloma of skin]

Benign neoplasm of other and unspecified endocrine glands

123 (0.87)

malignant neoplasm of female genital organs

101 (0.68)

Use of rivastigmine

97 (0.67)

Immunization not carried out

Phlebitis and thrombophlebitis of femoral vein, drug-induced

Nephropathy induced by heavy metals, drug-induced

Fenamates

229 (1.02)

Other cystitis, drug-induced

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

14 (0.14)

Direct fill therapy

132 (0.90)

Acute generalized exanthematous pustulosis

23 (0.21)

Benign neoplasm: Brain, supratentorial

11 (0.11)

Malignant neoplasm of rectosigmoid junction

8 (0.08)

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

Rhabdomyosarcoma, excluding all cancers (controls excluding all cancers)

-0.12 [-0.41, 0.17]

Secondary and unspecified malignant neoplasm of lymph nodes

61 (0.50)

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

116 (0.80)

0.11 [-0.22, 0.43]

Sequelae of injuries involving multiple and unspecified body regions

Immune checkpoint inhibitor medicines

Carcinoma in situ of other and unspecified sites

24 (0.23)

Paracoccidioidomycosis

0 (0.00)

Defects of catalase and peroxidase

0 (0.00)

Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

0.48 [-0.05, 1.02]

Dyslexia and other symbolic dysfunctions, not elsewhere classified

Other and unspecified medical devices associated with adverse incidents

Use of galantamine

50 (0.43)

Benign neoplasm: Liver/bile ducts (ICD-9)

Benign neoplasms

2788 (1.89)

Dislocation, sprain and strain of joint and ligaments of hip

30 (0.29)

Benign neoplasm: Uterine tubes and ligaments

Primary_lymphoid and hematopoietic malignant neoplasms

219 (1.14)

0.08 [-0.25, 0.42]

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

27 (0.26)

-0.33 [-0.98, 0.31]

Malignant neoplasm of nasal cavity and middle ear, excluding all cancers (controls excluding all cancers)

Duodenal ulcer - Chronic or unspecified with perforation, drug-induced

Pedestrian injured in transport accident

66 (0.55)

Benign neoplasm: Cornea

Occupant of special vehicle mainly used on industrial premises injured in transport accident

Taeniasis

Alport

Need for immunization against certain single viral diseases

0 (0.00)

Hypothyroidism, other/unspecified

1224 (1.65)

Use of eteplirsen

Left side

Type 1 diabetes, wide definition, subgroup 1

208 (1.07)

Flexion deformity

Preparation and fitting of bite rail to mouth

105 (0.70)

Contact with other hot fluids

16 (0.16)

Benign neoplasm: Short bones of lower limb

5 (0.05)

Abnormal involuntary movements

117 (0.80)

Surgical ablation of atrial fibrillation

5 (0.05)

Glaucoma-related operations

42 (0.38)

Miliaria crystallina

Immunodeficiency following hereditary defective response to Epstein-Barr virus

0 (0.00)

Dietary calcium deficiency

Nondiabetic hypoglycaemic coma, drug-induced

Neuroendocrine tumor and carcinoma of rectum, excluding all cancers (controls excluding all cancers)

0.11 [-0.24, 0.45]

Bacterial pneumonia (organism specified)

481 (1.51)

Systemic sclerosis, icd10

12 (0.12)

Hyperhidrosis

22 (0.21)

Carcinoma in situ of breast, other/unspecified

9 (0.09)

COPD, hospital admissions 1, only main diagnosis

370 (1.46)

Infliximab

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

L02BX Other hormone antagonists and related agents

31 (0.29)

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

26 (0.26)

0.16 [-0.19, 0.51]

Use of safinamide

Amiodarone users

80 (0.62)

Heart failure,strict

832 (1.77)

L04AD Calcineurin inhibitors

87 (0.65)

Pseudofolliculitis barbae

Neurological devices associated with adverse incidents

Caught, crushed, jammed or pinched in or between objects

29 (0.26)

Malignant neoplasm of pyriform sinus

Pemphigus vegetans

Benign neoplasm: Trachea

Nephrotic syndrome, drug-induced

Death from sequelae of obstetric causes

Symptoms and signs involving the circulatory and respiratory systems

2996 (1.79)

Open wound of forearm

67 (0.52)

Bus occupant injured in other and unspecified transport accidents

9 (0.10)

Injury of nerves and spinal cord at thorax level

7 (0.07)

Serum neuropathy, drug-induced

Other postsurgical states

67 (0.58)

hereditary angioödema type 3

Shock due to anaesthesia, drug-induced

Glycosuria

Mucinous and mucinous cystic tumor of rectum, excluding all cancers (controls excluding all cancers)

Night blindness

Malignant neoplasm of palate

Total (external) ophthalmoplegia

Carcinoma in situ of other/unspecified digestive organs

Benign neoplasm: Rectosigmoid junction

29 (0.28)

Injuries to the wrist and hand

1091 (1.57)

Abnormal findings in cerebrospinal fluid

Mucinous and mucinous cystic tumor, excluding all cancers (controls excluding all cancers)

-0.07 [-0.50, 0.36]

Event of undetermined intent

37 (0.32)

Niacin deficiency [pellagra]

Inflammatory bowel disease

313 (1.27)

Hypertensive diseases (excluding secondary)

3333 (2.02)

Sequelae of injuries of lower limb

90 (0.69)

Toxic liver disease with cholestasis, drug-induced

Other and unspecified injuries of wrist and hand

18 (0.17)

Pedal cyclist injured in noncollision transport accidents

90 (0.65)

Superficial frostbite

Supervision of high-risk pregnancy

398 (1.11)

Use of ipidacrine

Crushing injuries involving multiple body regions

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

25 (0.25)

Mycetoma

Motorcycle rider injured in other and unspecified transport accidents

51 (0.44)

Malignant neoplasm of breast, HER2-positive

Abnormalities of breathing

1371 (1.66)

Sclerodactyly

0 (0.00)

Persistent hyperplasia of thymus

Faecal incontinence

67 (0.53)

Any reimbursement code in KELA

5784 (1.89)

Motor neuron disease (with DMD)

14 (0.14)

Propionic acid derivatives

6143 (1.83)

Use of glatiramer acetate

14 (0.14)

Disorders of glycosaminoglycan metabolism, other/unspecified

8 (0.08)

Other benign neoplasms of uterus

35 (0.32)

Benign neoplasm: Tonsil

11 (0.11)

Melanoma in situ of lower limb, including hip

Use of donepezil, memantine and Ginkgo folium

Schizophrenia, schizotypal and delusional disorders

344 (1.37)

Intentional self-harm by jumping from a high place

Tuberculosis, IBD comorbidity

63 (0.52)

Use of bromocriptine

Severe combined immunodeficiency [SCID] with low T- and B-cell numbers

Benign neoplasm of male genital organs

14 (0.14)

Mouth breathing

361 (1.28)

Disorders of tooth development and eruption

45 (0.39)

Other specified/unspecified arthritis

232 (1.04)

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

Nephropathy induced by unspecified drug, medicament or biological substance

Trigonitis, drug-induced

Carcinoma in situ of skin

57 (0.48)

-0.11 [-0.55, 0.34]

Diabetes mellitus

2034 (1.90)

Alzheimer’s disease, wide definition, excluding more controls

174 (0.86)

Myasthenia gravis, drug-induced

0.18 [-0.10, 0.47]

Malignant neoplasm of nasal cavity and middle ear

Ototoxic hearing loss, drug-induced

Benign neoplasm: Urethra

Urethral discharge

Superficial injury of wrist and hand

138 (0.75)

Multiple superficial injuries of ankle and foot

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

8 (0.08)

-0.03 [-0.41, 0.35]

Bacterial intestinal infections, IBD co-morbidities

180 (1.06)

Contact with heat and hot substances

27 (0.24)

Lower leg

Dietary selenium deficiency

Care involving use of rehabilitation procedures

652 (1.48)

Social disorders starting during childhood or adolecense, excluding more controls

0.09 [-0.50, 0.68]

Unattended death

5 (0.05)

Stroke, including SAH

811 (1.75)

Type 2 diabetes, strict (exclude DM1)

1748 (1.88)

Café au lait spots

Traumatic amputation of shoulder and upper arm

Elevated blood glucose level

65 (0.53)

Alzheimer disease, excluding more controls

236 (1.01)

Undetermined asthma, excluding more controls

91 (0.61)

Insulin, fast-acting (human)

151 (0.94)

Benign neoplasm: Skin of trunk

31 (0.29)

Disorders of vitreous body and globe in diseases classified elsewhere

0 (0.00)

Bradycardia, unspecified, drug-induced

Oxicams

732 (1.52)

Haemorrhagic and haematological disorders of fetus and newborn

Other and unspecified acantholytic disorders

Neuropathy in association with hereditary ataxia

Retinoblastoma, excluding all cancers (controls excluding all cancers)

0 (0.00)

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

66 (0.55)

Arthropathy in neoplastic disease

Hyperprolactinaemia, drug-induced

0.19 [-0.20, 0.58]

Hanging, strangulation and suffocation, undetermined intent

0 (0.00)

Analgesic nephropathy, drug-induced

Myeloproliferative diseases

75 (0.61)

Gingival enlargement, drug-induced

Exposure to controlled fire, not in building or structure

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

28 (0.28)

0.30 [-0.25, 0.85]

Head Injury

Small cell lung cancer, helper endpoint

21 (0.21)

Opioids

2955 (1.91)

!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced

Diseases caused by chlamydiae

Adalimumab

58 (0.45)

Injury of blood vessels at forearm level

Colorectal cancer, excluding all cancers (controls excluding all cancers)

361 (1.72)

0.04 [-0.21, 0.28]

Symptoms and signs involving emotional state

20 (0.19)

Aux class for KRA_PSY_EATING, excluding more controls

Duodenal ulcer - Chronic or unspecified with haemorrhage, drug-induced

Malaise and fatigue

532 (1.42)

Carcinoma in situ of stomach

Disorders of visual cortex

0 (0.00)

COPD (mode)

514 (1.75)

Accidental poisoning by and exposure to alcohol

8 (0.08)

Intracranial trauma

684 (1.44)

Immunodeficiency with increased immunoglobulin M [IgM]

0 (0.00)

Heart failure and bmi 25plus

532 (1.65)

0.34 [0.03, 0.64]

Colon Squamous cell carcinoma, excluding all cancers (controls excluding all cancers)

Exposure to other and unspecified forces of nature

Other medical care

364 (1.27)

Nausea and vomiting

248 (1.11)

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

59 (0.50)

Use of entacapone

7 (0.07)

Benign neoplasm: Carotid body

Superficial injury of neck

16 (0.16)

Contusion of other and unspecified parts of foot

34 (0.30)

Malignant neoplasm, wide definition for exclusion

2559 (1.94)

Benign neoplasm: Other and unspecified parts of mouth

25 (0.24)

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

66 (0.52)

-0.04 [-0.39, 0.31]

Fibrosarcoma, excluding all cancers (controls excluding all cancers)

6 (0.06)

-0.08 [-0.66, 0.49]

Toxic effect of pesticides

Asthma, hospital admissions , main diagnosis only

833 (1.46)

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

13 (0.13)

0.09 [-0.58, 0.76]

Unspecified transport accident

Follow-up examination after treatment for conditions other than malignant neoplasms

624 (1.47)

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

41 (0.37)

0.34 [-0.08, 0.75]

Flatulence and related conditions

Imbalance of constituents of food intake

Cerebrovascular diseases (FINNGEN)

870 (1.74)

Atrophoderma of Pasini and Pierini

Melanoma in situ of other and unspecified parts of face

Q fever

Corrosions classified according to extent of body surface involved

Melanocytic naevi of ear and external auricular canal

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

54 (0.47)

0.22 [-0.09, 0.52]

Myopathy due to other toxic agents

0 (0.00)

Rapidly progressive nephritic syndrome, drug-induced

Sub-endpoint used in defining T1D endpoints

314 (1.27)

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

239 (1.22)

6-mercaptopurine

14 (0.13)

Allergic asthma (mode), excluding more controls

216 (0.94)

Pustulosis subcornealis

Gonarthrosis [arthrosis of knee](FG)

1304 (1.84)

Glucagon-like peptide-1 (GLP-1) analogues

570 (1.61)

Motorcycle rider injured in noncollision transport accidents

20 (0.19)

Benign neoplasm: Bones of skull and face

6 (0.06)

Acute myeloid leukaemia, helper endpoint

7 (0.07)

Moyamoya

Nephropathy related operations

118 (0.85)

Shoulder region

5 (0.05)

Examination and encounter for administrative purposes

46 (0.43)

Leishmaniasis

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

472 (1.55)

Bacterial pneumonia, not elsewhere classified

443 (1.49)

Abnormal findings on examination of blood, without diagnosis

464 (1.50)

L01XX Other antineoplastic agents

48 (0.43)

Carcinoma in situ of cervix uteri, exocervix

Carcinoma in situ of other and unspecified genital organs

11 (0.11)

Ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

Coxarthrosis [arthrosis of hip](FG)

614 (1.53)

Factors influencing health status and contact with health services

6930 (1.75)

Mucinous and mucinous cystic tumor of rectum

Use of dihydroergocryptine mesylate

Zygomycosis

0 (0.00)

Tic disorders

7 (0.07)

Benign neoplasm: Scapula and long bones of upper limb

9 (0.09)

Malignant neoplasm of other endocrine glands and related structures

Use of pergolide

Hydroxyapatite deposition disease

Injury of heart

Abnormal findings on diagnostic imaging of other body structures

111 (0.78)

Delayed milestone in childhood

Exposure to other and unspecified man-made environmental factors

11 (0.11)

Telogen effluvium, drug-induced

Drowning and submersion in swimming-pool or bath

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

400 (1.24)

Vaginal lichen planus

0.17 [-0.15, 0.49]

Benign neoplasm of middle ear and respiratory system

62 (0.51)

Intentional self-harm by smoke, fire and flames

Pedestrian injured in collision with car, pick-up truck or van

18 (0.18)

Cluster headache, strict

31 (0.29)

Discharge from other and unspecified firearms

ILD, hospital admissions 3, with pneumonia sepsis

74 (0.61)

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

315 (1.11)

Fitting and adjustment of other devices

338 (1.32)

Open wound of lower leg

116 (0.75)

Chronic bullous disease of childhood

Exposure to vibration

Asthma, excluding more controls

1068 (1.54)

0.10 [-0.07, 0.27]

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0 (0.00)

L04AC Interleukin inhibitors

26 (0.24)

Diabetic retinopathy, excluding more controls

308 (1.31)

0.22 [-0.10, 0.53]

Deficiency of nutrient element, unspecified, drug-induced

Ankle and foot

6 (0.06)

Supplementary factors related to causes of morbidity and mortality classified elsewhere

256 (1.09)

Handgun discharge, undetermined intent

Symptoms and signs involving the nervous and musculoskeletal systems

565 (1.48)

Epidermolysis bullosa

-0.10 [-0.34, 0.14]

Toxic liver disease with hepatic necrosis, drug-induced

Deficiency of multiple nutrient elements, drug-induced

Pseudopelade

Carcinoma in situ of skin of lower limb, including hip

14 (0.14)

FESS (DNB20)

100 (0.70)

Benign neoplasm of thyroid gland

23 (0.22)

Wilms' tumor, excluding all cancers (controls excluding all cancers)

0.22 [-0.20, 0.65]

Oxycodone

349 (1.33)

Complications of internal orthopaedic prosthetic devices, implants and grafts

201 (1.08)

Maltreatment syndromes

38 (0.34)

Unknown and unspecified causes of morbidity

62 (0.50)

Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis

Atopic dermatitis, strict definition

214 (0.88)

Exposure to uncontrolled fire in building or structure

Condition for Implicit Sepsis (Organ dysfunction codes)

1112 (1.73)

Neurological diseases, wide definition

4484 (1.86)

Mucopolysaccharidosis, type I

0 (0.00)

Systemic lupus erythematosus, unspecified

23 (0.22)

Emotional disorders starting during childhood or adolecense, excluding more controls

22 (0.19)

0.24 [-0.14, 0.61]

Benign neoplasm: Long bones of lower limb

16 (0.15)

Speech and linguistic disorders, excluding more controls

40 (0.30)

-0.14 [-0.63, 0.34]

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

35 (0.33)

Crushing injury of thorax and traumatic amputation of part of thorax

0 (0.00)

Complicated migraine, drug-induced

0 (0.00)

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

55 (0.46)

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

21 (0.21)

0.18 [-0.19, 0.54]

Traumatic shock

Type 1 diabetes

260 (1.18)

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

7032 (1.90)

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

17 (0.17)

Parkinson's disease, strict definition, excluding more controls

118 (0.81)

Carcinoma in situ of larynx

0 (0.00)

Degeneration of iris and ciliary body

0 (0.00)

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

83 (0.63)

-0.14 [-0.61, 0.34]

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

47 (0.41)

-0.28 [-0.76, 0.20]

ILD, hospital admission 2, with pulmonary infections

88 (0.69)

Carcinoma in situ of breast

5 (0.05)

0.10 [-0.56, 0.75]

Intracranial injury with prolonged coma

0 (0.00)

Frostbite involving multiple body regions and unspecified frostbite

0 (0.00)

Malignant neoplasm of breast, HER2-positive, excluding all cancers (controls excluding all cancers)

Anthrax

0 (0.00)

Injury of other and unspecified intrathoracic organs

47 (0.41)

Other thyrotoxicosis, drug-induced

Carcinoma in situ of colon

10 (0.10)

Other superficial injuries of ankle and foot

Carcinoma in situ of rectosigmoid junction

Malignant neoplasm of peripheral nerves and autonomic nervous system, excluding all cancers (controls excluding all cancers)

Burkitt lymphoma, helper endpoint

Cytomegalovirus infection, IBD co-morbidity

23 (0.23)

Benign lipomatous neoplasm of spermatic cord

Abnormal spermatozoa

98 (0.73)

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

0.51 [-0.03, 1.05]

Dental caries 1

4212 (1.66)

Calcinosis cutis

0.06 [-0.20, 0.33]

Other disorders of blood and blood-forming organs in diseases classified elsewhere

0 (0.00)

Other interventions on the root canals of the tooth

14 (0.14)

Secondary uncertain malignant neoplasm

112 (0.79)

Erythema elevatum diutinum

0 (0.00)

Iron deficiency, drug-induced

Weight loss

60 (0.47)

Other problems related to primary support group, including family circumstances

77 (0.54)

Benign neoplasms

2788 (1.89)

Brain glioblastoma, excluding all cancers (controls excluding all cancers)

9 (0.09)

0.17 [-0.36, 0.69]

Artificial joint operation, meniscal resection

1110 (1.81)

Undetermined asthma

91 (0.61)

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, excluding all cancers (controls excluding all cancers)

1649 (1.86)

Malignant neoplasm of other and unspecified male genital organs, excluding all cancers (controls excluding all cancers)

Psoriatic arthropathies, ICD10

67 (0.50)

Testicular hypofunction, drug-induced

0 (0.00)

Other porphyria, drug-induced

Typhus fever

Toxic effect of carbon monoxide

11 (0.11)

Benign neoplasm: Transverse colon

84 (0.66)

Malignant neoplasm of base of tongue

7 (0.07)

Congenital malformations of aortic and mitral valves

36 (0.34)

Operations 1 for CAVS

Dislocation, sprain and strain of joints and ligaments of knee

633 (1.49)

Febrile neutrophilic dermatosis [Sweet]

Environmental-pollution-related condition

Disorders of optic chiasm

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

0 (0.00)

Erectile dysfunction, exclusion

Benign neoplasm: Mediastinum

Chronic nephritic syndrome, drug-induced

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

7 (0.07)

0.07 [-0.47, 0.62]

Preparatory care for dialysis

45 (0.42)

Burn and corrosion of wrist and hand

34 (0.32)

Defects in post-translational modification of lysosomal enzymes

Food allergy

0.09 [-0.26, 0.44]

Nonscarring hair loss, unspecified, drug-induced

Cryptococcosis

Amputation

98 (0.75)

Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)

11 (0.12)

-0.01 [-0.54, 0.52]

General symptoms and signs

2523 (1.72)

Exposure to unspecified smoke, fire and flames

Speech disturbances, not elsewhere classified

67 (0.54)

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

55 (0.47)

Toxic nephropathy, not elsewhere classified, drug-induced

Squamous cell neoplasms and carcinoma of rectum, excluding all cancers (controls excluding all cancers)

0 (0.00)

Meconiumileus caused by cystic fibrosis

Dizziness and giddiness

788 (1.51)

Carcinoma in situ of stomach

Carcinoma in situ of cervix uteri, endocervix

Malignant immunoproliferative diseases

7 (0.07)

-0.21 [-0.70, 0.28]

Lymphomas

Disorders of branched-chain amino-acid metabolism, other/unspecified

0 (0.00)

ILD medications: azathioprine

132 (0.82)

Other symptoms and signs involving the circulatory and respiratory systems

48 (0.41)

Benign neoplasm: Adrenal gland

67 (0.57)

Carcinoma in situ of other and unspecified digestive organs

25 (0.25)

Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbons

0 (0.00)

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

560 (1.86)

Anagen effluvium

Specific developmental disorder of motor function

Injuries to the knee and lower leg

1501 (1.73)

Pregnant state, incidental

Outcome of delivery

299 (0.98)

Parodontitis, operation under 40 years and operation codes

41 (0.31)

Carcinoma in situ, thyroid and other endocrine glands

Crohn's disease (strict) with PSC

-0.17 [-0.46, 0.12]

Malignant neoplasm of gallbladder

Benign neoplasm: Pelvic bones, sacrum and coccyx

Azathioprine

132 (0.82)

Other specified transport accidents

Implicit fungal Sepsis

34 (0.33)

Eating disorders

53 (0.38)

Complications associated with artificial fertilization

12 (0.12)

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

42 (0.38)

0.27 [-0.24, 0.78]

Chagas' disease

0 (0.00)

Diseases of the eye and adnexa

4021 (1.78)

Migraine without aura, drug-induced

9 (0.09)

0.08 [-0.42, 0.58]

Carcinoma in situ of skin of eyelid, including canthus

Endometroid carcinoma of ovary, excluding all cancers (controls excluding all cancers)

6 (0.06)

0.20 [-0.28, 0.68]

Assault by other and unspecified firearm discharge

Malignant neoplasms of independent (primary) multiple sites

Other maltreatment syndromes

27 (0.26)

Benign neoplasm: Eye, unspecified

7 (0.08)

-0.07 [-0.43, 0.29]

Use of interferon beta-1b

Car occupant injured in noncollision transport accident

21 (0.20)

Chondrolysis

Unspecified early complication of trauma

Benign neoplasm: Pancreas

17 (0.17)

Carcinoma in situ of liver, gallbladder and bile ducts

Degenerative macular diseases, drug-induced

0.03 [-0.33, 0.40]

Sequelae of leprosy

Traumatic anuria

Gonarthrosis,primary

1179 (1.83)

Autoimmune hepatitis

0.15 [-0.36, 0.67]

Bacterial Sepsis

517 (1.68)

Alopecia mucinosa

0 (0.00)

Carcinoma in situ of lip, excluding all cancers

Carcinoma in situ of other and unspecified genital organs

11 (0.11)

Benign neoplasm: Brain, infratentorial

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

14 (0.14)

Dermatopolymyositis

12 (0.12)

Transitional cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

Erythema annulare centrifugum

0.33 [0.01, 0.64]

D07AA Corticosteroids, weak (group I)

99 (0.61)

Other surgical follow-up care

26 (0.25)

Omphalitis of newborn with or without mild haemorrhage

Adenocarcinoma of small intestine, excluding all cancers (controls excluding all cancers)

-0.17 [-0.48, 0.15]

Total colectomy

25 (0.23)

Adenosine deaminase [ADA] deficiency

Other external causes of accidental injury

3790 (1.77)

Pregnancy, childbirth and the puerperium

3349 (1.60)

Other injuries involving multiple body regions, not elsewhere classified

Benign neoplasm: Caecum

91 (0.71)

Crigler-Najjar syndrome

Benign neoplasm of other and unspecified intrathoracic organs

11 (0.12)

Family history of mental and behavioural disorders

Gastroenterology and urology devices associated with adverse incidents

Laparoscopic left hemicolectomy

10 (0.10)

Carcinoma in situ, thyroid

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

70 (0.56)

Mental and behavioural disorders due to alcohol

590 (1.63)

Acute pancreatitis (for exclusion)

213 (1.21)

Traumatic amputation of hip and thigh

Persons encountering health services for specific procedures, not carried out

57 (0.46)

ILD differential diagnosis

4233 (1.75)

Haemophagocytic lymphohistiocytosis

Complications following infusion, transfusion and therapeutic injection

13 (0.13)

Ill-defined and unknown causes of mortality

62 (0.53)

Malignant neoplasm of gum

Mental and behavioural disorders due to alcohol, excluding acute intoxication

510 (1.61)

Complications of cardiac and vascular prosthetic devices, implants and grafts

15 (0.15)

Contusion of toe(s) with damage to nail

12 (0.13)

Other intestinal obstruction of newborn

0 (0.00)

Other and unspecified injuries of head

38 (0.33)

Carcinoma in situ of other and unspecified sites

24 (0.23)

Aplastic and other anaemias

475 (1.57)

Disturbances of smell and taste

19 (0.18)

Lesch-Nyhan syndrome

Meconium ileus

Plague

0 (0.00)

Squamous cell neoplasms and carcinoma of rectum

0 (0.00)

Medullary carcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

-0.09 [-0.34, 0.15]

Injury of eye and orbit

116 (0.74)

Pedal cyclist injured in collision with motor vehicle

21 (0.20)

Superficial injury of lower leg

194 (0.93)

Early complications of trauma

42 (0.39)

Cystic fibrosis with intestinal manifestations

0 (0.00)

Benign neoplasm: Tongue

18 (0.18)

Androgen resistance syndrome

Intentional self-harm by crashing of motor vehicle

Benign leiomyoma with endometriosis

114 (0.73)

-0.10 [-0.38, 0.17]

Operations for atrial fibrillation

12 (0.12)

Phlebitis and thrombophlebitis of unspecified site, drug-induced

Ulcerative colitis

203 (0.97)

Chronic periodontitis, including avohilmo

991 (1.70)

Other specified types of T/NK-cell lymphoma, hilmo, excluding all cancers

0 (0.00)

Other gangliosidosis

0 (0.00)

Carcinoma in situ of skin, other sites/unspecified

Mental and behavioural disorders associated with the puerperium

8 (0.08)

Personal history of other diseases and conditions

63 (0.45)

Other protozoal diseases, not elsewhere classified/unspecified

Carcinoma in situ of skin of ear and external auricular canal

15 (0.16)

Abnormalities of gait and mobility

85 (0.62)

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

713 (1.90)

Anagen effluvium, drug-induced

Fitting and adjustment of external prosthetic device

Carcinoma in situ of middle ear and respiratory system

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

15 (0.15)

-0.07 [-0.41, 0.27]

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

5 (0.05)

Myiasis

Toxic colitis

Cleft lip and palate

Multiple sites

Umbilical haemorrhage of newborn

Benign neoplasm: Retina

Delivery

2680 (1.54)

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

Benign neoplasm: Skin of lower limb, including hip

22 (0.22)

Ovarian dysfunction: androgen excess, drug-induced

Acute nephritic syndrome, drug-induced

Cardiovascular devices associated with adverse incidents

Benign neoplasm: Skin of trunk

31 (0.29)

Benign neoplasm: Respiratory system, unspecified

Granulosa cell carcinoma of ovary, excluding all cancers (controls excluding all cancers)

0.19 [-0.14, 0.51]

Alcohol abuse, main dg, excluding more controls

150 (0.94)

0.19 [-0.07, 0.45]

Use of pramipexole

196 (1.08)

Pneumonia derived septicemia

28 (0.27)

Dental caries 2 and operation codes

690 (1.22)

Injury of nerves and spinal cord at neck level

10 (0.10)

Hydrocephalus, acquired, of newborn

Systemic sclerosis (FG)

12 (0.12)

Carcinoma in situ of liver, gallbladder and bile ducts

Contact with hot air and gases

5 (0.05)

Alpha thalassaemia

Other migraine, drug-induced

Haemorrhagic disease of fetus and newborn

Complications of other internal prosthetic devices, implants and grafts

34 (0.32)

Other skin changes

134 (0.84)

Transport accidents

487 (1.35)

Malignant neoplasm of uterus, part unspecified

Malignant hyperthermia due to anaesthesia, drug-induced

Toxic effect of other gases, fumes and vapours

Insulin, fast-acting or short human

392 (1.45)

Other birth injuries to central nervous system

Other injuries of lower limb, level unspecified

6 (0.06)

Correction of physiology of bite - very demanding therapy visit

19 (0.19)

Dyshormonogenetic goitre

Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)

-0.04 [-0.35, 0.27]

Right side

Sequelae of toxic effects of substances chiefly nonmedicinal as to source

Benign neoplasm: Urethra

Foreign body in genitourinary tract

9 (0.09)

Other specific joint derangements/joint disorders

871 (1.55)

Personal history of risk-factors, not elsewhere classified

10 (0.10)

Other hypertrophic osteoarthropathy

0 (0.00)

Contact with venomous snakes and lizards

Operations 2 for CAVS

Palsy of conjugate gaze

Cutaneous autosensitization

0 (0.00)

Crushing injury of wrist and hand

11 (0.11)

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1474 (1.70)

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

30 (0.28)

Carcoma in situ of toher and unspecified parts of intestine

0 (0.00)

Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)

5 (0.05)

Sequelae of intentional self-harm, assault and events of undetermined intent

Auxiliary class for KRA_PSY_CHILDOTH, excluding more controls

Hookworm diseases

Melanocytic naevi of upper limb, including shoulder

15 (0.15)

Tetanus, other/unspecified

Localized hypertrichosis

Giant cell arteritis with polymyalgia rheumatica

29 (0.28)

Traumatic amputations involving multiple body regions

Non-small cell lung cancer, squamous, helper endpoint

41 (0.37)

Other fluke infections

Benign neoplasm: Pharynx, unspecified

7 (0.07)

Lipodystrophy, not elsewhere classified, drug-induced

Contact with other sharp object(s)

51 (0.43)

Malignant neoplasm of meninges

Labyrinthine dysfunction

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

541 (1.52)

-0.14 [-0.30, 0.02]

102

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

61 (0.53)

0.60 [0.05, 1.16]

Encephalitis

19 (0.19)

Anhidrosis

Cough

400 (1.30)

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

241 (1.04)

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

140 (0.92)

Chronic congestive splenomegaly

Reye syndrome

Traumatic cerebral oedema

Burn and corrosion of hip and lower limb, except ankle and foot

14 (0.14)

Pseudomembranous colitis

7 (0.07)

Other effects of reduced temperature

Desensitization to allergens

38 (0.33)

Left hemicolectomy

17 (0.17)

Leprosy [Hansen's disease]

Toxic effect of other inorganic substances

Accident to watercraft causing other injury

Sudden infant death syndrome

Benign neoplasm: Thymus

-0.40 [-0.76, -0.04]

Drowning and submersion while in natural water

Symptoms and signs involving speech and voice

276 (1.15)

Aux class for eating disorder

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

46 (0.40)

-0.38 [-1.01, 0.24]

COPD differential diagnosis

4229 (1.75)

Neonatal jaundice due to other excessive haemolysis

Toxic liver disease with chronic lobular hepatitis, drug-induced

Occupant of streetcar injured in transport accident

Anxiety (asthma-related co-morbidities)

586 (1.27)

Excessive and redundant skin and subcutaneous tissue

Haemophagocytic syndrome, infection-associated

0 (0.00)

Benign neoplasm: Skin, unspecified

27 (0.25)

Drug-induced thyroiditis

-0.00 [-0.32, 0.31]

Abnormal findings on diagnostic imaging of central nervous system

38 (0.35)

Cutis rhomboidalis nuchae

Focal brain injury

48 (0.40)

Traumatic amputation of lower leg

Non-seminoma of testis, excluding all cancers (controls excluding all cancers)

0.14 [-0.21, 0.49]

Syncope and collapse

464 (1.40)

Other disorders involving the immune mechanism, not elsewhere classified

29 (0.28)

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs

Tuberculosis

58 (0.49)

Chancroid

Obstetrical tetanus

Fall on same level involving ice and snow

551 (1.45)

Lactose intolerance

26 (0.25)

Disorders of speech understanding and production

Intentional self-harm by jumping or lying before moving object

Miliaria profunda

Deficiency of other/unspecified vitamins

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

579 (1.53)

-0.15 [-0.32, 0.01]

Carcinoma in situ of skin of scalp and neck

23 (0.23)

Perifolliculitis capitis abscedens

Colorectal squamous cell carcinoma, excluding all cancers (controls excluding all cancers)

0 (0.00)

Other and unspecified injuries of neck

Assault by bodily force

57 (0.46)

Other interstitial pulmonary diseases

134 (0.90)

Fever of other and unknown origin

646 (1.61)

Certolizumab pegol

10 (0.10)

Hypothyroidism, levothyroxine purchases

1208 (1.64)

Intentional self-harm by drowning and submersion

Artificial joint re-operation

65 (0.56)

Crystal arthropathies, rheuma endpoint

7 (0.07)

Schizophrenia or delusion, excluding more controls

343 (1.37)

-0.05 [-0.29, 0.18]

Viral Sepsis

182 (1.04)

Melanocytic naevi of trunk

85 (0.61)

Use of donepezil and memantine

Exposure to noise

Duodenal ulcer - Acute with both haemorrhage and perforation, drug-induced

Bilateral sagittal split ramus osteotomy operation

17 (0.16)

Atopic dermatitis, strict definition with reimbursement

230 (0.91)

Crushing injury of head

Assault by drowning and submersion

Injury of nerves at forearm level

6 (0.06)

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

14 (0.14)

Malignant neoplasm of tonsil

Malignant neoplasm of other and unspecified parts of tongue

11 (0.11)

Keratosis punctata

Exposure to excessive heat of man-made origin

Intracranial laceration and haemorrhage due to birth injury

Malignant neoplasm of trachea

Malignant neoplasm of other and unspecified male genital organs

Exposure to ignition of highly flammable material

Malignant neoplasm of mesothelium and soft tissue

37 (0.35)

Foreign body on external eye

127 (0.82)

ILD medications: acetylcysteine

Carcinoma in situ of prostate

5 (0.05)

-0.21 [-0.65, 0.23]

Injury of muscle and tendon at ankle and foot level

13 (0.13)

Burn and corrosion of other internal organs

Intracranial injury

549 (1.36)

Dementia due to Parkinsons disease, excluding more controls

18 (0.18)

-0.12 [-0.62, 0.38]

Problems related to physical environment

Burns and corrosions confined to eye and internal organs

32 (0.31)

Hydrops fetalis due to haemolytic disease

Crushing injury of forearm

Myxoedema coma

Benign neoplasm: Lymph nodes

Implicit viral Sepsis

181 (1.04)

Haemorrhage, not elsewhere classified

37 (0.35)

Blastomycosis

Malignant neoplasm of bone and articular cartilage of limbs

0 (0.00)

Acquired coagulation factor deficiency

-0.02 [-0.28, 0.24]

Other benign neoplasms of skin

331 (1.25)

Other condition

98 (0.65)

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

8 (0.08)

Benign neoplasm: Parathyroid gland

13 (0.14)

Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

-0.02 [-0.44, 0.40]

Any operation in hilmo

9039 (1.81)

SLE, ICD10

27 (0.26)

Other anaemias

432 (1.51)

Peripheral artery disease

471 (1.56)

Benign neoplasm: Testis

Sequelae of burns, corrosions and frostbite

Malignant neoplasm of penis, excluding all cancers (controls excluding all cancers)

9 (0.10)

-0.14 [-0.59, 0.31]

Digeorge syndrome

Other and unspecified local infections of skin and subcutaneous tissue

67 (0.52)

Abnormal reflex

Contact with sharp glass

27 (0.25)

Crushing injury of hip and thigh

0 (0.00)

Diabetic retinopathy, strict definition

157 (0.98)

0.28 [-0.01, 0.58]

Contact with other and unspecified heat and hot substances

Benign neoplasm: Colon, unspecified

265 (1.39)

Symptoms and signs involving the urinary system

949 (1.68)

Other pulmonary diagnosis

4051 (1.74)

Pregnancy examination and test

238 (0.87)

Increased secretion of glucagon

Urolithiasis

341 (1.44)

Sleep disorders

188 (0.99)

Pneumonias (Asthma/COPD co-morbidities)

1641 (1.86)

Carcinoma in situ of cervix uteri

62 (0.48)

0.08 [-0.36, 0.51]

Crushing injury of neck

Provisional assignment of new diseases of uncertain etiology

429 (1.36)

Epidural haemorrhage

7 (0.07)

Blindness (ICD-9)

Symptoms and signs involving appearance and behaviour

8 (0.08)

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

106 (0.77)

-0.16 [-0.42, 0.10]

Carcinoma in situ of larynx

0 (0.00)

-0.09 [-0.41, 0.23]

Interstitial lung disease

134 (0.90)

Vaping related disorder

Lifestyle-related condition

9 (0.09)

Dysplastic lesion of the vagina of unknown severity

0 (0.00)

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

Benign neoplasm: Choroid

34 (0.30)

Toxic epidermal necrolysis [Lyell], drug-induced

Any event in hilmo or specialist outpatient

9164 (1.77)

Severe combined immunodeficiency [SCID] with reticular dysgenesis

25 (0.03)

0.16 [-0.28, 0.60]

Chronic myringitis

25 (0.03)

0.17 [-0.16, 0.50]

Corneal pigmentations and deposits

26 (0.03)

-0.02 [-0.48, 0.45]

IBD (strict) with PSC

26 (0.03)

12 (0.13)

-0.13 [-0.57, 0.31]

Malaria

27 (0.03)

5 (0.05)

0.04 [-0.28, 0.36]

Secondary systemic amyloidosis

27 (0.03)

5 (0.05)

0.44 [0.00, 0.88]

Mantle cell lymphoma

28 (0.03)

Malignant neoplasm of nasal cavity and sinuses

28 (0.03)

6 (0.06)

Cicatricial alopecia [scarring hair loss]

28 (0.03)

7 (0.07)

-0.47 [-0.99, 0.05]

Other and unspecified hypertrophic disorders of skin

28 (0.03)

0.52 [-0.11, 1.15]

Deaf mutism, not elsewhere classified

29 (0.03)

0.12 [-0.39, 0.63]

Mental and behavioural disorders due to hallucinogens

29 (0.03)

5 (0.05)

-0.03 [-0.35, 0.29]

Onycholysis

29 (0.03)

6 (0.06)

-0.48 [-0.84, -0.13]

Pemphigus

30 (0.03)

5 (0.05)

0.24 [-0.58, 1.07]

Hereditary motor and sensory neuropathy

30 (0.03)

0.25 [-0.34, 0.84]

Juvenile Open Angle Glaucoma

30 (0.03)

0.17 [-0.21, 0.55]

Leiomyosarcoma

31 (0.04)

Unspecified organic or symptomatic mental disorder

31 (0.04)

5 (0.05)

-0.25 [-0.61, 0.10]

Organ-limited amyloidosis

32 (0.04)

-0.02 [-0.37, 0.34]

Precocious central puberty

32 (0.04)

0.03 [-0.42, 0.48]

Disorders of iron metabolism

33 (0.04)

-0.14 [-0.37, 0.08]

Endometriosis of fallopian tube

33 (0.04)

7 (0.07)

0.09 [-0.34, 0.53]

Granuloma annulare

33 (0.04)

-0.09 [-0.56, 0.39]

Dissection of cerebral arteries, nonruptured

33 (0.04)

10 (0.11)

-0.03 [-0.41, 0.34]

Placental disorders

33 (0.04)

-0.25 [-1.12, 0.62]

Other rupture of muscle

34 (0.04)

5 (0.05)

-0.11 [-0.58, 0.36]

Benign neoplasm: Orbit, unspecified

34 (0.04)

6 (0.06)

-0.16 [-0.59, 0.27]

Other and unspecified papulosquamous disorders

34 (0.04)

-0.26 [-0.55, 0.03]

Primary ovarian failure

34 (0.04)

9 (0.09)

0.16 [-0.55, 0.87]

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

35 (0.04)

-0.29 [-0.87, 0.29]

Disorders of other and unspecified cranial nerves

35 (0.04)

7 (0.07)

0.10 [-0.49, 0.70]

Other chondrocalcinosis

36 (0.04)

-0.09 [-0.49, 0.31]

Unspecified maternal hypertension

36 (0.04)

6 (0.06)

0.50 [-0.10, 1.11]

Other and unspecified disorders of orbit

13 (0.02)

0.11 [-0.31, 0.53]

Hypertrophy of bone

13 (0.02)

-0.33 [-0.68, 0.02]

Reduction defects of lower limb

13 (0.02)

-0.13 [-0.46, 0.19]

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

13 (0.02)

Craniosynostosis EXCLUDE syndromes

14 (0.02)

0 (0.00)

-0.17 [-0.47, 0.13]

Microscopic polyangiitis

14 (0.02)

-0.31 [-0.74, 0.11]

Drug-induced tremor

14 (0.02)

-0.27 [-0.70, 0.16]

Oher contracture of tendon (sheath)

14 (0.02)

0.17 [-0.21, 0.55]

Congenital myopathies

14 (0.02)

-0.01 [-0.31, 0.29]

Disorders of puberty, other/unspecified

15 (0.02)

-0.08 [-0.46, 0.30]

Benign neoplasm: Connective and other soft tissue of thorax

15 (0.02)

5 (0.05)

0.15 [-0.25, 0.55]

Other congenital malformations of upper alimentary tract

15 (0.02)

-0.33 [-0.84, 0.18]

Disorders of amino-acid transport

15 (0.02)

5 (0.05)

0.15 [-0.15, 0.44]

Benign neoplasm: Penis

15 (0.02)

-0.08 [-0.35, 0.19]

Other fibroblastic disorders

15 (0.02)

0.05 [-0.32, 0.42]

Liver disorders in diseases classified elsewhere

15 (0.02)

0.14 [-0.21, 0.50]

Mild or no visual impairment, binocular

16 (0.02)

-0.12 [-0.58, 0.34]

Other dermatomyositis

16 (0.02)

0.27 [-0.12, 0.65]

Tracheo-bronchomalasia

16 (0.02)

-0.16 [-0.51, 0.18]

Other congenital malformations of kidney

16 (0.02)

-0.11 [-0.52, 0.29]

Familial erythrocytosis

16 (0.02)

-0.10 [-0.49, 0.28]

Postprocedural disorders of eye and adnexa, not elsewhere classified

17 (0.02)

0.01 [-0.27, 0.30]

Chronic thyroiditis

17 (0.02)

0.10 [-0.26, 0.46]

Sickle-cell disorders

17 (0.02)

-0.29 [-0.64, 0.05]

Chromophobe cell carcinoma of kidney

17 (0.02)

Other secondary gout

17 (0.02)

-0.01 [-0.43, 0.41]

Disorder of mineral metabolism, other/unspecified

17 (0.02)

0.14 [-0.15, 0.42]

Fetus and newborn affected by other complications of labour and delivery

17 (0.02)

-0.08 [-0.41, 0.25]

Drug-induced headache, not elsewhere classified

18 (0.02)

-0.01 [-0.52, 0.51]

Pseudopolyposis of colon

18 (0.02)

0.12 [-0.22, 0.47]

Onychogryphosis

18 (0.02)

-0.27 [-0.76, 0.23]

Ovarian dysfunction, other/unspecified

18 (0.02)

0.05 [-0.39, 0.49]

Other primary thrombocytopenia

19 (0.02)

-0.04 [-0.45, 0.36]

Other and unspecified disorders of autonomic nervous system

19 (0.02)

-0.35 [-0.82, 0.11]

Pediculosis and phthiriasis

19 (0.02)

-0.13 [-0.47, 0.22]

Paget disease

19 (0.02)

-0.04 [-0.48, 0.41]

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

19 (0.02)

5 (0.05)

0.04 [-0.48, 0.56]

Other specified/unspecified diseases of inner ear

20 (0.02)

5 (0.05)

-0.19 [-0.56, 0.18]

Ulcerative colitis (strict) with PSC

20 (0.02)

11 (0.12)

-0.10 [-0.55, 0.35]

Pityriasis rosea

21 (0.02)

5 (0.05)

-0.05 [-0.51, 0.40]

Other disorders of peripheral nervous system

21 (0.02)

-0.08 [-0.51, 0.36]

Acne conglobata

21 (0.02)

-0.18 [-0.56, 0.20]

Monocytic leukaemia

22 (0.03)

Non-seminoma of testis

22 (0.03)

Moderate visual impairment, monocular

22 (0.03)

0.01 [-0.38, 0.41]

Henoch-Schönlein purpura nephritis (HSPN)

22 (0.03)

-0.06 [-0.41, 0.29]

Adenocarcinomas of cervix

22 (0.03)

Factitial dermatitis

23 (0.03)

5 (0.05)

0.28 [-0.16, 0.73]

Other adrenocortical overactivity

23 (0.03)

0.04 [-0.32, 0.39]

CR(E)ST syndrome

23 (0.03)

8 (0.08)

-0.19 [-0.64, 0.26]

Benign neoplasm: Other parts of oropharynx

24 (0.03)

-0.12 [-0.62, 0.38]

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

24 (0.03)

0.11 [-0.32, 0.55]

Birth asphyxia

25 (0.03)

0.06 [-0.41, 0.53]

Severe visual impairment, binocular

25 (0.03)

0.29 [-0.15, 0.73]

Drug-induced osteoporosis

26 (0.03)

0.22 [-0.36, 0.80]

Other benign neoplasm of uterus: Cervix uteri

26 (0.03)

5 (0.05)

-0.02 [-0.42, 0.39]

Other disorders originating in the perinatal period

27 (0.03)

-0.15 [-0.62, 0.32]

Pigmented purpuric dermatosis

27 (0.03)

8 (0.08)

-0.11 [-0.59, 0.37]

Amoebiasis

28 (0.03)

0.02 [-0.40, 0.44]

Increased muscle tone

28 (0.03)

0.44 [-0.13, 1.00]

Other disorders of carbohydrate metabolism

28 (0.03)

0.12 [-0.25, 0.49]

Malignant neoplasm of anus and anal canal

28 (0.03)

5 (0.05)

Nonpyogenic thrombosis of intracranial venous system

29 (0.03)

9 (0.09)

0.29 [-0.21, 0.80]

Adrenogenital disorders

29 (0.03)

0.22 [-0.27, 0.71]

Malignant neoplasm of vulva

29 (0.03)

Benign neoplasm: Nasopharynx

30 (0.03)

8 (0.08)

0.41 [-0.31, 1.13]

Enduring personality changes

30 (0.04)

8 (0.09)

0.31 [-0.05, 0.67]

Other sideroblastic anaemias

31 (0.04)

-0.30 [-0.69, 0.09]

Acute inflammation of orbit

32 (0.04)

0.10 [-0.38, 0.57]

Other hereditary haemolytic anaemias

32 (0.04)

Other/unspecified crystal arthropathies

32 (0.04)

0.48 [-0.22, 1.18]

Transient synovitis

33 (0.04)

0.20 [-0.25, 0.65]

Reiter disease

33 (0.04)

0.05 [-0.44, 0.53]

Benign neoplasm: Ill-defined sites within the digestive system

33 (0.04)

6 (0.06)

-0.68 [-1.55, 0.18]

Other nonscarring hair loss

33 (0.04)

7 (0.07)

-0.21 [-0.86, 0.43]

Other specified and unspecified disorders of conjunctiva

33 (0.04)

6 (0.06)

-0.16 [-1.14, 0.83]

Intercostal neuropathy

34 (0.04)

7 (0.07)

0.35 [-0.32, 1.01]

Benign neoplasm: Uterine tubes and ligaments

34 (0.04)

-0.10 [-0.61, 0.42]

Cholesteatoma of external ear

34 (0.04)

0.35 [-0.06, 0.76]

Diabetes insipidus

35 (0.04)

5 (0.05)

0.74 [-0.19, 1.67]

Other congenital malformations of limb(s)

35 (0.04)

0.78 [-0.13, 1.69]

Mental and behavioural disorders of puerperium, not classified elsewhere

35 (0.04)

8 (0.08)

Unequal limb length (acquired)

36 (0.04)

8 (0.08)

0.00 [-0.55, 0.56]

Other forms of systemic lupus erythematosus

36 (0.04)

8 (0.08)

0.34 [-0.08, 0.76]

Other disorders of breast and lactation associated with childbirth

37 (0.04)

7 (0.07)

-0.20 [-0.72, 0.32]

Other acquired deformities of ankle and foot

37 (0.04)

6 (0.06)

-0.05 [-0.49, 0.38]

Renal tubulo-interstitial disorders in diseases classified elsewhere

37 (0.04)

-0.03 [-0.46, 0.39]

Other bursitis of elbow

37 (0.04)

6 (0.06)

-0.13 [-0.68, 0.42]

Nezelof syndrome

38 (0.04)

0.40 [-0.06, 0.86]

Muscular dystrophy

38 (0.04)

6 (0.06)

-0.17 [-0.52, 0.17]

Vitiligo

38 (0.04)

6 (0.06)

0.05 [-0.37, 0.47]

Xerosis cutis

39 (0.05)

13 (0.13)

0.01 [-0.45, 0.47]

Dysplastic lesion of unknown severity of the cervix uteri

39 (0.05)

13 (0.14)

0.00 [-0.46, 0.46]

HSIL lesion of the vagina

40 (0.05)

11 (0.11)

-0.04 [-0.57, 0.49]

Tarsal tunnel syndrome

41 (0.05)

14 (0.15)

0.12 [-0.30, 0.54]

Benign neoplasm: Brain, unspecified

41 (0.05)

6 (0.06)

-0.02 [-0.46, 0.41]

Other and unspecified bullous disorders

41 (0.05)

-0.13 [-0.67, 0.42]

Other and unspecified parapsoriasis

15 (0.02)

0.39 [-0.31, 1.08]

ILD related to systemic autoimmune disease

15 (0.02)

6 (0.06)

Unspecified severe protein-energy malnutrition

15 (0.02)

-0.10 [-0.34, 0.14]

Phantom limb syndrome

15 (0.02)

0 (0.00)

-0.12 [-0.41, 0.18]

Dermatopolymyositis, unspecified

15 (0.02)

0.01 [-0.41, 0.44]

Other and unspecified disorders of globe

16 (0.02)

-0.04 [-0.34, 0.26]

Listeriosis

16 (0.02)

-0.22 [-0.56, 0.11]

Other or unspecified immunodeficiency

16 (0.02)

-0.46 [-0.99, 0.07]

Lesion of medial popliteal nerve

16 (0.02)

-0.18 [-0.52, 0.17]

Testicular dysfunction, other/unspecified

16 (0.02)

0 (0.00)

0.03 [-0.41, 0.47]

Relapsing fevers

17 (0.02)

0.20 [-0.14, 0.53]

Syndrome of inappropriate secretion of antidiuretic hormone

17 (0.02)

0.02 [-0.39, 0.44]

Acute hepatitis B

17 (0.02)

0.38 [-0.11, 0.87]

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

17 (0.02)

-0.09 [-0.37, 0.19]

Adrenomedullary hyperfunction

17 (0.02)

0.38 [-0.03, 0.80]

Fluid overload

17 (0.02)

0.08 [-0.26, 0.42]

Benign neoplasm: Mediastinum

18 (0.02)

0.18 [-0.25, 0.60]

Recurrent cholesteatoma of postmastoidectomy cavity

18 (0.02)

-0.03 [-0.37, 0.31]

Biological medicines for asthma

18 (0.02)

10 (0.10)

0.18 [-0.50, 0.87]

Cerebral amyloid angiopathy

19 (0.02)

-0.13 [-0.49, 0.24]

Nondiabetic hypoglycaemic coma

19 (0.02)

0.21 [-0.16, 0.58]

Miliary tuberculosis

19 (0.02)

-0.04 [-0.30, 0.22]

Other infiltrative disorders of skin and subcutaneous tissue

19 (0.02)

-0.17 [-0.56, 0.22]

Abscess of tendon sheath

19 (0.02)

7 (0.07)

0.03 [-0.51, 0.58]

Defects in the complement system

20 (0.02)

0.20 [-0.39, 0.79]

Rheumatic heart disease, other

20 (0.02)

0.04 [-0.26, 0.34]

Apocrine sweat disorders, other sweat gland disorders

20 (0.02)

0.16 [-0.17, 0.50]

Postpolio syndrome

21 (0.02)

-0.12 [-0.41, 0.17]

Disorders of plasma-protein metabolism, not elsewhere classified

21 (0.02)

-0.35 [-0.96, 0.27]

Benign neoplasm: Lower jaw bone

21 (0.02)

6 (0.06)

0.24 [-0.22, 0.70]

Asymptomatic human immunodeficiency virus [HIV] infection status

22 (0.03)

-0.09 [-0.58, 0.39]

Cardiomyopathy in other diseases

22 (0.03)

5 (0.05)

0.13 [-0.37, 0.62]

Cutis laxa senilis

22 (0.03)

-0.46 [-1.01, 0.08]

Narcolepsy and cataplexy

22 (0.03)

-0.19 [-0.73, 0.34]

Discontinuity and dislocation of ear ossicles

22 (0.03)

-0.33 [-0.81, 0.15]

Benign neoplasm: Endocrine gland, other/unspecified

23 (0.03)

7 (0.08)

0.06 [-0.40, 0.53]

Pre-eclampsia superimposed on chronic hypertension

23 (0.03)

0.48 [-0.01, 0.97]

Nail dystrophy

23 (0.03)

-0.13 [-0.91, 0.65]

Osteomyelitis of vertebra

24 (0.03)

5 (0.05)

-0.17 [-0.49, 0.15]

Congenital malformations of gallbladder, bile ducts and liver

25 (0.03)

-0.24 [-0.96, 0.48]

Disseminated intravascular coagulation [defibrination syndrome]

25 (0.03)

-0.05 [-0.44, 0.35]

Localized adiposity

25 (0.03)

-0.13 [-0.46, 0.21]

Palatinal maxillary canine

26 (0.03)

-0.15 [-0.80, 0.51]

Acute hepatitis A

27 (0.03)

-0.33 [-0.80, 0.15]

Malignant immunoproliferative diseases

27 (0.03)

7 (0.07)

Other congenital malformations of female genitalia

28 (0.03)

5 (0.05)

-0.46 [-1.48, 0.57]

Disorders of myoneural junction and muscle in diseases classified elsewhere

28 (0.03)

6 (0.06)

0.20 [-0.31, 0.71]

Malignant neoplasm of bone and articular cartilage

28 (0.03)

Malignant neoplasm of renal pelvis

28 (0.03)

Mandibular hypoplasia

29 (0.03)

5 (0.05)

-0.44 [-0.97, 0.08]

Vitamin A deficiency

29 (0.03)

0.14 [-0.27, 0.55]

Thromboangiitis obliterans

29 (0.03)

0.16 [-0.23, 0.55]

Disorders of parathyroid gland, other and/or unspecified

30 (0.03)

5 (0.05)

0.37 [-0.12, 0.85]

Benign neoplasm: Bones of skull and face

30 (0.03)

6 (0.06)

-0.10 [-0.53, 0.32]

Other congenital malformations of brain

30 (0.03)

-0.10 [-0.53, 0.32]

Dacryoadenitis

30 (0.03)

-0.60 [-1.26, 0.06]

Diastasis of muscle

31 (0.04)

9 (0.10)

0.04 [-0.40, 0.48]

Whooping cough

31 (0.04)

0.38 [-0.52, 1.29]

Purulent endophthalmitis

32 (0.04)

5 (0.05)

-0.22 [-0.69, 0.26]

Arthropathy in Crohn disease

32 (0.04)

8 (0.08)

-0.56 [-1.27, 0.14]

Drug-induced adrenocortical insufficiency

33 (0.04)

13 (0.13)

0.18 [-0.21, 0.57]

Other corneal oedema

33 (0.04)

-0.15 [-0.65, 0.35]

Pneumoconiosis due to other inorganic dusts

33 (0.04)

-0.23 [-0.65, 0.20]

Deformity of finger(s)

33 (0.04)

8 (0.09)

0.54 [0.07, 1.02]

Degenerative myopia

33 (0.04)

0.03 [-0.31, 0.36]

Benign neoplasm: Short bones of lower limb

34 (0.04)

5 (0.05)

0.03 [-0.52, 0.57]

Congenital malformations of trachea and bronchus

34 (0.04)

0.44 [-0.06, 0.94]

Colitis, primary sclerosing, strict definition

34 (0.04)

15 (0.16)

-0.11 [-0.53, 0.31]

Lymphangioma, anys site

34 (0.04)

Congenital malformations of eyelid, lacrimal apparatus and orbit

35 (0.04)

9 (0.09)

-0.01 [-0.41, 0.40]

LSIL lesion of the vagina

35 (0.04)

6 (0.06)

Perforation of oesophagus

35 (0.04)

-0.33 [-0.99, 0.33]

Other disorders affecting eyelid function

36 (0.04)

9 (0.10)

0.12 [-1.21, 1.45]

Congenital malformations of the musculoskeletal system, not elsewhere classified

36 (0.04)

9 (0.09)

-0.27 [-0.71, 0.18]

Aspergillosis

37 (0.04)

8 (0.08)

0.04 [-0.45, 0.53]

Other abnormal auditory perceptions

37 (0.04)

9 (0.09)

-0.51 [-1.80, 0.79]

Benign neoplasm: Vagina

37 (0.04)

9 (0.09)

-0.43 [-0.89, 0.04]

Galactorrhea

38 (0.04)

-0.02 [-0.96, 0.91]

Thyrotoxicosis with toxic single thyroid nodule

38 (0.04)

0.16 [-0.35, 0.67]

Fibrosarcoma

39 (0.04)

6 (0.06)

Other abortion

39 (0.05)

0.00 [-0.42, 0.43]

Xanthelasma of eyelid

40 (0.05)

0.28 [-0.18, 0.74]

Conotruncal defects

41 (0.05)

5 (0.05)

-0.01 [-0.45, 0.43]

Folate deficiency anaemia

41 (0.05)

0.14 [-0.28, 0.56]

Acute lymphocytic leukaemia

41 (0.05)

5 (0.05)

Other immunodeficiencies

42 (0.05)

6 (0.06)

-0.08 [-0.67, 0.50]

Seminoma of testis

42 (0.05)

6 (0.06)

Disorders of male genital organs in diseases classified elsewhere

43 (0.05)

5 (0.05)

-0.54 [-1.05, -0.03]

Carcinoid syndrome

43 (0.05)

15 (0.16)

0.24 [-0.38, 0.86]

Benign neoplasm of other and unspecified intrathoracic organs

45 (0.05)

11 (0.12)

-0.19 [-0.67, 0.30]

Bullous keratopathy

45 (0.05)

6 (0.06)

-0.21 [-0.68, 0.25]

Cleft palate

46 (0.05)

5 (0.05)

-0.17 [-0.57, 0.23]

Hypertrophy of tongue papillae

47 (0.05)

13 (0.14)

-0.48 [-1.11, 0.14]

Other specified and unspecified strabismus

47 (0.05)

8 (0.08)

-0.06 [-0.55, 0.42]

Exophthalmic conditions

48 (0.06)

5 (0.05)

-0.13 [-0.62, 0.35]

Trichomoniasis

48 (0.06)

6 (0.06)

-0.06 [-0.52, 0.40]

Other protozoal intestinal diseases

49 (0.06)

12 (0.12)

0.14 [-0.47, 0.75]

Foreign body granuloma of skin and subcutaneous tissue

16 (0.02)

-0.04 [-0.39, 0.31]

Hereditary spherocytosis

16 (0.02)

Androgenic alopecia

16 (0.02)

7 (0.07)

-0.15 [-0.59, 0.30]

Mental and behavioural disorders due to use of volatile solvents

17 (0.02)

0.08 [-0.21, 0.37]

Nonalcoholic steatohepatitis

17 (0.02)

5 (0.05)

-0.19 [-0.58, 0.21]

Complications of anaesthesia during the puerperium

17 (0.02)

-0.27 [-0.70, 0.15]

Sequelae of inflammatory diseases of the central nervous system

17 (0.02)

0.13 [-0.19, 0.45]

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

17 (0.02)

0.03 [-0.25, 0.31]

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

17 (0.02)

-0.24 [-0.70, 0.22]

Congenital malformations of spine and bony thorax

18 (0.02)

-0.06 [-0.51, 0.39]

ILD and respiratory illness in diseases classified elsewhere

18 (0.02)

7 (0.08)

Fatigue fracture of vertebra

18 (0.02)

-0.23 [-0.62, 0.16]

Benign neoplasm: Scrotum

18 (0.02)

0 (0.00)

0.02 [-0.35, 0.38]

Disorders of sexual preference

19 (0.02)

0.04 [-0.24, 0.32]

Idiopathic peripheral autonomic neuropathy

19 (0.02)

0.19 [-0.26, 0.65]

Shigellosis

19 (0.02)

0 (0.00)

0.04 [-0.25, 0.33]

Female pelvic inflammatory disorders in diseases classified elsewhere

19 (0.02)

-0.16 [-0.55, 0.23]

Other disorders following mastoidectomy

20 (0.02)

-0.07 [-0.43, 0.29]

Neuroendocrine tumor and carcinoma of lung

20 (0.02)

5 (0.05)

Hypertensive encephalopathy

20 (0.02)

-0.06 [-0.47, 0.34]

Hypersensitivity angiitis

21 (0.02)

0 (0.00)

-0.16 [-0.61, 0.29]

Actinomycosis

21 (0.02)

0.50 [-0.08, 1.07]

Necrobiosis lipoidica, not elsewhere classified

21 (0.02)

6 (0.06)

0.02 [-0.40, 0.44]

Disease of hard tissues of teeth, NOS

22 (0.03)

6 (0.06)

Fetus and newborn affected by maternal complications of pregnancy

22 (0.02)

-0.16 [-0.60, 0.28]

Disorders of aromatic amino-acid metabolism

22 (0.03)

-0.23 [-0.58, 0.11]

Brain astrocytoma

22 (0.03)

Rheumatoid lung disease

22 (0.03)

0.21 [-0.18, 0.60]

Adenocarcinoma of small intestine

23 (0.03)

Disorders of phosphorus metabolism and phosphatases

23 (0.03)

-0.09 [-0.48, 0.30]

Generalized pustular psoriasis

23 (0.03)

0.24 [-0.13, 0.61]

Benign neoplasm: Brain, infratentorial

24 (0.03)

0.22 [-0.18, 0.62]

Necrotizing fasciitis

24 (0.03)

5 (0.05)

-0.11 [-0.47, 0.25]

Follicular adenocarcinoma of thyroid gland

25 (0.03)

Toxoplasmosis

25 (0.03)

0.04 [-0.32, 0.40]

Other infections specific to the perinatal period

26 (0.03)

-0.17 [-0.61, 0.27]

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

26 (0.03)

-0.24 [-0.66, 0.17]

Drug-induced polyneuropathy

27 (0.03)

5 (0.05)

0.40 [-0.40, 1.20]

Arthropathy in ulcerative colitis

27 (0.03)

10 (0.10)

-0.21 [-0.55, 0.13]

Gender identity disorders

28 (0.03)

5 (0.05)

-0.06 [-0.41, 0.29]

Nonhereditary hypogammaglobulinemia

28 (0.03)

12 (0.13)

-0.35 [-0.97, 0.27]

Other and unspecified disorders of pigmentation

28 (0.03)

9 (0.10)

0.17 [-0.27, 0.61]

Renal agenesis and other reduction defects of kidney

28 (0.03)

0.11 [-0.39, 0.60]

Disorders of adrenal gland, other and/or unspecified

28 (0.03)

0.32 [-0.09, 0.72]

Acromegaly and pituitary gigantism

29 (0.03)

7 (0.07)

0.30 [-0.22, 0.81]

Villonodular synovitis (pigmented)

29 (0.03)

0.18 [-0.24, 0.61]

Thrombotic microangiopathy

30 (0.04)

5 (0.05)

-0.10 [-0.51, 0.30]

Atlantoaxial subluxation

30 (0.04)

5 (0.05)

-0.01 [-0.81, 0.78]

Postinfectious hypothyroidism

30 (0.03)

0.21 [-0.17, 0.59]

Iron deficiency

31 (0.04)

10 (0.10)

-0.12 [-0.79, 0.55]

Typhoid and paratyphoid fevers

32 (0.04)

-0.04 [-0.46, 0.38]

Hereditary deficiency of other clotting factors

32 (0.04)

0.18 [-0.20, 0.57]

Benign neoplasm: Pharynx, unspecified

32 (0.04)

7 (0.07)

0.09 [-0.28, 0.46]

Other disorders of optic disc

33 (0.04)

8 (0.08)

-0.39 [-0.94, 0.16]

Other deformity of hallux (acquired)

33 (0.04)

9 (0.10)

-0.05 [-0.52, 0.42]

Colour vision deficiencies

33 (0.04)

-0.16 [-0.54, 0.21]

Osteopathy in diseases classified elsewhere

33 (0.04)

6 (0.06)

-0.21 [-0.76, 0.34]

Benign neoplasm: Prostate

33 (0.04)

7 (0.07)

0.21 [-0.24, 0.66]

Vascular dementia (other)

34 (0.04)

5 (0.05)

0.09 [-0.44, 0.61]

Other osteochondrodysplasias

34 (0.04)

0.44 [-0.23, 1.11]

Melanocytic naevi of lip

34 (0.04)

-0.61 [-1.55, 0.33]

Other specified and unspecified disorders of lens

35 (0.04)

0.06 [-0.32, 0.43]

Other nonthrombocytopenic purpura

35 (0.04)

-0.25 [-0.71, 0.22]

Postdysenteric arthropathy

35 (0.04)

0.36 [-0.40, 1.11]

Inflammatory disorders of male genital organs, not elsewhere classified

81 (0.09)

8 (0.08)

-0.41 [-1.04, 0.21]

Other/unspecified cytomegaloviral diseases

82 (0.09)

0.08 [-0.85, 1.00]

Viral pneumonia (known virus, not influenza)

82 (0.09)

15 (0.15)

-0.08 [-0.57, 0.41]

Gastrojejunal ulcer

83 (0.09)

10 (0.10)

0.20 [-0.38, 0.78]

Venous complications and haemorrhoids in pregnancy

84 (0.09)

14 (0.14)

0.28 [-0.69, 1.25]

Inflammation of lacrimal passages (chronic)

85 (0.09)

10 (0.10)

-0.36 [-0.88, 0.16]

Gingival hyperplasia

87 (0.10)

20 (0.19)

0.22 [-0.61, 1.05]

Habit and impulse disorders

88 (0.10)

17 (0.17)

-0.08 [-0.56, 0.41]

Carcinoma in situ, bladder

89 (0.10)

23 (0.23)

Inflammation of lacrimal passages (acute and unspecified)

90 (0.10)

15 (0.15)

-0.35 [-0.98, 0.28]

Benign neoplasm: Cranial nerves

92 (0.10)

18 (0.18)

-0.60 [-1.08, -0.12]

Amyloidosis, other/unspecified

93 (0.10)

15 (0.15)

0.21 [-0.24, 0.66]

Other congenital malformations of circulatory system

96 (0.11)

19 (0.19)

0.12 [-0.49, 0.73]

Disorders resulting from impaired renal tubular function

99 (0.11)

26 (0.25)

-0.07 [-0.61, 0.47]

Testicular hypofunction

100 (0.11)

31 (0.30)

Optic atrophy

101 (0.11)

9 (0.09)

-0.57 [-1.52, 0.38]

Abscess of Bartholin gland

102 (0.11)

12 (0.12)

0.14 [-0.30, 0.59]

Pneumoconiosis due to asbestos and other mineral fibres

104 (0.12)

27 (0.27)

-0.21 [-1.12, 0.70]

Chromosomal abnormalities, not elsewhere classified

105 (0.11)

12 (0.12)

0.19 [-0.28, 0.66]

Other specified/unspecified spondylopathies

107 (0.12)

16 (0.16)

0.45 [0.01, 0.88]

Erythema multiforme

109 (0.12)

16 (0.16)

0.17 [-0.48, 0.82]

Other specified/unspecified deforming dorsopathies

111 (0.12)

14 (0.14)

-0.01 [-0.45, 0.43]

Malignant neoplasm of small intestine

112 (0.13)

13 (0.13)

Benign neoplasm: Tongue

113 (0.12)

18 (0.18)

-0.10 [-0.65, 0.45]

Paranoid personality disorder

116 (0.13)

18 (0.18)

0.23 [-0.30, 0.75]

Retinal haemorrhage

117 (0.13)

15 (0.15)

Personality and behavioural disorders due to brain disease, damage and dysfunction

119 (0.13)

10 (0.10)

0.08 [-0.39, 0.55]

Chorioretinal inflammation

120 (0.13)

19 (0.19)

-0.10 [-0.59, 0.40]

Pure hyperglyceridaemia

122 (0.14)

16 (0.16)

0.03 [-0.33, 0.39]

Hodgkin lymphoma, hilmo

123 (0.13)

17 (0.17)

Intussusception

124 (0.14)

21 (0.21)

0.09 [-0.29, 0.47]

Campylobacter enteritis

126 (0.14)

21 (0.21)

0.01 [-0.51, 0.52]

Sixth [abducent] nerve palsy

127 (0.14)

19 (0.18)

0.37 [-0.13, 0.88]

Deep bite that required surgery

42 (0.05)

7 (0.07)

-0.35 [-0.73, 0.03]

Localized scleroderma [morphea]

42 (0.05)

7 (0.07)

0.23 [-0.24, 0.70]

Benign neoplasm: Bladder

43 (0.05)

9 (0.09)

0.07 [-0.33, 0.47]

Lesion of femoral nerve

43 (0.05)

-0.17 [-0.63, 0.30]

Atypical mycobacterium lung infection

44 (0.05)

8 (0.08)

0.06 [-0.50, 0.61]

Benign neoplasm: Bronchus and lung

45 (0.05)

8 (0.08)

0.06 [-0.64, 0.75]

Scleritis

45 (0.05)

6 (0.06)

0.36 [-0.21, 0.92]

Myotonic disorders

46 (0.05)

11 (0.12)

-0.29 [-0.98, 0.40]

Synovial hypertrophy, not elsewhere classified

47 (0.05)

5 (0.05)

0.24 [-0.30, 0.78]

Meningococcal infection

47 (0.05)

0.75 [-0.09, 1.58]

Panniculitis, unspecified

48 (0.06)

9 (0.09)

0.38 [-0.10, 0.87]

Myelodysplastic syndrome

49 (0.06)

7 (0.07)

Previous suicide attempt

49 (0.06)

9 (0.09)

0.03 [-0.34, 0.39]

Cellulitis of external ear

50 (0.06)

9 (0.09)

0.16 [-0.46, 0.78]

Other congenital malformations of male genital organs

50 (0.05)

5 (0.05)

0.32 [-0.14, 0.78]

Chronic hepatitis NAS

50 (0.06)

10 (0.10)

-0.11 [-0.73, 0.51]

Melanocytic naevi of eyelid, including canthus

51 (0.06)

11 (0.12)

-0.09 [-0.54, 0.36]

Intracranial and intraspinal abscess and granuloma

52 (0.06)

8 (0.08)

-0.06 [-0.49, 0.38]

Eosinophilic disease (BM)

53 (0.06)

12 (0.12)

-0.49 [-1.06, 0.07]

Dyshidrosis [pompholyx]

54 (0.06)

17 (0.17)

0.05 [-0.45, 0.55]

Disorder of the sleep-wake schedule

55 (0.06)

-0.11 [-0.62, 0.40]

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

55 (0.06)

7 (0.07)

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

56 (0.04)

-0.32 [-1.17, 0.53]

Other specified congenital malformation syndromes affecting multiple systems

57 (0.06)

11 (0.11)

0.43 [-0.31, 1.18]

Other localized connective tissue disorders

57 (0.06)

9 (0.09)

0.40 [-0.04, 0.83]

Lumbosacral root disorders, not elsewhere classified

58 (0.07)

-0.10 [-0.64, 0.44]

Sexual dysfunction

59 (0.07)

11 (0.11)

-0.08 [-0.73, 0.58]

Infection due to other mycobacteria

60 (0.07)

10 (0.10)

0.16 [-0.33, 0.66]

Asymmetry of jaw

60 (0.07)

15 (0.15)

-0.02 [-0.66, 0.63]

Oral leukoplakia

61 (0.07)

11 (0.11)

0.13 [-0.41, 0.66]

Peptic ulcer

61 (0.07)

7 (0.07)

0.54 [-0.25, 1.34]

Fistulae involving female genital tract

61 (0.07)

7 (0.07)

-0.18 [-1.03, 0.67]

Universal erythroderma, KELA reimbursement

62 (0.07)

8 (0.08)

0.08 [-0.35, 0.51]

Ovarian hyperstimulation (induction)

63 (0.07)

12 (0.12)

0.09 [-0.33, 0.51]

Contracture of joint

65 (0.07)

6 (0.06)

0.28 [-0.28, 0.84]

Ankylosing hyperostosis [Forestier]

66 (0.08)

10 (0.10)

-0.15 [-0.92, 0.61]

Epileptic seizures related to alcohol

67 (0.08)

-0.30 [-0.73, 0.12]

Complications following myocardial infarction

67 (0.08)

8 (0.08)

0.17 [-0.55, 0.90]

Iridocyclitis in diseases classified elsewhere

69 (0.08)

13 (0.13)

-0.22 [-0.58, 0.15]

Vascular dementia (sudden onset)

70 (0.08)

7 (0.07)

-0.22 [-0.60, 0.17]

Other and unspecified trigeminal disorders

71 (0.08)

13 (0.13)

0.03 [-0.51, 0.56]

All dysplastic lesions of the vagina

71 (0.08)

16 (0.16)

Graves ophthalmopathy

72 (0.08)

16 (0.16)

0.30 [-0.07, 0.67]

Deficiency of other B group vitamins

72 (0.08)

15 (0.15)

0.02 [-0.49, 0.53]

Disorders of puberty

73 (0.07)

6 (0.06)

Benign neoplasm: Liver/bile ducts

74 (0.08)

13 (0.13)

-0.35 [-0.85, 0.15]

Malignant neoplasm of testis

74 (0.08)

9 (0.09)

Respiratory conditions due to other external agents

76 (0.09)

19 (0.19)

-0.08 [-0.90, 0.74]

Achalasia of cardia

77 (0.09)

8 (0.08)

0.22 [-0.42, 0.87]

Fourth [trochlear] nerve palsy

79 (0.09)

14 (0.14)

0.55 [-0.22, 1.32]

Adult respiratory distress syndrome

80 (0.09)

13 (0.14)

-0.21 [-0.64, 0.23]

Allergic contact dermatitis due to drugs in contact with skin

81 (0.09)

16 (0.16)

-0.46 [-1.01, 0.10]

Mandibular retrognathia AND surgery (BSSRO)

81 (0.09)

13 (0.13)

-0.23 [-0.63, 0.18]

Tularaemia

82 (0.09)

9 (0.09)

-0.03 [-0.59, 0.52]

Vertigo of central origin

82 (0.09)

12 (0.12)

-0.69 [-1.49, 0.10]

Cleft lip, lip and palate or palate

83 (0.09)

10 (0.10)

-0.41 [-0.93, 0.12]

Portal vein thrombosis

84 (0.10)

8 (0.08)

0.40 [-0.16, 0.96]

Primary biliary cholangitis (PBC)

86 (0.10)

22 (0.22)

0.23 [-0.12, 0.58]

Hereditary ataxia

88 (0.10)

12 (0.12)

0.13 [-0.35, 0.62]

Dislocation of lens

88 (0.10)

14 (0.14)

Combined immunodeficiencies

90 (0.10)

11 (0.12)

0.47 [-0.06, 1.00]

Chronic Coagulation defects

90 (0.10)

14 (0.14)

-0.03 [-0.40, 0.33]

Anxious personality disorder

92 (0.10)

12 (0.12)

0.04 [-0.36, 0.45]

Brain glioblastoma and astrocytoma

94 (0.11)

12 (0.12)

Other congenital malformations of face and neck

117 (0.12)

13 (0.13)

-0.07 [-0.70, 0.55]

Other disorders of iris and ciliary body

118 (0.13)

23 (0.23)

-0.24 [-0.98, 0.50]

Hyperprolactinaemia

120 (0.13)

22 (0.21)

0.07 [-0.65, 0.79]

Atrial septal defect

122 (0.13)

15 (0.14)

0.32 [-0.19, 0.84]

Other and unspecified vasculitis limited to skin

123 (0.14)

21 (0.21)

-0.03 [-0.46, 0.40]

Nephrotic syndrome

124 (0.13)

19 (0.18)

0.36 [-0.11, 0.84]

Anisometropia and aniseikonia

126 (0.13)

20 (0.19)

-0.09 [-0.87, 0.68]

Background retinopathy and retinal vascular changes

127 (0.14)

17 (0.17)

-0.32 [-1.10, 0.45]

Benign neoplasm: Kidney

128 (0.14)

19 (0.18)

Progressive vascular leukoencephalopathy

129 (0.14)

17 (0.17)

0.14 [-0.46, 0.73]

Helminthiases

132 (0.14)

11 (0.11)

0.53 [-0.13, 1.20]

Chronic hepatitis, not elsewhere classified

133 (0.14)

22 (0.21)

-0.09 [-0.66, 0.48]

Other and unspecified mononeuropathies, also in other diseases

134 (0.14)

20 (0.19)

-0.05 [-0.60, 0.51]

Benign neoplasm of thyroid gland

135 (0.15)

23 (0.22)

0.15 [-0.51, 0.81]

Other and unspecified corneal deformities and disorders

137 (0.15)

23 (0.22)

-0.08 [-0.59, 0.43]

Schizotypal disorder

139 (0.15)

19 (0.19)

0.10 [-0.28, 0.47]

Malignant neoplasm of oral cavity

140 (0.15)

27 (0.26)

Other congenital malformations of skin

141 (0.14)

26 (0.24)

-0.59 [-1.21, 0.03]

Other deformities of toe(s)

143 (0.16)

29 (0.28)

0.21 [-0.14, 0.56]

Infections of breast associated with childbirth

143 (0.15)

23 (0.22)

-0.28 [-0.90, 0.34]

Chondrocostal junction syndrome [Tietze]

146 (0.16)

23 (0.22)

0.16 [-0.46, 0.78]

Giant cell arteritis

147 (0.16)

33 (0.31)

-0.10 [-0.49, 0.30]

Benign neoplasm: other/unspecified salivary gland

150 (0.16)

18 (0.18)

0.54 [-0.14, 1.21]

Other vitreous opacities

151 (0.16)

31 (0.29)

0.46 [-0.42, 1.34]

Respiratory tuberculosis, confirmed

152 (0.16)

13 (0.13)

-0.00 [-0.45, 0.45]

Generalized skin eruption due to drugs and medicaments

153 (0.16)

19 (0.18)

0.09 [-0.53, 0.72]

Polycythaemia vera

155 (0.17)

31 (0.30)

0.25 [-0.24, 0.74]

Medial epicondylitis

155 (0.17)

38 (0.36)

-0.25 [-0.67, 0.17]

All dysplastic lesions of the vulva

156 (0.17)

28 (0.26)

-0.13 [-0.65, 0.39]

Asthma and opportunity respiratory infection

158 (0.17)

28 (0.26)

0.01 [-0.42, 0.43]

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

159 (0.14)

18 (0.17)

0.20 [-0.34, 0.75]

Benign neoplasm of other and unspecified sites

160 (0.17)

25 (0.24)

-0.26 [-1.23, 0.72]

Muscle strain

161 (0.17)

30 (0.29)

0.10 [-0.48, 0.68]

Other congenital malformations of tongue, mouth and pharynx

55 (0.05)

5 (0.05)

-0.06 [-0.55, 0.42]

Pervasive developmental disorders excl. Autism + Asperger

55 (0.06)

0.35 [-0.51, 1.21]

Mature T/NK-cell lymphomas, hilmo

57 (0.07)

6 (0.06)

Other congenital malformations of ear

57 (0.06)

9 (0.09)

-0.10 [-0.55, 0.34]

Maxillary retrognathism

57 (0.06)

13 (0.13)

-0.42 [-0.95, 0.12]

Degenerative conditions of globe

58 (0.07)

8 (0.09)

0.02 [-0.34, 0.39]

Dermatopolymyositis (FG)

60 (0.07)

10 (0.10)

0.26 [-0.13, 0.64]

Congenital malformations of the respiratory system

60 (0.07)

14 (0.14)

0.92 [-0.22, 2.07]

Other specified/unspecified necrotizing vasculopathies

60 (0.07)

14 (0.15)

-0.50 [-1.48, 0.48]

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

61 (0.07)

10 (0.10)

0.33 [-0.10, 0.75]

Viral infections of central nervous system, not elsewhere classified/unspecified

61 (0.07)

10 (0.10)

0.10 [-0.59, 0.80]

Idiopathic urticaria

62 (0.07)

17 (0.17)

-0.10 [-0.64, 0.44]

Benign neoplasm: Liver

62 (0.07)

12 (0.12)

-0.29 [-0.83, 0.24]

Macular cyst

63 (0.07)

20 (0.20)

-0.24 [-0.84, 0.36]

Neonatal jaundice from other and unspecified causes

66 (0.05)

-0.34 [-0.84, 0.17]

Tic and related disorders

66 (0.07)

7 (0.07)

-0.03 [-0.47, 0.41]

Viral agents as the cause of diseases classified to other chapters

67 (0.07)

22 (0.22)

Disorders of brain, other and unspecified

68 (0.08)

5 (0.05)

0.57 [-0.40, 1.54]

Abscess of external ear

68 (0.08)

8 (0.08)

0.13 [-0.32, 0.59]

Toxic liver disease

69 (0.08)

12 (0.12)

-0.38 [-0.98, 0.22]

Hydatidiform mole

70 (0.08)

9 (0.09)

-0.02 [-0.71, 0.67]

Other and unspecified aplastic anaemias

71 (0.08)

7 (0.07)

0.47 [-0.56, 1.50]

Enteropathic arthropathies

72 (0.08)

19 (0.19)

-0.31 [-0.66, 0.04]

Heart failure and hypertrophic cardiomyopathy

72 (0.08)

12 (0.12)

0.14 [-0.40, 0.68]

Other bursitis of knee

73 (0.08)

11 (0.11)

-0.06 [-0.66, 0.55]

Other melanin hyperpigmentation

74 (0.08)

15 (0.15)

-0.13 [-0.58, 0.31]

Viral conjunctivitis

74 (0.08)

7 (0.07)

0.11 [-0.59, 0.82]

Acute myeloid leukaemia

75 (0.08)

7 (0.07)

Other degenerative diseases of the basal ganglia

76 (0.09)

11 (0.11)

-0.03 [-0.77, 0.72]

Polyarteritis nodosa and related conditions

78 (0.09)

11 (0.11)

0.22 [-0.25, 0.69]

Other superficial mycoses

79 (0.09)

17 (0.17)

0.10 [-0.45, 0.65]

Guillain-Barre syndrome

80 (0.09)

9 (0.09)

0.38 [-0.20, 0.96]

81 (0.06)

0.56 [-0.54, 1.65]

Molar incisor enamel hypoplasia

81 (0.07)

7 (0.07)

-0.33 [-2.95, 2.28]

Diseases of spleen

82 (0.09)

12 (0.12)

0.14 [-0.59, 0.87]

Mesothelioma

82 (0.09)

12 (0.12)

Autoimmune thyroiditis

83 (0.09)

12 (0.12)

0.46 [-0.02, 0.93]

Other congenital malformations of intestine

84 (0.10)

5 (0.05)

0.04 [-0.41, 0.50]

Carcinoma in situ of cervix uteri

86 (0.10)

62 (0.48)

Abscess of lung

88 (0.10)

11 (0.11)

0.42 [-0.17, 1.01]

Bursitis of shoulder

89 (0.10)

19 (0.19)

-0.10 [-0.50, 0.29]

Disorders of optic nerve, not elsewhere classified

90 (0.10)

18 (0.18)

-0.27 [-0.85, 0.32]

Ankylosing spondylitis, strict definition

91 (0.10)

18 (0.16)

-0.17 [-0.36, 0.03]

Hyperaldosteronism

92 (0.10)

16 (0.16)

-0.25 [-0.74, 0.24]

Hypotension due to drugs

95 (0.11)

13 (0.14)

-0.07 [-0.56, 0.42]

Pathological resorption of teeth

97 (0.11)

16 (0.16)

0.14 [-0.42, 0.71]

99 (0.11)

17 (0.17)

0.00 [-0.37, 0.37]

Torsion of ovary, ovarian pedicle and fallopian tube

100 (0.11)

13 (0.13)

0.39 [-0.37, 1.14]

Chronic conjunctivitis

102 (0.11)

21 (0.20)

-0.09 [-1.17, 0.99]

Lupus erythematosus

102 (0.11)

14 (0.14)

0.18 [-0.20, 0.55]

Scissor bite

104 (0.09)

13 (0.13)

0.13 [-0.30, 0.56]

Cystic kidney disease

106 (0.12)

22 (0.21)

-0.20 [-0.78, 0.39]

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

107 (0.12)

21 (0.21)

0.07 [-0.53, 0.67]

Benign neoplasm of male genital organs

109 (0.12)

14 (0.14)

0.11 [-0.29, 0.51]

Other retinal artery occlusion

111 (0.12)

13 (0.13)

0.51 [-0.40, 1.42]

Keratoconus

113 (0.12)

19 (0.19)

-0.03 [-0.37, 0.30]

Other/unspecified soft tissue disorders related to use, overuse and pressure

115 (0.13)

21 (0.20)

-0.11 [-0.66, 0.43]

Other disorders of bone density and structure

117 (0.13)

22 (0.22)

Autism spe

118 (0.11)

14 (0.14)

Corneal scars and opacities

119 (0.13)

19 (0.19)

-0.46 [-1.50, 0.58]

Ulcerative enterocolitis

120 (0.13)

21 (0.20)

-0.55 [-0.98, -0.12]

Clear cell adenocarcinoma of kidney

121 (0.13)

33 (0.31)

Other inflammation of vagina/vulva

123 (0.13)

17 (0.16)

-0.14 [-0.70, 0.42]

Other and unspecified disease of Bartholin gland

124 (0.13)

12 (0.12)

0.37 [-0.12, 0.85]

Other disorders of pigmentation

152 (0.16)

37 (0.34)

-0.05 [-0.75, 0.66]

Chronic lymphocytic leukaemia

153 (0.17)

26 (0.26)

Benign neoplasm: Other and unspecified parts of mouth

154 (0.17)

25 (0.24)

-0.23 [-1.00, 0.53]

Subacute thyroiditis

155 (0.17)

23 (0.22)

0.01 [-0.64, 0.65]

Generalized epilepsy, strict definition

156 (0.16)

17 (0.17)

-0.12 [-0.62, 0.38]

Mixed disorders of conduct and emotions

156 (0.14)

13 (0.13)

Viral meningitis

158 (0.16)

31 (0.29)

-0.17 [-0.66, 0.31]

Kela-code for behavioural disturbances in mental retardation

159 (0.17)

5 (0.05)

0.19 [-0.22, 0.60]

Benign neoplasm: Rectosigmoid junction

160 (0.17)

29 (0.28)

0.17 [-1.01, 1.35]

Erosion and ectropion of cervix uteri

161 (0.17)

19 (0.19)

0.24 [-0.34, 0.83]

Open bite

163 (0.14)

25 (0.22)

-0.20 [-0.61, 0.20]

Behavioural disorders

164 (0.16)

16 (0.16)

Barrett oesophagus

166 (0.18)

34 (0.31)

0.22 [-0.19, 0.62]

Other specified disorders of external ear

167 (0.18)

34 (0.33)

0.13 [-0.27, 0.53]

Alzheimer’s disease (undefined)

169 (0.18)

7 (0.07)

Benign neoplasm: Pituitary gland, craniopharyngeal duct

170 (0.18)

43 (0.39)

0.25 [-0.29, 0.79]

Hypermobility syndrome

172 (0.18)

30 (0.26)

0.02 [-0.39, 0.43]

Brain meningioma

173 (0.18)

29 (0.26)

Other and unspecified degenerative diseases of nervous system

176 (0.19)

17 (0.17)

0.88 [0.15, 1.62]

Failed induction of labour

177 (0.18)

33 (0.29)

-0.01 [-0.48, 0.46]

Extreme obesity with alveolar hypoventilation

179 (0.19)

30 (0.28)

0.17 [-0.20, 0.54]

Oesophageal obstruction

181 (0.19)

26 (0.25)

-0.09 [-0.94, 0.76]

Complications of the puerperium, not elsewhere classified

183 (0.19)

29 (0.27)

-0.30 [-1.33, 0.73]

Haemolytic anaemias

187 (0.19)

29 (0.28)

Benign neoplasm: Choroid

187 (0.20)

34 (0.30)

-0.12 [-0.67, 0.44]

Postprocedural disorders of digestive system, not elsewhere classified

190 (0.21)

31 (0.30)

1.00 [-1.66, 3.66]

Pneumococcal septicemia

192 (0.20)

0.23 [-0.70, 1.16]

Benign neoplasm of urinary organs

194 (0.21)

33 (0.31)

Bicipital tendinitis

200 (0.21)

36 (0.33)

-0.22 [-0.66, 0.22]

Neuralgia and neuritis, unspecified

204 (0.21)

39 (0.35)

0.01 [-0.41, 0.43]

Hypertrophic scar

207 (0.21)

34 (0.30)

-0.23 [-0.71, 0.24]

Radial styloid tenosynovitis [de Quervain]

210 (0.22)

49 (0.43)

0.19 [-0.15, 0.53]

Pericarditis

215 (0.23)

31 (0.29)

-0.13 [-0.59, 0.32]

Other and unspecified mononeuropathies of lower limb

128 (0.14)

24 (0.24)

-0.70 [-1.36, -0.05]

Occlusion and stenosis of arteries, not leading to stroke

129 (0.14)

12 (0.12)

-0.13 [-0.54, 0.29]

Acute nephritic syndrome

132 (0.15)

21 (0.21)

-0.80 [-3.29, 1.68]

Hidradenitis suppurativa

133 (0.14)

29 (0.27)

-0.23 [-0.53, 0.08]

Overjet

134 (0.11)

9 (0.09)

-0.33 [-1.05, 0.40]

Circumscribed brain atrophy

136 (0.15)

12 (0.12)

0.20 [-0.31, 0.72]

Peripheral retinal degeneration

137 (0.15)

22 (0.21)

0.39 [-0.13, 0.91]

Other articular cartilage disorders

139 (0.15)

24 (0.24)

0.69 [-0.41, 1.79]

Other specified and unspecified retinal disorders

140 (0.15)

23 (0.22)

0.10 [-0.53, 0.73]

Manic episode

141 (0.15)

22 (0.21)

0.24 [-0.19, 0.67]

Nontoxic diffuse goitre

145 (0.16)

25 (0.24)

0.03 [-0.35, 0.42]

Normal-pressure hydrocephalus

146 (0.16)

36 (0.33)

0.22 [-0.07, 0.51]

Anoxic brain damage

149 (0.16)

14 (0.15)

-0.51 [-1.28, 0.25]

Hypoparathyroidism

150 (0.16)

29 (0.28)

0.30 [-0.62, 1.23]

Kidney transplant status

151 (0.17)

45 (0.41)

0.13 [-0.26, 0.52]

Loose body in joint

152 (0.17)

16 (0.16)

0.59 [-0.09, 1.27]

Inguinal hernia, unilateral

153 (0.17)

21 (0.21)

-0.16 [-0.60, 0.27]

Juvenile arthritis (FINNGEN)

157 (0.15)

29 (0.26)

0.18 [-0.14, 0.51]

Cyst of Bartholin Gland

158 (0.17)

25 (0.24)

0.03 [-0.33, 0.40]

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

160 (0.17)

30 (0.28)

0.23 [-0.54, 1.00]

Essential (haemorrhagic) thrombocythaemia

161 (0.18)

31 (0.30)

0.10 [-0.29, 0.48]

Gonococcal infection

163 (0.18)

32 (0.31)

-0.01 [-0.41, 0.38]

Alcoholic gastritis

164 (0.18)

15 (0.15)

0.27 [-0.42, 0.95]

Maternal care for cervical incompetence

166 (0.17)

23 (0.22)

0.25 [-0.16, 0.67]

Atopic conjunctivitis

167 (0.16)

23 (0.21)

0.13 [-0.62, 0.89]

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

170 (0.18)

22 (0.21)

0.67 [-0.06, 1.39]

Moderate visual impairment, binocular

171 (0.18)

20 (0.19)

Other specified disorders of muscle

173 (0.19)

23 (0.22)

-0.27 [-1.17, 0.64]

Other, unspecified and serous retinal detachments

174 (0.19)

18 (0.18)

0.10 [-0.84, 1.05]

Vulvovaginal ulceration/inflammation in other diseases

177 (0.18)

41 (0.36)

0.22 [-0.26, 0.70]

Cerebral atherosclerosis

178 (0.18)

12 (0.12)

0.66 [0.09, 1.22]

Other intracranial haemorrhages

180 (0.19)

19 (0.19)

-0.01 [-0.46, 0.43]

Scar conditions and fibrosis of skin

181 (0.19)

24 (0.22)

0.05 [-0.63, 0.74]

Myeloid leukaemia

185 (0.19)

28 (0.28)

Other secondary coxarthrosis

187 (0.20)

23 (0.22)

0.46 [-0.07, 1.00]

Mumps

188 (0.20)

19 (0.19)

0.81 [-0.44, 2.05]

Other ulcerative colitis

191 (0.20)

43 (0.38)

-0.09 [-0.36, 0.18]

Secondary right heart disease

193 (0.20)

28 (0.26)

0.03 [-0.64, 0.70]

Mental and behavioural disorders due to use of other stimulants, including caffeine

195 (0.20)

30 (0.29)

0.19 [-0.18, 0.56]

Vascular dementia (subcortical)

202 (0.21)

19 (0.19)

-0.10 [-0.66, 0.46]

Atypical facial pain

206 (0.22)

40 (0.36)

0.21 [-0.57, 0.99]

Labour and delivery complicated by umbilical cord complications

208 (0.21)

27 (0.24)

-0.49 [-1.70, 0.72]

Maternal care for known or suspected disproportion

210 (0.22)

27 (0.25)

-0.17 [-0.55, 0.21]

Mixed hyperlipidaemia

215 (0.23)

31 (0.29)

-0.04 [-0.43, 0.36]

Immunodeficiencies

216 (0.23)

43 (0.39)

0.10 [-0.49, 0.70]

Monoarthritis, not elsewhere classified

220 (0.23)

38 (0.35)

-0.26 [-0.94, 0.43]

Adenocarcinoma and ductal carcinoma of pancreas

223 (0.22)

19 (0.18)

Nonspecific lymphadenitis

224 (0.21)

29 (0.25)

0.41 [-0.14, 0.96]

Malignant neoplasm of brain

227 (0.23)

23 (0.22)

Carcinoma in situ of breast, intraductal

230 (0.24)

57 (0.47)

Endocarditis

233 (0.24)

45 (0.43)

0.38 [-0.35, 1.11]

Astigmatism

236 (0.20)

35 (0.30)

Dystonia

241 (0.24)

44 (0.39)

0.20 [-0.23, 0.63]

Vascular dementia (multiple infarctions)

245 (0.24)

12 (0.12)

0.01 [-0.44, 0.46]

Unspecified abortion

247 (0.25)

45 (0.40)

-0.66 [-1.49, 0.16]

Emotional disorders and disorders of social functioning with onset specific to childhood

250 (0.18)

24 (0.21)

0.16 [-0.25, 0.56]

Mixed connective tissue disease

255 (0.26)

57 (0.49)

0.31 [-0.05, 0.67]

Cholesteatoma of middle ear

259 (0.26)

40 (0.36)

0.24 [-0.21, 0.69]

Noise effects on inner ear

264 (0.27)

31 (0.29)

-0.62 [-2.64, 1.40]

Other noninflammatory disorders of cervix uteri

265 (0.27)

40 (0.36)

0.23 [-0.43, 0.89]

Meningitis

270 (0.26)

34 (0.31)

-0.17 [-1.14, 0.79]

Male infertility

273 (0.27)

29 (0.26)

-0.14 [-0.64, 0.37]

Mild mental retardation

273 (0.26)

19 (0.19)

-0.45 [-1.41, 0.51]

Postmenopausal osteoporosis with pathological fracture

276 (0.27)

34 (0.30)

-0.06 [-0.41, 0.29]

Cholangitis (primary sclerosing, PSC)

357 (0.35)

62 (0.54)

0.21 [-0.21, 0.64]

Suggestive for eosinophilic asthma

362 (0.35)

64 (0.50)

0.01 [-0.23, 0.25]

Disorders of mineral metabolism

364 (0.35)

56 (0.45)

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

368 (0.34)

39 (0.36)

Malignant neoplasm of stomach

373 (0.32)

34 (0.31)

Vestibular neuronitis

378 (0.35)

56 (0.45)

0.04 [-0.31, 0.40]

Other obstructed labour

380 (0.36)

73 (0.60)

0.03 [-0.38, 0.43]

Conductive hearing loss, unspecified

385 (0.34)

73 (0.58)

-0.10 [-0.79, 0.59]

Schizoaffective disorder

390 (0.38)

86 (0.70)

-0.04 [-0.38, 0.31]

Erectile dysfunction

393 (0.39)

65 (0.54)

-0.05 [-0.43, 0.34]

Spontaneous rupture of synovium and tendon

397 (0.38)

74 (0.60)

-0.16 [-0.76, 0.44]

Viral infections of the central nervous system

402 (0.37)

56 (0.46)

-0.04 [-0.55, 0.48]

Brachial plexus disorders

403 (0.37)

67 (0.51)

0.10 [-0.29, 0.48]

Visual impairment including blindness (binocular or monocular)

406 (0.37)

45 (0.38)

-0.69 [-3.43, 2.05]

LSIL lesion of the cervix uteri

411 (0.37)

81 (0.58)

-0.24 [-0.64, 0.16]

Crohn's disease of small intestine

416 (0.42)

92 (0.77)

-0.22 [-0.53, 0.10]

Prolapse and hernia of ovary and fallopian tube

419 (0.36)

26 (0.24)

-0.14 [-0.58, 0.31]

Other shoulder lesions

423 (0.39)

75 (0.57)

0.10 [-0.32, 0.53]

Plantar fascial fibromatosis

425 (0.39)

83 (0.63)

-0.08 [-0.40, 0.24]

Malignant neoplasm of head and neck

429 (0.39)

60 (0.49)

Agranulocytosis

431 (0.39)

83 (0.62)

0.50 [-0.03, 1.03]

Emphysema

436 (0.40)

66 (0.56)

0.21 [-0.11, 0.53]

Other osteochondropathies

440 (0.40)

71 (0.59)

0.03 [-0.35, 0.42]

Infectious mononucleosis

444 (0.34)

54 (0.41)

0.19 [-0.34, 0.72]

Psoriatic arthropathies

450 (0.42)

70 (0.52)

-0.02 [-0.28, 0.25]

Vascular disorders of the intestines

457 (0.43)

59 (0.50)

0.16 [-0.33, 0.66]

Covid-19 confirmed case

462 (0.37)

274 (1.24)

0.32 [-0.37, 1.01]

Type 1 diabetes, definitions combined

469 (0.39)

69 (0.49)

0.23 [-0.07, 0.54]

Malignant neoplasm of pancreas

476 (0.41)

39 (0.34)

Vascular dementia (undefined)

481 (0.41)

30 (0.28)

-0.06 [-0.64, 0.52]

Mixed and other personality disorders

487 (0.44)

69 (0.55)

0.21 [-0.18, 0.61]

Other/unspecified enthesopathies, not elsewhere classified

493 (0.44)

82 (0.64)

0.04 [-0.49, 0.58]

Non-follicular lymphoma

500 (0.45)

78 (0.61)

Multiple myeloma

177 (0.19)

15 (0.15)

Infective bursitis

179 (0.19)

28 (0.27)

-0.14 [-0.79, 0.51]

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

181 (0.19)

36 (0.33)

Chronic iridocyclitis

183 (0.19)

36 (0.33)

-0.04 [-0.41, 0.33]

Intestinal malabsorption

186 (0.19)

34 (0.31)

-0.15 [-1.80, 1.50]

Polyarthritis, unspecified

187 (0.20)

31 (0.29)

-0.39 [-0.88, 0.10]

Optic neuritis

190 (0.20)

34 (0.31)

0.37 [-0.13, 0.86]

Oral leukoplakia and related diseases

191 (0.20)

38 (0.34)

0.30 [-0.17, 0.78]

Cluster headache, strict, including avohilmo

194 (0.20)

36 (0.33)

0.09 [-0.28, 0.46]

Papillary adenocarcinoma of thyroid gland

199 (0.21)

45 (0.41)

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

204 (0.21)

31 (0.28)

-0.06 [-0.56, 0.44]

Dermatographic urticaria

207 (0.21)

43 (0.36)

-0.01 [-0.40, 0.39]

Panniculitis affecting regions of neck and back

209 (0.22)

23 (0.22)

-0.32 [-0.79, 0.15]

Other congenital malformations of the digestive system

213 (0.18)

20 (0.18)

Recurring oral aphthae

215 (0.22)

41 (0.38)

-0.40 [-1.33, 0.54]

Lesion of plantar nerve

217 (0.23)

38 (0.33)

0.13 [-0.37, 0.63]

Other and unspecified disorders of white blood cells

221 (0.23)

25 (0.24)

0.20 [-0.47, 0.88]

Other salmonella infections

223 (0.23)

27 (0.25)

-0.28 [-0.78, 0.22]

Intermittent heterotropia

228 (0.18)

32 (0.28)

-0.43 [-0.87, 0.01]

Other disorders of male genital organs

230 (0.23)

31 (0.29)

0.34 [-0.32, 1.00]

Tongue abnormality

232 (0.24)

36 (0.32)

-0.07 [-0.63, 0.49]

Other and unspecified types of non-Hodgkin lymphoma, hilmo

234 (0.24)

36 (0.34)

Volvulus

236 (0.25)

19 (0.19)

Adenocarcinoma and papillary adenocarcinoma of stomach

243 (0.23)

13 (0.13)

Scabies

245 (0.24)

30 (0.28)

0.43 [-0.02, 0.89]

Fibromyalgia

248 (0.25)

62 (0.48)

-0.01 [-0.31, 0.28]

Other infective otitis externa

249 (0.25)

42 (0.37)

-0.19 [-0.57, 0.20]

Malignant neoplasm of thyroid gland

252 (0.25)

53 (0.45)

Presbyopia

256 (0.27)

56 (0.49)

-0.46 [-1.34, 0.42]

Pyothorax

260 (0.27)

28 (0.26)

Crohn's disease of large intestine

264 (0.28)

60 (0.53)

-0.16 [-0.52, 0.20]

Benign neoplasm of brain and other parts of central nervous system

269 (0.27)

47 (0.41)

-0.59 [-1.07, -0.11]

Residual foreign body in soft tissue

271 (0.26)

31 (0.28)

0.08 [-0.52, 0.67]

Systemic atrophies primarily affecting the central nervous system

274 (0.27)

31 (0.29)

0.52 [-0.96, 2.00]

Intrahepatic Cholestasis of Pregnancy (ICP)

279 (0.27)

35 (0.29)

Pneumonia due to Streptococcus pneumoniae

282 (0.28)

25 (0.23)

-0.35 [-2.65, 1.95]

Other/unspecified enthesopathies of lower limb, excluding foot

286 (0.28)

57 (0.47)

-0.36 [-0.82, 0.10]

Non-Hodgkin lymphoma, all

289 (0.28)

28 (0.26)

Obsessive-compulsive disorder

293 (0.26)

34 (0.28)

-0.03 [-0.37, 0.32]

Non-small cell lung cancer, squamous

295 (0.28)

41 (0.37)

Congenital malformations of eye, ear, face and neck

299 (0.24)

43 (0.36)

-0.36 [-1.13, 0.40]

Paralytic strabismus

305 (0.30)

39 (0.33)

1.00 [-2.10, 4.10]

Female infertility, associated with anovulation

309 (0.29)

56 (0.43)

0.23 [-0.14, 0.60]

Osteoporosis with pathological fracture (FG)

312 (0.30)

39 (0.34)

-0.00 [-0.36, 0.36]

Crohn disease (strict definition, require KELA, min 2 HDR)

315 (0.33)

66 (0.57)

-0.24 [-0.55, 0.06]

Other noninflammatory disorders of vulva and perineum

318 (0.29)

46 (0.35)

-0.02 [-0.52, 0.49]

Other specified/unspecified soft tissue disorders

321 (0.31)

37 (0.33)

0.20 [-0.23, 0.62]

Normotensive glaucoma

323 (0.31)

63 (0.52)

0.05 [-0.23, 0.33]

Other and unspecified abdominal hernia

326 (0.34)

51 (0.48)

0.29 [-0.20, 0.77]

Toxic effect of ethanol

327 (0.30)

27 (0.25)

-0.13 [-0.58, 0.32]

Other spirochaetal diseases

330 (0.31)

198 (0.99)

-0.32 [-0.89, 0.25]

Benign neoplasm: Stomach

337 (0.33)

74 (0.58)

0.17 [-0.43, 0.77]

Rheumatic fever incl heart disease

341 (0.33)

31 (0.30)

0.14 [-0.55, 0.83]

Other and unspecified psoriasis

343 (0.34)

45 (0.39)

0.09 [-0.22, 0.40]

Fracture of neck

348 (0.34)

41 (0.36)

-0.30 [-1.06, 0.45]

Other benign neoplasms of uterus

354 (0.33)

35 (0.32)

0.02 [-0.42, 0.46]

Other and unspecified mood [affective] disorders

356 (0.32)

48 (0.39)

-0.44 [-0.92, 0.04]

Post-traumatic stress disorder

358 (0.31)

52 (0.40)

-0.01 [-0.39, 0.38]

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

364 (0.35)

72 (0.58)

-0.11 [-0.35, 0.14]

Benign neoplasm of meninges

368 (0.34)

62 (0.48)

0.15 [-0.22, 0.53]

Asthma mixed form (mode)

370 (0.34)

50 (0.43)

Malignant neoplasm of corpus uteri

375 (0.34)

55 (0.46)

Antepartum haemorrhage, not elsewhere classified

379 (0.34)

54 (0.42)

0.06 [-0.57, 0.68]

Hydrocephalus

382 (0.36)

62 (0.51)

0.31 [-0.02, 0.65]

Other diseases of stomach and duodenum

435 (0.42)

60 (0.52)

1.00 [0.18, 1.82]

Malignant neoplasm of rectum

439 (0.39)

77 (0.61)

Viral hepatitis

443 (0.38)

69 (0.57)

0.02 [-0.38, 0.43]

Disorders of optic nerve and visual pathways

449 (0.40)

71 (0.55)

-0.07 [-0.52, 0.37]

Multiple gestation

455 (0.41)

80 (0.61)

-0.16 [-0.89, 0.57]

Disturbance of activity and attention

460 (0.28)

52 (0.38)

0.23 [-0.08, 0.55]

Spermatocele

468 (0.44)

73 (0.60)

-0.15 [-0.52, 0.22]

Other benign neoplasms of connective and other soft tissue

475 (0.42)

84 (0.64)

0.32 [-0.46, 1.11]

Otitis externa, unspecified

480 (0.39)

74 (0.54)

0.17 [-0.19, 0.54]

Benign neoplasm of major salivary glands

487 (0.45)

75 (0.58)

0.14 [-0.32, 0.59]

Malignant neoplasm of kidney, except renal pelvis

491 (0.44)

62 (0.50)

Other inflammation of eyelid

498 (0.42)

93 (0.64)

-0.38 [-0.92, 0.15]

Macular pucker

502 (0.45)

103 (0.71)

0.01 [-0.26, 0.28]

Streptococcal septicaemia

513 (0.45)

83 (0.67)

0.56 [0.02, 1.10]

Perforation of tympanic membrane

518 (0.42)

80 (0.61)

0.01 [-0.32, 0.34]

Trigger finger

527 (0.45)

97 (0.63)

0.05 [-0.27, 0.36]

Benign neoplasm of mouth and pharynx

533 (0.47)

91 (0.67)

0.27 [-0.40, 0.93]

Migraine without aura and triptan purchases

540 (0.43)

128 (0.77)

0.13 [-0.11, 0.37]

Ulcerative colitis, NAS

543 (0.45)

97 (0.63)

-0.35 [-0.59, -0.11]

Alcohol-induced chronic pancreatitis

546 (0.50)

74 (0.64)

0.21 [-0.10, 0.53]

Seropositive rheumatoid arthritis, strict definition

553 (0.48)

117 (0.76)

0.08 [-0.13, 0.30]

Benign neoplasm of breast

557 (0.46)

86 (0.61)

-0.24 [-0.63, 0.15]

Seronegative rheumatoid arthritis

569 (0.49)

90 (0.63)

0.14 [-0.19, 0.47]

Diabetic maculopathy

574 (0.51)

0.27 [-0.07, 0.62]

Other disorders of amniotic fluid and membranes

579 (0.45)

84 (0.55)

0.05 [-0.58, 0.67]

Malignant melanoma of skin

587 (0.50)

86 (0.64)

Disorders of muscles

590 (0.50)

87 (0.65)

0.08 [-0.38, 0.54]

Bacterial, viral and other infectious agents

605 (0.51)

75 (0.59)

Other disorders of kidney and ureter

611 (0.52)

119 (0.85)

Other diseases of oesophagus

617 (0.51)

88 (0.67)

0.26 [-0.30, 0.82]

Perineal laceration during delivery

627 (0.44)

99 (0.59)

-0.01 [-0.48, 0.47]

Benign leiomyoma with endometriosis

638 (0.50)

114 (0.73)

Retinal breaks without detachment

654 (0.54)

116 (0.75)

0.03 [-0.23, 0.28]

Benign neoplasm of eye and adnexa

402 (0.37)

70 (0.54)

-0.37 [-2.05, 1.31]

Neuromuscular dysfunction of bladder

403 (0.38)

68 (0.53)

0.09 [-0.27, 0.45]

Chronic suppurative otitis media

408 (0.34)

53 (0.44)

0.13 [-0.36, 0.61]

Memory loss

411 (0.37)

66 (0.52)

0.35 [-0.34, 1.04]

Ptosis of eyelid

416 (0.39)

94 (0.71)

-0.01 [-0.40, 0.38]

Malignant neoplasm of bladder

419 (0.38)

42 (0.35)

Other complications of labour and delivery, not elsewhere classified

424 (0.35)

69 (0.48)

-0.08 [-0.65, 0.49]

Pyogenic arthritis

426 (0.39)

55 (0.46)

0.00 [-0.57, 0.58]

Pruritus

429 (0.37)

71 (0.52)

0.43 [0.06, 0.79]

Postprocedural endocrine and metabolic disorders, not elsewhere classified

431 (0.40)

95 (0.66)

0.17 [-0.20, 0.54]

Viral warts

437 (0.38)

80 (0.60)

0.29 [-0.25, 0.82]

Social phobias

440 (0.35)

60 (0.46)

0.14 [-0.17, 0.45]

Ménière disease

444 (0.40)

60 (0.47)

0.28 [-0.14, 0.69]

Invasive ventilation

454 (0.42)

66 (0.56)

0.35 [-0.21, 0.91]

Arterial embolism and thrombosis

458 (0.41)

35 (0.31)

-0.08 [-0.54, 0.39]

Endometriosis diagnosis and infertility diagnosis occurring together

464 (0.42)

97 (0.71)

-0.10 [-0.37, 0.18]

Benign neoplasm: Caecum

471 (0.47)

91 (0.71)

0.19 [-0.19, 0.58]

Mental disorders, not otherwise specified

476 (0.41)

67 (0.53)

0.16 [-0.41, 0.72]

Divergent concomitant strabismus

482 (0.42)

71 (0.58)

0.17 [-0.17, 0.50]

Use of antiglaucoma preparations and miotics

494 (0.43)

73 (0.59)

-0.11 [-0.45, 0.22]

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

501 (0.40)

102 (0.62)

-0.31 [-0.54, -0.08]

Other diseases of biliary tract

507 (0.46)

74 (0.60)

0.65 [-0.11, 1.40]

Idiopathic gout

520 (0.48)

79 (0.64)

-0.06 [-0.33, 0.21]

Other and unspecified myopathies

527 (0.46)

67 (0.54)

0.81 [0.06, 1.55]

Malignant neoplasm of urinary organs

536 (0.47)

68 (0.53)

Respiratory tuberculosis

537 (0.45)

51 (0.45)

0.23 [-0.26, 0.71]

Benign neoplasm of other and unspecified endocrine glands

541 (0.49)

123 (0.87)

0.32 [-0.13, 0.76]

Acute gastritis

545 (0.48)

62 (0.51)

0.30 [-0.14, 0.74]

Tubulo-interstitial nephritis, not specified as acute or chronic

550 (0.47)

49 (0.41)

0.07 [-0.86, 1.00]

Other disorders of the genitourinary system

557 (0.50)

109 (0.78)

0.29 [-0.37, 0.95]

Other local infections of skin and subcutaneous tissue

561 (0.47)

70 (0.53)

0.22 [-0.35, 0.79]

Postpartum haemorrhage due to retained placenta

571 (0.47)

84 (0.58)

0.12 [-0.30, 0.53]

Other/unspecified synovitis and tenosynovitis

577 (0.48)

98 (0.69)

0.03 [-0.53, 0.58]

Chalazion

580 (0.46)

82 (0.59)

0.05 [-0.27, 0.37]

Diabetic neuropathy

590 (0.53)

78 (0.60)

0.39 [-0.10, 0.89]

Glomerular disorders in diseases classified elsewhere

593 (0.54)

131 (0.96)

-0.00 [-0.43, 0.43]

Hypertrophy of breast

605 (0.51)

141 (0.85)

0.02 [-0.16, 0.21]

Coeliac disease

615 (0.49)

91 (0.64)

0.04 [-0.39, 0.47]

Other keratitis

618 (0.49)

85 (0.62)

-0.16 [-0.67, 0.35]

Hydronephrosis

633 (0.53)

93 (0.68)

-0.26 [-0.72, 0.19]

Sequelae of infectious and parasitic diseases

643 (0.53)

67 (0.54)

0.03 [-1.31, 1.36]

Benign mammary dysplasia

652 (0.51)

90 (0.60)

-0.15 [-0.61, 0.31]

Other sleep disorders

669 (0.55)

90 (0.65)

0.34 [-0.17, 0.84]

Prolonged pregnancy

680 (0.49)

100 (0.61)

-0.14 [-0.51, 0.24]

Purpura and other haemorrhagic conditions

688 (0.53)

102 (0.70)

0.17 [-0.46, 0.80]

Retinal detachment with retinal break

693 (0.57)

116 (0.81)

0.29 [0.02, 0.57]

Pneumonitis due to solids and liquids

706 (0.57)

66 (0.53)

Abdominal aortic aneurysm (AAA)

717 (0.61)

117 (0.86)

0.03 [-0.22, 0.28]

Chronic periodontitis

725 (0.60)

136 (0.89)

Unspecified lump in breast

734 (0.56)

127 (0.81)

0.08 [-0.29, 0.45]

Other bursopathies

751 (0.60)

127 (0.86)

-0.11 [-0.50, 0.28]

Glaucoma, exfoliation

762 (0.57)

77 (0.57)

-0.09 [-0.40, 0.22]

Inflammatory diseases of prostate (prostatitis)

780 (0.64)

115 (0.79)

0.03 [-0.27, 0.33]

Erosion of teeth, including avohilmo

788 (0.56)

179 (0.97)

-0.11 [-0.40, 0.18]

Malignant neoplasm of breast, HER-negative

810 (0.55)

143 (0.81)

Other and unspecified nerve root and plexus disorders, also in other diseases

823 (0.64)

171 (0.99)

0.16 [-0.13, 0.44]

Other embolism and thrombosis

832 (0.64)

104 (0.72)

0.21 [-0.08, 0.50]

Spondylolisthesis/Spondylolysis

859 (0.65)

148 (0.86)

0.09 [-0.12, 0.30]

Maternal care for known or suspected malpresentation of fetus

875 (0.58)

148 (0.82)

0.08 [-0.27, 0.43]

Seborrhoeic keratosis

891 (0.67)

183 (1.00)

-0.15 [-0.51, 0.22]

Cerebral palsy and other paralytic syndromes

931 (0.66)

102 (0.73)

-0.09 [-0.65, 0.46]

Nonorganic sleeping disorders

941 (0.63)

161 (0.91)

Nontoxic multinodular goitre

951 (0.66)

155 (0.88)

0.09 [-0.10, 0.29]

Myalgia

963 (0.64)

215 (1.07)

-0.09 [-0.36, 0.19]

Other infectious diseases

557 (0.49)

52 (0.42)

Other disorders of bladder

565 (0.50)

104 (0.75)

0.13 [-0.49, 0.74]

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

573 (0.49)

88 (0.61)

0.22 [-0.14, 0.59]

Other contact dermatitis

579 (0.49)

65 (0.51)

0.11 [-0.28, 0.49]

Degenerative macular diseases

586 (0.50)

108 (0.78)

-0.25 [-0.71, 0.22]

Hallux rigidus

590 (0.50)

129 (0.85)

0.05 [-0.18, 0.27]

Other disorders of eye and adnexa

609 (0.48)

95 (0.63)

0.23 [-0.18, 0.64]

Infective dermatitis

616 (0.50)

87 (0.62)

0.25 [-0.14, 0.63]

Persistent delusional disorders

620 (0.51)

61 (0.50)

0.09 [-0.26, 0.44]

627 (0.51)

55 (0.47)

-1.00 [-3.01, 1.01]

Thyrotoxicosis with diffuse goitre

638 (0.52)

108 (0.71)

0.24 [0.01, 0.48]

Inguinal hernia, bilateral

654 (0.56)

95 (0.72)

0.10 [-0.19, 0.39]

Other disorders of conjunctiva

661 (0.53)

96 (0.65)

-0.27 [-0.69, 0.15]

Cardiac arrest

673 (0.56)

51 (0.42)

0.04 [-0.43, 0.51]

Volume depletion

680 (0.53)

76 (0.59)

-0.48 [-1.22, 0.27]

Viral pneumonia

689 (0.53)

112 (0.77)

-0.19 [-0.76, 0.37]

Disorder of lipoprotein metabolism, unspecified

696 (0.58)

124 (0.84)

0.37 [-0.03, 0.76]

Endometriosis ASRM stages 1,2

722 (0.56)

137 (0.80)

Alcohol withdrawal state with delirium

729 (0.59)

59 (0.50)

0.09 [-0.26, 0.44]

Malignant melanoma

738 (0.58)

109 (0.73)

Tuberculosis, wide

755 (0.57)

65 (0.53)

0.33 [-0.28, 0.94]

Pain in thoracic spine

767 (0.58)

123 (0.77)

0.04 [-0.30, 0.38]

Obstructed labour due to maternal pelvic abnormality

782 (0.60)

137 (0.88)

0.02 [-0.23, 0.27]

Postmenopausal atrophic vaginitis

799 (0.60)

225 (1.06)

-0.26 [-0.71, 0.18]

Benign neoplasm of ovary

812 (0.59)

128 (0.79)

0.16 [-0.28, 0.59]

Ectopic pregnancy

841 (0.61)

128 (0.76)

0.24 [-0.08, 0.56]

Panic disorder

865 (0.59)

115 (0.71)

0.04 [-0.24, 0.31]

Delirium, not induced by alcohol and other psychoactive substances

884 (0.64)

73 (0.54)

0.39 [-0.23, 1.01]

Non-small cell lung cancer

888 (0.64)

156 (0.99)

Diabetic nephropathy

922 (0.73)

144 (0.97)

-0.06 [-0.65, 0.52]

Acute and transient psychotic disorders

934 (0.68)

100 (0.70)

-0.11 [-0.41, 0.20]

Adhesive capsulitis of shoulder

943 (0.72)

166 (1.00)

0.06 [-0.22, 0.35]

Maternal care for other conditions predominantly related to pregnancy

958 (0.64)

166 (0.87)

-0.10 [-0.41, 0.21]

Certain disorders involving the immune mechanism

976 (0.73)

195 (1.13)

0.22 [-0.08, 0.52]

Other diseases of intestine

996 (0.84)

147 (1.05)

0.15 [-0.33, 0.62]

Other (seronegative) rheumatoid arthritis, wide

1027 (0.72)

160 (0.93)

0.17 [-0.11, 0.46]

Duodenal ulcer

1039 (0.76)

119 (0.86)

0.14 [-0.25, 0.53]

Pre-eclampsia or eclampsia

1052 (0.69)

160 (0.84)

-0.00 [-0.25, 0.25]

Enthesopathies of lower limb, excluding foot

1061 (0.72)

209 (1.07)

0.12 [-0.17, 0.42]

AV-block

1076 (0.76)

163 (0.96)

-0.03 [-0.28, 0.21]

All dysplastic lesions of the cervix uteri

1101 (0.69)

179 (0.85)

-0.14 [-0.43, 0.15]

Lung diseases due to external agents

1109 (0.75)

140 (0.94)

0.25 [-0.57, 1.08]

Non-invasive ventilation

1115 (0.79)

235 (1.16)

0.29 [-0.12, 0.69]

Iridocyclitis

1145 (0.71)

184 (0.95)

-0.04 [-0.30, 0.23]

Other disorders of bone

1179 (0.73)

187 (1.02)

-0.04 [-0.39, 0.31]

Malignant neoplasm of skin

1205 (0.78)

607 (1.54)

Hydrocele

1229 (0.81)

139 (0.97)

-0.08 [-0.40, 0.24]

Thyrotoxicosis

1275 (0.80)

208 (1.02)

0.26 [0.03, 0.50]

Benign neoplasm: Colon, unspecified

1306 (0.91)

265 (1.39)

0.01 [-0.32, 0.33]

Aortic aneurysm

1366 (0.92)

259 (1.35)

0.07 [-0.14, 0.29]

Acute renal failure

1417 (0.93)

220 (1.25)

0.02 [-0.35, 0.39]

Early onset COPD

1570 (0.96)

240 (1.28)

0.22 [0.03, 0.41]

Other appendicitis

2238 (1.99)

252 (2.02)

0.25 [-0.42, 0.93]

Other/unspecified seropositive rheumatoid arthritis

1393 (0.83)

Functional dyspepsia

1440 (0.86)

221 (1.02)

-0.04 [-0.35, 0.26]

Other systemic involvement of connective tissue (FG)

1370 (0.82)

236 (1.11)

0.09 [-0.20, 0.38]

Colorectal cancer

2071 (1.24)

290 (1.55)

Psoriasis

1528 (0.91)

240 (1.08)

0.00 [-0.18, 0.18]

All dysplastic lesions of the cervix uteri, vagina or vulva

1259 (0.74)

210 (0.92)

-0.18 [-0.52, 0.15]

Alcohol abuse, main dg

1376 (0.81)

150 (0.94)

Other and unspecified nonorganic psychotic disorders

1379 (0.81)

198 (1.08)

-0.05 [-0.31, 0.20]

Colonic or urogenital fistula

1640 (0.96)

249 (1.16)

-0.08 [-0.31, 0.15]

Coronary artery bypass grafting

1771 (1.03)

308 (1.35)

0.06 [-0.12, 0.23]

101

Acute pharyngitis

891 (0.51)

119 (0.73)

0.11 [-0.36, 0.58]

Persistent mood disorders

1480 (0.85)

188 (1.03)

0.00 [-0.22, 0.22]

Malignant neoplasm of bronchus and lung

1319 (0.76)

188 (1.09)

Single delivery by forceps and vacuum extractor

1087 (0.62)

152 (0.73)

-0.17 [-0.54, 0.21]

Fracture of lumbar spine and pelvis

1514 (0.87)

187 (1.02)

0.02 [-0.30, 0.33]

Chronic gastritis

1651 (0.93)

282 (1.29)

0.23 [-0.15, 0.62]

Benign lipomatous neoplasm

1659 (0.93)

259 (1.16)

0.19 [-0.14, 0.53]

TMD related pain

1392 (0.78)

15 (0.14)

Primary open-angle glaucoma, strict

1622 (0.90)

223 (1.11)

0.01 [-0.19, 0.21]

Other enthesopathies

1672 (0.93)

283 (1.18)

-0.06 [-0.30, 0.19]

Speech and linguistic disorders

540 (0.30)

40 (0.30)

Substance use, excluding alcohol

1595 (0.88)

206 (1.13)

0.11 [-0.11, 0.33]

Chronic kidney disease

1908 (1.05)

320 (1.45)

-0.08 [-0.41, 0.25]

Female infertility, cervigal, vaginal, other or unspecified origin

1636 (0.90)

276 (1.10)

0.15 [-0.14, 0.44]

Osteoporosis

1504 (0.82)

204 (1.03)

0.06 [-0.18, 0.29]

Maternal care for known or suspected abnormality of pelvic organs

1393 (0.76)

219 (0.96)

0.17 [-0.20, 0.53]

Cutaneous abscess, furuncle and carbuncle

1688 (0.92)

273 (1.30)

0.09 [-0.22, 0.40]

Other arthritis (FG)

1644 (0.90)

277 (1.14)

-0.10 [-0.36, 0.16]

Dentofacial anomalies [including malocclusion]

1278 (0.68)

229 (0.98)

-0.11 [-0.46, 0.23]

Other disorders of veins

1883 (1.01)

348 (1.27)

0.07 [-0.11, 0.25]

Maternal care for other known or suspected fetal problems

1280 (0.68)

217 (0.90)

0.06 [-0.33, 0.45]

Peritonsillar abscess

1427 (0.76)

179 (0.91)

-0.10 [-0.31, 0.11]

Pre-eclampsia or poor fetal growth

1492 (0.79)

226 (0.95)

0.03 [-0.22, 0.27]

Other menopausal disorders

1932 (1.02)

482 (1.42)

-0.10 [-0.35, 0.16]

Status post-ami

1566 (0.82)

77 (0.60)

0.11 [-0.20, 0.42]

Other viral diseases, not elsewhere classified

1248 (0.65)

156 (0.88)

0.35 [-0.57, 1.28]

Fracture of foot, except ankle

1473 (0.76)

197 (0.97)

0.39 [0.04, 0.73]

Deviated nasal septum

2037 (1.04)

292 (1.16)

0.04 [-0.21, 0.29]

Postmenopausal bleeding

1845 (0.94)

284 (1.12)

0.02 [-0.28, 0.32]

Systemic connective tissue disorders

1837 (0.93)

318 (1.25)

0.04 [-0.29, 0.37]

Glaucoma suspect

2006 (1.01)

309 (1.25)

0.17 [-0.04, 0.38]

Personality disorders

1938 (0.97)

276 (1.23)

Basal cell carcinoma

2115 (1.06)

541 (1.52)

Acute alcohol intoxication, ICD10

1853 (0.92)

181 (1.00)

0.24 [-0.00, 0.47]

Other and unspecified iron deficiency

1849 (0.91)

290 (1.21)

0.12 [-0.18, 0.41]

Other strabismus

1282 (0.63)

176 (0.91)

-0.11 [-0.44, 0.21]

Excessive attrition of teeth

1784 (0.87)

413 (1.28)

-0.15 [-0.42, 0.13]

Rheumatoid arthritis

2026 (0.99)

306 (1.20)

0.09 [-0.11, 0.29]

Pulmonary embolism

2186 (1.07)

302 (1.37)

0.08 [-0.19, 0.34]

Papulosquamous disorders

2114 (1.03)

349 (1.26)

-0.02 [-0.22, 0.17]

Infections with a predominantly sexual mode of transmission

1782 (0.87)

264 (1.08)

0.19 [-0.14, 0.53]

Coronary angioplasty

2426 (1.17)

389 (1.41)

0.01 [-0.21, 0.22]

Acute bronchiolitis

304 (0.15)

18 (0.15)

-0.15 [-0.84, 0.53]

Temporomandibular joint disorders, including avohilmo

1630 (0.78)

330 (1.08)

-0.04 [-0.32, 0.24]

Polyp of the female genital tract

2094 (1.00)

350 (1.20)

-0.05 [-0.32, 0.23]

Hypothyroidism, drug reimbursement

2001 (0.95)

335 (1.32)

0.23 [-0.02, 0.48]

Acute laryngitis and tracheitis

742 (0.35)

93 (0.61)

0.12 [-0.16, 0.39]

Disorders of refraction and accommodation

1256 (0.59)

232 (1.07)

-0.11 [-0.56, 0.33]

Other disorders of eyelid

2230 (1.05)

410 (1.39)

-0.12 [-0.35, 0.10]

Behavioural syndromes associated with physiological disturbances and physical factors

1766 (0.82)

263 (1.05)

0.04 [-0.27, 0.36]

Allergic asthma (mode)

1339 (0.62)

216 (0.94)

0.14 [-0.09, 0.36]

Endometriosis

2036 (0.94)

360 (1.21)

-0.05 [-0.21, 0.12]

Single delivery by caesarean section

1865 (0.85)

302 (1.07)

-0.05 [-0.37, 0.26]

Unstable angina pectoris

2627 (1.17)

356 (1.33)

-0.04 [-0.24, 0.17]

Second line medication for Crohn's disease

2474 (1.10)

522 (1.37)

-0.06 [-0.26, 0.14]

Unspecified dementia

1995 (0.87)

87 (0.59)

-0.24 [-0.65, 0.16]

Pregnancy hypertension

2159 (0.95)

359 (1.21)

0.00 [-0.19, 0.19]

Hallux valgus (acquired)

2279 (0.99)

371 (1.29)

-0.07 [-0.25, 0.11]

Chronic sinusitis

2434 (1.05)

420 (1.33)

0.10 [-0.10, 0.31]

Hypertensive Heart Disease

2517 (1.09)

262 (1.25)

0.23 [-0.02, 0.48]

Diseases of liver

2546 (1.10)

331 (1.35)

-0.02 [-0.29, 0.25]

Other headache syndromes

2413 (1.02)

424 (1.35)

0.16 [-0.06, 0.38]

Alzheimer’s disease (Late onset)

2261 (0.95)

152 (0.80)

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2071 (0.87)

292 (1.23)

False labour

1959 (0.82)

319 (1.03)

0.01 [-0.25, 0.27]

Primary gonarthrosis, bilateral

2917 (1.21)

478 (1.45)

-0.01 [-0.18, 0.16]

Kela-code for severe mental illness

2919 (1.21)

420 (1.50)

-0.07 [-0.28, 0.15]

Degeneration of macula and posterior pole

2667 (1.09)

404 (1.31)

-0.16 [-0.34, 0.03]

Visual disturbances

2350 (0.96)

439 (1.38)

-0.10 [-0.43, 0.22]

Other diseases of pleura

3073 (1.25)

468 (1.56)

0.08 [-0.27, 0.42]

Hernia of abdominal wall

4365 (1.78)

646 (2.13)

0.10 [-0.09, 0.30]

Benign neoplasm of colon, rectum, anus and anal canal

3771 (1.53)

741 (1.93)

0.11 [-0.11, 0.33]

Renal failure

3250 (1.31)

504 (1.73)

0.03 [-0.25, 0.30]

Gonarthrosis, primary, with knee surgery

3058 (1.23)

580 (1.62)

0.00 [-0.15, 0.16]

Allergic rhinitis

1569 (0.63)

245 (0.97)

-0.01 [-0.21, 0.20]

Non-ischemic cardiomyopathy

2788 (1.10)

324 (1.40)

0.30 [-0.00, 0.61]

Other viral diseases

1999 (0.78)

251 (1.06)

0.41 [-0.15, 0.97]

Epilepsy

2605 (1.02)

277 (1.11)

0.19 [-0.08, 0.47]

Iron deficiency anaemia

2726 (1.07)

380 (1.32)

0.18 [-0.13, 0.49]

Alcohol dependence

3028 (1.19)

295 (1.35)

0.03 [-0.17, 0.23]

Sciatica+with lumbago

3126 (1.22)

541 (1.50)

0.00 [-0.18, 0.18]

Ovarian cyst

3182 (1.23)

569 (1.50)

0.09 [-0.12, 0.30]

Recurrent or chronic depression

2563 (0.98)

466 (1.30)

0.04 [-0.13, 0.21]

Female genital prolapse

2639 (1.01)

390 (1.20)

0.02 [-0.15, 0.19]

Migraine

2276 (0.86)

445 (1.21)

0.04 [-0.14, 0.22]

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3047 (1.15)

513 (1.40)

0.01 [-0.24, 0.26]

Dental pulpitis 3

766 (0.29)

34 (0.21)

Viral and other specified intestinal infections

1874 (0.70)

183 (0.90)

0.14 [-0.27, 0.55]

Fracture at wrist and hand level

2434 (0.89)

313 (1.20)

-0.03 [-0.31, 0.25]

Viral infections characterized by skin and mucous membrane lesions

2677 (0.98)

402 (1.36)

0.14 [-0.49, 0.76]

Disorders of skin appendages

2675 (0.97)

446 (1.33)

-0.17 [-0.45, 0.10]

Coxarthrosis, primary

3427 (1.25)

552 (1.49)

0.09 [-0.10, 0.28]

Atherosclerosis, excluding cerebral and coronary sclerosis

3540 (1.28)

431 (1.48)

0.20 [-0.01, 0.40]

Carpal tunnel syndrome

3573 (1.28)

622 (1.53)

0.03 [-0.12, 0.18]

Bacterial infection, other or unspecified

3845 (1.38)

590 (1.69)

0.32 [-0.09, 0.74]

Fracture of femur

2887 (1.02)

225 (1.04)

0.47 [0.13, 0.81]

Menorrhagia

3247 (1.13)

534 (1.40)

0.08 [-0.12, 0.28]

Noninfective enteritis and colitis

3155 (1.10)

480 (1.45)

-0.23 [-0.46, -0.01]

COPD

4054 (1.41)

596 (1.78)

0.26 [0.09, 0.43]

Rotator cuff syndrome

4025 (1.38)

676 (1.59)

-0.02 [-0.22, 0.18]

Appendectomy

28805 (10.67)

4634 (11.26)

0.75 [0.48, 1.02]*

Non-rheumatic valve diseases

3686 (1.25)

607 (1.60)

Inflammatory diseases of female pelvic organs

4128 (1.37)

651 (1.58)

0.10 [-0.14, 0.34]

Cholecystectomy

4680 (1.55)

849 (1.84)

0.16 [-0.03, 0.36]

Alzheimer disease

3318 (1.08)

236 (1.01)

0.03 [-0.27, 0.34]

Other anxiety disorders

2873 (0.93)

407 (1.18)

0.07 [-0.12, 0.26]

Disorders of sclera, cornea, iris and ciliary body

3448 (1.11)

511 (1.38)

0.11 [-0.17, 0.38]

Other and unspecified tonsillitis

2907 (0.93)

324 (1.15)

0.12 [-0.17, 0.41]

Heart failure and coronary heart disease

3909 (1.26)

385 (1.44)

0.22 [-0.01, 0.45]

Glaucoma

3908 (1.24)

552 (1.53)

0.06 [-0.11, 0.23]

110

Acute bronchitis

3454 (1.09)

415 (1.37)

0.27 [-0.07, 0.61]

Other functional intestinal disorders

3575 (1.12)

499 (1.54)

0.29 [0.01, 0.57]

Coxarthrosis

4161 (1.30)

614 (1.53)

0.09 [-0.10, 0.27]

Nonsuppurative otitis media

1362 (0.42)

130 (0.60)

0.20 [-0.10, 0.49]

Acute sinusitis

3771 (1.16)

508 (1.33)

0.13 [-0.10, 0.35]

Disorders of ocular muscles, binocular movement, accommodation and refraction

2728 (0.83)

427 (1.28)

-0.04 [-0.37, 0.28]

Venous thromboembolism

4426 (1.35)

580 (1.63)

0.18 [-0.05, 0.40]

Pain in joint

3911 (1.15)

727 (1.48)

0.14 [-0.06, 0.34]

Atrial fibrillation and flutter with reimbursement

5254 (1.50)

888 (1.79)

0.14 [-0.08, 0.36]

146

Parodontitis or/and operation codes

4755 (1.35)

935 (1.70)

Other degenerative diseases of the nervous system

4174 (1.17)

342 (1.20)

0.27 [-0.03, 0.57]

Pure hypercholesterolaemia

5490 (1.51)

922 (1.75)

-0.01 [-0.23, 0.22]

Infections of the skin and subcutaneous tissue

4367 (1.17)

615 (1.56)

0.12 [-0.14, 0.38]

Other arrhythmias

4945 (1.32)

764 (1.57)

0.08 [-0.13, 0.29]

Diverticular disease of intestine

6286 (1.67)

1029 (1.96)

-0.13 [-0.30, 0.05]

104

Sleep apnoea

6144 (1.63)

1282 (1.93)

0.06 [-0.09, 0.22]

Leiomyoma of uterus

4475 (1.17)

724 (1.39)

0.03 [-0.13, 0.19]

141

Hyperplasia of prostate

6543 (1.70)

973 (1.93)

-0.12 [-0.33, 0.09]

Parodontitis or operation codes

5402 (1.39)

995 (1.70)

Sleep apnoea, including avohilmo

6569 (1.63)

1406 (1.94)

0.04 [-0.12, 0.20]

Other neurological diseases

5715 (1.40)

747 (1.60)

0.05 [-0.22, 0.32]

Disorders of eyelid, lacrimal system and orbit

5089 (1.24)

885 (1.57)

-0.11 [-0.35, 0.13]

Disorders of choroid and retina

5870 (1.41)

904 (1.66)

0.05 [-0.23, 0.32]

Sensorineural hearing loss

5710 (1.37)

874 (1.61)

-0.06 [-0.23, 0.11]

Anomalies of dental arch relationship, including avohilmo

1237 (0.29)

136 (0.67)

-0.11 [-0.54, 0.33]

All anxiety disorders

4302 (1.01)

586 (1.27)

0.03 [-0.15, 0.20]

Acute tubulo-interstitial nephritis

5636 (1.29)

660 (1.54)

0.20 [-0.08, 0.48]

Other intervertebral disc disorders

6534 (1.49)

1051 (1.71)

0.06 [-0.09, 0.22]

Varicose veins

6013 (1.36)

760 (1.59)

0.08 [-0.07, 0.23]

212

Anaemias

5883 (1.33)

806 (1.69)

0.12 [-0.12, 0.36]

Conjunctivitis

4261 (0.94)

693 (1.36)

-0.11 [-0.30, 0.08]

Sleep disorders (combined)

7157 (1.59)

1418 (1.89)

0.06 [-0.11, 0.23]

Alcohol use disorder, Swedish definition

6279 (1.38)

648 (1.70)

0.08 [-0.08, 0.24]

Any dementia

5602 (1.21)

376 (1.23)

Migraine, single triptan purchase ok & required. ICD-code if available is included

5286 (1.13)

920 (1.41)

0.18 [0.01, 0.35]

Other acute lower respiratory infections

4601 (0.95)

515 (1.35)

0.24 [-0.05, 0.52]

Other disorders of urethra and urinary system

5910 (1.22)

825 (1.47)

0.05 [-0.19, 0.29]

Asthma/COPD (KELA code 203)

6473 (1.32)

1078 (1.56)

0.05 [-0.11, 0.22]

125

Dementia

6077 (1.24)

451 (1.32)

0.01 [-0.25, 0.27]

Angina pectoris

7741 (1.53)

934 (1.73)

0.03 [-0.14, 0.20]

102

Stroke, excluding SAH

7158 (1.38)

749 (1.72)

-0.03 [-0.27, 0.20]

Suppurative and unspecified otitis media

2641 (0.50)

279 (0.92)

0.20 [-0.07, 0.48]

Lower back pain or/and sciatica

7337 (1.41)

1159 (1.65)

0.09 [-0.09, 0.26]

Maternal care related to the fetus and amniotic cavity and possible delivery problems

6180 (1.15)

960 (1.34)

-0.04 [-0.35, 0.27]

Myocardial infarction, strict

6757 (1.25)

672 (1.63)

0.17 [-0.03, 0.36]

Type 2 diabetes, wide definition

8770 (1.61)

1201 (1.84)

0.14 [-0.01, 0.29]

250

All-cause Heart Failure

8079 (1.44)

820 (1.76)

Bleeding

8037 (1.43)

1079 (1.84)

0.11 [-0.15, 0.36]

Heart failure, strict

8151 (1.44)

832 (1.77)

0.30 [0.07, 0.54]

Complications of labour and delivery

7206 (1.25)

1135 (1.46)

-0.15 [-0.44, 0.14]

Depression

7753 (1.27)

1086 (1.55)

0.02 [-0.15, 0.18]

Codeine or tramadol medication

9606 (1.57)

1716 (1.82)

0.09 [-0.08, 0.25]

Asthma

7266 (1.16)

1068 (1.54)

Dermatitis and eczema

6533 (1.03)

1149 (1.47)

0.09 [-0.11, 0.29]

Autoimmune diseases excluding thyroid diseases

9347 (1.44)

1337 (1.66)

0.16 [-0.06, 0.38]

Diseases of male genital organs

10712 (1.60)

1440 (1.93)

-0.22 [-0.45, 0.01]

Metabolic disorders

10994 (1.63)

1706 (1.89)

0.05 [-0.17, 0.26]

Diabetes, insulin treatment (Kela reimbursement)

11160 (1.65)

1658 (1.89)

Atrial fibrillation and flutter

10877 (1.61)

1376 (1.89)

0.16 [-0.05, 0.38]

160

STROKE

10115 (1.46)

1105 (1.75)

0.04 [-0.18, 0.26]

Hernia

13156 (1.82)

1752 (2.10)

0.03 [-0.14, 0.20]

115

Coronary atherosclerosis

11401 (1.56)

1343 (1.84)

0.10 [-0.07, 0.28]

147

Pregnancy with abortive outcome

9805 (1.33)

1459 (1.56)

-0.07 [-0.28, 0.15]

Intestinal infectious diseases

10172 (1.36)

1206 (1.83)

0.09 [-0.16, 0.33]

Type 2 diabetes, definitions combined

12402 (1.67)

1750 (1.88)

0.07 [-0.06, 0.20]

350

First line medication for Crohn's disease

11753 (1.53)

2070 (1.77)

0.15 [-0.01, 0.31]

Major coronary heart disease event

10932 (1.36)

1189 (1.80)

0.10 [-0.08, 0.28]

105

Use of hypnotics and sedatives

13521 (1.57)

1732 (1.80)

-0.02 [-0.17, 0.12]

Chronic lower respiratory diseases

11992 (1.34)

1754 (1.73)

0.08 [-0.09, 0.25]

106

Cardiac arrhythmias

14482 (1.61)

1960 (1.91)

0.22 [0.00, 0.43]

107

Malignant neoplasm

13597 (1.49)

2323 (1.91)

Episodal and paroxysmal disorders

15476 (1.56)

2482 (1.82)

0.06 [-0.11, 0.23]

Autoimmune diseases

16302 (1.51)

2430 (1.75)

0.16 [-0.05, 0.36]

207

Influenza and pneumonia

15723 (1.46)

1780 (1.87)

0.15 [-0.09, 0.38]

Hard cardiovascular diseases

15850 (1.42)

1706 (1.89)

0.09 [-0.09, 0.27]

Other heart diseases

18140 (1.62)

2228 (1.92)

0.11 [-0.09, 0.31]

Bronchitis

12378 (1.09)

1411 (1.60)

0.19 [-0.04, 0.41]

Soft tissue disorders

17687 (1.55)

2826 (1.83)

0.03 [-0.14, 0.21]

Noninflammatory disorders of female genital tract

16617 (1.42)

2597 (1.58)

0.07 [-0.13, 0.26]

Single spontaneous delivery

16344 (1.40)

2419 (1.55)

-0.20 [-0.43, 0.04]

Gingivitis and periodontal diseases

14545 (1.22)

2336 (1.55)

Hypertension, essential

20882 (1.72)

2915 (2.05)

0.00 [-0.14, 0.15]

327

Dorsopathies

19613 (1.55)

2874 (1.81)

0.05 [-0.10, 0.21]

Other diseases of upper respiratory tract

15681 (1.22)

2237 (1.60)

0.03 [-0.14, 0.21]

Acute upper respiratory infections

14701 (1.12)

1740 (1.60)

0.09 [-0.09, 0.28]

Depression medications

20099 (1.47)

2788 (1.73)

0.07 [-0.09, 0.24]

Statin medication

24186 (1.76)

3856 (1.98)

0.05 [-0.08, 0.19]

300

Hypertension

25262 (1.70)

-0.02 [-0.16, 0.13]

392

Falls/tendency to fall

19610 (1.31)

2504 (1.73)

0.03 [-0.14, 0.21]

Arthropathies

25115 (1.60)

3680 (1.87)

0.01 [-0.16, 0.17]

Diseases of oral cavity, salivary glands and jaws

21370 (1.27)

3359 (1.65)

-0.04 [-0.24, 0.15]

Any mental disorder

23272 (1.28)

2492 (1.66)

0.03 [-0.12, 0.18]

Dental caries 3 and operation codes, only avohilmo

22426 (1.19)

3383 (1.65)

Dental caries 1 and operation codes, only avohilmo

23820 (1.17)

3569 (1.63)

COPD/asthma/ILD related infections

27383 (1.30)

3074 (1.77)

0.14 [-0.05, 0.33]

Pain (limb, back, neck, head abdominally)

38975 (1.78)

5158 (2.05)

0.11 [-0.05, 0.27]

Antihypertensive medication - note that there are other indications

41125 (1.73)

5633 (1.98)

0.09 [-0.07, 0.25]

314

Cardiovascular diseases (excluding rheumatic etc)

41490 (1.61)

5152 (1.99)

0.04 [-0.13, 0.21]

101

Other disturbances of cerebral status of newborn

5 (0.01)

Neonatal aspiration syndromes

5 (0.01)

Congenital malformations of great veins

5 (0.01)

0.03 [-0.34, 0.39]

Periodic paralysis

5 (0.01)

Disorders of purine and pyrimidine metabolism, other/unspecified

5 (0.01)

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

5 (0.01)

-0.06 [-0.37, 0.25]

Lipodystrophy, not elsewhere classified

5 (0.01)

0 (0.00)

0.21 [-0.08, 0.49]

Lichen nitidus

5 (0.01)

Coccidioidomycosis

5 (0.01)

Congenital malformations of nose

5 (0.01)

0 (0.00)

0.12 [-0.16, 0.41]

Gangrene and necrosis of lung

5 (0.01)

Hypoplasia of dental enamel, prenatal , including avohilmo

5 (0.01)

0 (0.00)

-0.11 [-0.48, 0.26]

Subclinical iodine-deficiency hypothyroidism

5 (0.01)

Polydactyly

5 (0.01)

Photocontact dermatitis [berloque dermatitis]

5 (0.01)

Other disorders of bone development and growth

5 (0.01)

0 (0.00)

Epiphyseal arrest

5 (0.01)

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

5 (0.01)

Pseudosarcomatous fibromatosis

6 (0.01)

Benign neoplasm: Carotid body

6 (0.01)

-0.01 [-0.36, 0.33]

Benign neoplasm: Aortic body and other paraganglia

6 (0.01)

Calcification and ossification of muscle

6 (0.01)

0.18 [-0.14, 0.49]

Cardiomyopathy due to drugs and other external agents

6 (0.01)

-0.14 [-0.42, 0.14]

Nightmares

6 (0.01)

-0.01 [-0.30, 0.28]

Cyst of iris, ciliary body and anterior chamber

6 (0.01)

0.08 [-0.17, 0.33]

Congenital malformations of larynx

6 (0.01)

0.31 [-0.07, 0.69]

Kaposi sarcoma

6 (0.01)

Sequelae of hyperalimentation

6 (0.01)

-0.02 [-0.29, 0.26]

Other infective spondylopathies

7 (0.01)

0.09 [-0.18, 0.37]

Echinococcosis

7 (0.01)

Drug-induced acute pancreatitis

7 (0.01)

-0.15 [-0.42, 0.12]

Disorders of muscle tone of newborn

7 (0.01)

-0.01 [-0.33, 0.31]

Chronic drug-induced interstitial lung disorders

7 (0.01)

-0.07 [-0.35, 0.21]

Other and unspecified heterotropia

7 (0.01)

0.46 [0.06, 0.86]

Secondary lactase deficiency

7 (0.01)

Classical phenylketonuria

7 (0.01)

Congenital malformation syndromes due to known exogenous causes, not elsewhere classified

7 (0.01)

Congenital malformation of biliary tract

7 (0.01)

-0.10 [-0.46, 0.26]

Benign lipomatous neoplasm of intrathoracic organs

8 (0.01)

Calcium deposit in bursa

8 (0.01)

0 (0.00)

0.11 [-0.17, 0.40]

Carcinoma in situ of oral cavity and pharynx

8 (0.01)

Disorders of glycoprotein metabolism

8 (0.01)

Bladder disorders in in diseases classified elsewhere

8 (0.01)

Granulosa cell carcinoma of ovary

8 (0.01)

Syndactyly

8 (0.01)

0 (0.00)

-0.09 [-0.40, 0.21]

conjunctival scars

8 (0.01)

0.12 [-0.20, 0.43]

Enteropathogenic Escherichia coli infection

8 (0.01)

-0.17 [-0.47, 0.14]

Haematosalpinx/Haematoma of broad ligament

9 (0.01)

0.18 [-0.11, 0.48]

Mitochondrial myopathy

9 (0.01)

Labyrinthine fistula

9 (0.01)

0.16 [-0.15, 0.48]

Benign lipomatous neoplasm of spermatic cord

9 (0.01)

Carcinoma in situ of endometrium

9 (0.01)

Mechanical strabismus

9 (0.01)

-0.14 [-0.47, 0.19]

Benign neoplasm of mesothelial tissue

9 (0.01)

0 (0.00)

Physiological and behavioural disorders associated with sexual development and orientation

9 (0.01)

0 (0.00)

0.04 [-0.27, 0.34]

Merkel cell carcinoma of skin

9 (0.01)

Disorders of glossopharyngeal nerve

9 (0.01)

-0.43 [-0.74, -0.12]

Mental and behavioural disorders due to cocaine

9 (0.01)

-0.13 [-0.43, 0.18]

Acne varioliformis

10 (0.01)

-0.12 [-0.57, 0.33]

Choroidal detachment

10 (0.01)

0.04 [-0.27, 0.35]

Alkalosis

10 (0.01)

0.05 [-0.30, 0.39]

Small plaque parapsoriasis

10 (0.01)

0.15 [-0.16, 0.46]

Congenital malformations of ear causing impairment of hearing

10 (0.01)

0.11 [-0.24, 0.47]

Other chromosome abnormalities, not elsewhere classified

10 (0.01)

0.42 [-0.01, 0.85]

Other respiratory conditions originating in the perinatal period

5 (0.01)

Vertiginous syndromes in diseases classified elsewhere

5 (0.01)

Other disorders of skin and subcutaneous tissue related to radiation

5 (0.01)

0.07 [-0.27, 0.41]

Other inherited muscular atrophy

5 (0.01)

Polyglandular dysfunction, other/unspecified

5 (0.01)

Disorders of sulfur-bearing amino-acid metabolism

5 (0.01)

Pityriasis lichenoides et varioliformis acuta

5 (0.01)

0.01 [-0.26, 0.28]

Other and unspecified cicatricial alopecia

5 (0.01)

-0.17 [-0.49, 0.14]

Pityriasis alba

5 (0.01)

Congenital pneumonia

5 (0.01)

Vitreous prolapse

5 (0.01)

0 (0.00)

0.03 [-0.29, 0.34]

Fetal alcohol syndrome (dysmorphic)

6 (0.01)

Transient acantholytic dermatosis [Grover]

6 (0.01)

0 (0.00)

0.02 [-0.27, 0.31]

Complications of anaesthesia during pregnancy

6 (0.01)

0.26 [-0.05, 0.57]

Nutritional marasmus

6 (0.01)

0 (0.00)

-0.03 [-0.24, 0.18]

Drug-induced Cushing's syndrome

6 (0.01)

Induced delusional disorder

6 (0.01)

Secondary sideroblastic anaemia due to drugs and toxins

6 (0.01)

Other acantholytic disorders

6 (0.01)

0 (0.00)

-0.16 [-0.49, 0.18]

Other and unspecified hereditary haemolytic anaemias

6 (0.01)

0 (0.00)

Chromomycosis and phaeomycotic abscess

6 (0.01)

Bartonellosis

7 (0.01)

Traumatic arthropathy

7 (0.01)

Compression of brain

7 (0.01)

Other fusion of spine

7 (0.01)

-0.02 [-0.27, 0.23]

Knuckle pads

7 (0.01)

-0.01 [-0.26, 0.24]

Hypotony of eye

7 (0.01)

0 (0.00)

Benign neoplasm: Lymph nodes

7 (0.01)

-0.04 [-0.43, 0.35]

Benign neoplasm: Cornea

7 (0.01)

0.32 [0.04, 0.60]

Huntington disease

7 (0.01)

Ependymoma

7 (0.01)

Benign neoplasm: Connective and other soft tissue of abdomen

8 (0.01)

0 (0.00)

-0.13 [-0.48, 0.23]

Other and unspecified thalassaemias

8 (0.01)

Transepidermal elimination disorders

8 (0.01)

Conditions involving the integument and temperature regulation of fetus and newborn

8 (0.01)

0 (0.00)

Disorders of vagus nerve

8 (0.01)

0 (0.00)

Chondrosarcoma

8 (0.01)

Erysipeloid

8 (0.01)

Abuse of non-dependence-producing substances

8 (0.01)

Benign neoplasm: Heart

9 (0.01)

0.05 [-0.29, 0.40]

Hypoplasia of dental enamel, including avohilmo

9 (0.01)

0.11 [-0.39, 0.60]

Sphingolipidosis, other/unspecified

9 (0.01)

Mucocutaneous lymph node syndrome [Kawasaki]

9 (0.01)

0.39 [0.04, 0.74]

Yaws

9 (0.01)

Malignant otitis externa

9 (0.01)

0.05 [-0.23, 0.32]

Ischaemic infarction of muscle

9 (0.01)

Polyneuropathy due to other toxic agents

9 (0.01)

Other and unspecified pemphigus

9 (0.01)

-0.03 [-0.45, 0.39]

Diseases of thymus

9 (0.01)

0 (0.00)

0.16 [-0.15, 0.47]

Turner's syndrome

9 (0.01)

Other conditions related to polyarteritis nodosa

9 (0.01)

0 (0.00)

0.01 [-0.29, 0.31]

Lichen striatus

10 (0.01)

Transient retinal artery occlusion

10 (0.01)

-0.10 [-0.44, 0.24]

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

10 (0.01)

-0.07 [-0.37, 0.23]

Other hyperalimentation

10 (0.01)

0.09 [-0.25, 0.43]

Staphylococcal scalded skin syndrome

10 (0.01)

Idiopathic progressive neuropathy

10 (0.01)

0.05 [-0.18, 0.29]

Magnesium deficiency

11 (0.01)

0.13 [-0.22, 0.48]

Metabolic disorder, other/unspecified

11 (0.01)

0 (0.00)

0.12 [-0.24, 0.48]

Ototoxic hearing loss

11 (0.01)

0 (0.00)

0.19 [-0.14, 0.52]

Eclampsia

11 (0.01)

0.09 [-0.21, 0.39]

Organic amnesic syndrome, not induced by alcohol and other psychoactive substances

12 (0.01)

Sequelae of malnutrition and other nutritional deficiencies

12 (0.01)

0 (0.00)

-0.01 [-0.31, 0.28]

Thyroid crisis or storm

12 (0.01)

0 (0.00)

0.05 [-0.28, 0.39]

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

12 (0.01)

0.09 [-0.20, 0.39]

Ankylosis of teeth

12 (0.01)

Lordosis

12 (0.01)

0.03 [-0.45, 0.51]

Mucinous and mucinous cystic tumor

12 (0.01)

0 (0.00)

Hyperchylomicronaemia

13 (0.02)

-0.05 [-0.37, 0.26]

Other and unspecified disorders of lacrimal system

5 (0.01)

-0.32 [-0.63, -0.01]

Choroidal degeneration

5 (0.01)

Disorders of endocrine glands in diseases classified elsewhere

5 (0.01)

-0.10 [-0.41, 0.21]

Other histiocytosis syndromes

5 (0.01)

Other recurrent vertebral subluxation

5 (0.01)

Eosinophilic cellulitis [Wells]

5 (0.01)

Aortic arch syndrome [Takayasu]

5 (0.01)

0.22 [-0.07, 0.50]

Other trisomies and partial trisomies of the autosomes, not elsewhere classified

5 (0.01)

Cystic fibrosis, other manifestations/unspecified

5 (0.01)

Fetal death of unspecified cause

5 (0.01)

0.11 [-0.16, 0.38]

Birth injury to scalp

5 (0.01)

Osteolysis

6 (0.01)

Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms

6 (0.01)

Congenital malformation of optic disc

6 (0.01)

Cyst of spleen

6 (0.01)

-0.14 [-0.44, 0.17]

Enterohaemorrhagic Escherichia coli infection

6 (0.01)

-0.18 [-0.48, 0.12]

Drug-induced aplastic anaemia

6 (0.01)

0 (0.00)

-0.02 [-0.27, 0.23]

Mixed disorder of acid-base balance

6 (0.01)

Disorders of other digestive organs in diseases classified elsewhere

6 (0.01)

Albinism

6 (0.01)

Juvenile dermatomyositis

6 (0.01)

Lichen planopilaris

7 (0.01)

-0.43 [-0.76, -0.10]

Psoas tendinitis

7 (0.01)

0.28 [-0.17, 0.74]

Drug-induced hypopituitarism

7 (0.01)

Feeding problems of newborn

7 (0.01)

0.00 [-0.35, 0.36]

Benign neoplasm: Lacrimal gland and duct

7 (0.01)

Abscess of spleen

7 (0.01)

Flatback syndrome

7 (0.01)

Other conditions of integument specific to fetus and newborn

7 (0.01)

0 (0.00)

Lumbosacral plexus disorders

7 (0.01)

0.17 [-0.14, 0.48]

Otitis media in diseases classified elsewhere

7 (0.01)

Cicatricial pemphigoid

8 (0.01)

-0.03 [-0.36, 0.29]

Acne keloid

8 (0.01)

0.12 [-0.16, 0.40]

Benign neoplasm: Respiratory system, unspecified

8 (0.01)

0.24 [-0.12, 0.60]

Erythrasma

8 (0.01)

-0.04 [-0.34, 0.27]

Autoimmune polyglandular failure

8 (0.01)

0.17 [-0.12, 0.46]

Congenital absence, atresia and stenosis of small intestine

8 (0.01)

Other congenital malformations of posterior segment of eye (coloboma)

8 (0.01)

Other infestations

8 (0.01)

0.01 [-0.33, 0.35]

Malignant neoplasm of thymus

8 (0.01)

Complications specific to multiple gestation

9 (0.01)

0.22 [-0.22, 0.65]

Hereditary factor VIII deficiency

9 (0.01)

0.21 [-0.15, 0.58]

Pityriasis rubra pilaris

9 (0.01)

-0.12 [-0.47, 0.22]

Iodine-deficiency-related goitre

9 (0.01)

Other perinatal haematological disorders

9 (0.01)

0.07 [-0.23, 0.37]

Scleritis and episcleritis in diseases classified elsewhere

9 (0.01)

Molar incisor enamel hypoplasia, with caries

9 (0.01)

0 (0.00)

-0.11 [-0.58, 0.37]

Spina bifida

9 (0.01)

0.32 [0.03, 0.61]

Lymphocyte function antigen-1 [LFA-1] defect

9 (0.01)

Malignant neoplasm of nasopharynx

9 (0.01)

0 (0.00)

Bacterial meningoencephalitis and meningomyelitis

9 (0.01)

0 (0.00)

Keratopathy (bullous aphakic) following cataract surgery

10 (0.01)

0 (0.00)

Alcoholic myopathy

10 (0.01)

Dengue fever [classical dengue]

10 (0.01)

0.07 [-0.20, 0.33]

Neuroendocrine tumor and carcinoma of rectum

10 (0.01)

Retained (old) intraocular foreign body

10 (0.01)

Congenital malformations of cardiac chambers and connections

10 (0.01)

-0.34 [-1.19, 0.50]

Malignant neoplasm of oropharyng

10 (0.01)

Type 1 diabetes, strict definition, subgroup 2

11 (0.01)

-0.05 [-0.44, 0.33]

Actinic reticuloid

11 (0.01)

Precocious puberty

11 (0.01)

0 (0.00)

0.28 [-0.20, 0.76]

Rapidly progressive nephritic syndrome

11 (0.01)

-0.07 [-0.44, 0.31]

Other congenital musculoskeletal deformities

12 (0.01)

0 (0.00)

0.09 [-0.25, 0.44]

Other cranial nerve disorders in other disorders

12 (0.01)

-0.03 [-0.34, 0.29]

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

12 (0.01)

0 (0.00)

0.09 [-0.25, 0.42]

Other parasitologically confirmed or unspecified malaria

12 (0.01)

0.08 [-0.20, 0.37]

Internuclear ophthalmoplegia

12 (0.01)

0.19 [-0.13, 0.51]

Atrophy of thyroid (acquired)

12 (0.01)

-0.00 [-0.25, 0.24]

Retrobulbar neuritis in diseases classified elsewhere

13 (0.02)

0.28 [-0.06, 0.62]

Hypothalamic dysfunction, including iatrogenic, not elsewhere classified

13 (0.02)

0.17 [-0.15, 0.50]

Acquired clawhand, clubhand, clawfoot and clubfoot

13 (0.02)

0.05 [-0.31, 0.40]

Mandibular prognathia AND surgery (LeFortI or BSSRO)

13 (0.02)

-0.33 [-0.78, 0.13]

Other leukaemias of specified cell type

13 (0.02)

Benign neoplasm: Connective and other soft tissue of pelvis

13 (0.02)

0.14 [-0.19, 0.47]

Selective deficiency of immunoglobulin A [IgA]y

14 (0.02)

-0.15 [-0.56, 0.26]

Congenital lactase deficiency

14 (0.02)

-0.00 [-0.24, 0.24]

Other specified and unspecified disorders of choroid

14 (0.02)

-0.09 [-0.46, 0.29]

Congenital malformations of oesophagus

14 (0.02)

0.29 [-0.26, 0.83]

Congenital retinoschisis

15 (0.02)

0.04 [-0.21, 0.30]

Malignant neoplasm of penis

15 (0.02)

Disorders of glycosaminoglycan metabolism

5 (0.01)

Coalworker pneumoconiosis

5 (0.01)

0 (0.00)

Anetoderma (of Jadassohn-Pellizzari/Pasini and pierini)

5 (0.01)

Disorders of tyrosine metabolism

5 (0.01)

Other changes in lacrimal passages

5 (0.01)

Cytomegaloviral pneumonitis

5 (0.01)

-0.10 [-0.38, 0.18]

Disorders of hypoglossal nerve

5 (0.01)

Irritant contact dermatitis due to drugs in contact with skin

5 (0.01)

Postinflammatory hyperpigmentation

5 (0.01)

Lipid storage disorder, other/unspecified

5 (0.01)

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

5 (0.01)

Chronic postrheumatic arthropathy [Jaccoud]

6 (0.01)

Filariasis

6 (0.01)

Other and unspecified disorders of sclera

6 (0.01)

Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere

6 (0.01)

Diffuse (eosinophilic) fasciitis

6 (0.01)

-0.06 [-0.28, 0.16]

Nephropathy induced by other drugs, medicaments and biological substances

6 (0.01)

-0.26 [-0.51, 0.00]

Congenital absence, atresia and stenosis of large intestine

6 (0.01)

0.11 [-0.11, 0.33]

Ovarian dysfunction: androgen excess

6 (0.01)

0.02 [-0.22, 0.26]

Intracranial nontraumatic haemorrhage of fetus and newborn

6 (0.01)

Brain mixed glioma

6 (0.01)

Severe combined immunodeficiency [SCID] with low or normal B-cell numbers

7 (0.01)

0 (0.00)

Sleep terrors [night terrors]

7 (0.01)

0.43 [0.09, 0.77]

Acquired atrophy of ovary and fallopian tube

7 (0.01)

0.09 [-0.27, 0.46]

Disorder of visual pathways, unspecified

7 (0.01)

-0.20 [-0.47, 0.07]

Other or unspecified common variable immunodeficiency

7 (0.01)

-0.06 [-0.40, 0.28]

Other and unspecified postprocedural disorders of eye and adnexa

7 (0.01)

0.09 [-0.16, 0.33]

Glaucoma secondary to drugs

7 (0.01)

-0.22 [-0.60, 0.15]

Pemphigus vulgaris

7 (0.01)

0.48 [0.09, 0.87]

Haemolytic-uraemic syndrome

7 (0.01)

0.14 [-0.16, 0.43]

Cerebral arteritis

7 (0.01)

-0.00 [-0.32, 0.32]

Toxic erythema

8 (0.01)

0.18 [-0.09, 0.45]

Mucinosis of skin

8 (0.01)

0 (0.00)

Immunodeficiency associated with other major defects

8 (0.01)

0.01 [-0.37, 0.40]

Acute disseminated encephalitis/encephalomyelitis

8 (0.01)

-0.07 [-0.37, 0.22]

Chronic respiratory disease originating in the perinatal period

8 (0.01)

0.12 [-0.20, 0.44]

Reduction defects of upper limb

8 (0.01)

0.35 [0.07, 0.64]

Tympanosclerosis

8 (0.01)

-0.14 [-0.49, 0.20]

Rickettsioses

8 (0.01)

-0.15 [-0.53, 0.23]

Other porphyria

9 (0.01)

0.11 [-0.20, 0.42]

Telogen effluvium

9 (0.01)

-0.05 [-0.39, 0.28]

Polyp of middle ear

9 (0.01)

-0.14 [-0.42, 0.13]

Hereditary erythropoietic porphyria

9 (0.01)

Kwashiorkor

9 (0.01)

0 (0.00)

0.23 [-0.06, 0.52]

Other mosquito-borne viral fevers

9 (0.01)

0.05 [-0.23, 0.33]

Abnormal pulmonary venous return

9 (0.01)

-0.13 [-0.42, 0.16]

Abnormalities of ear ossicles

9 (0.01)

-0.00 [-0.29, 0.28]

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

9 (0.01)

-0.27 [-0.58, 0.04]

Unspecified pneumoconiosis

9 (0.01)

Other haemoglobinopathies

9 (0.01)

-0.07 [-0.35, 0.20]

Periodontosis

10 (0.01)

Intestinal helminthiases, other/unspecified

10 (0.01)

Birth injury to peripheral nervous system

10 (0.01)

-0.04 [-0.48, 0.40]

Tuberculosis of nervous system

10 (0.01)

Other combined immunodeficiencies

10 (0.01)

Sunburn

10 (0.01)

-0.23 [-0.49, 0.03]

Other eccrine sweat disorders

10 (0.01)

Drug-induced autoimmune haemolytic anaemia

11 (0.01)

Maternal care for (suspected) damage to fetus from alcohol

11 (0.01)

0 (0.00)

-0.24 [-0.56, 0.08]

Complications of anaesthesia during labour and delivery

11 (0.01)

0 (0.00)

-0.05 [-0.38, 0.28]

Labyrinthitis

11 (0.01)

0 (0.00)

-0.35 [-0.72, 0.02]

Benign neoplasm: Female genital organ, unspecified

11 (0.01)

5 (0.05)

0.23 [-0.15, 0.60]

Other retinal disorders in diseases classified elsewhere

11 (0.01)

-0.02 [-0.36, 0.32]

Other congenital malformations of skull and face bones

12 (0.01)

0.17 [-0.13, 0.48]

Mononeuritis multiplex

12 (0.01)

0.03 [-0.34, 0.40]

Erythema in diseases classified elsewhere

12 (0.01)

0.15 [-0.15, 0.45]

Cardiovascular disorders originating in the perinatal period

12 (0.01)

-0.19 [-0.53, 0.15]

Myelofibrosis

12 (0.01)

Benign neoplasm: Extrahepatic bile ducts

12 (0.01)

-0.23 [-0.59, 0.13]

Drug-induced dystonia

12 (0.01)

-0.10 [-0.53, 0.34]

Balanced rearrangements and structural markers, not elsewhere classified

13 (0.02)

Restrictive cardiomyopathy

13 (0.02)

-0.06 [-0.34, 0.22]

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

13 (0.02)

-0.24 [-0.59, 0.11]

Femoral hernia, bilateral

13 (0.02)

-0.16 [-0.46, 0.15]

Kissing spine

13 (0.02)

-0.20 [-0.47, 0.08]

Otorrhoea

14 (0.02)

-0.28 [-0.73, 0.17]

Severe bullous disorders, KELA reimbursement

14 (0.02)

0.21 [-0.13, 0.56]

Folliculitis decalvans

14 (0.02)

0.11 [-0.20, 0.42]

Other hypertrichosis

14 (0.02)

-0.09 [-0.54, 0.37]

Livedoid vasculitis

15 (0.02)

6 (0.06)

0.14 [-0.30, 0.58]

Qualitative platelet defects

15 (0.02)

-0.01 [-0.40, 0.38]

Pneumonia due to Haemophilus influenzae

15 (0.02)

0 (0.00)

-0.37 [-0.82, 0.09]

Other and unspecified myoneural disorders

15 (0.02)

0.10 [-0.24, 0.44]

Benign neoplasm: Pelvic bones, sacrum and coccyx

15 (0.02)

-0.09 [-0.48, 0.31]

Acquired keratosis [keratoderma] palmaris et plantaris

15 (0.02)

0.13 [-0.26, 0.51]

Congenital lens malformations

15 (0.02)

-0.05 [-0.48, 0.39]

Atrioventricular septal defect

16 (0.02)

-0.04 [-0.35, 0.27]

Allergic bronchopulmonary aspergillosis (ABPA)

16 (0.02)

0.19 [-0.16, 0.54]

Other zoonotic bacterial diseases, not elsewhere classified

5 (0.01)

0 (0.00)

Birth injury to skeleton

5 (0.01)

Dysplastic lesion of the vulva of unknown severity

5 (0.01)

0.07 [-0.20, 0.35]

Disorders of muscle in diseases classified elsewhere

6 (0.01)

Edwards' syndrome and Patau's syndrome

6 (0.01)

Disorders of glycine metabolism

6 (0.01)

0 (0.00)

Drug-induced interstitial lung disorders, unspecified

6 (0.01)

0.16 [-0.18, 0.50]

Adult-onset Still disease

6 (0.01)

0.02 [-0.28, 0.33]

Anaemia due to enzyme disorders

6 (0.01)

Benign neoplasm: Trachea

6 (0.01)

Thoracic root disorders

6 (0.01)

0.30 [-0.02, 0.62]

Nocardiosis

6 (0.01)

Fetus and newborn affected by complications of placenta, cord and membranes

6 (0.01)

-0.00 [-0.26, 0.25]

Thyrotoxicosis factitia

7 (0.01)

0.00 [-0.32, 0.32]

Disorder of amino-acid metabolism, other/unspecified

7 (0.01)

Diphtheria

7 (0.01)

-0.11 [-0.38, 0.16]

Burkitt lymphoma

7 (0.01)

Arthropathy in hypersensitivity reactions classified elsewhere

7 (0.01)

Cryoglobulinemia

7 (0.01)

-0.30 [-0.58, -0.02]

Benign neoplasm: Male genital organ, other/unspecified

7 (0.01)

Defects in glycoprotein degradation

7 (0.01)

0 (0.00)

Monosomies and deletions from the autosomes, not elsewhere classified

7 (0.01)

0.05 [-0.29, 0.39]

Polyclonal hypergammaglobulinaemia

7 (0.01)

Osteosarcoma

7 (0.01)

0 (0.00)

Abscess of mediastinum

8 (0.01)

0 (0.00)

0.04 [-0.28, 0.36]

Intermittent hydrarthrosis

8 (0.01)

-0.25 [-0.58, 0.08]

Benign neoplasm: Renal pelvis

8 (0.01)

-0.06 [-0.34, 0.23]

Ovarian dysfunction: estrogen excess

8 (0.01)

Hyperfunction of pituitary gland, other and/or unspecified

8 (0.01)

0.12 [-0.13, 0.37]

Cystic fibrosis

8 (0.01)

Sleepwalking [somnambulism]

8 (0.01)

0.09 [-0.20, 0.37]

Obstetric embolism

8 (0.01)

Lens-induced iridocyclitis

9 (0.01)

-0.23 [-0.56, 0.09]

Other specified/unspecified disorders of tympanic membrane

9 (0.01)

0 (0.00)

-0.07 [-0.42, 0.28]

Inflammatory myopathy

9 (0.01)

0.04 [-0.21, 0.29]

Contact urticaria

9 (0.01)

0.19 [-0.22, 0.59]

Carcinoma in situ of oral cavity

9 (0.01)

Malignant neoplasm of vagina

9 (0.01)

Lichenoid drug reaction

9 (0.01)

0 (0.00)

-0.16 [-0.52, 0.20]

Lipomatosis, not elsewhere classified

9 (0.01)

0.07 [-0.28, 0.43]

Hypertension, portal

9 (0.01)

0 (0.00)

-0.22 [-0.57, 0.13]

Other nonautoimmune haemolytic anaemias

9 (0.01)

-0.07 [-0.32, 0.18]

Traumatic spondylopathy

9 (0.01)

-0.33 [-0.65, -0.01]

Disorders of copper metabolism

10 (0.01)

Non-neuropathic heredofamilial amyloidosis

10 (0.01)

Carcinoma in situ of vulva

10 (0.01)

Other specific arthropathies

10 (0.01)

5 (0.05)

-0.32 [-0.63, -0.01]

Acquired pure red cell aplasia [erythroblastopenia]

10 (0.01)

0.13 [-0.36, 0.61]

Osteochondrodysplasia with defects of growth of tubular bones and spine

10 (0.01)

0.07 [-0.18, 0.33]

Other degenerative disorders of eyelid and periocular area

11 (0.01)

0.04 [-0.26, 0.34]

Endometriosis in cutaneous scar

11 (0.01)

-0.11 [-0.45, 0.24]

Hereditary hypogammaglobulinemia

11 (0.01)

5 (0.05)

0.13 [-0.17, 0.42]

Pemphigus erythematosus

11 (0.01)

Isolated patent ductus arteriosus

11 (0.01)

0.04 [-0.30, 0.37]

Disorder of bilirubin metabolism, other/unspecified

11 (0.01)

Fractures involving multiple body regions

12 (0.01)

0 (0.00)

0.00 [-0.27, 0.28]

Congenital malformations of lung

12 (0.01)

0.15 [-0.17, 0.48]

Slow fetal growth and fetal malnutrition

12 (0.01)

-0.05 [-0.49, 0.39]

Lung transplantation

12 (0.01)

-0.04 [-0.47, 0.40]

Polyglandular dysfunction

12 (0.01)

0.14 [-0.17, 0.45]

Common variable immunodeficiency

12 (0.01)

-0.26 [-0.67, 0.14]

Malignant neoplasm of ureter

12 (0.01)

Toxic encephalopathy

13 (0.02)

-0.07 [-0.39, 0.25]

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

13 (0.02)

-0.22 [-0.59, 0.16]

Female infertility, uterine origin

13 (0.02)

0.12 [-0.26, 0.50]

Congenital ichthyosis

13 (0.02)

-0.12 [-0.45, 0.21]

Systemic sclerosis,strict definition

13 (0.02)

6 (0.06)

-0.22 [-0.64, 0.20]

Other infective (teno)synovitis

14 (0.02)

-0.04 [-0.47, 0.39]

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

14 (0.02)

-0.04 [-0.31, 0.24]

Other and unspecified localized connective tissue disorders

14 (0.02)

0.26 [-0.06, 0.58]

Choroidal haemorrhage and rupture

14 (0.02)

-0.03 [-0.35, 0.29]

Epileptic seizures related to drugs

15 (0.02)

-0.14 [-0.45, 0.17]

Plasmodium falciparum malaria

15 (0.02)

0.01 [-0.26, 0.28]

Haemophilus septicemia

15 (0.02)

-0.15 [-0.45, 0.15]

Disorders of sphingolipid metabolism and other lipid storage disorders

15 (0.02)

0.11 [-0.26, 0.47]

Other and unspecified disorders of binocular movement

15 (0.02)

0.20 [-0.33, 0.72]

Hypothyroidism, autoimmune, DX-based

15 (0.02)

0.04 [-0.31, 0.38]

Marasmic kwashiorkor

15 (0.02)

0.35 [-0.00, 0.70]

Malignant neoplasm of adrenal gland

16 (0.02)

Pityriasis lichenoides chronica

16 (0.02)

0.08 [-0.30, 0.45]

Other specified and unspecified disorders of iris and ciliary body

16 (0.02)

-0.34 [-0.81, 0.14]

Cleft lip

16 (0.02)

-0.23 [-0.64, 0.19]

Gastrointestinal stromal tumor and sarcoma

16 (0.02)

11 (0.12)

Cleft hard palate NOS

17 (0.02)

0.11 [-0.24, 0.46]

Ehlers-Danlos syndrome

17 (0.02)

7 (0.07)

-0.07 [-0.49, 0.34]

Thalassaemia

17 (0.02)

Post-traumatic hydrocephalus, unspecified

17 (0.02)

0.23 [-0.10, 0.57]

Pneumoconiosis due to dust containing silica

17 (0.02)

-0.03 [-0.43, 0.38]

Cerebral oedema

17 (0.02)

-0.06 [-0.36, 0.24]

Maxillary prognathism

18 (0.02)

0.19 [-0.16, 0.54]

Benign neoplasm: Endocrine pancreas

18 (0.02)

0.13 [-0.33, 0.60]

Cholinergic urticaria

18 (0.02)

0.54 [0.13, 0.94]

Fibrosis of liver

19 (0.02)

-0.16 [-0.60, 0.27]

Benign neoplasm: Eye, unspecified

19 (0.02)

7 (0.08)

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

19 (0.02)

0.20 [-0.55, 0.95]

Other mycoses, not elsewhere classified/unspecified

19 (0.02)

0.35 [-0.13, 0.82]

Other proliferative retinopathy

20 (0.02)

0.06 [-0.41, 0.53]

Noninfective disorders of pinna

11 (0.01)

0.08 [-0.18, 0.34]

Chronic inflammatory disorders of orbit

11 (0.01)

0 (0.00)

-0.06 [-0.41, 0.29]

Cytomegaloviral hepatitis

11 (0.01)

0.02 [-0.34, 0.37]

11 (0.01)

0.21 [-0.20, 0.62]

Lung transplant status

12 (0.01)

-0.05 [-0.48, 0.38]

Other and unspecified atrophic disorders of skin

12 (0.01)

0.03 [-0.28, 0.34]

Benign neoplasm: Urinary organ, other/unspecified

12 (0.01)

0.02 [-0.35, 0.40]

Behçet disease

12 (0.01)

-0.21 [-0.53, 0.11]

Biliary cirrhosis, NAS

12 (0.01)

0.12 [-0.17, 0.42]

Other/unspecified postprocedural disorders of ear and mastoid process

12 (0.01)

0 (0.00)

0.33 [-0.00, 0.67]

Other specified/unspecified disorders of middle ear and mastoid

12 (0.01)

-0.10 [-0.39, 0.19]

Benign neoplasm: Ciliary body

13 (0.02)

-0.03 [-0.38, 0.31]

Other congenital malformations of digestive system

13 (0.02)

5 (0.05)

0.38 [0.01, 0.76]

Acrodermatitis continua

13 (0.02)

-0.02 [-0.26, 0.23]

Airway disease due to specific organic dust

13 (0.02)

0.07 [-0.26, 0.40]

Fracture of spine, level unspecified

13 (0.02)

-0.20 [-0.51, 0.11]

Benign neoplasm: Hypopharynx

14 (0.02)

0.20 [-0.30, 0.70]

Chloasma

14 (0.02)

0.03 [-0.28, 0.35]

Enterobiasis

14 (0.02)

-0.10 [-0.51, 0.31]

Maxillary hypoplasia

14 (0.02)

0.24 [-0.12, 0.60]

Lipoprotein deficiency

14 (0.02)

0.19 [-0.17, 0.56]

Contracture of muscle

15 (0.02)

0 (0.00)

0.04 [-0.38, 0.46]

Eccrine sweat disorders

15 (0.02)

0.09 [-0.26, 0.44]

Neuroendocrine tumor and carcinoma of pancreas

15 (0.02)

Benign neoplasm: Central nervous system, other parts/unspecified

15 (0.02)

-0.18 [-0.50, 0.14]

Phantom limb syndrome with pain

15 (0.02)

0 (0.00)

-0.12 [-0.43, 0.19]

Benign lipomatous neoplasm of of intra-abdominal organs

15 (0.02)

0.08 [-0.27, 0.42]

Hereditary nephropathy, not elsewhere classified

15 (0.02)

-0.11 [-0.49, 0.27]

Other and unspecified syphilis

15 (0.02)

0 (0.00)

-0.27 [-0.63, 0.09]

Systemic disorders of connective tissue in diseases classified elsewhere

16 (0.02)

0.10 [-0.24, 0.43]

Benign neoplasm: Testis

16 (0.02)

-0.20 [-0.64, 0.23]

Malignant neoplasm of hypopharynx

16 (0.02)

Other specified/unspecified disorders of ear

16 (0.02)

-0.01 [-0.34, 0.32]

Meningitis, viral

16 (0.02)

0.51 [-0.01, 1.03]

Small kidney of unknown cause

17 (0.02)

0.20 [-0.16, 0.57]

Melanocytic naevi of ear and external auricular canal

17 (0.02)

1.00 [-0.39, 2.39]

Hypersplenism

17 (0.02)

0.23 [-0.21, 0.67]

Kela reimbursement Agammaglobulinemia (D80-84)

17 (0.02)

6 (0.06)

-0.05 [-0.44, 0.34]

Acanthosis nigricans

17 (0.02)

0.12 [-0.24, 0.48]

Other congenital malformations of heart

17 (0.02)

0.10 [-0.41, 0.61]

Drug-induced systemic lupus erythematosus

18 (0.02)

5 (0.05)

0.29 [-0.24, 0.83]

Congenital malformations of pulmonary and tricuspid valves

18 (0.02)

0.29 [-0.25, 0.82]

Neuroendocrine tumor and carcinoma of stomach

18 (0.02)

Complex cardiac defects

18 (0.02)

0.09 [-0.39, 0.56]

Other and unspecified neuropathies

19 (0.02)

0 (0.00)

0.07 [-0.36, 0.50]

Benign intracranial hypertension

19 (0.02)

0.02 [-0.40, 0.44]

Benign neoplasm: Ribs, sternum and clavicle

19 (0.02)

0 (0.00)

0.39 [0.06, 0.73]

Hypospadias

19 (0.02)

-0.18 [-0.53, 0.16]

Benign neoplasm: Floor of mouth

19 (0.02)

5 (0.05)

0.15 [-0.21, 0.52]

Drug-induced myopathy

20 (0.02)

-0.08 [-0.44, 0.27]

Postviral fatigue syndrome

20 (0.02)

6 (0.06)

0.29 [-0.25, 0.83]

Disorder of carbohydrate metabolism, other/unspecified

20 (0.02)

0.00 [-0.30, 0.30]

Benign neoplasm: Epididymis

21 (0.02)

0.23 [-0.11, 0.56]

Right ventricular outflow tract obstruction

21 (0.02)

0.78 [-0.89, 2.44]

Rheumatic fever without mention of heart involvement

21 (0.02)

-0.15 [-0.48, 0.18]

Enteritis due to Yersinia enterocolitica

22 (0.03)

-0.20 [-0.57, 0.18]

Rhinophyma

22 (0.03)

5 (0.05)

0.45 [-0.00, 0.90]

Tick-borne viral encephalitis

22 (0.03)

0 (0.00)

0.09 [-0.37, 0.54]

Selective deficiency of immunoglobulin G [IgG] subclasses

22 (0.03)

9 (0.10)

-0.38 [-0.86, 0.11]

Liposarcoma

22 (0.03)

6 (0.06)

Other and unspecified diseases of spleen

23 (0.03)

-0.01 [-0.49, 0.48]

Other congenital malformations, not elsewhere classified

23 (0.03)

0.28 [-0.23, 0.79]

Endometroid carcinoma of ovary

23 (0.03)

6 (0.06)

Secondary sideroblastic anaemia

24 (0.03)

6 (0.06)

0.03 [-0.31, 0.37]

Frontotemporal dementia

36 (0.04)

0.19 [-0.21, 0.60]

Other endophthalmitis

36 (0.04)

0.07 [-0.32, 0.46]

Mesial bite

37 (0.04)

-0.08 [-0.60, 0.43]

Disorder of pancreatic internal secretion, other and/or unspecified

37 (0.04)

6 (0.06)

0.03 [-0.35, 0.40]

Crystalline deposits in vitreous body

37 (0.04)

14 (0.15)

0.05 [-0.33, 0.43]

Localized skin eruption due to drugs and medicaments

37 (0.04)

-0.31 [-1.03, 0.42]

Striae atrophicae

38 (0.04)

8 (0.08)

-0.59 [-2.43, 1.26]

Polymyositis

39 (0.05)

0.23 [-0.10, 0.55]

Benign neoplasm: Spinal meninges

39 (0.05)

9 (0.09)

-0.29 [-0.80, 0.21]

Malignant neoplasm of parotid gland

40 (0.05)

Congenital malformations of anterior segment of eye

41 (0.05)

-0.15 [-0.66, 0.37]

Severe visual impairment, monocular

41 (0.05)

0.00 [-0.55, 0.56]

Lagophthalmos

41 (0.05)

-0.02 [-0.62, 0.59]

Blindness or visual impairment, binocular

42 (0.05)

0.01 [-0.35, 0.38]

Down's syndrome

42 (0.05)

-0.22 [-0.55, 0.10]

Nystagmus and other irregular eye movements

43 (0.05)

10 (0.10)

0.15 [-0.62, 0.92]

Gilbert syndrome

43 (0.05)

9 (0.10)

0.16 [-0.29, 0.61]

Social disorders starting during childhood or adolescence

44 (0.05)

HSIL lesion of the vulva

45 (0.05)

9 (0.09)

-0.17 [-0.58, 0.24]

Other and unspecified pemphigoid

46 (0.05)

10 (0.11)

-0.08 [-0.53, 0.37]

Glaucoma secondary to eye trauma

46 (0.05)

0.41 [-0.12, 0.93]

Chronic myeloid leukaemia [CML], BCR/ABL-positive

47 (0.05)

9 (0.10)

0.17 [-0.39, 0.73]

Pneumocystosis

48 (0.06)

15 (0.16)

0.19 [-0.53, 0.91]

Other disorders of binocular vision

48 (0.05)

12 (0.12)

-0.11 [-0.59, 0.37]

Benign neoplasm: Parathyroid gland

49 (0.06)

13 (0.14)

0.11 [-0.30, 0.51]

Calcific tendinitis

49 (0.06)

12 (0.13)

-0.11 [-0.53, 0.32]

Perioral dermatitis

50 (0.06)

12 (0.12)

-0.08 [-0.59, 0.43]

Other or unspecified paralytic strabismus

50 (0.06)

Other bacterial agents as the cause of diseases classified to other chapters

51 (0.06)

0.20 [-0.17, 0.58]

Mandibular prognathia

51 (0.05)

6 (0.06)

-0.23 [-0.96, 0.50]

Atypical virus infections of central nervous system

52 (0.06)

10 (0.11)

-0.00 [-0.95, 0.94]

Other bursal cyst

53 (0.06)

14 (0.14)

-0.71 [-2.02, 0.60]

Guttate psoriasis

54 (0.06)

8 (0.08)

0.11 [-0.26, 0.48]

Chorioretinal scars

20 (0.02)

-0.11 [-0.44, 0.22]

Myositis ossificans

20 (0.02)

0.35 [-0.05, 0.76]

Periodontal disease, other/unspecified

21 (0.02)

Benign neoplasm: Retina

21 (0.02)

-0.03 [-0.45, 0.38]

Other and unspecified nonscarring hair loss

21 (0.02)

-0.09 [-0.54, 0.36]

Supernumerary teeth EXCLUDE clefts and syndromes

22 (0.03)

-0.01 [-0.30, 0.29]

Embolism and thrombosis of abdominal aorta

22 (0.03)

0.03 [-0.33, 0.38]

Acute myringitis

22 (0.03)

6 (0.06)

-0.30 [-0.91, 0.31]

Premenstrual syndrome

22 (0.03)

-0.11 [-0.62, 0.39]

Acquired stenosis of external ear canal

23 (0.03)

0.38 [-0.27, 1.04]

Other congenital malformations of nervous system

23 (0.03)

10 (0.10)

-0.12 [-0.63, 0.40]

Hair colour and hair shaft abnormalities

23 (0.03)

-0.30 [-0.70, 0.10]

Muscle wasting and atrophy, not elsewhere classified

24 (0.03)

0.11 [-0.28, 0.50]

Other congenital malformations of urinary system

24 (0.03)

0.10 [-0.30, 0.50]

Disorders of pituitary gland, other and/or unspecified

25 (0.03)

8 (0.09)

-0.04 [-0.37, 0.30]

Birth trauma

25 (0.03)

-0.23 [-1.02, 0.55]

Histrionic personality disorder

26 (0.03)

0.13 [-0.45, 0.70]

Acute thyroiditis

26 (0.03)

0.05 [-0.39, 0.49]

Other/unspecified mastoiditis and related conditions

27 (0.03)

7 (0.08)

-0.20 [-0.79, 0.38]

Open bite that required surgery (Lefort1 or BSSRO)

27 (0.03)

7 (0.07)

-0.03 [-0.47, 0.41]

Adenocarcinoma and Papillary adenocarcinoma of kidney

28 (0.03)

Carcinoma in situ of breast, lobular

28 (0.03)

9 (0.10)

Cervical root disorders

28 (0.03)

0.27 [-0.15, 0.68]

Infarction of spleen

28 (0.03)

0.16 [-0.22, 0.55]

Other specified acquired deformities of limbs

28 (0.03)

0.31 [-0.10, 0.72]

Rheumatic fever with heart involvement

29 (0.03)

0.15 [-0.23, 0.53]

Urticaria due to cold and heat

29 (0.03)

6 (0.06)

-0.16 [-0.76, 0.45]

Unspecified renal colic

30 (0.04)

0.27 [-0.15, 0.69]

Polymorphous light eruption

30 (0.03)

0 (0.00)

0.23 [-0.29, 0.75]

Marginal zone B-cell lymphoma

30 (0.04)

13 (0.14)

Ankylosis of joint

31 (0.04)

5 (0.05)

0.36 [-0.07, 0.78]

Palindromic rheumatism

31 (0.04)

6 (0.06)

0.29 [-0.05, 0.63]

Phakomatoses, not elsewhere classified

32 (0.04)

Other and unspecified primary disorders of muscles

32 (0.04)

8 (0.08)

0.37 [-0.20, 0.93]

Congenital malformations of posterior segment of eye

33 (0.04)

7 (0.07)

-0.13 [-0.50, 0.24]

Other benign neoplasm of uterus: Corpus uteri

33 (0.04)

6 (0.06)

0.14 [-0.57, 0.84]

Hereditary sideroblastic anaemia

33 (0.04)

0.20 [-0.11, 0.51]

Traction detachment of retina

33 (0.04)

-0.14 [-0.73, 0.44]

Other and unspecified disorders of adult personality and behaviour

33 (0.04)

7 (0.07)

0.04 [-0.34, 0.42]

Other and unspecified immunodeficiencies with predominantly antibody defects

34 (0.04)

14 (0.15)

-0.00 [-0.41, 0.41]

Hydrocephalus in other diseases

34 (0.04)

0.15 [-0.21, 0.51]

Chronic myeloid leukaemia

34 (0.04)

6 (0.06)

Multifocal fibrosclerosis

34 (0.04)

0.46 [-0.16, 1.09]

Other congenital malformations of peripheral vascular system

35 (0.04)

5 (0.05)

0.27 [-0.45, 0.98]

Congenital hydrocephalus

35 (0.04)

0.19 [-0.20, 0.57]

Unspecified contracted kidney

35 (0.04)

0.31 [-0.11, 0.73]

Gout due to impairment of renal function

36 (0.04)

6 (0.06)

-0.18 [-1.55, 1.20]

Convergence insufficiency and excess

36 (0.04)

8 (0.08)

-0.59 [-1.12, -0.06]

Scarlet fever

37 (0.04)

5 (0.05)

0.05 [-0.37, 0.47]

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

37 (0.04)

0.13 [-0.27, 0.53]

Isolated proteinuria with specified morphological lesion

37 (0.04)

7 (0.07)

-0.09 [-0.59, 0.40]

Cleft lip and cleft lip and palate

37 (0.04)

5 (0.05)

-0.25 [-0.82, 0.31]

Disorders of magnesium metabolism

38 (0.04)

0.14 [-0.29, 0.58]

Valgus deformity, not elsewhere classified

39 (0.04)

5 (0.05)

0.53 [0.05, 1.01]

Glaucoma secondary to eye inflammation

39 (0.05)

7 (0.07)

-0.06 [-0.74, 0.63]

Endometriosis of intestine

40 (0.05)

10 (0.10)

-0.03 [-0.48, 0.41]

Felty syndrome

41 (0.05)

0.40 [0.00, 0.80]

Otorrhagia

41 (0.05)

9 (0.10)

-0.27 [-0.89, 0.35]

Human immunodeficiency virus [HIV] disease resulting in other conditions

41 (0.05)

7 (0.07)

-0.13 [-0.68, 0.43]

Tibial collateral bursitis [Pellegrini-Stieda]

42 (0.05)

13 (0.14)

0.29 [-0.65, 1.23]

Iliotibial band syndrome

42 (0.05)

10 (0.10)

0.17 [-0.33, 0.67]

Malignant neoplasm of eye and adnexa

43 (0.05)

Benign neoplasm: Spinal cord

43 (0.05)

10 (0.10)

-0.27 [-0.67, 0.12]

Drug-induced osteoporosis with pathological fracture

45 (0.05)

7 (0.07)

0.04 [-0.48, 0.56]

Respiratory disorders in diseases classified elsewhere

45 (0.05)

12 (0.12)

-0.31 [-1.02, 0.41]

Corneal degeneration

46 (0.05)

10 (0.10)

-0.01 [-0.49, 0.47]

Protein-energy malnutrition of moderate and mild degree

47 (0.05)

6 (0.06)

0.09 [-0.33, 0.50]

Benign neoplasm: Scapula and long bones of upper limb

47 (0.05)

9 (0.09)

-0.65 [-1.39, 0.09]

Other drug-induced secondary parkinsonism

48 (0.06)

10 (0.11)

-0.03 [-0.51, 0.46]

Other prurigo

48 (0.06)

10 (0.10)

0.22 [-0.27, 0.71]

Drug-induced obesity

49 (0.06)

12 (0.13)

0.38 [-0.10, 0.85]

Benign neoplasm: Oesophagus

49 (0.06)

8 (0.08)

-0.46 [-0.98, 0.07]

Horner syndrome

50 (0.06)

10 (0.10)

-0.52 [-1.28, 0.24]

Polyarteritis nodosa

50 (0.06)

8 (0.09)

0.26 [-0.17, 0.70]

Benign neoplasm: Tonsil

51 (0.06)

11 (0.11)

0.01 [-0.40, 0.41]

Other acute disseminated demyelination

52 (0.06)

7 (0.07)

0.27 [-0.17, 0.70]

Hirsutism in women

53 (0.06)

7 (0.07)

-0.30 [-0.70, 0.09]

Other specified and unspecified disorders of eyelid

53 (0.06)

8 (0.08)

0.07 [-0.36, 0.51]

Senile degeneration of the brain, not elsewhere classified

54 (0.06)

0.37 [-0.11, 0.85]

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

55 (0.04)

0.12 [-0.54, 0.78]

Early syphilis

56 (0.06)

8 (0.08)

-0.21 [-0.75, 0.33]

Oral lichen ruber planus

57 (0.07)

14 (0.14)

0.20 [-0.25, 0.65]

Wegener granulomatosis

57 (0.07)

11 (0.11)

-0.23 [-0.78, 0.32]

Tetraplegia

58 (0.07)

0.16 [-0.26, 0.58]

Graves ophthalmopathy, strict

59 (0.07)

13 (0.13)

0.30 [-0.09, 0.70]

Other and unspecified acquired haemolytic anaemias

60 (0.07)

7 (0.07)

-0.10 [-0.56, 0.35]

Cushing syndrome

60 (0.07)

11 (0.12)

0.33 [-0.25, 0.90]

Ulcer of vagina/vulva

60 (0.07)

10 (0.10)

-0.45 [-1.12, 0.22]

Other specified/unspecified nutritional deficiencies

61 (0.07)

11 (0.12)

-0.28 [-0.82, 0.26]

Endocrine disorders, other/unspecified

61 (0.07)

18 (0.18)

-0.03 [-0.79, 0.73]

Ankyloglossia

62 (0.06)

0.10 [-0.34, 0.54]

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

63 (0.07)

7 (0.07)

-0.27 [-0.86, 0.33]

Habitual aborter

64 (0.07)

17 (0.17)

-0.50 [-2.67, 1.66]

Collapsed vertebra, not elsewhere classified

66 (0.08)

6 (0.06)

-0.09 [-0.58, 0.39]

Other and unspecified haemorrhagic conditions

66 (0.07)

10 (0.10)

-0.05 [-0.80, 0.71]

Disorders of oesophagus in diseases classified elsewhere

67 (0.08)

7 (0.07)

0.79 [0.17, 1.41]

Vitamin D deficiency

68 (0.08)

8 (0.08)

0.48 [-0.00, 0.97]

Hypertension, Pulmonary Arterial

37 (0.04)

7 (0.07)

0.23 [-0.29, 0.74]

Calcaneal spur

37 (0.04)

10 (0.10)

0.20 [-0.44, 0.84]

Postprocedural disorders of ear and mastoid process, not elsewhere classified

37 (0.04)

-0.00 [-0.49, 0.49]

Acute drug-induced interstitial lung disorder

37 (0.04)

7 (0.07)

0.04 [-0.45, 0.54]

Unspecified human immunodeficiency virus [HIV] disease

38 (0.04)

0.12 [-0.45, 0.69]

Other disorders of amino-acid metabolism

38 (0.04)

-0.04 [-0.42, 0.33]

Benign neoplasm: Bone and articular cartilage, unspecified

38 (0.04)

-0.08 [-0.51, 0.36]

Profound mental retardation

38 (0.04)

Caries in Clefts patients

39 (0.04)

7 (0.07)

-0.39 [-0.95, 0.17]

Hypothyroidism due to medicaments and other exogenous substances

40 (0.05)

7 (0.07)

0.34 [-0.35, 1.02]

Osteonecrosis due to drugs

40 (0.05)

13 (0.14)

0.12 [-0.73, 0.97]

Drug-induced gout

41 (0.05)

-0.20 [-0.54, 0.14]

Impacted maxillary canine

41 (0.04)

0.06 [-0.41, 0.53]

Osteomalacia

42 (0.05)

8 (0.08)

0.15 [-0.47, 0.77]

Recurrent and persistent haematuria

42 (0.05)

-0.14 [-0.52, 0.25]

Bruxism

43 (0.05)

15 (0.15)

Unspecified protein-energy malnutrition

43 (0.05)

5 (0.05)

0.01 [-0.45, 0.46]

Other and unspecified acne

44 (0.05)

9 (0.09)

-0.07 [-0.60, 0.45]

Von Willebrand disease

45 (0.05)

8 (0.08)

-0.20 [-0.55, 0.15]

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

45 (0.05)

15 (0.16)

-0.06 [-0.59, 0.48]

Melanoma of uvea

46 (0.05)

7 (0.07)

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

47 (0.05)

10 (0.10)

0.21 [-0.22, 0.64]

Erosion of teeth

47 (0.05)

14 (0.14)

0.44 [-0.26, 1.14]

Exfoliative dermatitis

48 (0.06)

8 (0.08)

0.23 [-0.26, 0.71]

Hypersomnia

48 (0.06)

11 (0.11)

0.40 [-0.11, 0.92]

Delayed puberty

49 (0.05)

0.06 [-0.36, 0.49]

Congenital malformations of breast

49 (0.06)

6 (0.06)

-0.44 [-1.03, 0.15]

Bacterial sepsis of newborn

50 (0.05)

0.19 [-0.37, 0.75]

Other and unspecified disorders of psychological development

50 (0.05)

-0.09 [-0.52, 0.35]

Chronic myeloproliferative disease

51 (0.06)

12 (0.13)

0.10 [-0.30, 0.50]

Other disorders of central nervous system

52 (0.06)

-0.04 [-0.51, 0.43]

Congenital musculoskeletal deformities of head, face, spine and chest

53 (0.06)

6 (0.06)

0.39 [-0.64, 1.41]

Infection of intervertebral disc (pyogenic)

54 (0.06)

12 (0.13)

-0.09 [-0.51, 0.34]

Cauda equina syndrome

55 (0.06)

10 (0.10)

0.31 [-0.40, 1.01]

Cholangitis (primary sclerosing, PSC), with reimbursement 202

55 (0.06)

18 (0.18)

-0.03 [-0.54, 0.48]

Failed attempted abortion

56 (0.06)

5 (0.05)

-0.69 [-1.85, 0.48]

Other and unspecified spinal muscular atrophies

57 (0.07)

5 (0.05)

-0.11 [-0.60, 0.37]

Pyogenic granuloma

57 (0.06)

7 (0.07)

0.13 [-0.38, 0.64]

Other bursitis, not elsewhere classified

58 (0.07)

8 (0.08)

0.33 [-0.21, 0.86]

Respiratory distress of newborn

59 (0.04)

-0.12 [-0.73, 0.48]

Disorder of thyroid, unspecified

60 (0.07)

7 (0.07)

0.27 [-0.35, 0.89]

Congenital malformations of great arteries

60 (0.06)

13 (0.13)

-0.04 [-0.51, 0.43]

Myasthenia gravis

61 (0.07)

14 (0.14)

0.08 [-0.36, 0.53]

Benign neoplasm: Pancreas

61 (0.07)

17 (0.17)

-0.15 [-0.59, 0.29]

Pulmonary eosinophilia, not elsewhere classified

61 (0.07)

9 (0.09)

-0.33 [-0.77, 0.12]

Benign neoplasm: Short bones of upper limb

62 (0.07)

8 (0.08)

-0.29 [-1.07, 0.50]

Thyroiditis, unspecified

63 (0.07)

9 (0.09)

-0.05 [-0.58, 0.47]

Spinal osteochondrosis

65 (0.07)

6 (0.06)

0.25 [-0.17, 0.68]

Other disorders of choroid

66 (0.07)

10 (0.10)

-0.33 [-1.08, 0.43]

Beningn neoplasm: Meninges, unspecified

67 (0.08)

8 (0.08)

0.07 [-0.57, 0.71]

Severe mental retardation

69 (0.08)

-0.03 [-0.30, 0.24]

Cardiomyopathy, Hypertrophic obstructive

70 (0.08)

13 (0.13)

0.11 [-0.30, 0.52]

Haemorrhagic disorder due to circulating anticoagulants

70 (0.08)

8 (0.08)

-0.61 [-1.21, 0.00]

Parapsoriasis

71 (0.08)

14 (0.14)

0.25 [-0.57, 1.06]

Juvenile rheumatoid arthirtis

72 (0.08)

13 (0.13)

0.17 [-0.25, 0.59]

Benign neoplasm: Brain, supratentorial

72 (0.08)

11 (0.11)

-0.20 [-0.97, 0.57]

Other diseases caused by chlamydiae

73 (0.08)

12 (0.13)

-0.01 [-0.72, 0.70]

Measles

74 (0.08)

9 (0.09)

0.16 [-0.36, 0.68]

Other assisted single delivery

74 (0.08)

8 (0.08)

-0.05 [-1.01, 0.91]

Patellar tendinitis

76 (0.08)

5 (0.05)

-0.17 [-0.67, 0.34]

Other bursitis of hip

77 (0.09)

12 (0.12)

0.07 [-0.68, 0.82]

Alcohol induced polyneuropathy

79 (0.09)

5 (0.05)

0.06 [-0.35, 0.48]

Hyphaema and other vascular disorders of iris and ciliary body

79 (0.09)

16 (0.16)

-0.19 [-0.86, 0.48]

IgA nephropathy (IgA glomerulonephritis)

80 (0.09)

22 (0.22)

-0.14 [-0.51, 0.24]

Torticollis

97 (0.10)

12 (0.12)

-0.04 [-0.53, 0.44]

Anorexia

99 (0.11)

-0.67 [-1.53, 0.18]

ILD-related respiratory insufficiency

100 (0.11)

23 (0.22)

0.14 [-0.28, 0.56]

Anosmia

101 (0.11)

10 (0.10)

0.18 [-0.34, 0.70]

Autonomic disorders

102 (0.11)

18 (0.18)

-1.00 [-3.97, 1.97]

Benign neoplasm: Duodenum

104 (0.12)

21 (0.21)

0.45 [-0.25, 1.15]

Alopecia areata

106 (0.12)

28 (0.28)

0.49 [-0.13, 1.11]

Respiratory and cardiovascular disorders specific to the perinatal period

107 (0.07)

-0.12 [-1.24, 1.01]

Hyperkinetic disorders (excl. ADHD)

109 (0.11)

6 (0.06)

-0.10 [-1.24, 1.04]

Obstructive hydrocephalus

111 (0.12)

11 (0.11)

0.49 [-0.20, 1.18]

Other bullous disorders

113 (0.12)

14 (0.14)

-0.07 [-0.94, 0.79]

Dependent personality disorder

113 (0.13)

18 (0.18)

0.54 [-0.06, 1.15]

LSIL lesion of the vulva

116 (0.13)

20 (0.20)

-0.08 [-0.57, 0.40]

Other and unspecified hydrocephalus

118 (0.13)

15 (0.15)

0.37 [-0.16, 0.90]

Syphilis

119 (0.13)

14 (0.14)

-0.51 [-1.53, 0.50]

Carcinoma in situ of breast

120 (0.13)

5 (0.05)

Urethritis and urethral syndrome

123 (0.13)

17 (0.17)

-0.25 [-1.19, 0.69]

Algoneurodystrophy

124 (0.13)

27 (0.26)

-0.01 [-0.39, 0.38]

Central retinal artery occlusion

125 (0.14)

19 (0.19)

0.05 [-0.96, 1.06]

Idiopathic thrombocytopenic purpura

126 (0.13)

16 (0.16)

Paraplegia, diplegia of upper limbs

127 (0.14)

15 (0.15)

-0.04 [-0.67, 0.60]

Sacrococcygeal disorders, not elsewhere classified

129 (0.14)

22 (0.21)

0.00 [-0.51, 0.52]

Unspecified nephritic syndrome

131 (0.14)

14 (0.14)

0.10 [-0.37, 0.57]

Agoraphobia

132 (0.14)

24 (0.23)

0.18 [-0.21, 0.57]

Ulcerative proctitis

133 (0.14)

26 (0.22)

-0.29 [-0.61, 0.04]

Other facial nerve disorders

134 (0.15)

21 (0.21)

-0.08 [-1.32, 1.17]

Mixed specific developmental disorders

136 (0.12)

7 (0.07)

0.51 [-0.03, 1.05]

Complications following abortion and ectopic and molar pregnancy

138 (0.15)

26 (0.25)

Melanoma in situ

139 (0.15)

21 (0.20)

Lichen simplex chronicus

140 (0.15)

18 (0.17)

0.00 [-0.37, 0.38]

Communicating hydrocephalus

141 (0.16)

17 (0.17)

0.39 [-0.08, 0.86]

Dissocial personality disorder

145 (0.16)

19 (0.19)

-0.03 [-0.40, 0.34]

Disorders of eyelid in diseases classified elsewhere

146 (0.16)

19 (0.18)

0.11 [-0.45, 0.66]

Venous complications and haemorrhoids in the puerperium

49 (0.06)

6 (0.06)

-0.10 [-0.52, 0.31]

Neuroendocrine tumor and carcinoma of small intestine

50 (0.06)

9 (0.09)

Late syphilis

50 (0.06)

6 (0.06)

-0.22 [-0.75, 0.31]

Hypertrophy of (infrapatellar) fat pad

51 (0.06)

6 (0.06)

0.17 [-0.38, 0.72]

Thiamine deficiency

52 (0.06)

0.08 [-0.39, 0.55]

Blindness, monocular

53 (0.06)

5 (0.05)

0.19 [-0.76, 1.14]

Varus deformity, not elsewhere classified

54 (0.06)

9 (0.09)

0.30 [-0.12, 0.72]

Systemic sclerosis

54 (0.06)

12 (0.12)

-0.02 [-0.53, 0.50]

Other autoimmune haemolytic anaemias

55 (0.06)

9 (0.09)

0.19 [-0.77, 1.16]

Sequelae of poliomyelitis

56 (0.06)

-0.35 [-0.92, 0.22]

Secondary thrombocytopenia

57 (0.07)

13 (0.14)

0.41 [-0.18, 1.00]

Charcot foot

57 (0.07)

13 (0.13)

-0.15 [-0.63, 0.33]

Peroneal tendinitis

58 (0.07)

14 (0.14)

Acute mastoiditis

59 (0.07)

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

60 (0.06)

5 (0.05)

0.05 [-0.35, 0.45]

Other cestode infections

60 (0.07)

0.15 [-0.18, 0.47]

Other papulosquamous disorders

61 (0.07)

6 (0.06)

-0.29 [-0.67, 0.09]

Squamous cell neoplasms and carcinoma of cervix

61 (0.07)

Monoplegia

61 (0.07)

9 (0.09)

-0.02 [-0.46, 0.43]

Postzoster neuralgia

62 (0.07)

10 (0.10)

-0.07 [-0.63, 0.49]

Kyphosis

63 (0.07)

9 (0.09)

0.39 [-0.29, 1.07]

Spondylopathies in diseases classified elsewhere

65 (0.07)

6 (0.06)

-0.80 [-1.81, 0.21]

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

66 (0.08)

7 (0.07)

-0.25 [-1.04, 0.54]

Other disorders of binocular movement

66 (0.07)

13 (0.13)

-0.32 [-0.84, 0.21]

Unspecified parasitic disease

67 (0.08)

-0.37 [-0.95, 0.21]

Other meningitis

68 (0.08)

13 (0.13)

-0.33 [-1.21, 0.54]

Alcoholic cardiomyopathy

70 (0.08)

-0.07 [-0.48, 0.33]

Other crystal arthropathies

70 (0.08)

7 (0.07)

-0.01 [-0.53, 0.51]

Other overlap syndromes

71 (0.08)

13 (0.13)

0.53 [0.16, 0.89]

Acute otitis externa, noninfective

72 (0.08)

9 (0.09)

0.33 [-0.30, 0.95]

Third [oculomotor] nerve palsy

72 (0.08)

8 (0.08)

-0.33 [-1.55, 0.88]

Benign neoplasm: Peripheral nerves and autonomic nervous system

73 (0.08)

11 (0.11)

-0.07 [-0.99, 0.84]

Perichondritis of external ear

74 (0.08)

9 (0.09)

-0.38 [-1.27, 0.52]

Drug-induced cataract

74 (0.08)

14 (0.14)

-0.01 [-0.54, 0.52]

Benign neoplasm: Vulva

75 (0.08)

11 (0.11)

-0.06 [-0.60, 0.48]

Leukaemia of unspecified cell type

76 (0.09)

7 (0.07)

Acute poliomyelitis

79 (0.09)

10 (0.10)

0.34 [-0.58, 1.27]

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

79 (0.08)

6 (0.06)

0.25 [-0.64, 1.15]

Benign neoplasm: Other/unspecified site

80 (0.09)

12 (0.12)

-0.16 [-1.05, 0.72]

Immunodeficiency with predominantly antibody defects

81 (0.09)

29 (0.29)

-0.31 [-0.96, 0.34]

Other specific arthropathies, wide

82 (0.09)

16 (0.16)

0.27 [-0.23, 0.76]

Undescended testicle

82 (0.08)

7 (0.07)

0.20 [-0.23, 0.63]

Hereditary retinal dystrophy

83 (0.09)

12 (0.12)

-0.01 [-0.38, 0.35]

Papilloedema, unspecified

84 (0.09)

11 (0.11)

0.05 [-0.37, 0.46]

Dronedarone medication

85 (0.10)

25 (0.25)

-0.06 [-0.47, 0.36]

Hyperosmolality and hypernatraemia

87 (0.10)

11 (0.11)

-0.18 [-1.04, 0.68]

Malignant neoplasm of lip

88 (0.10)

9 (0.10)

Erythema intertrigo

89 (0.10)

16 (0.16)

-0.52 [-1.16, 0.13]

Epiphora

90 (0.10)

12 (0.12)

-0.40 [-0.92, 0.13]

Acute epiglottitis

92 (0.10)

14 (0.14)

-0.04 [-0.51, 0.42]

Psoriasis (vulgaris), strict definition

93 (0.10)

22 (0.21)

-0.02 [-0.31, 0.27]

Other nutritional anaemias

96 (0.11)

8 (0.08)

0.39 [-0.29, 1.07]

Other and unspecified epidermal thickening

98 (0.11)

19 (0.19)

0.15 [-0.40, 0.69]

Anaemia in chronic diseases classified elsewhere

100 (0.11)

28 (0.28)

Other conjunctival vascular disorders and cysts

101 (0.11)

15 (0.15)

0.08 [-0.46, 0.63]

Hypersensitivity pneumonitis due to organic dust

102 (0.11)

13 (0.13)

0.18 [-0.47, 0.82]

Protozoal diseases

103 (0.11)

22 (0.22)

0.38 [-0.51, 1.28]

Bullous pemphigoid

105 (0.12)

16 (0.16)

-0.12 [-0.62, 0.37]

Bulimia nervosa (incl. atypical)

107 (0.11)

14 (0.13)

0.09 [-0.38, 0.55]

Gluteal tendinitis

108 (0.12)

30 (0.29)

0.39 [-0.19, 0.97]

Small fibre neuropathy

110 (0.12)

28 (0.28)

0.10 [-0.37, 0.57]

Oligomenorrhoea

112 (0.12)

26 (0.24)

-0.00 [-0.49, 0.49]

Prurigo nodularis

113 (0.13)

16 (0.16)

0.01 [-0.44, 0.45]

Benign neoplasm: Lip

115 (0.13)

14 (0.14)

0.59 [-0.86, 2.05]

Premature separation of placenta [abruptio placentae]

125 (0.14)

25 (0.25)

0.49 [-0.16, 1.14]

Other and unspecified diseases of blood and blood-forming organs

126 (0.14)

17 (0.17)

0.02 [-0.55, 0.58]

Ulcerative ileocolitis

128 (0.14)

29 (0.27)

-0.32 [-0.72, 0.09]

Pyoderma

129 (0.14)

9 (0.09)

-0.00 [-0.42, 0.42]

Hepatocellular carcinoma

131 (0.14)

21 (0.21)

Adrenocortical insufficiency

132 (0.14)

24 (0.23)

0.40 [-0.11, 0.91]

Major anomalies of jaw size

134 (0.14)

18 (0.18)

0.28 [-0.36, 0.92]

Benign neoplasm: Larynx

135 (0.15)

23 (0.22)

Other and unspecified follicular disorders

137 (0.15)

31 (0.29)

-0.18 [-0.77, 0.41]

Torsion of testis

139 (0.14)

8 (0.08)

-0.28 [-0.91, 0.35]

Erythema nodosum

139 (0.15)

22 (0.21)

-0.20 [-0.68, 0.28]

Arthropathies in other diseases classified elsewhere

141 (0.15)

32 (0.30)

0.04 [-0.37, 0.45]

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

142 (0.16)

20 (0.19)

0.48 [-0.77, 1.73]

Pulmonary oedema

145 (0.16)

16 (0.16)

0.06 [-0.42, 0.54]

Suppurative otitis media, unspecified

147 (0.15)

14 (0.14)

Other demyelinating diseases of the central nervous system

149 (0.16)

29 (0.27)

0.24 [-0.14, 0.62]

Other epidermal thickening

150 (0.16)

35 (0.33)

0.11 [-0.43, 0.64]

Benign neoplasm: Appendix

152 (0.18)

23 (0.24)

0.43 [-0.53, 1.39]

Other lesions of median nerve

153 (0.16)

18 (0.18)

-0.09 [-0.51, 0.33]

Sacroiliitis, not elsewhere classified

154 (0.16)

29 (0.26)

-0.21 [-0.45, 0.03]

Juvenile osteochondrosis

156 (0.15)

26 (0.25)

-0.21 [-0.92, 0.51]

Lactose intolerance, other/unspecified

157 (0.17)

22 (0.22)

0.03 [-0.24, 0.29]

Cerebral palsy

159 (0.16)

14 (0.14)

-0.02 [-0.57, 0.53]

Other specified disorders of kidney and ureter

160 (0.17)

34 (0.33)

-0.28 [-1.08, 0.53]

Tooth agenesis EXCLUDE clefts and syndromes

162 (0.13)

15 (0.14)

-0.47 [-0.87, -0.07]

Other other unspecified disorders of the circulatory system

164 (0.18)

37 (0.35)

0.08 [-0.54, 0.70]

Follicular lymphoma, hilmo

165 (0.18)

36 (0.34)

Other noninfective disorders of lymphatic vessels and lymph nodes

166 (0.18)

23 (0.22)

-0.09 [-0.78, 0.59]

Other and unspecified iridocyclitis

169 (0.18)

33 (0.31)

-0.24 [-0.76, 0.28]

Other specified/unspecified inflammatory spondylopathies

170 (0.18)

34 (0.30)

0.11 [-0.43, 0.65]

Other disorders of gingiva or/and edentulous alveolar ridge

172 (0.18)

34 (0.31)

Other eating disorders

173 (0.17)

20 (0.18)

Pneumonia due to other infectious organisms, not elsewhere classified

175 (0.19)

32 (0.31)

0.09 [-0.50, 0.67]

Melanocytic naevi of upper limb, including shoulder

68 (0.08)

15 (0.15)

0.20 [-0.34, 0.74]

Disorders of porphyrin and bilirubin metabolism

70 (0.08)

12 (0.13)

0.26 [-0.12, 0.63]

Causalgia

70 (0.08)

14 (0.14)

-0.12 [-0.61, 0.37]

Motor disorders

71 (0.07)

Brain glioblastoma

72 (0.08)

9 (0.09)

Benign neoplasm: Other and unspecified parts of small intestine

72 (0.08)

17 (0.18)

0.85 [-0.42, 2.13]

Other disorders of electrolyte and fluid balance, not elsewhere classified

73 (0.08)

6 (0.06)

Congenital malformations of uterus and cervix

74 (0.08)

9 (0.09)

-0.24 [-0.76, 0.29]

Dermatitis herpetiformis

74 (0.08)

12 (0.12)

-0.08 [-1.04, 0.89]

Cardiomyopathies, Secondary/extrinsic

75 (0.08)

5 (0.05)

-0.17 [-0.57, 0.24]

Other and unspecified nail disorders

76 (0.09)

6 (0.06)

0.20 [-0.83, 1.23]

Congenital deformities of hip

78 (0.08)

10 (0.10)

-0.31 [-0.83, 0.22]

Hypoplasia of dental enamel , including avohilmo

79 (0.07)

7 (0.07)

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

80 (0.09)

13 (0.13)

-0.60 [-1.11, -0.10]

Infections specific to the perinatal period

81 (0.06)

-0.06 [-0.57, 0.46]

Impaction of intestines

82 (0.09)

9 (0.10)

-0.21 [-0.69, 0.27]

Anomalies of pupillary function

82 (0.09)

11 (0.11)

0.14 [-0.33, 0.61]

Granulomatous disorders of skin and subcutaneous tissue

82 (0.09)

13 (0.13)

0.01 [-0.45, 0.47]

Drug-induced hypoglycaemia without coma

84 (0.10)

10 (0.10)

0.23 [-0.32, 0.77]

Congenital deformities of feet

85 (0.09)

13 (0.13)

Discitis, unspecified

87 (0.10)

20 (0.21)

0.24 [-0.18, 0.65]

conjunctival degenerations and deposits

88 (0.10)

18 (0.18)

-0.64 [-1.29, 0.01]

Other disorders of Eustachian tube

89 (0.10)

17 (0.17)

-0.45 [-1.05, 0.15]

Encephalopathy

90 (0.10)

7 (0.07)

0.27 [-0.14, 0.68]

Oral leukoplakia, including avohilmo

91 (0.10)

15 (0.15)

-0.06 [-0.58, 0.46]

Spinal instabilities

93 (0.10)

21 (0.20)

-0.36 [-0.85, 0.14]

Congenital malformations of the nervous system

95 (0.10)

17 (0.17)

-0.11 [-0.75, 0.54]

Melanocytic naevi of scalp and neck

98 (0.11)

21 (0.21)

-0.12 [-0.78, 0.54]

Adhesive middle ear disease

100 (0.11)

16 (0.16)

0.19 [-0.33, 0.70]

Viral encephalitis, not elsewhere classified/unspecified

101 (0.11)

11 (0.11)

-0.22 [-3.55, 3.11]

Certain zoonotic bacterial diseases

102 (0.11)

9 (0.09)

-0.30 [-1.03, 0.43]

Disorders of synovium and tendon in diseases classified elsewhere

103 (0.12)

12 (0.12)

-0.17 [-0.81, 0.46]

Moderate mental retardation

105 (0.11)

5 (0.05)

0.16 [-0.23, 0.55]

Vascular dementia (mixed)

106 (0.12)

17 (0.18)

-0.29 [-0.84, 0.25]

Retinoschisis and retinal cysts

108 (0.12)

16 (0.16)

0.29 [-0.17, 0.75]

Malignant neoplasm of cervix uteri

109 (0.12)

5 (0.05)

Hereditary corneal dystrophies

111 (0.12)

25 (0.24)

0.03 [-0.31, 0.37]

Acidosis

113 (0.13)

16 (0.16)

0.36 [-0.11, 0.84]

Secondary polycythaemia

115 (0.13)

16 (0.16)

0.02 [-0.37, 0.42]

Other and unspecified paralytic syndromes

117 (0.13)

9 (0.09)

-0.48 [-1.25, 0.30]

Dermatitis due to ingested food

118 (0.09)

-0.16 [-0.49, 0.17]

Acquired haemolytic anaemia

119 (0.13)

19 (0.19)

-0.01 [-0.94, 0.92]

Myositis

120 (0.13)

13 (0.13)

0.20 [-0.32, 0.71]

Sleep disorders, other/unspecified

121 (0.13)

23 (0.22)

0.06 [-0.47, 0.58]

Temporal arteritis

123 (0.13)

29 (0.28)

-0.04 [-0.42, 0.35]

Short Achilles tendon (acquired)

124 (0.14)

20 (0.20)

-0.18 [-0.83, 0.48]

Motor neuron disease

126 (0.14)

14 (0.14)

0.18 [-0.39, 0.74]

Malnutrition

126 (0.14)

13 (0.13)

0.29 [-0.28, 0.85]

Schizoid personality disorder

128 (0.14)

18 (0.18)

-0.18 [-0.62, 0.27]

Chondromalacia

129 (0.14)

26 (0.25)

0.01 [-0.91, 0.94]

Benign neoplasm: Conjunctiva

132 (0.14)

15 (0.15)

-0.13 [-0.72, 0.46]

Disorder of external ear, unspecified

133 (0.15)

29 (0.28)

0.09 [-0.36, 0.54]

Malignant neoplasm of oesophagus

134 (0.14)

18 (0.18)

Vertical strabismus

135 (0.14)

19 (0.18)

-0.15 [-1.18, 0.89]

Serous carcinoma of ovary

137 (0.15)

24 (0.23)

Other erythematous conditions

139 (0.15)

13 (0.12)

Meralgia paraesthetica

139 (0.15)

26 (0.25)

0.11 [-1.01, 1.23]

Benign neoplasm: Long bones of lower limb

141 (0.15)

16 (0.15)

-0.53 [-1.51, 0.45]

Other diseases of spinal cord

143 (0.15)

19 (0.19)

-0.20 [-1.05, 0.66]

Other encephalitis

143 (0.16)

18 (0.18)

0.02 [-0.63, 0.67]

Chronic mastoiditis

146 (0.16)

26 (0.26)

-0.28 [-0.77, 0.21]

Allergic purpura

147 (0.15)

23 (0.22)

-0.14 [-0.68, 0.40]

Type 1 diabetes, wide definition, subgroup 2

149 (0.16)

20 (0.20)

Benign neoplasm: Anus and anal canal

151 (0.17)

17 (0.17)

0.46 [-0.32, 1.25]

Other diseases of gallbladder

281 (0.29)

30 (0.28)

0.07 [-0.45, 0.58]

Embolic stroke with flimmer

282 (0.28)

15 (0.15)

0.13 [-0.59, 0.85]

Nontoxic single thyroid nodule

285 (0.28)

57 (0.48)

0.49 [-0.12, 1.09]

Postprocedural disorders of nervous system

288 (0.28)

55 (0.45)

0.13 [-0.31, 0.57]

Vascular syndromes of brain in cerebrovascular disorders

290 (0.29)

37 (0.34)

0.17 [-0.47, 0.81]

Endometriosis of rectovaginal septum and vagina

294 (0.28)

58 (0.47)

-0.04 [-0.29, 0.22]

Other benign neoplasm of uterus: Other parts/unspecified

298 (0.28)

25 (0.24)

0.01 [-0.40, 0.43]

Lyme disease

302 (0.29)

195 (0.98)

-0.32 [-0.87, 0.22]

Simple and mucopurulent chronic bronchitis

308 (0.30)

36 (0.33)

-0.30 [-0.99, 0.38]

Generalized epilepsy

309 (0.29)

25 (0.23)

0.19 [-0.20, 0.58]

Focal epilepsy, mode (most common among epilepsy diagnosis)

313 (0.30)

132 (0.76)

0.40 [-0.06, 0.86]

Other congenital malformations

317 (0.26)

48 (0.38)

-0.45 [-1.23, 0.33]

Benign neoplasm: Cerebral meninges

319 (0.30)

51 (0.41)

0.21 [-0.18, 0.60]

Other specified/unspecified bacterial intestinal infections

322 (0.31)

58 (0.50)

-0.38 [-1.07, 0.31]

Thyroiditis

325 (0.31)

50 (0.42)

0.21 [-0.30, 0.71]

Hypermetropia

326 (0.26)

52 (0.44)

-0.27 [-0.76, 0.22]

Lichen sclerosus et atrophicus

329 (0.31)

58 (0.45)

-0.20 [-0.53, 0.13]

Excessive vomiting in pregnancy

334 (0.31)

54 (0.43)

-0.06 [-0.33, 0.21]

Heterophoria

337 (0.28)

46 (0.37)

-0.15 [-0.49, 0.19]

Unspecified/other endometriosis

343 (0.32)

68 (0.51)

-0.04 [-0.32, 0.24]

Scoliosis

346 (0.28)

60 (0.47)

0.20 [-0.14, 0.53]

Chronic tubulo-interstitial nephritis

354 (0.33)

31 (0.29)

0.64 [-0.18, 1.45]

Nonalcoholic fatty liver disease

356 (0.35)

80 (0.63)

-0.11 [-0.45, 0.23]

Benign neoplasm: Parotid gland

357 (0.35)

63 (0.52)

0.02 [-0.48, 0.51]

Olecranon bursitis

363 (0.36)

54 (0.47)

0.35 [-0.20, 0.91]

Hyperkalaemia

365 (0.36)

48 (0.43)

0.62 [0.07, 1.18]

Other inflammatory liver diseases

368 (0.36)

56 (0.48)

-0.01 [-0.72, 0.69]

Synovial cyst of popliteal space [Baker]

373 (0.35)

68 (0.56)

0.04 [-0.42, 0.49]

Other Crohn's disease

378 (0.39)

76 (0.63)

-0.28 [-0.57, 0.02]

MS-disease / Multiple Sclerosis

381 (0.37)

62 (0.51)

0.15 [-0.11, 0.40]

Allergic urticaria

386 (0.33)

54 (0.43)

0.14 [-0.29, 0.57]

Secondary hypertension

394 (0.37)

87 (0.69)

0.07 [-0.28, 0.43]

Transient global amnesia

397 (0.38)

71 (0.57)

-0.10 [-0.40, 0.20]

Melanocytic naevi of lower limb, including hip

149 (0.16)

28 (0.26)

0.39 [-0.14, 0.92]

Hypertrophic cardiomyopathy

150 (0.16)

23 (0.22)

0.23 [-0.18, 0.63]

Anankastic personality disorder

151 (0.16)

25 (0.23)

0.25 [-0.20, 0.70]

Pterygium

153 (0.16)

12 (0.12)

0.05 [-0.25, 0.34]

Dialysis

154 (0.17)

33 (0.31)

0.19 [-0.36, 0.74]

Left ventricular outflow tract obstruction, narrow definition

157 (0.16)

38 (0.35)

-0.12 [-0.48, 0.24]

Aphakia

158 (0.17)

8 (0.08)

0.49 [-0.20, 1.18]

SLE (Finngen)

160 (0.17)

29 (0.28)

0.28 [-0.03, 0.59]

Right bundle-branch block

161 (0.17)

30 (0.29)

0.06 [-0.37, 0.48]

Cluster headache, wide

163 (0.17)

31 (0.29)

0.11 [-0.31, 0.53]

Polyhydramnios

164 (0.17)

22 (0.20)

0.36 [-0.24, 0.96]

Dementia due to Parkinson's disease

166 (0.18)

18 (0.18)

Dissociative [conversion] disorders

169 (0.18)

29 (0.27)

-0.04 [-0.44, 0.35]

Small cell lung cancer

170 (0.18)

21 (0.21)

Other and unspecified mononeuropathies of upper limb

171 (0.19)

28 (0.27)

0.46 [-0.95, 1.87]

Other and unspecified mental retardation

173 (0.17)

9 (0.09)

-0.50 [-1.44, 0.43]

Other and unspecified coagulation defects

175 (0.18)

45 (0.41)

0.12 [-0.16, 0.40]

Toxic effect of alcohol

177 (0.19)

13 (0.13)

-0.07 [-0.45, 0.31]

Disorders of globe

178 (0.19)

19 (0.19)

-0.08 [-0.56, 0.39]

Macular hole

180 (0.19)

42 (0.38)

0.33 [-0.18, 0.84]

Biomechanical lesions, not elsewhere classified

182 (0.19)

22 (0.20)

-0.26 [-0.73, 0.22]

Sequelae of tuberculosis

185 (0.19)

18 (0.18)

0.34 [-0.21, 0.89]

Chronic nephritic syndrome

187 (0.20)

35 (0.33)

0.06 [-0.38, 0.49]

Dissection of aorta

189 (0.20)

26 (0.25)

0.22 [-0.26, 0.71]

Malignant neoplasm of ovary

191 (0.19)

25 (0.23)

Hyperfunction of pituitary gland

193 (0.20)

31 (0.28)

0.21 [-0.94, 1.35]

Bacterial meningitis

199 (0.21)

22 (0.21)

-0.08 [-1.15, 0.99]

Mental and behavioural disorders due to cannabinoids

204 (0.20)

26 (0.25)

0.06 [-0.30, 0.42]

Other obstetric trauma

206 (0.21)

33 (0.29)

0.19 [-0.35, 0.74]

Other arterial embolism and thrombosis

208 (0.22)

17 (0.17)

-0.02 [-0.63, 0.58]

Other specified/unspecified dorsopathies

212 (0.22)

28 (0.27)

-0.34 [-0.88, 0.20]

Amblyopia ex anopsia

215 (0.19)

25 (0.23)

-0.11 [-0.72, 0.51]

Other diseases of pericardium

217 (0.23)

39 (0.36)

0.20 [-0.42, 0.82]

Ulcerative rectosigmoiditis

221 (0.21)

38 (0.30)

-0.38 [-0.67, -0.09]

Other acquired deformities of musculoskeletal system and connective tissue

223 (0.23)

31 (0.28)

-0.31 [-0.93, 0.30]

Hepatic failure, not elsewhere classified

226 (0.23)

27 (0.26)

0.00 [-0.52, 0.52]

Impetigo

228 (0.20)

23 (0.21)

Ectropion of eyelid

230 (0.24)

27 (0.25)

-0.33 [-0.77, 0.12]

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

234 (0.24)

39 (0.35)

0.04 [-0.39, 0.47]

Melanocytic naevi of other and unspecified parts of face

236 (0.24)

44 (0.38)

-0.32 [-0.87, 0.24]

Congenital malformations of ovaries, fallopian tubes and broad ligaments

241 (0.24)

43 (0.38)

0.13 [-0.25, 0.51]

Other disorders of nervous system

245 (0.25)

42 (0.36)

0.31 [-0.08, 0.70]

Ingrowing nail

248 (0.24)

46 (0.41)

-0.24 [-0.69, 0.21]

Other specified/unspecified systemic involvement of connective tissue

251 (0.26)

53 (0.47)

0.19 [-0.22, 0.60]

Melanocytic naevi, other sites/unspecified

255 (0.25)

51 (0.42)

0.02 [-0.39, 0.43]

Specific development disorders of scholastic skills

259 (0.21)

12 (0.11)

0.08 [-0.36, 0.52]

Arterial embolism and thrombosis of lower extremity artery

264 (0.26)

19 (0.18)

-0.06 [-0.45, 0.34]

Bullous disorders

266 (0.26)

39 (0.35)

-0.17 [-1.00, 0.66]

Cirrhosis of liver, NAS

270 (0.27)

27 (0.25)

0.29 [-0.14, 0.71]

Other follicular disorders

274 (0.27)

60 (0.50)

-0.20 [-0.53, 0.14]

Other sexually transmitted chlamydial diseases

278 (0.25)

42 (0.35)

0.47 [-0.04, 0.98]

Other and unspecified rosacea

281 (0.28)

51 (0.41)

-0.26 [-0.67, 0.16]

Primary angle-closure glaucoma

282 (0.28)

40 (0.37)

-0.19 [-0.55, 0.16]

Tobacco use

285 (0.29)

44 (0.40)

0.23 [-0.09, 0.55]

Multiple myeloma and malignant plasma cell neoplasms

288 (0.29)

34 (0.32)

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

292 (0.29)

51 (0.44)

-0.37 [-1.09, 0.35]

Acute posthaemorrhagic anaemia

295 (0.30)

33 (0.32)

0.06 [-1.03, 1.14]

conjunctival haemorrhage

299 (0.29)

48 (0.40)

-0.15 [-0.59, 0.28]

Oral leukoplakia and related diseases, including avohilmo

304 (0.30)

58 (0.47)

0.23 [-0.20, 0.65]

Lymphoid leukaemia

308 (0.30)

45 (0.40)

Cyst of kidney

310 (0.31)

57 (0.49)

-0.58 [-2.01, 0.84]

Unspecified chronic bronchitis

314 (0.31)

29 (0.27)

-0.40 [-1.29, 0.49]

Acute lymphadenitis

318 (0.28)

34 (0.29)

0.22 [-0.27, 0.72]

Bronchiectasis

320 (0.31)

57 (0.47)

-0.12 [-0.56, 0.31]

Varicella [chickenpox]

322 (0.30)

38 (0.35)

0.59 [-0.14, 1.33]

Convergent concomitant strabismus

326 (0.28)

37 (0.32)

-0.17 [-0.52, 0.18]

Anogenital herpesviral [herpes simplex] infection

327 (0.32)

53 (0.45)

-0.07 [-0.48, 0.34]

Inflammatory disease of cervix uteri

330 (0.31)

48 (0.41)

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

336 (0.33)

69 (0.57)

0.03 [-0.52, 0.58]

Specific development disorders of speech and language

339 (0.23)

29 (0.25)

-0.24 [-0.77, 0.29]

Nonischemic cardiomyopathy

343 (0.34)

44 (0.39)

0.03 [-0.27, 0.34]

Thrombocytopenia, unspecified

347 (0.33)

50 (0.42)

0.28 [-0.28, 0.83]

Lesion of sciatic nerve

354 (0.34)

38 (0.35)

0.15 [-0.38, 0.68]

Pediculosis, acariasis and other infestations

356 (0.33)

39 (0.34)

0.24 [-0.22, 0.70]

Dermatitis due to substances taken internally

357 (0.23)

29 (0.26)

0.09 [-0.64, 0.81]

Benign neoplasm: Transverse colon

364 (0.36)

84 (0.66)

0.26 [-0.16, 0.68]

Other peripheral vertigo

367 (0.35)

79 (0.63)

0.21 [-0.37, 0.78]

Other and/or unspecified nontoxic goitre

368 (0.35)

55 (0.44)

0.12 [-0.15, 0.40]

Congenital malformations and deformations of the musculoskeletal system

375 (0.26)

45 (0.35)

Melanocytic naevi of trunk

378 (0.33)

85 (0.61)

-0.30 [-0.65, 0.04]

Chronic periodontitis, complicated

381 (0.37)

80 (0.63)

Restless leg syndrome

386 (0.36)

103 (0.74)

0.23 [-0.10, 0.56]

Other peripheral vascular diseases

395 (0.37)

52 (0.42)

0.32 [-0.19, 0.84]

Fibrosis and cirrhosis of liver

399 (0.37)

50 (0.42)

0.14 [-0.26, 0.54]

Benign neoplasm: salivary glands, exclude unknown (D119)

402 (0.39)

70 (0.56)

0.18 [-0.38, 0.73]

Sequelae of other and unspecified infectious and parasitic diseases

404 (0.38)

45 (0.40)

Polycystic ovarian syndrome, broad definition

410 (0.36)

70 (0.49)

-0.04 [-0.30, 0.23]

Respiratory tuberculosis, not confirmed

412 (0.37)

39 (0.36)

0.32 [-0.16, 0.80]

Acne

417 (0.31)

51 (0.37)

-0.03 [-0.32, 0.27]

Flat foot [pes planus] (acquired)

420 (0.38)

85 (0.65)

-0.16 [-0.44, 0.11]

Other neurotic disorders

424 (0.40)

52 (0.47)

-0.26 [-0.76, 0.25]

Other disorders of cornea

426 (0.38)

73 (0.57)

-0.13 [-0.54, 0.28]

Reactive arthropathies

429 (0.38)

81 (0.62)

0.13 [-0.53, 0.79]

Other and unspecified glaucoma

432 (0.39)

50 (0.43)

0.03 [-0.32, 0.37]

Twin gestation

437 (0.39)

73 (0.56)

-0.19 [-0.96, 0.58]

Smoking dependency

442 (0.42)

71 (0.57)

0.13 [-0.18, 0.45]

Stenosis and insufficiency of lacrimal passages

445 (0.38)

64 (0.50)

-0.06 [-0.47, 0.36]

Polycystic ovarian syndrome

163 (0.17)

23 (0.20)

-0.05 [-0.30, 0.20]

Wide developmental disorders

164 (0.14)

17 (0.16)

Other specified/unspecified disorders of bone/cartilage

166 (0.18)

18 (0.18)

0.58 [-2.48, 3.63]

Disorders of orbit

167 (0.18)

24 (0.22)

0.17 [-0.19, 0.53]

Benign neoplasm of other and unspecified female genital organs

169 (0.18)

31 (0.29)

-0.24 [-0.79, 0.31]

Other and unspecified acute skin changes due to ultraviolet radiation

170 (0.18)

25 (0.25)

-0.18 [-0.84, 0.49]

Other renal tubulo-interstitial diseases

172 (0.18)

15 (0.15)

-0.49 [-1.18, 0.19]

Impacted maxillary molar

174 (0.16)

20 (0.17)

-0.04 [-0.77, 0.69]

Other/unspecified disorders of vestibular function

177 (0.19)

27 (0.26)

0.64 [-0.01, 1.29]

Benign neoplasm: Small intestine

178 (0.19)

39 (0.37)

0.86 [-0.26, 1.98]

Diffuse large B-cell lymphoma

180 (0.19)

30 (0.28)

Episcleritis

181 (0.19)

36 (0.32)

-0.27 [-0.83, 0.28]

Secondary parkinsonism

183 (0.19)

23 (0.23)

Other endocrine disorders

187 (0.16)

39 (0.35)

Other specified and unspecified disorders of eye and adnexa

188 (0.20)

27 (0.25)

0.06 [-0.70, 0.81]

Separation of retinal layers (serosa)

191 (0.20)

20 (0.19)

0.29 [-0.18, 0.76]

Placenta praevia

192 (0.20)

31 (0.28)

-0.16 [-0.99, 0.66]

Congenital iodine-deficiency syndrome/hypothyroidism

195 (0.21)

22 (0.21)

0.30 [-0.16, 0.76]

Other acute skin changes due to ultraviolet radiation

201 (0.21)

26 (0.25)

Pustulosis palmaris et plantaris

205 (0.22)

38 (0.35)

0.22 [-0.16, 0.60]

Herpesviral keratitis and keratoconjunctivitis

208 (0.22)

31 (0.29)

Osteonecrosis

210 (0.22)

39 (0.35)

0.23 [-0.19, 0.66]

Type1 diabetes, definitions combined, early onset

215 (0.20)

49 (0.40)

0.21 [-0.15, 0.57]

Septal defects

216 (0.18)

37 (0.32)

0.03 [-0.41, 0.48]

Other disorders of prostate

219 (0.23)

35 (0.33)

-0.06 [-0.71, 0.58]

Ovarian dysfunction

222 (0.22)

34 (0.27)

0.02 [-0.29, 0.34]

Emotional disorders starting during childhood or adolescence

224 (0.17)

22 (0.19)

Vitamin deficiency, wide

229 (0.23)

31 (0.28)

0.32 [-0.12, 0.77]

Distal bite

233 (0.15)

16 (0.15)

0.01 [-0.44, 0.46]

Inflammatory disorders of breast

235 (0.23)

41 (0.35)

-0.46 [-0.93, 0.02]

Congenital malformations of the urinary system

239 (0.23)

37 (0.32)

-0.09 [-0.63, 0.45]

Other disorders starting during childhood or adolescence

243 (0.17)

15 (0.13)

Lesion of lateral popliteal nerve

247 (0.25)

39 (0.35)

-0.11 [-0.66, 0.43]

Other secondary gonarthrosis

250 (0.26)

50 (0.45)

-0.06 [-0.46, 0.34]

Benign neoplasm: Descending colon

254 (0.27)

52 (0.45)

0.77 [-0.47, 2.00]

Recurrent dislocation of patella

256 (0.25)

53 (0.46)

0.21 [-0.08, 0.50]

Alcohol-induced acute pancreatitis

262 (0.27)

30 (0.29)

0.22 [-0.20, 0.65]

Other and unspecified disorders of skin and subcutaneous tissue

265 (0.27)

49 (0.42)

0.21 [-0.50, 0.92]

Amenorrhoea

270 (0.25)

42 (0.34)

0.51 [-0.16, 1.17]

Otalgia

272 (0.23)

45 (0.37)

-0.19 [-0.80, 0.42]

Vasomotor rhinitis (mode)

273 (0.27)

50 (0.42)

-0.27 [-0.81, 0.27]

Other disorders of white blood cells

276 (0.28)

38 (0.34)

-0.11 [-0.74, 0.52]

Prepatellar bursitis

281 (0.29)

45 (0.41)

0.13 [-0.32, 0.58]

Other disorders of optic [2nd] nerve and visual pathways

284 (0.28)

41 (0.36)

-0.41 [-0.89, 0.06]

Femoral hernia

287 (0.29)

36 (0.33)

-0.09 [-0.46, 0.27]

Viral pneumonia (unknown virus, not influenza)

290 (0.27)

54 (0.46)

0.22 [-0.23, 0.67]

Other puerperal infections

294 (0.27)

55 (0.44)

-0.08 [-0.58, 0.42]

Thyrotoxicosis with toxic multinodular goitre

296 (0.29)

37 (0.33)

0.08 [-0.20, 0.37]

Non-small cell lung cancer, adenocarcinoma

301 (0.30)

56 (0.49)

Cerebral aneurysm, nonruptured

307 (0.30)

71 (0.57)

0.10 [-0.24, 0.43]

Abnormal findings on antenatal screening of mother

309 (0.28)

50 (0.39)

0.26 [-0.23, 0.76]

Left bundle-branch block

312 (0.31)

61 (0.51)

0.12 [-0.28, 0.52]

Oesophagitis

316 (0.31)

51 (0.45)

0.12 [-0.35, 0.60]

Other and unspecified visual disturbances

319 (0.30)

75 (0.59)

0.11 [-0.33, 0.56]

Benign neoplasm: Adrenal gland

322 (0.33)

67 (0.57)

0.33 [-0.20, 0.85]

Myeloproliferative diseases (CML excluded)

325 (0.32)

66 (0.55)

0.17 [-0.16, 0.50]

Sicca syndrome [Sjögren]

326 (0.32)

67 (0.54)

0.15 [-0.22, 0.52]

Ankylosing spondylitis

328 (0.30)

59 (0.45)

-0.15 [-0.30, 0.01]

Other diseases of blood and blood-forming organs

332 (0.33)

49 (0.42)

0.15 [-0.27, 0.56]

Urethral stricture

337 (0.33)

51 (0.45)

-0.12 [-0.66, 0.43]

Suppurative and necrotic conditions of lower respiratory tract

342 (0.34)

39 (0.35)

Corns and callosities

345 (0.34)

64 (0.54)

0.27 [-0.12, 0.65]

Female infertility, tubal origin

353 (0.37)

52 (0.46)

0.28 [-0.32, 0.89]

Cerebral cysts

355 (0.34)

45 (0.40)

0.13 [-0.45, 0.70]

Impacted cerumen

388 (0.35)

59 (0.46)

-0.08 [-0.92, 0.75]

Recurrent dislocation and subluxation of joint

396 (0.36)

53 (0.43)

0.07 [-0.24, 0.38]

Haemangioma and lymphangioma, any site

400 (0.35)

56 (0.44)

-0.03 [-0.51, 0.46]

Graves disease, strict definition

402 (0.38)

73 (0.55)

0.25 [-0.01, 0.50]

Embedded teeth, including avohilmo

404 (0.32)

56 (0.42)

-0.67 [-1.33, -0.01]

Cholera

410 (0.41)

49 (0.46)

-0.20 [-0.68, 0.29]

Eustachian salpingitis and obstruction

412 (0.36)

53 (0.42)

0.31 [-0.09, 0.70]

Chronic ulcer of skin, not elsewhere classified

418 (0.39)

61 (0.52)

0.25 [-0.15, 0.65]

Pleural plaque

420 (0.40)

77 (0.60)

0.00 [-0.37, 0.37]

Pneumothorax

424 (0.40)

71 (0.60)

0.13 [-0.48, 0.73]

Missing teeth due to accident, extraction or parodontitis

427 (0.39)

91 (0.66)

-0.32 [-1.49, 0.85]

Migraine with aura and triptan purchases

429 (0.36)

103 (0.64)

0.12 [-0.13, 0.36]

Infections of genitourinary tract in pregnancy

432 (0.37)

65 (0.49)

0.21 [-0.31, 0.73]

Uterine polyps

435 (0.40)

84 (0.64)

-0.05 [-0.57, 0.47]

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

438 (0.40)

69 (0.54)

0.23 [-0.17, 0.62]

Visual field defects

442 (0.41)

73 (0.59)

0.12 [-0.55, 0.78]

Adenocarcinoma and papilloma adenocarcinoma of rectum

447 (0.40)

73 (0.58)

0.05 [-0.28, 0.37]

Disorders of continuity of bone

455 (0.40)

87 (0.67)

0.17 [-0.22, 0.56]

Entropion and trichiasis of eyelid

459 (0.42)

63 (0.51)

0.06 [-0.25, 0.36]

Cardiomyopathy, other and unspecified

468 (0.44)

78 (0.63)

0.24 [-0.18, 0.66]

Congenital malformations of genital organs

474 (0.35)

70 (0.53)

0.03 [-0.38, 0.43]

Inflammatory diseases of the central nervous system

478 (0.42)

61 (0.49)

-0.18 [-0.99, 0.64]

Embolic stroke

483 (0.43)

36 (0.33)

0.09 [-0.64, 0.82]

Alzheimer’s disease (Early onset)

497 (0.42)

28 (0.25)

Other specified/unspecified hearing loss

501 (0.44)

60 (0.49)

1.00 [-1.01, 3.01]

Poor fetal growth

512 (0.41)

75 (0.51)

-0.01 [-0.32, 0.31]

Other diseases of arteries and capillaries

515 (0.46)

83 (0.65)

0.51 [0.01, 1.02]

Generalized epilepsy, mode (most common among epilepsy diagnosis)

526 (0.44)

19 (0.18)

0.11 [-0.28, 0.49]

Use of disulfiram, acamprosate or naltrexone

533 (0.49)

92 (0.73)

-0.14 [-0.43, 0.15]

LSIL lesion of the cervix uteri, vagina or vulva

539 (0.45)

103 (0.68)

-0.26 [-0.71, 0.18]

Cervicocranial syndrome

541 (0.46)

88 (0.64)

-0.00 [-0.38, 0.37]

Familial hypercholesterolemia, with ischemic heart disease

546 (0.50)

71 (0.56)

0.43 [0.04, 0.82]

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

552 (0.47)

54 (0.46)

0.18 [-0.25, 0.61]

Impotence

215 (0.23)

40 (0.36)

-0.13 [-0.55, 0.29]

Drug-induced neutropenia

219 (0.23)

49 (0.42)

-0.01 [-0.52, 0.51]

Lesion of radial nerve

222 (0.23)

25 (0.24)

0.39 [-0.07, 0.85]

Degeneration of the brain due to alcohol

224 (0.23)

13 (0.13)

0.57 [-0.15, 1.28]

Cysts of oral region, not elsewhere classified

229 (0.23)

32 (0.29)

0.07 [-0.48, 0.61]

Hordeolum and other deep inflammation of eyelid

232 (0.22)

43 (0.38)

-0.29 [-0.97, 0.39]

Tuberculosis of other organs, strict

232 (0.24)

15 (0.15)

0.43 [-0.40, 1.27]

Status epilepticus

235 (0.23)

19 (0.18)

1.00 [-0.06, 2.06]

Deposits [accretions] on teeth

237 (0.23)

66 (0.55)

0.17 [-0.42, 0.76]

Other necrotizing vasculopathies (FG)

243 (0.25)

54 (0.47)

-0.20 [-0.61, 0.21]

Neovascular glaucoma

247 (0.25)

29 (0.27)

-0.25 [-0.94, 0.44]

Hypopituitarism

249 (0.25)

42 (0.35)

-0.96 [-6.00, 4.09]

Hypertensive Renal Disease

250 (0.26)

38 (0.36)

0.01 [-0.40, 0.43]

Calcific tendinitis of shoulder

254 (0.26)

52 (0.45)

-0.01 [-0.33, 0.31]

Oesophageal varices

256 (0.26)

20 (0.19)

0.28 [-0.17, 0.74]

Rubella [German measles]

261 (0.27)

34 (0.33)

-0.38 [-0.99, 0.24]

Mental and behavioural disorders due to opioids

264 (0.26)

23 (0.22)

0.03 [-0.31, 0.36]

Autoimmune hyperthyroidism

269 (0.27)

54 (0.46)

0.12 [-0.20, 0.45]

Trigeminal neuralgia

271 (0.27)

55 (0.48)

0.76 [-0.39, 1.90]

Rheumatic valve diseases

275 (0.27)

23 (0.23)

0.09 [-0.68, 0.86]

Calculus of lower urinary tract

280 (0.28)

44 (0.40)

0.18 [-0.24, 0.60]

Ocular pain

284 (0.27)

51 (0.41)

0.20 [-0.23, 0.62]

Colorectal neuroendocrine tumor and carcinoma

287 (0.33)

33 (0.34)

Postprocedural musculoskeletal disorders, not elsewhere classified

289 (0.29)

52 (0.45)

0.28 [-0.09, 0.64]

Lichen simplex chronicus and prurigo

293 (0.29)

44 (0.38)

0.16 [-0.20, 0.52]

Other otitis externa (chronic)

296 (0.29)

62 (0.53)

0.20 [-0.21, 0.61]

Myocarditis

300 (0.30)

44 (0.39)

0.05 [-0.39, 0.49]

Other aneurysm

306 (0.31)

41 (0.37)

0.19 [-0.45, 0.83]

Mandibular retrognathia

309 (0.22)

42 (0.35)

-0.02 [-0.38, 0.34]

Other coagulation defects

312 (0.30)

59 (0.49)

-0.08 [-0.47, 0.31]

Other noninflammatory disorders of vagina

316 (0.29)

51 (0.41)

-0.37 [-0.93, 0.19]

Vascular diseases of the intestine

318 (0.32)

32 (0.30)

0.07 [-0.82, 0.96]

Reactive arthropathies, FINNGEN

322 (0.31)

62 (0.51)

0.24 [-1.08, 1.57]

Dementia in other diseases classified elsewhere

325 (0.32)

37 (0.34)

Metatarsalgia

326 (0.31)

69 (0.53)

-0.19 [-0.56, 0.17]

Other diseases of jaws

327 (0.32)

68 (0.57)

-0.68 [-1.59, 0.24]

Deep endometriosis

331 (0.31)

66 (0.51)

-0.05 [-0.31, 0.22]

Idiopathic pulmonary fibrosis

337 (0.33)

65 (0.55)

0.12 [-0.24, 0.48]

Eating disorder

342 (0.28)

41 (0.31)

Benign neoplasm of middle ear and respiratory system

343 (0.33)

62 (0.51)

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

351 (0.33)

51 (0.40)

0.09 [-0.14, 0.32]

Varicose veins of other sites

355 (0.34)

43 (0.37)

-0.04 [-0.61, 0.54]

Postpartum haemorrhage due to anatomy

357 (0.31)

52 (0.38)

0.08 [-0.40, 0.57]

Osteomyelitis

359 (0.34)

54 (0.47)

0.14 [-0.38, 0.67]

Crohn's disease NAS

364 (0.37)

72 (0.61)

-0.28 [-0.57, 0.00]

Other diseases of appendix

368 (0.42)

34 (0.36)

0.46 [-0.24, 1.17]

Haemangioma, any site

371 (0.33)

53 (0.43)

-0.07 [-0.54, 0.40]

Other diseases of pancreas

377 (0.37)

85 (0.71)

-0.07 [-0.53, 0.39]

Anorexia (incl.atypical)

380 (0.33)

30 (0.25)

-0.38 [-1.06, 0.29]

Nail disorders

383 (0.35)

62 (0.50)

-0.43 [-0.96, 0.10]

Nummular dermatitis

388 (0.36)

59 (0.48)

0.13 [-0.28, 0.54]

Biological medication for rheuma

390 (0.35)

105 (0.66)

-0.05 [-0.29, 0.20]

Benign neoplasm of bone and articular cartilage

396 (0.36)

54 (0.43)

Multiple delivery

400 (0.37)

60 (0.48)

-0.43 [-1.24, 0.37]

Psychotic depression

403 (0.37)

50 (0.42)

0.02 [-0.32, 0.37]

Otosclerosis

405 (0.38)

60 (0.49)

-0.05 [-0.28, 0.18]

Left ventricular outflow tract obstruction (LVOTO), broad definition

411 (0.37)

79 (0.60)

-0.02 [-0.35, 0.32]

Carcinoma in situ of skin

414 (0.39)

57 (0.48)

Mucosal proctocolitis

418 (0.36)

82 (0.55)

-0.29 [-0.53, -0.05]

Sudden idiopathic hearing loss

422 (0.39)

59 (0.45)

0.25 [-0.38, 0.88]

Ulcer of oesophagus

425 (0.40)

63 (0.53)

0.00 [-0.40, 0.40]

Seborrhoeic dermatitis

428 (0.39)

84 (0.65)

-0.06 [-0.40, 0.29]

Other diseases of peritoneum

430 (0.44)

57 (0.53)

-0.03 [-0.61, 0.55]

Hemiplegia

433 (0.39)

51 (0.46)

-0.11 [-0.70, 0.47]

Other and unspecified urticaria

985 (0.61)

180 (1.00)

0.15 [-0.14, 0.45]

Chronic periapical parodontitis

1020 (0.73)

207 (1.12)

Benign neoplasm: Rectum, anus and anal canal

1034 (0.80)

197 (1.15)

-0.07 [-0.42, 0.29]

Hypotension

1047 (0.73)

133 (0.85)

0.23 [-0.19, 0.65]

Follicular cysts of skin and subcutaneous tissue

1059 (0.73)

173 (1.02)

0.04 [-0.27, 0.36]

Acute nasopharyngitis (common cold)

1065 (0.72)

130 (0.89)

-0.26 [-0.69, 0.18]

Malignant neoplasm of breast, HER-positive

1089 (0.71)

259 (1.09)

Other diseases of blood and blood-forming organs, wide

1104 (0.76)

180 (0.98)

0.83 [-1.15, 2.80]

Bipolar affective disorders

1122 (0.76)

177 (0.97)

-0.02 [-0.28, 0.25]

Iron deficiency anaemia secondary to blood loss (chronic)

1128 (0.75)

130 (0.82)

0.40 [-0.10, 0.90]

1172 (0.74)

137 (0.77)

-0.16 [-0.34, 0.01]

Gout, unspecified

1199 (0.85)

178 (1.04)

-0.08 [-0.31, 0.14]

Cervicobrachial syndrome

1221 (0.79)

219 (1.11)

-0.13 [-0.37, 0.12]

Polyarthrosis

1242 (0.78)

187 (1.04)

0.11 [-0.12, 0.34]

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1294 (0.78)

104 (0.71)

0.13 [-0.19, 0.45]

Acute peritonitis

1357 (1.26)

142 (1.24)

Other diseases of the respiratory system

1382 (0.86)

168 (0.94)

0.14 [-0.20, 0.47]

Gastric ulcer

1474 (0.91)

149 (0.87)

0.34 [-0.04, 0.71]

Obesity related asthma

1499 (0.93)

315 (1.29)

0.10 [-0.09, 0.30]

Diseases of peritoneum

1769 (1.45)

198 (1.51)

0.48 [-1.05, 2.01]

Other disorders of breast

455 (0.40)

88 (0.61)

-0.48 [-0.97, 0.01]

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

459 (0.40)

77 (0.60)

Other disorders of glucose regulation and pancreatic internal secretion

467 (0.42)

68 (0.54)

0.27 [-0.15, 0.69]

Stomatitis and related lesions

472 (0.41)

63 (0.50)

-0.50 [-1.03, 0.03]

Benign neoplasm: Ascending colon

478 (0.45)

119 (0.85)

0.17 [-0.23, 0.56]

Achilles tendinitis

482 (0.44)

91 (0.67)

0.16 [-0.21, 0.54]

Spinal enthesopathy

494 (0.42)

23 (0.22)

0.14 [-0.40, 0.67]

Mental retardation

501 (0.40)

28 (0.26)

Decubitus ulcer and pressure area

512 (0.45)

51 (0.45)

0.47 [-0.65, 1.58]

Diplopia

524 (0.45)

91 (0.63)

0.19 [-0.44, 0.81]

Congenital malformations of the circulatory system

532 (0.35)

97 (0.64)

-0.05 [-0.45, 0.36]

Congenital malformations of heart and great arteries

536 (0.35)

87 (0.59)

-0.01 [-0.42, 0.41]

Abnormalities of forces of labour

538 (0.46)

88 (0.65)

-0.31 [-0.72, 0.11]

Trochanteric bursitis

541 (0.48)

116 (0.78)

-0.03 [-0.40, 0.35]

Spondylopathies (FG)

545 (0.44)

96 (0.61)

-0.14 [-0.30, 0.01]

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

551 (0.45)

68 (0.56)

0.19 [-0.14, 0.52]

Other or ill-defined heart diseases

557 (0.48)

47 (0.41)

Glomerulonephritis

564 (0.48)

84 (0.64)

0.20 [-0.30, 0.70]

Paralytic ileus

573 (0.58)

64 (0.61)

0.19 [-1.35, 1.72]

Candidiasis

578 (0.47)

101 (0.69)

0.21 [-0.43, 0.86]

Chronic laryngitis and laryngotracheitis

583 (0.51)

105 (0.70)

-0.02 [-0.50, 0.46]

Other specified and unspecified personality disorders

590 (0.50)

86 (0.66)

0.18 [-0.16, 0.52]

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

606 (0.47)

117 (0.70)

0.14 [-0.23, 0.50]

Retained placenta and membranes, without haemorrhage

615 (0.51)

94 (0.66)

0.03 [-0.59, 0.65]

Orchitis and epididymitis

619 (0.51)

88 (0.68)

0.12 [-0.39, 0.63]

Allergic contact dermatitis

626 (0.49)

108 (0.71)

0.12 [-0.20, 0.43]

Other mental disorders due to brain damage and dysfunction and to physical disease

638 (0.52)

91 (0.67)

-0.18 [-0.69, 0.33]

Other pleural conditions

646 (0.54)

103 (0.78)

-0.48 [-1.94, 0.98]

Vocal cord dysfunction

653 (0.52)

118 (0.73)

0.24 [-0.10, 0.58]

Sarcoidosis

671 (0.57)

129 (0.88)

0.25 [-0.01, 0.52]

Retinal vascular occlusion

680 (0.56)

98 (0.71)

-0.00 [-0.54, 0.54]

Polymyalgia rheumatica

689 (0.55)

109 (0.77)

-0.12 [-0.43, 0.20]

Bell's palsy

693 (0.56)

108 (0.77)

-0.06 [-0.34, 0.23]

Benign neoplasm of other and ill-defined parts of digestive system

720 (0.59)

148 (0.91)

-0.01 [-0.42, 0.39]

Lateral epicondylitis

728 (0.60)

97 (0.64)

-0.05 [-0.31, 0.20]

Bronchitis, not specified as acute or chronic

738 (0.57)

65 (0.50)

0.06 [-0.41, 0.53]

Lesion of ulnar nerve

752 (0.61)

129 (0.86)

0.22 [-0.10, 0.54]

Insomnia

763 (0.58)

141 (0.88)

-0.06 [-0.40, 0.28]

Migraine without aura

781 (0.53)

177 (0.93)

0.05 [-0.17, 0.27]

Other hammer toe(s) (acquired)

792 (0.59)

144 (0.86)

-0.10 [-0.32, 0.13]

Hypertrophy of breast in women and men

811 (0.62)

176 (0.99)

-0.01 [-0.19, 0.17]

Benign neoplasm: Sigmoid colon

840 (0.69)

173 (1.06)

0.45 [0.08, 0.83]

Endometriosis of ovary

863 (0.63)

150 (0.87)

-0.03 [-0.22, 0.16]

Medical treatment for female infertility

883 (0.63)

160 (0.85)

-0.05 [-0.47, 0.37]

Other predominantly sexually transmitted diseases, not elsewhere classified

893 (0.61)

140 (0.81)

0.18 [-0.20, 0.56]

Colon adenocarcinoma

931 (0.75)

127 (0.93)

Aneurysms, operations, SAH

942 (0.65)

151 (0.94)

0.05 [-0.23, 0.32]

Pre-eclampsia

953 (0.65)

146 (0.80)

-0.02 [-0.27, 0.22]

Vascular dementia

967 (0.65)

73 (0.57)

-0.18 [-0.70, 0.34]

Anterior Iridocyclitis

996 (0.65)

157 (0.87)

-0.03 [-0.33, 0.28]

Premature rupture of membranes

1021 (0.65)

152 (0.76)

-0.28 [-0.73, 0.17]

Gout, strict definition

1036 (0.78)

154 (0.97)

-0.10 [-0.32, 0.11]

Tinnitus

1048 (0.73)

196 (1.02)

-0.17 [-0.48, 0.14]

Presbycusis

1060 (0.72)

102 (0.68)

-0.11 [-0.41, 0.19]

TMD muscular pain linked with fibromyalgia

1076 (0.70)

Otitis externa

1091 (0.67)

187 (0.99)

0.13 [-0.19, 0.46]

Parkinson's disease

1105 (0.74)

125 (0.83)

0.09 [-0.23, 0.41]

Obstructed labour due to malposition and malpresentation of fetus

1126 (0.69)

195 (0.98)

-0.33 [-0.86, 0.20]

Blepharochalasis

1130 (0.76)

262 (1.23)

-0.20 [-0.41, 0.01]

Abrasion of teeth

1178 (0.77)

256 (1.15)

-0.25 [-0.65, 0.14]

Type 1 diabetes, wide definition

1205 (0.81)

231 (1.14)

Cervicalgia

1223 (0.78)

194 (1.04)

-0.11 [-0.41, 0.19]

Focal epilepsy, strict definition

1273 (0.77)

140 (0.79)

0.34 [-0.14, 0.82]

Mycoses

1299 (0.78)

234 (1.13)

0.87 [-0.07, 1.81]

Colorectal adenocarcinoma

1363 (0.90)

197 (1.15)

Impingement syndrome of shoulder

1405 (0.91)

220 (1.07)

-0.02 [-0.27, 0.22]

Soft tissue disorders related to use, overuse and pressure

1502 (0.92)

269 (1.25)

0.02 [-0.25, 0.30]

Hernia of abdominal wall, postoperative

1845 (1.47)

346 (2.01)

0.18 [-0.08, 0.44]

Viral haemorrhagic fevers, not elsewhere classified/unspecified

503 (0.45)

59 (0.48)

-0.10 [-0.49, 0.29]

Covid-19 suspected case

519 (0.39)

165 (0.87)

0.01 [-0.61, 0.62]

Other disorders of penis

527 (0.41)

96 (0.74)

0.08 [-0.32, 0.48]

Adenomyosis (Endometriosis of uterus)

536 (0.44)

102 (0.68)

0.11 [-0.14, 0.35]

Asthma and allergy

541 (0.36)

109 (0.67)

0.09 [-0.14, 0.33]

Myopia

543 (0.41)

105 (0.71)

0.11 [-0.15, 0.37]

Herpesviral [herpes simplex] infections

547 (0.45)

88 (0.63)

-0.12 [-0.71, 0.47]

Mental and behavioural disorders due to sedatives or hypnotics

554 (0.48)

65 (0.55)

0.06 [-0.32, 0.45]

Atrophic disorders of skin

560 (0.47)

93 (0.62)

-0.27 [-0.68, 0.14]

Thoracic aortic aneurysm

570 (0.53)

133 (0.93)

0.04 [-0.17, 0.25]

Recurring oral aphthae, including avohilmo

576 (0.45)

104 (0.71)

0.27 [-0.50, 1.05]

Benign lipomatous neoplasm of other sites/unspecified

579 (0.51)

67 (0.53)

0.46 [-0.11, 1.03]

Pilonidal cyst

587 (0.49)

80 (0.61)

0.03 [-0.24, 0.30]

Dermatophytosis

591 (0.49)

110 (0.77)

0.97 [0.12, 1.81]

Abscess of anal and rectal regions

605 (0.53)

75 (0.59)

-0.07 [-0.42, 0.27]

COPD-related respiratory insufficiency

605 (0.53)

105 (0.77)

0.23 [-0.04, 0.50]

Mixed conductive and sensorineural hearing loss

613 (0.51)

90 (0.64)

0.09 [-0.29, 0.47]

Other malignant neoplasms of skin (=non-melanoma skin cancer)

618 (0.51)

521 (1.48)

Unspecified kidney failure

629 (0.53)

92 (0.71)

-0.20 [-0.75, 0.35]

Rheumatism, unspecified

639 (0.52)

114 (0.75)

-0.15 [-0.40, 0.11]

Puerperal sepsis

668 (0.55)

107 (0.74)

0.02 [-0.50, 0.53]

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

679 (0.41)

114 (0.70)

-0.17 [-0.63, 0.30]

Maternal care for known or suspected fetal abnormality and damage

686 (0.51)

118 (0.71)

-0.01 [-0.52, 0.49]

Temporomandibular joint disorders

692 (0.53)

130 (0.75)

0.01 [-0.30, 0.32]

Squamous cell neoplasms and carcinomas of the skin

705 (0.57)

106 (0.77)

Retinal vascular disorders

713 (0.58)

100 (0.72)

0.04 [-0.46, 0.54]

Other obstructive and reflux uropathy

725 (0.57)

31 (0.28)

-0.20 [-1.02, 0.61]

Diseases of the myoneural junction and muscle

732 (0.58)

99 (0.71)

1.00 [-0.51, 2.51]

Alzheimer’s disease (Atypical or mixed)

747 (0.56)

60 (0.48)

HSIL lesion of the cervix uteri

762 (0.56)

113 (0.65)

-0.09 [-0.38, 0.20]

Ulcer of lower limb, not elsewhere classified

772 (0.62)

137 (0.94)

0.12 [-0.24, 0.49]

Hypokalaemia

786 (0.62)

107 (0.77)

0.10 [-0.28, 0.49]

Enterocolitis due to Clostridium difficile

806 (0.65)

102 (0.76)

-0.33 [-0.86, 0.21]

HSIL lesion of the cervix uteri, vagina or vulva

822 (0.59)

128 (0.71)

-0.09 [-0.40, 0.22]

Vitamin B12 deficiency anaemia

831 (0.61)

83 (0.61)

0.22 [-0.09, 0.53]

Lichen ruber planus, wide definition including periferal and oral lichen planus

853 (0.64)

169 (0.95)

0.05 [-0.27, 0.37]

Wet age-related macular degeneration

871 (0.63)

112 (0.70)

-0.15 [-0.37, 0.07]

Other/unspecified rheumatoid arthritis

890 (0.66)

0.14 [-0.16, 0.44]

Pleural effusion

930 (0.70)

136 (0.89)

0.33 [-0.19, 0.84]

Other diseases of liver

941 (0.71)

167 (1.01)

0.00 [-0.36, 0.37]

Psoriasis vulgaris

951 (0.69)

156 (0.91)

-0.05 [-0.25, 0.14]

Other and unspecified polyneuropathies, also in other diseases

962 (0.72)

172 (1.03)

-0.15 [-0.49, 0.19]

Inflammatory bowel disease, strict (require KELA)

980 (0.67)

196 (0.97)

-0.30 [-0.52, -0.09]

Coagulation defects, purpura and other haemorrhagic conditions

1012 (0.67)

159 (0.91)

0.03 [-0.43, 0.49]

Other disorders of patella

1034 (0.73)

178 (1.01)

0.04 [-0.18, 0.26]

Diseases of salivary glands

1043 (0.70)

186 (1.03)

0.32 [-0.08, 0.73]

Unspecified acute lower respiratory infection

1056 (0.69)

109 (0.69)

0.19 [-0.21, 0.58]

Alcoholic liver disease

1063 (0.70)

78 (0.60)

0.03 [-0.28, 0.34]

Hyperparathyroidism

1086 (0.70)

156 (0.93)

-0.09 [-0.45, 0.28]

Radiculopathy

1103 (0.77)

157 (0.95)

0.01 [-0.27, 0.28]

Corneal ulcer

1116 (0.72)

156 (0.91)

0.43 [-0.01, 0.87]

Spondyloarthritis

1158 (0.72)

147 (0.83)

-0.12 [-0.29, 0.06]

Other female pelvic inflammatory diseases

1195 (0.92)

194 (1.21)

0.05 [-0.33, 0.43]

Disorders of parathyroid gland

1211 (0.74)

180 (1.01)

0.02 [-0.36, 0.39]

Hypo-osmolality and hyponatraemia

1236 (0.79)

128 (0.78)

0.25 [-0.08, 0.57]

Preterm labour and delivery

1285 (0.80)

203 (0.98)

-0.16 [-0.49, 0.17]

DVT of lower extremities

1338 (0.84)

148 (0.85)

0.23 [-0.04, 0.50]

Benign paroxysmal vertigo

1382 (0.84)

219 (1.02)

-0.10 [-0.35, 0.15]

Fibroblastic disorders

1472 (0.92)

229 (1.14)

-0.03 [-0.31, 0.25]

Salpingitis and oophoritis

1486 (1.10)

226 (1.35)

0.27 [-0.07, 0.60]

Acute pancreatitis

1644 (1.00)

213 (1.21)

0.30 [-0.04, 0.63]

Other or unspecified ileus, impaction or obstruction

2809 (1.77)

309 (1.80)

0.31 [-0.16, 0.78]

Emotionally unstable personality disorder

667 (0.53)

110 (0.74)

0.10 [-0.15, 0.36]

Other disorders of the musculoskeletal system and connective tissue

677 (0.54)

104 (0.69)

-0.01 [-0.35, 0.33]

Inflammatory disease of uterus

685 (0.55)

110 (0.71)

0.00 [-0.35, 0.36]

Interstitial lung disease endpoints

692 (0.57)

134 (0.90)

-0.04 [-0.37, 0.29]

Endometriosis of pelvic peritoneum

698 (0.55)

131 (0.78)

-0.01 [-0.23, 0.20]

Subarachnoid haemorrhage

724 (0.55)

100 (0.75)

0.03 [-0.30, 0.36]

Generalized anxiety disorder

731 (0.53)

108 (0.66)

-0.22 [-0.51, 0.07]

Other diseases of lip and oral mucosa

742 (0.59)

150 (0.93)

0.14 [-0.23, 0.51]

Phobic anxiety disorders

759 (0.49)

115 (0.74)

0.03 [-0.24, 0.30]

Other disorders of skin and subcutaneous tissue, not elsewhere classified

767 (0.59)

121 (0.80)

0.35 [-0.09, 0.78]

Pain and other conditions associated with female genital organs and menstrual cycle

785 (0.54)

154 (0.79)

0.03 [-0.24, 0.30]

Somatoform disorder

800 (0.60)

152 (0.93)

0.07 [-0.26, 0.39]

Chronic pancreatitis

821 (0.66)

117 (0.84)

0.37 [-0.01, 0.74]

Benign neoplasm: Rectum

842 (0.70)

177 (1.11)

-0.06 [-0.41, 0.28]

Chondropathies

869 (0.61)

145 (0.91)

0.00 [-0.33, 0.34]

Migraine with aura

885 (0.57)

176 (0.83)

0.03 [-0.19, 0.26]

Cardiomyopathy (excluding other)

890 (0.69)

121 (0.83)

-0.04 [-0.29, 0.21]

Acute and subacute iridocyclitis

924 (0.62)

142 (0.80)

-0.06 [-0.31, 0.19]

Zoster [herpes zoster]

940 (0.66)

159 (0.97)

-0.05 [-0.68, 0.57]

Other extrapyramidal and movement disorders in other diseases

949 (0.67)

207 (1.12)

0.25 [-0.06, 0.55]

Subjective visual disturbances

960 (0.67)

201 (1.02)

-0.20 [-0.56, 0.15]

IBD patients in KELA-register

980 (0.67)

196 (0.97)

Continuous positive airway pressure

1008 (0.69)

206 (1.10)

0.08 [-0.19, 0.34]

Palmar fascial fibromatosis [Dupuytren]

1028 (0.76)

139 (0.87)

0.05 [-0.21, 0.31]

Familial hypercholesterolemia

1041 (0.78)

147 (0.93)

0.13 [-0.23, 0.49]

Glomerular diseases

1056 (0.76)

192 (1.15)

0.05 [-0.33, 0.42]

Endometriosis ASRM stages 3,4

1062 (0.70)

188 (0.97)

-0.05 [-0.25, 0.14]

Nasal polyp

1083 (0.76)

188 (1.06)

0.06 [-0.13, 0.25]

Intestinal adhesions without obstruction

1102 (1.03)

124 (1.00)

0.03 [-0.54, 0.59]

Ganglion

1110 (0.73)

178 (0.91)

-0.11 [-0.43, 0.21]

Other disorders of teeth and supporting structures

1115 (0.75)

185 (0.98)

0.28 [-0.25, 0.80]

Postpartum haemorrhage

1150 (0.70)

176 (0.83)

Intracerebral haemorrhage

1193 (0.74)

123 (0.86)

0.10 [-0.27, 0.46]

Cardiomyopathy

1209 (0.82)

172 (1.02)

0.10 [-0.16, 0.36]

Other bacterial intestinal infections

1233 (0.82)

180 (1.06)

-0.54 [-1.10, 0.01]

Cholecystitis

1283 (0.89)

134 (0.89)

0.59 [0.16, 1.02]

Phlebitis and thrombophlebitis (not including DVT)

1319 (0.85)

196 (1.03)

0.06 [-0.19, 0.32]

Schizophrenia

1374 (0.90)

191 (1.16)

0.13 [-0.16, 0.42]

Primary coxarthrosis, bilateral

1463 (0.88)

254 (1.21)

0.10 [-0.10, 0.30]

Malignant neoplasm of colon

1616 (1.19)

209 (1.40)

Ventral hernia

2611 (1.63)

384 (1.97)

0.15 [-0.11, 0.41]

Other gastritis (incl. Duodenitis)

1535 (0.92)

213 (1.10)

0.10 [-0.31, 0.50]

Long labour

1187 (0.71)

184 (0.89)

0.04 [-0.26, 0.34]

Seropositive rheumatoid arthritis, wide

1432 (0.85)

231 (1.09)

0.13 [-0.08, 0.33]

Hyperkinetic disorders

518 (0.31)

55 (0.39)

Complications predominantly related to the puerperium

1329 (0.79)

218 (1.03)

-0.27 [-0.74, 0.19]

All influenza (not pneumonia)

1177 (0.70)

160 (1.00)

0.15 [-0.29, 0.58]

Irritable bowel syndrome

1393 (0.82)

235 (1.04)

-0.04 [-0.33, 0.24]

Cellulitis

1380 (0.82)

205 (1.09)

0.03 [-0.38, 0.44]

Gestational [pregnancy-induced] hypertension

1208 (0.71)

205 (0.96)

0.07 [-0.16, 0.29]

Melanocytic naevi

1227 (0.72)

248 (1.09)

-0.13 [-0.41, 0.15]

Primary_lymphoid and hematopoietic malignant neoplasms

1492 (0.87)

219 (1.14)

Diabetic retinopathy

1769 (1.03)

308 (1.31)

0.15 [-0.20, 0.49]

Tooth eruption problems

614 (0.35)

81 (0.51)

-0.82 [-1.88, 0.25]

Early lumbar disc prolapse, operated

1493 (0.86)

84 (0.61)

0.08 [-0.14, 0.30]

Focal epilepsy

1426 (0.81)

148 (0.80)

0.41 [-0.05, 0.87]

Umbilical hernia

1997 (1.13)

301 (1.42)

-0.02 [-0.22, 0.18]

Nontoxic goitre/thyroid nodule

1457 (0.82)

248 (1.12)

0.12 [-0.06, 0.29]

Dentinal caries

1341 (0.76)

218 (1.09)

Labour and delivery complicated by fetal stress [distress]

1121 (0.63)

170 (0.78)

-0.01 [-0.38, 0.35]

Chronic rhinitis, nasopharyngitis and pharyngitis

1404 (0.79)

286 (1.16)

-0.02 [-0.26, 0.21]

Other noninflammatory disorders of uterus, except cervix

1278 (0.72)

199 (0.96)

0.13 [-0.11, 0.37]

Paroxysmal tachycardia

1620 (0.91)

288 (1.30)

0.06 [-0.21, 0.33]

Haemorrhoids and perianal venous thrombosis

1737 (0.97)

293 (1.27)

-0.01 [-0.23, 0.22]

Haemorrhage in early pregnancy

1446 (0.81)

219 (0.97)

-0.09 [-0.38, 0.19]

Non-allergic asthma (mode)

1121 (0.62)

182 (0.95)

Actinic keratosis

1664 (0.92)

338 (1.36)

-0.36 [-0.59, -0.14]

Other and unspecified disorders of vitreous body

1705 (0.94)

331 (1.25)

0.08 [-0.17, 0.33]

Calcific aortic valvular stenosis, operated

1649 (0.91)

244 (1.12)

0.04 [-0.16, 0.24]

Obesity, other/unspecified

1832 (1.00)

333 (1.32)

0.15 [-0.03, 0.32]

Impacted teeth

806 (0.43)

99 (0.53)

0.14 [-0.25, 0.52]

Conduction disorders

1808 (0.97)

283 (1.21)

0.08 [-0.18, 0.35]

Other diseases of anus and rectum

1794 (0.96)

288 (1.24)

0.23 [-0.11, 0.57]

Diaphragmatic hernia

1954 (1.04)

332 (1.31)

0.07 [-0.16, 0.30]

severe traumatic brain injury, does not include concussion

1722 (0.91)

172 (0.92)

0.19 [-0.14, 0.52]

Gout

2108 (1.12)

280 (1.30)

-0.10 [-0.29, 0.10]

Calculus of kidney and ureter

2018 (1.07)

314 (1.39)

0.04 [-0.20, 0.28]

Crossbite

311 (0.16)

20 (0.16)

-0.19 [-0.58, 0.21]

Pollen allergy

780 (0.41)

132 (0.72)

-0.06 [-0.30, 0.17]

1674 (0.88)

210 (0.96)

-0.16 [-0.34, 0.02]

1456 (0.76)

54 (0.45)

0.38 [-0.05, 0.82]

Procreative management

1441 (0.75)

297 (1.08)

-0.25 [-0.73, 0.22]

Deforming dorsopathies

1509 (0.79)

243 (1.06)

0.19 [-0.03, 0.42]

Paralytic ileus and intestinal obstruction

3996 (2.10)

451 (2.17)

0.27 [-0.23, 0.77]

Fracture of skull and facial bones

1502 (0.78)

172 (0.90)

-0.32 [-0.69, 0.05]

Retinal detachments and breaks

2047 (1.05)

314 (1.27)

0.17 [-0.10, 0.45]

Later onset COPD

2292 (1.17)

327 (1.44)

0.29 [0.05, 0.53]

Fracture of rib(s), sternum and thoracic spine

2013 (1.02)

253 (1.13)

0.08 [-0.18, 0.35]

Female infertility

1918 (0.97)

338 (1.21)

0.18 [-0.09, 0.45]

Other hearing loss

1913 (0.97)

216 (0.99)

0.24 [-0.14, 0.62]

Nontraumatic intracranial haemmorrhage

1774 (0.88)

203 (1.14)

0.09 [-0.21, 0.39]

Hyperlipidaemia, other/unspecified

2436 (1.20)

408 (1.51)

0.02 [-0.27, 0.30]

Other noninfective gastroenteritis and colitis

1643 (0.81)

217 (1.06)

0.00 [-0.35, 0.35]

Cervical disc disorders

2246 (1.10)

384 (1.41)

0.10 [-0.11, 0.30]

Redundant prepuce, phimosis and paraphimosis

1721 (0.84)

178 (0.94)

-0.21 [-0.47, 0.05]

Diseases of external ear

1763 (0.86)

295 (1.20)

0.05 [-0.26, 0.36]

Other abnormal products of conception

1746 (0.85)

272 (1.04)

-0.08 [-0.49, 0.34]

Gestational diabetes (for exclusion)

1624 (0.79)

275 (0.97)

0.13 [-0.11, 0.37]

Urticaria

1541 (0.74)

267 (1.14)

0.18 [-0.08, 0.44]

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1401 (0.67)

244 (0.87)

0.00 [-0.31, 0.32]

All influenza

1812 (0.87)

256 (1.22)

0.10 [-0.23, 0.43]

Malignant neoplasm of prostate

2492 (1.19)

428 (1.51)

Disorders of vitreous body

2268 (1.08)

440 (1.43)

0.10 [-0.16, 0.37]

Other benign neoplasms of skin

2113 (1.01)

331 (1.25)

-0.72 [-1.27, -0.16]

Disorders of lacrimal system

1933 (0.92)

345 (1.20)

-0.06 [-0.37, 0.24]

Gastroduodenal ulcer

2389 (1.14)

257 (1.20)

0.30 [-0.04, 0.64]

Dementia in Alzheimer disease

1920 (0.91)

132 (0.77)

-0.16 [-0.50, 0.18]

Basal cell carcinoma, including avohilmo

2299 (1.09)

552 (1.52)

Diseases of pulp and periapical tissues

2171 (1.02)

364 (1.36)

Retention of urine

2495 (1.18)

327 (1.31)

0.07 [-0.24, 0.39]

Benign neoplasm: Colon

3005 (1.41)

611 (1.86)

0.15 [-0.09, 0.39]

Extrapyramidal and movement disorders

2213 (1.02)

362 (1.42)

0.23 [-0.08, 0.54]

Other disorders of fluid, electrolyte and acid-base balance

2335 (1.07)

279 (1.22)

0.35 [0.01, 0.70]

Malignant neoplasm of breast

1963 (0.89)

418 (1.27)

Suicide or other Intentional self-harm

1869 (0.85)

252 (1.20)

-0.04 [-0.26, 0.18]

Obesity due to excess calories

2405 (1.09)

502 (1.57)

0.19 [0.03, 0.36]

Other abnormal uterine and vaginal bleeding

1966 (0.88)

226 (0.99)

0.07 [-0.23, 0.37]

Conjunctivitis (acute, non atopic)

1524 (0.68)

197 (0.88)

-0.13 [-0.50, 0.23]

Coxarthrosis, primary, with hip surgery

2561 (1.14)

420 (1.41)

0.07 [-0.11, 0.26]

Other diseases of the digestive system

2490 (1.11)

326 (1.37)

0.20 [-0.15, 0.55]

Keratitis

2233 (0.98)

321 (1.23)

0.28 [-0.09, 0.65]

Disorders of psychological development

793 (0.35)

62 (0.41)

0.10 [-0.40, 0.60]

Embedded and impacted teeth

1234 (0.53)

159 (0.69)

-0.17 [-0.54, 0.20]

Otitis media, unspecified

665 (0.29)

72 (0.49)

0.25 [-0.18, 0.68]

Asthma-related pneumonia

2365 (1.02)

372 (1.41)

0.11 [-0.10, 0.32]

Disorders of vestibular function (Vertigo)

2508 (1.08)

384 (1.25)

0.01 [-0.23, 0.26]

Disorders of breast

2339 (0.98)

424 (1.28)

-0.12 [-0.33, 0.09]

Irregular menses

2353 (0.99)

441 (1.29)

0.07 [-0.19, 0.34]

Other reaction to severe stress, and adjustment disorders

2354 (0.97)

362 (1.27)

-0.08 [-0.35, 0.18]

Spinal stenosis

3031 (1.24)

531 (1.50)

-0.02 [-0.18, 0.14]

Other/unspecified dorsalgia

2669 (1.08)

363 (1.26)

0.07 [-0.18, 0.31]

Deep bite

637 (0.25)

76 (0.54)

-0.04 [-0.36, 0.28]

Other septicaemia

3154 (1.27)

437 (1.65)

0.44 [0.01, 0.87]

Glucosamine medication

2914 (1.16)

453 (1.40)

-0.10 [-0.33, 0.12]

Schizophrenia or delusion

2890 (1.14)

343 (1.37)

Spontaneous abortion

2553 (1.00)

395 (1.20)

-0.16 [-0.54, 0.21]

Childhood asthma (age<16)

886 (0.35)

82 (0.46)

Other and unspecified anaemias

2994 (1.17)

423 (1.49)

0.13 [-0.22, 0.48]

Spondylosis

3329 (1.29)

578 (1.57)

0.08 [-0.11, 0.27]

Acute alcohol intoxication

2797 (1.07)

244 (1.15)

0.19 [-0.02, 0.39]

Reimbursement for rheumatic diseases

2936 (1.10)

532 (1.36)

-0.00 [-0.17, 0.16]

Other arthrosis

3452 (1.29)

651 (1.68)

-0.17 [-0.35, 0.02]

Sequelae of cerebrovascular disease

3269 (1.22)

356 (1.41)

-0.01 [-0.31, 0.29]

Disorders of other endocrine glands

2425 (0.90)

389 (1.26)

-0.03 [-0.43, 0.38]

Crowding of teeth, including avohilmo

534 (0.19)

41 (0.30)

-0.18 [-0.64, 0.28]

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1186 (0.42)

113 (0.58)

0.13 [-0.17, 0.43]

Disorders of synovium and tendon

3167 (1.13)

541 (1.41)

0.02 [-0.21, 0.25]

Coronary revascularization (ANGIO or CABG)

3909 (1.40)

639 (1.68)

0.03 [-0.14, 0.19]

149

Obesity

3675 (1.28)

0.17 [0.02, 0.33]

Fracture of shoulder and upper arm

2700 (0.93)

304 (1.16)

0.00 [-0.26, 0.27]

Other cataract

3517 (1.21)

495 (1.41)

0.10 [-0.13, 0.32]

Diseases of the digestive system

3631 (1.24)

485 (1.54)

0.17 [-0.11, 0.45]

Valvular heart disease excluding rheumatic fever

3701 (1.24)

607 (1.59)

0.13 [-0.11, 0.37]

Childhood allergy (age < 16)

710 (0.23)

59 (0.34)

-0.09 [-0.37, 0.19]

Asthma-related acute respiratory infections

2613 (0.86)

408 (1.26)

0.05 [-0.14, 0.25]

Meniscus derangement

4394 (1.42)

721 (1.75)

-0.16 [-0.35, 0.04]

Transient ischemic attack

4099 (1.31)

502 (1.47)

-0.07 [-0.33, 0.18]

Dermatitis

3563 (1.14)

595 (1.46)

0.11 [-0.16, 0.38]

Osteopathies and chondropathies

3685 (1.15)

572 (1.57)

0.09 [-0.15, 0.34]

Allergic conjunctivitis

2867 (0.89)

527 (1.33)

-0.12 [-0.31, 0.08]

Other retinal disorders

4165 (1.30)

643 (1.53)

-0.00 [-0.28, 0.28]

Atopic dermatitis

1894 (0.59)

464 (1.13)

-0.03 [-0.21, 0.15]

Gastro-oesophageal reflux disease

4099 (1.26)

782 (1.71)

-0.05 [-0.27, 0.16]

Asthma, unspecified (mode)

3686 (1.13)

588 (1.46)

0.14 [-0.04, 0.32]

Bacterial pneumoniae

4122 (1.26)

459 (1.48)

0.23 [-0.10, 0.56]

Erysipelas

4547 (1.37)

599 (1.61)

0.10 [-0.10, 0.30]

Other disorders of skin and subcutaneous tissue

4207 (1.25)

724 (1.64)

0.11 [-0.19, 0.41]

Alcohol use disorder, ICD-based

4477 (1.30)

466 (1.56)

0.08 [-0.10, 0.25]

Diseases of arteries, arterioles and capillaries (FINNGEN)

4988 (1.42)

667 (1.71)

0.21 [0.02, 0.40]

Fracture of lower leg, including ankle

4346 (1.18)

567 (1.51)

-0.14 [-0.37, 0.09]

Alzheimer’s disease, wide definition

4422 (1.18)

174 (0.86)

0.03 [-0.30, 0.36]

Asthma-related infections

3863 (1.02)

588 (1.44)

0.06 [-0.12, 0.24]

Acute suppurative otitis media

1723 (0.44)

172 (0.73)

0.18 [-0.16, 0.51]

Shoulder lesions

5807 (1.49)

964 (1.69)

-0.03 [-0.22, 0.16]

Fracture of forearm

3722 (0.95)

489 (1.31)

-0.13 [-0.34, 0.09]

Other maternal disorders predominantly related to pregnancy

4378 (1.11)

697 (1.28)

0.02 [-0.22, 0.27]

Low back pain

5144 (1.29)

800 (1.52)

0.15 [-0.04, 0.33]

Pain in limb

5108 (1.25)

922 (1.66)

0.04 [-0.18, 0.26]

Polycystic ovarian syndrome, consortium definition

4782 (1.16)

746 (1.42)

0.06 [-0.15, 0.27]

Polyarthropathies

5725 (1.39)

858 (1.61)

-0.00 [-0.18, 0.17]

Acute appendicitis

84045 (24.83)

9164 (22.89)

0.76 [0.56, 0.96]*

Excessive, frequent and irregular menstruation

5380 (1.26)

911 (1.51)

0.05 [-0.12, 0.23]

Internal derangement of knee

6390 (1.48)

386 (1.31)

0.06 [-0.15, 0.27]

Spondylopathies

6551 (1.47)

1053 (1.70)

-0.03 [-0.18, 0.12]

Tonsillectomy and adenotomy

2509 (0.55)

477 (0.97)

0.10 [-0.10, 0.30]

Heart failure and antihypertensive medication

6830 (1.45)

792 (1.75)

Disorders of lipoprotein metabolism and other lipidaemias

7753 (1.63)

1296 (1.88)

0.03 [-0.17, 0.23]

Substance abuse

6507 (1.36)

686 (1.70)

Medical abortion

5996 (1.22)

863 (1.47)

-0.04 [-0.22, 0.14]

Dental caries 2 and operation codes, only avohilmo

3415 (0.69)

676 (1.22)

Hypothyroidism, strict autoimmune

6663 (1.34)

1035 (1.60)

0.15 [-0.03, 0.32]

235

Inguinal hernia

7997 (1.61)

958 (1.82)

-0.04 [-0.19, 0.11]

120

Dementia, including avohilmo

6289 (1.25)

485 (1.34)

0.06 [-0.20, 0.32]

Cholelithiasis

8785 (1.70)

1107 (1.86)

0.23 [0.05, 0.42]

114

Gonarthrosis

8245 (1.57)

1304 (1.84)

-0.02 [-0.17, 0.13]

111

Diarrhoea and gastroenteritis of presumed infectious origin

7387 (1.39)

880 (1.77)

0.20 [-0.07, 0.47]

Constipation

7173 (1.35)

1045 (1.69)

0.08 [-0.13, 0.29]

Nerve, nerve root and plexus disorders

8188 (1.54)

1340 (1.79)

0.08 [-0.09, 0.26]

Asthma (only as main-diagnosis)

5669 (1.05)

833 (1.46)

Other soft tissue disorders, not elsewhere classified

7084 (1.32)

1239 (1.69)

0.04 [-0.15, 0.23]

Other disorders of ear

8181 (1.41)

1214 (1.66)

-0.09 [-0.27, 0.09]

Cystitis

6883 (1.16)

1040 (1.44)

0.05 [-0.20, 0.31]

Anxiety disorders

7097 (1.16)

988 (1.47)

Renal tubulo-interstitial diseases

8895 (1.46)

1126 (1.78)

0.15 [-0.11, 0.41]

Other bacterial diseases

10136 (1.60)

1393 (1.96)

0.25 [0.01, 0.49]

Autoimmune diseases excluding thyroid diseases, strict definition

9165 (1.43)

1302 (1.65)

Disorders of the thyroid gland

9064 (1.41)

1471 (1.70)

0.24 [0.05, 0.42]

172

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

10066 (1.49)

1309 (1.68)

0.12 [-0.04, 0.27]

193

Mood [affective] disorders

8898 (1.31)

1221 (1.60)

0.02 [-0.14, 0.18]

Diseases of oesophagus, stomach and duodenum

10790 (1.55)

1612 (1.86)

0.07 [-0.14, 0.27]

Depression or dysthymia

8780 (1.23)

1255 (1.50)

0.01 [-0.14, 0.16]

Chronic diseases of tonsils and adenoids

7147 (0.99)

916 (1.32)

0.01 [-0.16, 0.19]

Diseases of middle ear and mastoid

4517 (0.62)

498 (1.10)

0.14 [-0.10, 0.38]

Dorsalgia

10854 (1.47)

1635 (1.73)

0.06 [-0.10, 0.22]

Acute upper respiratory infections of multiple and unspecified sites

8011 (1.02)

924 (1.48)

0.14 [-0.10, 0.38]

Arthrosis

13708 (1.65)

2132 (1.92)

-0.00 [-0.16, 0.16]

104

Senile cataract

12559 (1.49)

1644 (1.75)

0.03 [-0.14, 0.21]

Other diseases of urinary system

11590 (1.29)

1725 (1.59)

0.06 [-0.18, 0.29]

Other dorsopathies, not elsewhere classified

13971 (1.53)

2197 (1.80)

0.04 [-0.12, 0.19]

Other joint disorders

13691 (1.48)

2182 (1.80)

0.02 [-0.15, 0.18]

Other diseases of intestines

17249 (1.84)

2481 (2.14)

0.03 [-0.16, 0.23]

All pneumoniae

14776 (1.47)

1652 (1.86)

0.13 [-0.11, 0.38]

Artrosis, including avohilmo

17644 (1.69)

2923 (1.99)

0.01 [-0.15, 0.17]

108

Ischaemic heart disease, wide definition

15912 (1.46)

1751 (1.86)

0.13 [-0.06, 0.31]

131

Dental pulpitis 1, only avohilmo

15998 (1.43)

2328 (1.75)

Paracetamol of NSAID medication

63741 (1.57)

8169 (1.84)

0.04 [-0.11, 0.20]

Acute appendicitis, with complications

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints